DEVELOPMENT DOCUMENT FOR PROPOSED EFFLUENT LIMITATIONS
GUIDELINES, NEW SOURCE PERFORMANCE STANDARDS AND PRETREATMENT STANDARDS
FOR THE
PHARMACEUTICAL MANUFACTURING
POINT SOURCE CATEGORY
ANNE GORSUCH
ADMINISTRATOR
FREDERIC A. EIDSNESS, JR.
ASSISTANT ADMINISTRATOR
FOR WATER
STEVEN SCHATZOW
DIRECTOR
OFFICE OF WATER REGULATIONS AND STANDARDS
JEFFERY D. DENIT
DIRECTOR, EFFLUENT GUIDELINES DIVISION
DEVEREAUX BARNES
ACTING CHIEF, ORGANIC CHEMICALS BRANCH
Frank H. Hund, Ph.D.
Daniel S. Lent
Joseph S. Vital is
Project Officers
November 1982
Effluent Guidelines Division
Office of Water
U.S. Environmental Protection Agency
Washington, D.C. 20460
-------
ABSTRACT
This document presents the findings of a study of the
Pharmaceutical Manufacturing Point Source Category for the
purpose of developing effluent limitations guidelines for
existing and new point sources and to establish pretreatment
standards for existing and new dischargers to publicly owned
treatment works to implement Sections 301, 304, 306, 307, 308,
and 501 of the Clean Water act (the Federal Water Pollution
Control Act Amendments of 1972, 33 USC 1251 et. seq., as amended
by the Clean Water Act of 1977, P.L. 95-217 (the
document was also prepared in response to
Agreement in Natural Resources Defense Council,
)). This
Settlement
v. Train,
8 ERG 2120 (D.D.C. 1976), modified 12 ERC 1833 (D.D.C. 1979).
The information presented supports regulations proposed in
February 1982, to improve and restate standards (originally
promulgated in 1976) for best practicable control technology
currently available (BPT) and to institute new source performance
standards (NSPS) and pretreatment standards for new and existing
sources (PSNS and PSES) for the Pharmaceutical Manufacturing
Point Source Category. The report presents and discusses data
gathering efforts, consideration of subcategorization,
characterization of wastewaters, selection of pollutant
parameters, review of treatment technology, cost and nonwater
quality considerations and development of regulatory options and
effluent limitations.
-------
TABLE OF CONTENTS
Section
Title
EXECUTIVE SUMMARY
II
III
IV
VI
A. Summary and Conclusions
B. Effluent Standards
C. Impact of Regulation
INTRODUCTION
A. Purpose and Legal Authority
B. Prior EPA Regulations
C. Scope of this Rulemaking
n. Definition of the Industry
E. Summary of Methodology
F. Data and Information Gathering Program
G. Processing of Data and Information
DESCRIPTION OF THE INDUSTRY
A. Introduction
B. Detailed Industry Profile
C. Manufacturing Processes
D. Raw Materials and Products
E. Current Direct Discharge Performance
F. Comparison of Current Permits with 1976 BPT
INDUSTRY SUBCATEGORIZATION
A. Introduction
B. Basis for Subcategorization
C. Selected Subcategories
D. Subcategory Characteristics
E. Decision Not to Subcategorize for Regulatory
Purposes
WASTE CHARACTERIZATION
A. Introduction
B. Traditional Pollutants
C. Priority Pollutants
D. Wastewater Flow Characteristics
E. Precision and Accuracy Program
SELECTION OF POLLUTANT PARAMETERS
A. Introduction
B. Traditional Pollutants
C. Priority Pollutants
Page
1
1
2
3
6
6
8
8
8
11
13
25
32
32
32
33
42
43
44
63
63
63
64
65
66
68
68
68
73
78
79
98
98
98
101
-------
VII
CONTROL AND TREATMENT TECHNOLOGY
120
A. Introduction
B. In-Plant Source Control
C. In-Plant Treatment
D. End-of-Pipe Treatment '.
E. Ultimate Disposal
VIII COST, ENERGY, AND NON-WATER OUALITY ASPECTS
i
A. Introduction ;
B. Cost Development '.
C. Analytical Costs for Monitoring:
Priority Pollutants ;
0. Energy Considerations
E. Non-Water Ouality Aspects !
IX
XI
XII
XIII
XIV
A. Description of Data
B. Definition and Use of Variability Factors.
A. Summary
B. Identification of BPT \
BEST CONVENTIONAL POLLUTANT CONTROL TECHNOLOGY
CURRENTLY
AVAILABLE (BCT)
A. Summary
B. Identification of BCT
BEST AVAILABLE TECHNOLOGY ECONOMICALLY ACHIEVABLE
(BAT) ',
A. Summary
B. Identification of BAT ;
NEW SOURCE PERFORMANCE STANDARDS ,
• A. Summary
B. Identification of NSPS ;
A. Summary
B. Identification of Pretreatment Standards
120
120
122
135
142
156
157
172
173
174
ANALYSIS OF LONG TERM DATA FOR POLLUTANTS OF CONCERN 232
232
236
BEST PRACTICABLE TECHNOLOGY CURRENTLY AVAILABLE (BPT) 246
246
247
254
254
254
267
267
268
272
272
272
PRETREATMEMT STANDARDS FOR NEW AND EXISTING SOURCES 275
275
276
-------
A
B
r
XV REFERENCES ^..^ *> 280
XVI ACKNOWLEDGEMENTS 294
XVIT ABBREVIATIONS * SYMBOLS 291
XVIII APPENDICES
Glossary /\_1
308 Portfolio for Pharmaceutical Manufacturing B-l
Pharmaceutical Manufacturing Plants in the
Original 308 Data Base C-l
\
n Supplemental 308 Portfolio for the Pharmaceutical
Manufacturing Industry 0-1
E Pharmaceutical Manufacturing Plants in the
Supplemental 308 Data Base E-l
F Pharmaceutical Industry General Plant Information
(308 Data) and Probable Future Treatment F-l
G Screening/Verification Plant Oata G-l
H Priority Pollutant Occurrence as Reported in Original
30R Portfolio nata H-l
I 308 Portfolio (Traditional Pollutant Data) i-i
.1 308 Portfolio (Wastewater Flow Data) j_i
K RSKERL Data K-l
L Current In-Place Treatment Technologies L-l
M Pharmaceutical Industry Wastewater Discharge Methods M-l
N Cost of Treatment and Control Systems N-l
N-l Approach
N-2 Capital Cost Indices
0 Screening/Verification Plant Descriptions 0-1
and Samples Points .
P English Units to Metric Units Conversion Table P-l
iii
-------
TABLES ;
Number Title Page
II-l Summary of 308 Portfolio Mailing , 27
II-?. Characteristics of the 26 Plants Selected
for Screening , . . 28
II-3 Characteristics of the 5 Plants Selected
for Verification 29
II-4 Characteristics of Plants Selected for
Long Term Study ! ' ^
II-5 Comparison of Characteristics of Screening and
Long Term Plants with Those of the Total Pharma-
ceutical Manufacturing Population 31
III-l Pharmaceutical Industry Geographical Distribution 45
III-?. Subcategory Breakdown 48
III-3 Production Operation Breakdown 49
III-4 Direct Dischargers: Comparison of Plant Per-
formance vs. 1976 BPT Percent Removal Design
Criteria • ; • 50
111-5 Direct Dischargers: Comparison of Dlant Performance
vs. Proposed BCT and BAT Concentration Design
III-6 Ranking of Direct Dischargers by Effluent
BOD Concentration [ ' 54
III-7 Ranking of Direct Dischargers by Effluent
COD Concentration 56
i •
III-8 Ranking of Direct Dischargers by Effluent
TSS Concentration ; 57
III-9 Ranking of Direct Dischargers by BOn:
Percent Removal ' 59
111-10 Ranking of Direct Dischargers by COD
Percent Removal 60
III-ll Comparison of Current Permits with 1976 BPT 61
V-l Summary of Long Term Data ; 81
IV
-------An error occurred while trying to OCR this image.
-------
VTt-2
Estimated Achievable Long-Term Average Effluent
Vt I -3
VII-4
VTII-1
VIII-?,
VIII-3
VIII-A
vm-5
VIII-6
VIII-7
VIII-8
vin-9
viii-in
VIII-11
VIII-12
VIII-13
VIII-14
VIII-15
Concentrations for the Priority Pollutant Metals
Summary of End-of-Pipe Treatment Processes
Summary of Wastewater Discharges
Raw Waste Loads for Subcategory Rase Cases:
Traditional Pollutants
Typical Priority Pollutant Concentrations
Used for Base Case In-Plant Costs
Cyanide Destruction: Equipment Cost Rases and
Energy Requirements
Cyanide Destruction: Capital Costs
Cyanide Destruction: Total Annual Costs
Variation with Flow
Cyanide Destruction: Total Annual Costs
Variation with Influent CN Concentration
Chromium Reduction: Equipment Cost Rases
and Energy Requirements
Chromium Reduction: Capital Costs
Chromium Reduction: Total Annual Costs
Variation with Flow
Chromium Reduction: Total Annual Costs Variation
with Influent Concentration
Chromium Reduction: Total Annual Costs
Variation with Effluent Concentration
Metal Precipitation: Equipment Cost Rases
and Energy Requirements
Metal Precipitation: Capital Costs
Metal Precipitation: Total Annual Costs
Variation with Flow
Metal Precipitation: Total Annual Costs
Variation with Influent Concentration
vi
144
145
146
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
-------
VII1-16 Metal Precipitation: Total Annual Costs
Variation with Effluent Concentration 192
VIII-17 Steam Stripping Cost Data 193
i
VIII-18 Activated Sludge System: Equipment Cost Bases
and Energy Requirements 194
VII1-19 Activated Sludge System: Capital Costs 195
VII1-20 Activated Sludge System: Total Annual Costs 196
VIII-21 Rotating Biological Contactor (RBC) System: Equip-
ment Costs Bases and Energy Requirements 197
VIII-22 Rotating Biological Contactor (RBC) System: Capital
and Total Annual Costs 198
VIII-23 Polishing Pond: Cost Bases 199
VIII-24 Polishing Pond: Capital and Total Annual
Costs 200
VII1-25 Activated Sludge System with Filtration: Equip-
ment Costs Bases and Energy Requirements 201
VIII-26 Activated Sludge System with Filtration:
Capital Costs 202
VIII-27 Activated Sludge system with Filtration: Total
Annual Costs 203
VIII-28 Rotating Biological Contactor (RBC) System with
Filtration: Equipment Costs Bases and
Energy Requirements 204
VIII-29 Rotating Biological Contactor System with
Filtration: Capital and Total Annual Costs 205
VII1-30 Wastewater Hauling/Treatment Costs 206
VIII-31 Analytical Costs for Monitoring Priority
Pollutants 207
IX-1 Plant Identifiers and Subcategories in Pharma-
ceutical Long Term Data Base 242
IX-2 Daily Variability Factors 243
IX-3 30-Day Variability Factors 244
VTI
-------
IX-4 Long Term Average Concentrations, Variability
Factors, and Limitations 245
X-l BPT Limitations 247
X-2 Effluent TSS Performance of Direct Dischargers
(308 and Long-Term Data) ; 252
X-3 Subcategory Breakdown of TSS Group Plants Compared
to all Direct Dischargers 253
i
XI-1 BCT Limitations ; 254
XI-2 Incremental BPT and BCT Annual Costs and Removals 265
XI-3 BCT Cost Test Criteria 266
XII-1 BAT Limitations 267
XIII-1 New Source Performance Standards 272
XIV-1 Pretreatment Standards for New and Existing
Sources : 275
XIV-2 Comparison of POTW and Direct Discharger
Removal Rates for Solvents 279
vi i i
-------
FIGURES
Number Title
III-l Geographic nistribution
VII-1 Cyanide Destruction System - ChTorination
VII-2 Cyanide Destruction System - Alkaline
Hydrolysis
Vll-3 Chromium Reduction System
VII-4 Metals Removal System Alkaline Precipitation
VII-5 Steam Stripping Unit
Vll-fi Activated Carbon Adsorption Unit
VII-7 Examples of Augmented Biological Systems
VII-8 Typical Clarifier Configurations
VII-9 Filtration Unit
VII1-1 Activated Sludge Annual Treatment"Cost vs.
Wastewater Flow
VIII-?. Activated Sludge With Supplemental Treatment.
Annual Treatment Cost vs. Wastewater Flow
VII1-3 RBC System Annual Treatment Cost vs.
Wastewater Flow
VIH-/1 RBC System With Supplemental Treatment. Annual
Treatment Cost vs. Wastewater Flow
VII1-5 Polishing Pond Annual Treatment Cost vs. Waste-
water Flow
VIII-6 Cyanide Destruction Annual Treatment Cost vs.
Wastewater Flow
VIII-7 Cyanide Destruction Annual Treatment Cost vs.
Influent CN Concentration
VIII-8 Cyanide Destruction Unit Treatment Cost vs.
Wastewater Flow
Page
62
147
148
149
150
151
152
153
154
155
208
209
210
211
212
213
214
215
IX
-------
VIII-9 Cyanide Destruction Unit Treatment Cost vs.
Influent CN Concentration
VIII-in Chromium Reduction Annual Treatment Cost vs.
Wastewater Flow
VIII-11 Chromium Reduction Unit Treatment Cost vs.
Wastewater Flow
VII1-12 Chromium Reduction Annual Treatment Cost vs.
Influent Cr Concentration
VII1-13 Chromium Reduction Unit Treatment Cost vs.
Influent Cr Concentration '
VII1-14 Chromium Reduction Annual Treatment Cost vs.
Effluent Cr Concentration
VIII-15 Chromium Reduction Unit Treatment Cost vs.
Effluent Cr Concentration
VIII-16 Metals Precipitation Annual Treatment Cost vs.
Wastewater Flow
VIII-17 Metals Precipitation Unit Treatment Cost vs.
Wastewater Flow
VIII-18 Metals Precipitation Annual Treatment Cost vs.
Influent Metals Concentration
VIII-19 Metals Precipitation Unit Treatment Cost vs.
Influent Concentration
VIII-20 Metals Precipitation Annual Treatment Cost vs.
Effluent Metals Concentration
VIII-21 Metals Precipitation Unit Treatment Cost vs..
Effluent Metals Concentration
VII1-22 Steam Stripping Annual Cost vs. Flow Rate and
Steam Cost
VIII-23 Steam Stripping Unit Cost vs. Flow Rate and
Steam Cost
VIII-24 Wastewater Hauling Costs vs. Wastewater Flow
216
217
218
219
220
221
222
223
224
225
226
227
22R
229
230
231
-------
SECTION I
EXECUTIVE SUMMARY
A. SUMMARY AND CONCLUSION
This document presents the technical data to support effluent
limitations for the pharmaceutical manufacturing point source
category as required by the Clean Water Act (The Act) and related
settlement agreements. It also presents the technologies to
achieve limitations as defined by an amended best practicable
control technology currently available (BPT), best available
technology economically achievable (BAT) and best conventional
pollutant control technology (BCT), and standards as defined by
new source performance standards (NSPS), and pretreatment
standards for new and existing sources (PSNS and PSES).
The focus of the effort in developing these limitations and
standards was a complex development program utilizing industry
data obtained under Section 308 of ' the Act, supplemented by
additional data collection programs for selected portions of the
industry.
The pharmaceutical manufacturing point source category
manufactureres biological products, medicinal chemicals,
botanical products and pharmaceutical products covered by
Standard Industrial Classification Code (SIC) Numbers 2831, 2833,
and 2834, and other commodities described within this report.
The industry is characterized by diversity of product, process,
plant size, and process stream complexity. Subcategories based
on process characteristics were defined for purposes of technical
evaluation. Although these subcategories were also considered
for regulatory purposes, such separation was not found to be
appropriate for this industry. This is largely because of the
predominance, particularly among larger plants, of multi-
subcategory operations as well as the diversity within each
defined subcategory.
Sections III through VIII of this document describe the technical
data and engineering analyses used to develop the regulatory
technology options. The rationales by which the Agency selected
the technology options for each of the proposed effluent
limitations are presented in Sections X through XIV. Effluent
limitations guidelines based on the application of BPT, BAT and
BCT are to be achieved by direct dischargers. New source
performance standards (NSPS) based on best available demonstrated
-------
technology are to be achieved by new facilities. Pretreatment
standards for both existing sources (PSES) and new sources (PSNS)
are to be achieved by indirect dischargers for those pollutants
which are incompatible with or not susceptible to treatment in a
publicly owned treatment works (POTW). These effluent
limitations and standards are required by Sections 301, 304, and
307 of the Clean Water Act of 1977 (P.L. 95-217).
B. EFFLUENT LIMITATIONS GUIDELINES
1. BPT Limitations
Proposed BPT limitations* are summarized below:
Parameter
TSS (mg/1)
Cyanide (»»g/l)
Maximum
30-Day Average
217
375
Daily
Maximum
643
The existing BPT limitations for BODS, • COD and pH remain
unchanged. However, alternative 30-day average maximum
concentrations are proposed for BODS and COD so that the existing
BPT limitations may not, in some cases, be more stringent than
the BCT and BAT concentration limitations. The 30-day
concentration limitations are equal to the proposed BODS and COD
limitations for BCT and BAT. In all cases, the less stringent of
the limitations will apply. The existing TSS limitations, which
apply to 3 out of 5 subcategories, will be replaced by a new
less Stringent TSS limitation" applicable to all 5 subcategories.
2. BAT limitations
Proposed BAT limitations are summarized below:
Parameter
Maximum
30-Day Average
Daily
Maximum
COD (mg/1)
Cyanide (//g/1)
570
375
1024
643
3. BCT limitations
Proposed BCT limitations are summarized below:
Parameter
BOD (mg/1)
TSS (mg/1)
Maximum
30-Day Average
113
110
Daily
Maximum
252
291
-------
4. NSPS limitations
Proposed NSPS limitations are summarized below:
Parameter
BODS (mg/1)
COD (mg/1)
TSS (mg/1)
Cyanide (i>g/l)
Maximum
30-Day Average
51
449
72
375
Daily
Maximum
126
853
195
643
5. PSES and PSNS
Proposed PSES and PSNS are summarized below:
Parameter 30 Day Average
Maximum
375
Daily
Maximum
643
Cyanide (ug/1)
C. IMPACT OF REGULATION ,
1. BPT Regulation
Proposed BPT effluent limitations for cyanide will prevent the
discharge of 17,000 Ibs of cyanide per year to surface waters.
The total annual and investment costs that may be incurred are
estimated to be $628,000 and $1,740,000, respectively. Increases
in energy consumption costs as a result of these limitations are
expected to be negligible when compared with the other wastewater
treatment energy costs of this proposed regulation. The
information used to develop these estimates was taken from 308
survey and sampling program results.
No overall decrease in the discharge of TSS is expected as a
result of the revised BPT TSS limitations. Although limitations
are being established for the first time for subcategory A and C
plants, any reduction of TSS achieved by these plants would be
offset by the relaxation of the TSS limitations for subcategory
B, D, and E plants. No implementation costs are attributable to
this revised limitation because the costs are either attributable
to compliance with the current BPT BOD5 and COD limitations or
are ..not necessary because this limitation can be met by
improvements in treatment system operation.
2. BCT Regulations
Proposed BCT effluent limitations will reduce the discharge of
BOD5. by an estimated 6,500 Ibs/day (1200 tons/yr) and TSS by
-------
4,425 Ibs/day (807 tons/yr). These values are based on the
available data for direct discharges as reported in 308 responses
and long term daily data submissions with adjustment estimates to
reflect all industry direct dischargers. Incremental sludge
generation due to the proposed limitations is estimated to be
6395 Ibs/day (1167 tons/yr). Sludge estimates are based on a
ratio of sludge to BOD removal of 0.3 and a sludge to TSS removal
ratio of 1.0.
Costs to implement BCT were estimated on a conservative basis at
$7.72 million for total annual costs and $19.4 million for
investment costs (1980 dollars). These costs are likely to be
somewhat overstated in that they do not reflect site-specific
opportunities for modification (as opposed to adding new
treatment units.
The incremental energy cost impact of , the proposed BCT is
approximately $900,000 per year for about 22 M M KWH/yr of
electricity. This power can be generated by approximately 37,000
BBL of fuel oil. This energy cost when added to the estimated
$2.2 M M (for 56 M M KWH/yr) currently being expended for
wastewater treatment energy consumption results in a new energy
consumption cost for wastewater treatment of $3.1 MM (for 78 M M
KWH/yr). Since the total energy consumption costs of the
pharmaceutical industry are about $50 M M to $80 M M, the
increment is less than 2 percent bringing the total energy costs
devoted to wastewater treatment to about 4-6 percent of the
industry total.
3. BAT Regulation
Proposed BAT regulations will prevent the discharge of
approximately 4.4 million pounds per year of COD (beyond what is
removed by the BPT regulation) to the nation's surface waters.
There are no costs for incremental energy requirements
attributable to this regulation.
4. PSES and PSNS Regulations
Proposed pretreatment standards for existing sources (PSES)
control the discharge of cyanide to POTWs. It is estimated that
these standards will prevent the discharge of 5900 Ibs per year
of cyanide to the Nation's POTWs. Total annual and investment
costs that may be incurred in complying with these standards are
$323,000 and $880,000, respectively. Energy use increases as a
result of these standards are expected to be negligible when
compared with the total energy use of the industry.
5. NSPS Regulation
-------
The NSPS standards will require the average new source direct
discharger to reduce its discharge of BOD5, TSS and COD by
30,000, 15,000 and 83,000 pounds per year, respectively, more
than that required of an average existing source direct
discharger. The average annual costs for a new source are
expected to be 38% above those incurred by a existing source and
sludge generation is expected to be 18% higher. 5n
consumption costs for wastewater treatment are expected to be
higher than those for an average existing source.
-------
SECTION II
INTRODUCTION
A- PURPOSE AND LEGAL AUTHORITY '! "
The Federal Water Pollution Control Act Amendments of 1972
established a comprehensive program to restore and maintain the
chemical, physical, and biological integrity of the Nation's
waters [ Section 101(a) ]. By July 1, 1977, existing industrial
direct dischargers were required to achieve effluent limitations
requiring the application of the best practicable control
technology currently available (BPT) [ Section 301(b)(1)(A) ].
By July 1, 1983, these dischargers were required to achieve
effluent limitations requiring the application of the best
available technology economically achievable (BAT) which will
result in reasonable further progress toward the national goal of
eliminating the discharge of all pollutants [ Section
301(b)(2)(A) J. New industrial direct dischargers were required
!rS™?mPly with Section 306 new source performance standards
(NSPS) based on best available demonstrated technology. New and
existing dischargers to publicly owned treatment works (POTW)
were subject to pretreatment standards under Sections 307(b) and
(c) of the Act. The requirements for direct dischargers were to
be incorporated into National Pollutant Discharge Elimination
System (NPDES) permits issued under Section 402 of the Act.
Pretreatment standards were made enforceable directly against
dischargers to POTWs (indirect dischargers).
Although Section 402(a)U) of the 1972 Act authorized local
authorities to set requirements for direct dischargers on a case-
by-case basis, Congress intended that for the most part control
requirements would be based on regulations promulgated by the EPA
Administrator. Section 304(b) of the Act required the
Administrator to promulgate regulatory guidelines for direct
discharger effluent limitations setting forth the degree of
effluent reduction attainable through the application of best
practicable control technology (BPT) and best available
technology economically achievable (BAT). , Moreover, Sections
304(c) and 306 of the Act required promulgation of regulations
for NSPS, and Sections 304(f), 307(b), and 307(c) required
promulgation of regulations for pretreatment standards. In
addition to these regulations for designated industry categories,
Section 307(a) of the Act required the Administrator to
promulgate effluent standards applicable to all dischargers of
toxic pollutants. Finally, Section 501(a) of the Act authorized
the Administrator to prescribe any additional regulations
necessary to carry out his or her functions under the Act.
-------
The EPA was unable to promulgate many of these regulations by the
dates contained in the Act. In 1976 EPA was sued by several
environmental groups; in settlement of this lawsuit, EPA and the
plaintiffs executed a settlement agreement, which was approved by
the Court. This agreement required EPA to develop a program and
adhere to a schedule for promulgating for 21 major industries BAT
effluent limitations guidelines, pretreatment standards, and new
source performance standards for 65 "toxic" pollutants and
classes of pollutants. (40)
On December 27, 1977, the President signed into law the Clean
Water Act of 1977. Although this law = makes several important
Changes in the federal water pollution control program, its most
significant feature is its incorporating into the Act several ot
the basic elements of the settlement agreement program for toxic
pollution control. Sections 301(b)(2)(A) and 301(b)(2)(O of the
Act now require the achievement by July 1, 1984, of effluent
limitations requiring application of BAT for toxic pollutants,
including the 65 priority pollutants and classes of pollutants
which Congress declared toxic under Section 307(a) of the Act.
Likewise, EPA's programs for new source performance standards and
pretreatment standards are now aimed principally at toxic
pollutant controls. Moreover, to strengthen the toxics control
program, Congress added Section 304(e) to the Act, authorizing
the Administrator to prescribe best management practices (BMPs)
to prevent the release of toxic and hazardous pollutants from
plant site runoff, spillage or leaks, sludge or waste disposal,
and drainage from raw material storage associated with or
ancillary to the manufacturing or treatment process.
In keeping with its emphasis on toxic pollutants, the Clean Water
Act of 1977' also revised the control program for conventional
pollutants (including biochemical oxygen demand, suspended
solids, fecal col iform, oil and grease, and PH) identified under
Section 304(a)(4). Instead of BAT for conventional pollutants,
' the new Section 301(b)(2)(E) requires by July 1, 1984 achievement
of effluent limitations requiring the application of the best
conventional pollutant control technology (BCT). The factors
considered in assessing BCT include the reasonableness of the
relationship between the costs of attaining a reduction in
effluents and the effluent reduction benefits derived, and the
comparison of the cost and level of reduction for an industrial
discharge with the cost and level of rfduction of similar
parameters for a typical POTW [Section 304(b) 4) B) • For
nontoxic, nonconventional pollutants, Sections 301(bH^HJ) and
301(b)(2)(F) require achievement of BAT effluent limitations
within three years after their establishment or after July 1,
1984 (whichever is later), but not later than July 1, 1987.
7 .
-------
This document presents the technical bases for the application of
revised BPT, and new BAT, BCT, new source performance standards
(NSPS), pretreatment standards for existing sources (PSES), and
pretreatment standards for new sources (PSNS) for the
pharmaceutical manufacturing point source category.
B. PRIOR EPA REGULATIONS
On November 17, 1976, the EPA promulgated interim final BPT
regulations for the pharmaceutical manufacturing point source
category at 41 Federal Register 50676, 40.CFR Part 439, Subparts
A-E. (27). The BPT regulations set monthly limitations for BODS
and COD based on percent removals for'all subcategories. No
daily maximums were established for these two parameters. The pH
was set as within the range of 6.0 to 9.0 ;standard units. The
rulemaking also set an average of daily TSS values for any
calendar month for subcategories B, D, and!E. No TSS limits were
established for categories A and C. Subpart A (the section
applicable to the fermentation operations subcategory) was
amended on February 4, 1977 (42 FR 6814), to improve the language
referring to separable mycelia and solvent recovery and to allow
the inclusion of spent beers (broths) in the calculation of raw
waste loads for subcategory A in those instances where the spent
beer is actually treated in the wastewater treatment system.
These regulations were never challenged and are presently in
effect. The technical basis for these regulations was provided
in EPA 440/1-75/060, published in December 1976. This report,
which formed the technical basis for BPT is henceforth referred
to as the 1976 Development Document. (55) These BPT regulations
were never challenged, and are still in effect.
C. SCOPE OF THIS RULEMAKING
In EPA's initial rulemaking (August 1973 thru November 1976),
emphasis was placed on the achievement of BPT based on the
control of familiar, primarily conventional pollutants, such as
BOD, TSS and pH and non-conventional pollutants, such as COD. By
contrast, in this round of rulemaking, EPA's efforts are directed
toward amending existing BPT limitations and instituting BAT and
BCT effluent limitations and new source performance standards,
PSES and PSNS, with added attention given to toxic pollutants.
D. DEFINITION OF THE INDUSTRY
The pharmaceutical manufacturing point source category is defined
as those manufacturing plants producing or utilizing the
following products, processes, and activities:
(1) Biological products covered by Standard Industrial
Classification (SIC) Code No. 2831.
-------
(2) Medicinal chemicals and botanical products covered by
SIC Code No. 2833.
(3) Pharmaceutical products covered by SIC Code No. 2834.
(4) All fermentation, biological and natural extraction,
chemical synthesis, and formulation products which are considered
as pharmaceutically active ingredients by the Food and Drug
Administration, but which are not covered by SIC Code Nos. 2831,
2833, or 2834. (Products of these types which may not contain
pharmaceutically active ingredients will be included if they are
manufactured by processes, and result in wastewaters, which
closely correspond to those of a pharmaceutical product.
Examples of ingredients which fall into this category are citric
acid, benzoic acid, gluconic acid, fumaric acid, and caffeine.)
(5) Cosmetic preparations covered by SIC Code No. 2844
which function as a skin treatment. (This would exclude
lipsticks, eyeshadows, mascaras, rouges, perfumes, and colognes
which enhance appearance or provide a pleasing odor, but do not
provide skin care. In general, this would also exclude
deodorants, manicure preparations, and shaving preparations which
do not primarily function as a skin treatment.)
(6) The portion of a product with multiple end uses which
is attributable to pharmaceutical manufacturing either as a final
pharmaceutical product, component of a pharmaceutical formulation
or a pharmaceutical intermediate. (Products with pharmaceutical
and nonpharmaceutical end uses will be entirely covered under
this point source category if the products are used primarily as
Pharmaceuticals.
(7) Pharmaceutical research which includes biological,
microbiological, and chemical research, product development,
clinical and pilot plant activities. (This includes animal farms
at which pharmaceutical research is conducted or at which phar-
maceutically active ingredients are tested on the farm animals.
This does not include farms which breed, raise, and/or hold
animals for research at another site. Also excluded are ordinary
feedlot or farm operations using feed which contains
pharmaceutically active ingredients since the wastewater
generated from these operations is not characteristic of
pharmaceutical wastewater).
Products or activities specifically excluded
pharmaceutical manufacturing category are:
from the
(1) Surgical and medical instruments and apparatus
by SIC Code No. 3841.
covered
-------
(2) Orthopedic, prosthetic, and surgical appliances and
supplies covered by SIC Code No. 3842.
3843.
8081.
(3) Dental equipment and supplies covered by SIC Code No.
(4) Medical laboratories covered by SIC Code No. 8071.
(5) Dental laboratories covered by SIC Code No. 8072.
(6) Outpatient care facilities covered by SIC Code No.
(7) Health and allied services, not
covered by SIC Code No. 8091.
elsewhere classified,
(8) Diagnostic devices not covered by SIC Code No. 3841.
(9) Animal feeds which include pharmaceutically active
ingredients such as vitamins and antibiotics. (The major portion
of the product is nonpharmaceutical and the wastewater which
results from the manufacture of feed is not characteristic of
pharmaceutical manufacturing.)
(10) Foods and beverages which are fortified with vitamins
or other pharmaceutically active ingredients. (The major portion
of the product is nonpharmaceutical and the wastewater which
results from the manufacture of these products is not
characteristic of pharmaceutical manufacturing.)
In the previous regulation based on BPT, the pharmaceutical
manufacturing point source category was grouped into five product
or activity areas. This subcategorization was based on distinct
differences in manufacturing processes, raw materials, products,
and wastewater characteristics and treatability. The five sub-
categories that were selected are:
(1 ) Subcategory A
(2) Subcategory B
(3) Subcategory C
(4) Subcategory D
(5) Subcategory E
Fermentation Products.
Biological and Natural Extraction
Products.
Chemical Synthesis Products.
Formulation Products.
Pharmaceutical Research.
For the purposes of the 1977-82 study, EPA decided to de-
emphasize pharmaceutical research (Subcategory E).
Pharmaceutical research does not fall within the SIC Code Nos.
2831, 2833, and 2834, which were identified in the Consent
Decree, and does not appear to be a significant part of the
10
-------
industry from the point of view of effluent. In addition, this
activity does not involve production and wastewater generation on
a regular basis. However, in cases where the pharmaceutical
research activity does involve the production of active
ingredients by processes generating wastewater which are similar
to those in the current study, the information contained in the
proposed development document may be used by permit writers and
other interested parties.
The subcategory breakdown utilized for the current study was used
for evaluative purposes only. In terms of analyzing raw waste
characteristics, wastewater flow, treatment technology
alternatives, etc., a breakdown of the industry by
product/process (i.e., subcategories) was the most practical.
However, as explained in more detail below, separate
subcategories were not considered necessary for regulatory
purposes, because one set of limits could be met by all
pharmaceutical plants. Therefore, the limitations proposed will
be applicable across the industry irrespective of the process
source of the waste.
E. SUMMARY OF METHODOLOGY
As explained in more detail in Section II. E EPA first gathered
technical and descriptive data about the industry, from which the
Agency proceeded to develop the proposed regulations. EPA used
four basic sources in acquiring data to support these new
regulations. These sources included:
(1) Data acquired from industry under Section 308 of the
Act. Using this approach, 308 Portfolio questionnaires were
distributed to a representative sample of the industry. This was
followed by a sampling and verification program from candidate
plants chosen from the first group. This program used the
analytical protocol for pollutant detection and measurement
developed under section 304(h).
(2) Data acquired through open literature, search using
documents from or relevant to the pharmaceutical industry.
(3) Data acquired from EPA regional offices, state and
other government offices, and pharmaceutical plant visits.
(4) The Administrative Record from the 1976 rulemaking for
the pharmaceutical industry, including the 1976 Development
Document.
EPA then studied the pharmaceutical industry to determine whether
differences in such factors as raw materials, final products,
manufacturing processes, equipment, water use, wastewater
11
-------
constituents, and age and size of the manufacturing facilities
required the development of separate effluent limitations and
standards for different segments of the industry. This study
required the identification of raw waste and treated effluent
characteristics, including: (1) the water sources and volume
used, (2) the manufacturing processes employed, (3) the
location of pollutant and wastewater sources within the plant,
and (4) the wastewater constituents including toxic pollutants.
After tentatively designating subcategories, EPA then identified
the constituents of wastewaters which should be considered for
effluent limitations and standards.
Next, the EPA identified several distinct control and treatment
technologies, including both in-plant and end-of-process tech-
nologies, which currently are in use or capable of being used to
control or treat pharmaceutical industry wastewater. The Agency
compiled and analyzed historical and newly acquired effluent data
utilizing these various technologies. Long-term performance,
operational limitations, and reliability for each treatment and
control technology were also considered and statistical analyses
of long term data performed in order to derive performance
standards and variability factors. Additionally, the EPA
evaluated the non-water environmental impact of these
technologies on air quality, solid waste generation, and energy
requirements.
The EPA developed base cases representative of each subcategory
(based on waste load characteristics) to derive treatment
processes and capital and operating costs for each technology.
These costs were presented as curve functions of waste loading
and flow. The technologies evaluated included biological
end-of-pipe processes (e.g., biological enhancement), as well as
in-plant priority pollutant treatments (cyanide destruction and
steam stripping). The annual unit costs (including capital
amortization) were totaled at varying flows and waste loads for
each of the four subcategories. The agency then evaluated the
economic impact of these costs on the industry as a whole. Costs
and economic impacts are discussed more fully in "Economic Impact
Analysis of Proposed Effluent Limitations Guidelines, New Source
Performance Standards and Pretreatment Standards for the
Pharmaceutical Manufacturing Point Source Category."
EPA identified various control and treatment technologies as BPT,
BAT, BCT, NSPS, PSES, and PSNS. The proposed regulations,
however, do not require the installation of any particular
technology. Rather, they require achievement of effluent
limitations representative of the proper application of these
technologies or equivalent technologies. A pharmaceutical
plant's existing controls should be fully evaluated, and existing
12
-------
treatment systems fully optimized before commitment to any new or
additional end-of-pipe treatment technology.
F. DATA AND INFORMATION GATHERING PROGRAM
EPA used a number of sources in acquiring data to support
regulations for the pharmaceutical manufacturing point source
category. These sources are identified and discussed below in
the 9 following subsections?
(1) Preliminary data was obtained from the five sources
described below. This information was used to direct the other
data gathering efforts.
(a) Data acquired from 22 plants which served as the supportive
data base for the BPT regulations issued in November, 1976.
(b) Data acquired from PEDCo,
(discussed in Section V).
RTP and RSKERL/Ada studies
(c) Information acquired through an open literature search. (A
major portion of this effort has been performed by The Research
Corporation of New England (TRC). Some of the important
literature sources were documents prepared by the Pharmaceutical
Manufacturers Association (PMA); the Executive Directory of U_^.
Pharmaceutical Industry, Third Edition, Chemical Economics
Services,Princeton, New Jersey; (51) and the Directory of
Chemical Producers - U.S.A., Medicinals, Stanford Research
Institute, Menlo Park, California. (50))
(d) Data acquired from EPA regional offices, state and other
government offices, and pharmaceutical plant visits.
(e) The administrative record relating to previous EPA
regulations included the original Development Document (EPA-
440/1-75/060, December 1976) and its appendices. This record was
very useful in obtaining general information on the pharmacutical
manufacturing industry. We reviewed this document for
information on use or suspected presence of toxic and
nonconventional pollutants, applicable production process
controls, and available effluent treatment techniques. The
administrative record also included the original economic impact
analysis documents.
(2) Data acquired from the industry under Section 308 of the
Act. (This approach included (a) the distribution of 308
Portfolios to members of the industry population which we
identified and (b) wastewater sampling of candidate plants which
were selected in accordance with the criteria discussed in
13
-------
Section V.) The objectives of
Pharmaceutical Manufacturing were:
the 308 Portfolio for
(1) To obtain information for the
hensive industry profile.
construction of a compre-
(2) To obtain information on production, wastewater generation,
and wastewater treatment at existing facilities to expand the
data base for guidelines development.
(3) To ascertain industry-specific problems which
considered in guidelines development.
need to be
(4) To develop a list of candidate plants for priority pollutant
sampling. ;
The 308 request also was used to solicit information from the
industry which it felt would be relevant to this rulemaking
effort and to develop individual plant contacts to lay the
foundations for future inquiry.
The 308 Portfolio for Pharmaceutical Manufacturing presented in
Appendix B, was developed by EPA and Burns and Roe Industrial
Service Corp. (BRISC) with the cooperation of the PMA
Environmental Task Force during the spring and summer of 1977.
During the same period, a distribution mailing list was
formulated. The 308 Portfolios initially were sent only to PMA
member firms and to nonmember plants included in previous EPA
guidelines work. This decision was based on the following
assumptions and facts:
(1) PMA members were considered more likely to provide quality
responses to the 308 Portfolio.
(2) Development and distribution of the 308 Portfolio could in
part be assisted and coordinated by the PMA.
(3) Many of the essential contacts had already been established
with the PMA.
i ' "
(4) The Agency felt that the 308 Portfolio need cover only a
statistically representative sample of pharmaceutical plants in
the United States. The PMA has members which range from small
one-plant firms to firms with as many as 25 plants, some of which
are large manufacturing complexes. The PMA members are
principally manufacturers of prescription Pharmaceuticals,
medical devices, and diagnostics. However, PMA member firms also
produce a significant portion of the over-the-counter drugs on
the market. These members account for approximately 90 to 95
percent of the U.S. sales of prescription products and about 50
14
-------
percent of the free world's total output of ethical
Pharmaceuticals. For the purpose of the 308 Portfolio, the PMA
member firms were judged to provide a statistically
representative distribution.
The PMA List of Administrative Officers of the Member Firms
Associates, October 1976 Edition, which contains 130 member
firms, was used as a basis for the mailing list. Many of the 130
members are subsidiaries or divisions of common member or non-
member parent firms. Table II-l summarizes the Original 308
Portfolio distribution and response. Of the 442 portfolios that
were mailed in 1977, a total of 431 were returned. One hundred
five of these were from nonpharmaceutical/nonmanufacturing
plants, while another 50 were duplicates of plants already
covered. For purposes of this study, EPA decide to exclude
exclusively Subcategory E plant as explained earlier. The 32
plants that had only Subcategory E operations were dropped from
the survey. Thus, a total of 244 pharmaceutical manufacturing
plants are presently included in the original 308 data base.
They are listed in Appendix C.
(3) Supplemental 308 Portfolio
Since 1977, EPA has identified more than 500 additional
facilities that may be part of this industry. The open
literature file developed by TRC identified a total of 990
possible pharmaceutical sites in the United States. The data
file was reviewed by BRISC and PEDCo, an EPA contractor with
process design and construction experience in the pharmaceutical
industry. This led to a revised listing of more than 540 plant
sites of approximately 400 companies which were not included in
the original 308 Portfolio distribution, but which were possible
producers of pharmaceutically active ingredients.
Although EPA knew that this segment of the industry (principally
comprised of non-PMA-member companies) accounts for only a small
fraction of sales (5-10 percent), the total wastewater volume was
unknown. The Agency also expected that these plants are small
producers upon whom new regulations could have a major impact.
In an effort to define the entire pharmaceutical population,
obtain a more complete profile of the industry, and confirm the
assumption that the PMA member firms included in the initial
survey do indeed represent the industry, a Supplemental 308
Portfolio for Pharmaceutical Manufacturing was developed during
the fall of 1978. This questionnaire, presented in Appendix D,
is an abbreviated form of the original 308 Portfolio and was
distributed to 540 possible pharmaceutical sites in April 1979.
Table II-l presents a summary of the Supplemental 308 Portfolio
distribution program. Of the 540 supplemental portfolios, 355
were returned. After accounting for the 128
15
-------
nonpharmaceutical/nonmanufacturing plants, 4 duplicate
portfolios, and 3 Subcategory E-only plants, 220 plants were
identified as pharmaceutical manufacturers. They are listed in
Appendix E.
The end result of the two questionnaire mailings was a
comprehensive pharmaceutical industry data base containing 464
manufacturing plants. Throughout later sections of this report,
references to 308 Portfolio data are to the comprehensive data
base of 464 plants. Table II-l summarizes distribution and
response return counts for the entire 308 Portfolio program.
There are some differences in the information requested by first
and second 308 questionnaires. Both versions contained a general
information section requesting company name, number of employees,
etc. The original 308 requested information on research and
development facilities which was dropped from the supplemental
form. Products manufactured and method of production were
covered by both the original and supplemental portfolios.
The most significant difference between the two mailings was in
the wastewater data section. The original 308 was very detailed
in this area. Water source, water use, wastewater source and
wastewater disposal information was requested. The original
questionnaire contained questions concerning solid wastes,
changes in treatment operation, and operating costs all of which
were dropped from the Supplemental 308. In the supplemental form
wastewater data was requested only if end-of-pipe treatment was
practiced. Both forms of the portfolio requested data relating
to priority pollutant occurrence in raw materials and wastewater.
The supplemental portfolio was shortened because the second group
of plants to whom this portfolio was sent were considered to be
smaller and less complex on average and to have less data and
response resources.
(4) Plant Visits and Direct Contacts
During the screening/verification phase of this project, we also
gathered information on production capacity, manufacturing
process, waste flows, water reuse, wastewater treatment systems
and performance, and best management practices (BMP). The visits
also provided an opportunity to update and clarify information
from the 308 Portfolio responses.
An additional plant visit was made to a selected pharmaceutical
manufacturing site for the purposes of the precision and accuracy
(P/A) analysis. This visit is discussed in Section V which
reviews th analytical sampling results.
16
-------
We also telephoned plant personnel to clarify 308 and long term
data responses.
(5) Screening Program
a. Background
EPA focused its sampling and analysis on the toxic pollutants
designed in the Act. However, ,we also sampled and analyzed
conventional and nonconventional pollutants. We have explained
our analysis methods for toxic organic pollutants in the preamble
to the proposed regulation for the leather Tanning point source
category (44 FR 38749, July 2, 1974). Before proceeding to
analyze industrial wastes, we had to isolate specific toxic
pollutants for analysis. The list of 65 pollutants and classes
of pollutants potentially includes thousands of specific
pollutants; analyses for all of them would overwhelm private and
government resources. To make the task more manageable,
therefore, EPA selected 129 specific toxic pollutants for study
in this and other industry rulemakings. The criteria for
choosing these pollutants included the frequency of their
occurrence in water, their chemical stability and structure, the
amount of the chemical produced, and the availability of chemical
standards for measurement.
The screening program for the pharmaceutical manufacturing
industry was developed to obtain data indicating the presence of
priority pollutants and the extent of their presence in the
industry's wastewater. The resulting plant-by-plant priority
pollutant concentrations are included in the
screening/verification data base.
b. Selection of Screening Plant Candidates
In order to prepare a list of pharmaceutical manufacturing plants
for the screening program, specific criteria were developed which
served as the basis for the selection process. Each candidate
plant was subjected to these criteria to determine its
acceptability as a screening candidate. The object of the
selection process was to prepare an optimal list of candidates
which was representative of the pharmaceutical industry in terms
of production methods, product lines, wastewater characteristics,
treatment technology, and other characteristics, and yet would
result in sampling at the smallest number of sites. Brief
discussions of each criterion used in the selection process are
presented in the paragraphs that follow.
One of the major criteria for selecting candidate plants for the
screening program was the pharmaceutical plant's subcategory or
type of production operation. Four different types of production
17
-------
operations are utilized in the making of pharmaceutical products.
They are fermentation, biological/ natural extraction, chemical
synthesis, and mixing/compounding/ formulation (see fuller
discussion in section III). Because of the distinct
characteristics of each operation, the properties of a plant's
wastewater will be influenced by the operation(s) employed at the
site. Since the major portion of wastewater flow is generated by
pharmaceutical manufacturing plants employing more than one type
of production operation at a particular site, the goal of the
selection process was to choose plants that would not only cover
the above four categories, but that would also provide a
satisfactory production operation mix (i.e., provide various
combinations of the above four subcategories). Also, past
experience indicated that Subcategories A and C were more likely
to have priority pollutants in their discharge than Subcategories
B and D. Therefore, the selection process concentrated on
obtaining plants with these production operations. The end
result was that the screening list had proportionately more
Subcategory A and C plants than the pharmaceutical industry as a
whole.
i , , , - , , ,
Another important criterion of the selection process dealt with
the type of treatment at the plant, since the final effluent
quality of any wastewater discharge will be dependent upon the
treatment used. For the screening program, the goal was to try
to select those plants that had significant treatment. In this
analysis, significant treatment was defined as treatment beyond
equalization, neutralization, and primary sedimentation, namely,
biological, physical/chemical, or other; secondary treatment.
Therefore, the end result was that the screening list reflected a
relatively higher degree of treatment than the pharmaceutical
industry as a whole.
As stated previously, the purpose of the screening program was to
determine the nature and extent of priority pollutants in the
pharmaceutical industry's wastewaters. Probably the most
important factor affecting the presence of these pollutants in a
plant's effluent is their use as raw materials in the production
operation. Thus, to optimize the screening program, the
selection process concentrated on selecting those plants that
used a large number of different priority pollutants in their
operations.
Some pharmaceutical plants indicated that they had performed
their own wastewater sampling over a period of time. Information
of this kind was thought to be important, since it could provide
background information on the plant's effluent quality and assist
in the analyses of the sampling data \ gathered during the
screening program. Therefore, consideration was given to those
facilities known to have historical sampling data.
18
-------
The amount of wastewater discharged by a particular pharma-
ceutical manufacturing plant is dependent upon many factors.
Some of the more important factors are type of production
operation, product line, plant size, treatment costs, etc. For
the screening program, it was thought to be desirable to select
plants which discharged varying quantities of wastewater. In
this way, the screening could ascertain the effect of small and
large flows on priority pollutant levels and also be relatively
representative of the pharmaceutical industry as a whole.
However, since it was necessary for a plant to have a measurable
wastewater flow in order to be sampled, plants having zero (or
very low) wastewater flows were omitted.
Another criterion for selecting plant candidates had to do with
company ownership of the particular manufacturing plant. The
goal was to minimize, wherever possible, the number of plants
operated by a single company. First, this would avoid "biasing"
the screening data because of a particular company's operating
procedures. Second, it would minimize the resource impact
(personnel, time, costs, etc.) sampling would have on an
individual company.
Although they were not as significant as the above criteria in
the selection of plant candidates, each manufacturing plant's
geographic location, age, number of employees, etc. were also
considered. For plant location and age, the selection process
tried to obtain a good variety of facilities reflecting the total
pharmaceutical manufacturing industry.
In order to satisfy the more important criteria, the selection
process regarding plant employment tended to emphasize larger
facilities since past experience indicated that the larger plants
generally had more complex operations. Thus, the screening list
would tend to contain more of the larger manufacturing plants
than the pharmaceutical industry as a whole would.
The development of the final list of pharmaceutical plants to
comprise the screening program was accomplished in a step-wise
fashion. For each plant, the BPT data file, 308 Portfolio,
federal and state government documents, and other available
information were reviewed in order to prepare a preliminary
screening list. This list was frequently reviewed and revised on
the basis of the aforementioned criteria in an attempt to develop
an optimal final list. The goal was to ensure that the final
list of screening plants maximized the specified criteria, yet
comprised a minimum number of plants to be sampled.
The end result of the selection process was that 26 pharma-
ceutical manufacturing plants comprised the final screening list.
Pertinent data on the selected plants are shown in Table I1-2.
19
-------
c. Screening Protocol
Following the final selection of the 26 screening plants,
preparations were made for the actual sampling activities. The
sampling protocol developed by EPA and discussed in "Sampling and
Analysis Procedures for Screening of Industrial Effluent for
Priority Pollutants" (60) served as the basis for the collection
and analysis of screening samples at the subject pharmaceutical
manufacturing sites. An overview of the screening methods is
discussed below.
The general rule was to obtain 24-hour samples wherever possible.
In some instances, this was altered to accommodate a particular
aspect of the plant to be screened. Certain facilities had batch
operations and/or did not operate "around-the-clock." For these
situations, samples of less than 24 hours, generally 8 hours,
were collected. On the other hand, some facilities had varying
operations which showed fluctuating characteristics over a period
longer than 24 hours. Here a longer sampling time was warranted,
generally on the order of 48 hours. In most cases, however, 24
hour samples were collected. To cover certain unique situations,
the sample period was increased or decreased as necessary. No
significant impact was expected from these modifications, since
the major goal of the screening program was only to identify the
presence and typical levels of priority pollutants in the
wastewaters of the pharmaceutical manufacturing industry.
The types of samples collected during the screening program were
based upon the sampling protocol developed by EPA. To identify
these priority pollutants, classified as acid or base/neutral
extractables and metals, composite samples were obtained. For
the volatile organics and phenols portion of the priority
pollutants, grab samples were taken. Samples were analyzed in
accordance with the analytical techniques outlined in "Sampling
and Analysis Procedures for Screening of Industrial Effluents for
Priority Pollutants" (60).
Two sampling locations of specific interest were the influent and
effluent of the plants' wastewater treatment systems. The
influent to the treatment system was important in the analyses to
determine the levels of priority pollutants generated by the
various pharmaceutical manufacturing operations. The effluent
from the treatment system was critical in determining the effect
of the various treatment systems on the removal of priority
pollutants and the resultant levels reaching the receiving
waters.
Samples were also usually collected at other locations throughout
a particular facility. This was done to obtain supplementary
information on a specific operation or treatment step or to
20
-------
ensure that certain characteristics unique to a certain plant
were adequately covered. Some examples of these sample locations
are intake water, specific production wastewaters, holding tanks,
cooling water, etc. The end result was that more detailed
information for each screening plant was made available for the
analyses of the fate of priority pollutants in pharmaceutical
wastewaters.
(6) Verification Program
As previously mentioned, the screening program was developed .to
obtain data which could be used to indicate the presence of
priority pollutants and to characterize their nature and extent
in the pharmaceutical industry's wastewaters. Having obtained
these data, the EPA then selected five of the screening plants
for the verification program that used the assortment of major
priority pollutants as raw materials for the manufacture of
Pharmaceuticals. The purpose of the verification program was to
confirm the data obtained during the screening program and to
more accurately quantify the concentrations, loadings, and
percent reductions of those pollutants found at significant
levels during the screening program.
a. Selection of_ Verification Plant Candidates
The final list of pharmaceutical plants to comprise the verifi-
cation study is given in Table II-3. EPA developed this list by
selecting those plants that satisfied one or more of the
following criteria:
Those plants with BPT-type treatment systems.
Those plants that use cyanide as a raw material.
Those plants with in-plant control measures such as
cyanide destruction, steam stripping, and solvent
recovery.
In addition, EPA selected plants that would not only cover the
four subcategories, but that would also provide a satisfactory
production operation mix (i.e., provide various combinations of
subcategories at particular plants).
b. Verification Protocol
Prior to verification sampling, preliminary grab samples were
collected from the verification sampling locations to determine
the applicability of the planned analytical methods. However,
the data obtained from these grab samples were not used to
21
-------
quantify effluent levels or to
achieved by the treatment systems.
calculate percent removals
The results of analyzing the screening visit samples were usually
discussed with operating personnel to determine if priority
pollutants found were used by the plant as . either raw,
intermediate, or final products. These results and the data
obtained from the aforementioned grab samples were used to
determine the final verification sampling locations and to define
the priority pollutant verification analyses to be performed.
For a detailed discussion of the sampling methods employed in the
verification program, the reader is referred to "Sampling and
Analysis Procedures for Screening of Industrial Effluents for
Priority Pollutants" (60). With respect: to sampling time, the
verification program was directed toward gathering three days of
24-hour samples. Where automatic composite samples were not
feasible, manual composite samples were obtained for analysis of
acid and base/neutral extractables, metals, and conventional and
non-conventional pollutants. Grab samples were taken for
analysis of volatile organics, phenols, and cyanides. Some
wastewater streams were grab sampled once ;for analysis of all
parameters. Samples for the verification iphase were analyzed in
accordance with the 304(h) approved methods found in "Analytical
Methods for the Verification Phase of the BAT Review" (129).
The analysis of verification samples was performed under a
detailed quality-assurance/quality-control 'procedure. The proce-
dure required analyses of duplicate extractions for samples
collected on the first day of verification sampling. Samples
taken on the second and third days of verification sampling were
extracted and analyzed, spiked with appropriate amounts of pollu-
tants, and reanalyzed. Spike recoveries were calculated from the
data generated during these analyses. The spiking and reanalysis
requirement was deleted if the original pollutant concentration
was below the detectable limit. Another requirement was that
samples not analyzed, spiked, and re-extracted within 72 hours of
sample collection were subjected to an additional spiking,
holding, and analysis. This requirement was designed to
determine whether the pollutants degrade during storage.
As in the previous case of the sampling programs, the two
sampling locations of specific interest were the influent and
effluent of each plant's wastewater treatment systems. The
treatment system's influent was important in the analyses to
determine the levels of priority pollutants generated by the
various pharmaceutical manufacturing operations. The treatment
system's effluent was critical in determining the effect of the
various treatment systems on the removal of priority pollutants
and the resultant levels reaching the receiving waters.
22
-------
In addition to the above, samples were usually collected at other
locations throughout a particular facility. This was done to
obtain supplementary information on a specific operation or
treatment step or to ensure that certain characteristics unique
to a plant were adequately covered. Examples of these sampling
locations are intake water, cooling water, specific production
wastewaters, etc. The end result was a more detailed analysis of
the fate of priority pollutants for each verification plant.
Since a goal of the verification program was to quantify those
pollutants found during the screening program, the same sampling
locations were generally used for the two programs.
(7) Long-Term Data Program
In addition to 308 and Screening/Verification data, the Agency
was interested in obtaining data which would reveal traditional
pollutant raw waste loads and their day-to-day variability. This
required obtaining data, collected over a consecutive time
period, which reflected fluctuations in process effluent.
Therefore, the Agency decided to identify those plants which had
collected data through self-monitoring. The Agency was
particularly interested in data for the conventional parameters
Biochemical Oxygen Demand (BOD), and Total Suspended Solids
(TSS), the non-conventional parameter Chemical Oxygen Demand
(COD), and cyanide (CN).
As in the Screening and Verification programs, specific criteria
were developed which served as the basis for the selection
process. The controlling factor for assembling a list of
candidate plants was whether the plant in question had been
conducting a self-monitoring program. Once a list of candidate
plants had been developed, they were subjected to criteria
similar to those for the screening program.
One of the major points of concern for selecting long-term plants
was the subcategory or type of production operation. The prime
objective was to select plants that would encompass the four
subcategories and combinations of subcategories. This was done
to provide a representative cross section of production processes
and the consequent wastewater effluents found within the
industry. An equally important criterion for selection was the
type of wastewater treatment used by the candidate plant. It was
also desirable to include not only plants that had exemplary "BPT
type" but also plants with typical "BPT type" treatment. If
possible more than one type of treatment system was included.
Also important as a selection criterion was the amount of
wastewater discharged. Again an attempt was made to cover a
range of wastewater flows that was representative of the
industry.
23
-------
Another criterion for selection involved company ownership. An
attempt was made to select plants operated by different
companies. This was done for two reasons. This would avoid
biasing the data because of a particular company's operation
circumstances and policy. Also, it would reduce the resource
burden that sampling would be for an individual company.
However, for comparative purposes it was desirable to have some
plants common to both the Screening/Verification data base and
the Long-Term data base.
Other criteria considered but not as significant were geographic
location of each plant, plant age, and number of employees.
Using the criteria outlined above, thirty-five (35) plants were
selected as long-term data candidates. Questionnaires were sent
to these plants and responses were received from 22 plants. The
respondents represented a good cross section of the industry as
indicated by the statistics which follow:
SUBCATEGORY CLASSIFICATION
SINGLE SUBCATEGORY PLANTS
Subcategory A only
Subcategory B only
Subcategory C only
Subcategory D only
MIXED SUBCATEGORY PLANTS
13
WASTEWATER FLOW
Less than 0.1 MGD
0.1 to 1.0 MGD
1.0 to 10.0 MGD
DISCHARGE TYPE
Direct
Indirect
11
plants
plants
4 plants
17
The responses were carefully reviewed to see that the treatment
systems and data were suitable. One plant (#12123) was
eliminated from traditional pollutant consideration because data
were available for cyanide removal only. Five more plants were
eliminated because they were indirect dischargers whose treatment
systems were in place to avoid sewer use charges rather than to
achieve a permit-specified performance. The data base contained
17 plants with reasonable treatment schemes at this point of the
review. The remaining plants were scrutinized to determine the
24
-------
level of performance of their waste treatment facilities. Four
of the remaining plants were eliminated due to poor performance
of their facilities, which made their data unsuitable as a basis
for limitations reflecting good technology as required for BCT,
BAT, and NSPS. The performance of the remaining plants was
averaged and served as the basis for BCT and BAT regulations.
Three plants classified as marginal performers were eliminated
from the data base before averaging for NSPS purposes. Details
on the exact plant selection process are provided in Section X.
Table I1-4 presents the total list of Long-Term Data Plants with
selected characteristics.
Table I1-5 presents a comparison of the screening plants and
long-term plants versus the total pharmaceutical manufacturing
population.
(8) PCS Data
Another source of data was the current PCS (Permit Compliance
Schedule) for pharmaceutical manufacturers possessing NPDES
permits. These permits contain the limitations under which the
individual plants are currently being regulated. A comparison of
the permit limitations versus 1976 BPT limitations is presented
in Section III.
G. Processing of Data and Information
Stanford Research Institute (SRI) was contracted to do a two-part
statistical analysis of the pharmaceutical industry data base.
Long-term effluent data were evaluated to determine variability
of pollutant removal resulting from long-term operation. The
analysis centered on effluent data yielding daily and monthly
variability factors for each pollutant. Alternative methods for
calculating variability factors were developed, permitting the
recommendation of a meaningful and useful variability allowance
for regulatory purposes.
In the second part of the analysis, screening and verification
data were evaluated to determine the frequency of occurrence of
each priority pollutant occurring in the manufacture of
Pharmaceuticals. A frequency ranking was prepared for groups of
priority pollutants and is discussed in Section V. In addition,
the statistical pattern of concentrations of each pollutant
present was analyzed. Frequency of occurrence and concentration
information were two criteria on which the selection of specific
priority pollutants for regulation was based. In addition, we
considered whether treatment required by other regulations would
control these pollutants. Section VI contains a detailed
25
-------
discussion of this selection process in light of the criteria for
exclusion in paragraph 8 of the Consent Agreement.
26
-------
TABLE II-l
PHARMACEUTICAL SUMMARY
SUMMARY OF 308 PORTFOLIO MAILING
Original Supplemental Comprehensive
308's 308's Data Base
Portfolios Distributed;
Plants in the Initial Mailing
"Additional" Plants Included
in Survey
Portfolios Not Returned;
Portfolio Processing;
Duplicate Portfolios
Non-Mfg. (Non-Pharm.) Portfolios
Exclusively Research
(Subcategory E) Portfolios
Manufacturing Portfolios;
442
396
46
-11
-187
-50
-105
540
523
17
-185
-135
-4
-128
982
919
63
-196
-322
-54
-233
-32
244a
(a) These plants are listed in Appendix C.
(b) These plants are listed in Appendix E.
-3
220b
-35
464
27
-------
TABLE II-2
PHARMACEUTICAL INDUSTRY
CHARACTERISTICS OF THE 26 PLANTS SELECTED FOR SCREENING
Plant No.
Subcategory EOP Treatment*
Wastewater
Flow
(MDG)
EPA
Region
Startup
Year
12015
12022
12026
12036
12038
12044
12066
12097
12108
12119
12132
12161
12204
12210
12231
12236
12248
12256
12257
12342
12411
12420
12439
12447
12462
12999**
D AS,AC 0.101 III
A C AS,TF 1.300 III
C AS,AL 0.101 II
A AS,TF,AL 1.128 V
A B C D AS,AL 0.855 V
A D Primary Treatment Only 2.97 V
BCD AS,AL 0.26 V
CD AS 0.035 V
A CD Primary Treatment Only - II
AD AS 0.0.32 II
A C AS,TF 1.000 III
A C D AS 1.332 II
A B C D AS 0.850 II
B C AL 0.002 IV
AD AL 0.50 II
C AS 0.810 IV
D AS 0.035 III
A B C D Primary Treatment Only 30.00 I
A B C D AS .600 V
A C D None 0.701 II
BCD AL 0.30 IV
B D AS 1.33 V
C D AS,AL 0.01 II
A B C D Primary Treatment Only 1.50 V
A AS,AL 0.170 VII
C D Primary Treatment Only 0.45 VII
Subcategory Totals: A » 15
Legend: AC = activated carbon AS
AL = aerated lagoon TF
1960
1951
1950
1948
1954
1938
1953
1951
N/A
1977
1941
1969
1907
1973
1968
1952
1961
1948
1965
N/A
1970
1973
1974
N/A
1972
N/A
activated
trickling
*
**
See Appendix M for in-plant and end-of -pipe treatment
308 Portfolio was not received from this plant.
28
-------
TABLE I1-3
PHARMACEUTICAL INDUSTRY
CHARACTERISTICS OF THE FIVE PLANTS SELECTED FOR VERIFICATION
PLANT CODE
12026
12038
SUBCATEGORY MAJOR TREATMENT
C Activated Sludge
Aerated Lagoon
Polishing Pond
ABCD
12097
12236
CD
C
Activated Carbon
Activated Sludge
Aerated Lagoon
Phys i cal-Chemi cal
Thermal Oxidation
Activated Sludge
Physical-Chemical
Activated Sludge
COMMENTS
Has Solvent Recovery
Uses Cyanide;
Has Steam Stripping;
Has Solvent Recovery
Uses Cyanide;
Has Solvent Recovery
Uses Cyanide;
Has Solvent Recovery
12411
BCD
Aerated Lagoon
On-Site Incineration
of Solvents
29
-------
TABLE n-4
PHARMACEUTICAL INDUSTRY
CHARACTERISTICS OF 23 PLANTS SELECTED FOR LONG TERM STUDY
Plant No.
12015
12022
12026
12036
12097
12098
12117
12123
12160
12161
12186
12187
12235
12236
12248
12257
12294
12307
12317
12420
12439
12459
12462
Subcategory
D
A C
C
A
C D
D
B D
C D
D
A CD
C D
C
C
C
D
A B C D
C D
D
D
B D
C D
D
A
EOP
Treatment*
AS, AC
AS, TF
AS, AL
AS, TF, AL
AS
AS
AS
Primary Treatment Only
AS
AS
AS, AL
TF
Primary Treatment Only
AS
AS
AS
AS
AS, AL
AS
AS
AS,AL
AL
AS, AL
Wastewater
Flow (MGD)
0.101
1.448
0.161
5.156**
0.064
0.006
0.101
0.932
0.029
1.653
0.037
1.065
No Data
0.816
0.110
0.755
0.118
0.002
0.740
0.164
No Data
0.049
0.209
EPA
Region
III
III
II
V
V
II
III
II
II
II
II
I
II
IV
III
V
II
II
IV
V
II
II
VII
Startup
Year
1960
1951
1950
1948
1951
1975
1882
1937
1974
1969
1976
1949
1971
1952
1961
1922
1969
1975
1972
1973
1974
1977
1972
Employment
300
100
0
100
100
0
400
200
200
800
0
0
0
200
700
4000
300
100
2000
100
0
Not
0
- 400
- 200
- 100
- 200
- 200
- 100
- 500
- 300
- 300
- 900
- 100
- 100
- 100
- 300
- 800
- 4500
- 400
- 200
- 2500
- 200
- 100
Reported
- 25
Subcategory Totals: A = 5 Legend: AC
B= 3 • • AL
C = 12 AS :
D = 16 TF :
* See Appendix L for in-plant and end-of-pipe treatment
** Includes non-process flows.
Activated Carbon
Aerated Lagoon
Activated Sludge
Trickling Filter
-------
TABLE H - 5
PHARMACEUTICAL INDUSTRY
COMPARISON OF SCREENING PLANTS AND LONG TERM PLANTS
VERSUS TOTAL PHARMACEUTICAL MANUFACTURING POPULATION
Item
Total Number of Plants
Subcategory
A
B
C
D
Wastewater Quantity
Less than 0.1 Mgal/d
0.1 to 1.0 Mgal/d
1.0 to 10.0 Mgal/d
Greater than 10.0 Mgal/d
EPA Region
I
II
PR
III
IV
V
VI
VII
VIII
IX
X
Plant Age (1978 Basis)
Less than 5 years
5 to 1 0 years
10 to 2 5 years
25 to 50 years
50 to 100 years
Greater than 100 years
Employment
Less than 1 00
100 to 500
500 to 1000
Greater than 1000
Screening
Plants
26
57.7%
34.6
69.2
73.1
23.1%
46.2
26.9
3.8
3.7%
14.8
14.8
14.8
11.1
33.3
0.0
7.4
0.0
0.0
0.0
18.2%
18.2
22.7
36.4
4.5
0.0
8.4%
45.8
20.8
25.0
Long Term Plants
Total
All Single Subcat. Only
23
22.7%
13.0
52.2
69.6
28.6%
52.4
19.0
0.0
4.3%
17.4
30.4
17o4
8.7
17.4
OoO
4.3
0.0
OoO
0.0
17.4%
34.8
8.7
30.4
8.7
0.0
31.8%
50.0
9.0
9.0
13
15.4%
0.0
30.8
53.8
33.3%
50.0
16.7
0.0
.- 8.3%
16.7
33.3
16.7
16.7
8.3
0.0
8.3
0.0
0.0
0.0
23.0%
30.8
15.4
30.7
0.0
0.0
41.7%
41.7
8.3
8.3
464
8.0%
17.2
28.7
80.2
80.0%
15.1
4.3
0.6
3
26.1
9.5
9.5
10.6
20.0
3.4
6.0
1.3
8.6
1.3
16.2^*)
22.7 (*)
27.8 (*)
19.9 (*)
12.0 (*)
1.4 (*)
36.9%
41.0
10.8
11.3
*Only (original) 308 Portfolio plants had these data and, thus, were used to calculate
these figures.
31
-------
SECTION III
DESCRIPTION OF THE INDUSTRY
A. INTRODUCTION
In order to establish an industry data base upon which proposed
regulations can be developed and promulgated, a comprehensive
profile was developed from survey, sampling and existing data
sources.
This section presents information assembled to describe, in a
quantitative and specific manner, the pharmaceutical
manufacturing industry. The data comes from responses to
requests provided by companies in the industry as well as
information obtained from open literature and other sources.
Processes, production, plant size, age, geographical location,
employment, and current wastewater discharge performance are
discussed and tabularly presented.
B. DETAILED INDUSTRY PROFILE
The objectives of the 308 Questionnaire were to obtain infor-
mation from pharmaceutical manufacturing facilities and to
develop an industry profile that includes plant size, age,
location, and production activities. Appendix F lists each of
the 464 manufacturing plants contained in the comprehensive EPA
data base by plant code number (assigned for identification
purposes), applicable manufacturing subcategories, manufacturing
employment, and year of operational startup. Plants with code
numbers in the 12000 series are from the original 308 Portfolio
survey; those with 20000 series numbers are from the Supplemental
308 Portfolio survey.
Table III-l shows the geographical distribution of the industry
and the number of manufacturing plants by state and EPA region.
Also shown are the average number of manufacturing employees per
plant and the average plant startup year.
Most of the pharmaceutical industry is located in the eastern
half of the United States (See Figure III-l.) Of the 464
manufacturing plants in the comprehensive data base, almost 80
percent are in the East. New Jersey (with about 16 percent) and
Region II (with approximately 36 percent) is the largest
pharmaceutical manufacturing state and EPA region, respectively.
The data show that Regions II, III, V, and VII (the Northeast and
Midwest) have generally older plants than Regions IV, VI, VIII,
and IX (the South and West). This is due to the recent trend
toward building plants in the "Sun Belt" of the United States.
32
-------
Puerto Rico has close to 10 percent of the industry and is
becoming a major pharmaceutical manufacturing center.
Table II1-2 breaks down the industry by manufacturing
subcategory. These process-based subcategories were used for a
review of the industry, although these distinctions were not
carried through for purposes of developing the newly proposed
regulations. Subcategory D (formulating/mixing/ compounding) is
the most prevalent pharmaceutical manufacturing operation, with
80 percent of the plants in the industry engaged in this
activity. Fifty-eight percent of the plants have operations in
only Subcategory D. The remainder also have operations in other
subcategories.
Table II1-3 summarizes the total number of batch, continuous, and
semi-continuous manufacturing operations by subcategory for the
entire pharmaceutical industry. Batch-type production is the
most common type of manufacturing technique for each of the four
subcategories.
C. MANUFACTURING PROCESSES
One of the most important generalizations which can be made about
the wastewaters produced and discharged by the pharmaceutical
industry is their extreme diversity. Products, processes, and
the materials to which wastewater is exposed vary greatly. With
the goal of relating those discharges with some common
characteristics, subcategories based on unit ' manufacturing
processes were defined. The broad manufacturing processing areas
considered were (a) fermentation, (b) biological and natural
extraction, (c) chemical synthesis, and (d) formulation.
One characteristic of processing in this industry is that the
ratio of finished product to the quantity of raw materials,
solvents, and other processing materials is generally very low.
This is most apparent in natural extraction (Subcategory B),
followed by fermentation (A), synthesis (C), and formulation (D),
respectively.
1. Fermentation
Fermentation is the usual method for producing most antibiotics
and steroids. The fermentation process involves three basic
steps: inoculum and seed preparation, fermentation, and product
recovery.
Production of a fermentation pharmaceutical begins with spores
from the plant master stock. The spores are activated with
water, nutrients, and warmth; they are then propagated through
33
-------
the use of agar plates, test tubes, and flasks until enough mass
is produced for transfer to the seed tank. In less critical
fermentations, a single seed tank may serve several fermenters.
In this type of operation, the seed tank is never emptied
completely, so the seed remaining will serve as the inoculum for
the next seed batch. The seed tank may be sterilized and
inoculated only when contamination occurs.
Fermentation is conventionally a large-scale batch process. A
fermentation cycle begins with a water wash and steam
sterilization of the fermenter vessel. Sterilized nutrient raw
materials in water are then charged to the fermenter.
Microorganisms are transferred to the fermenter from the seed
tank and fermentation begins. During fermentation, air is
sparged into the batch and temperature is carefully controlled.
After a fermentation period of from twelve hours to a week, the
fermenter batch whole broth is ready for filtration. Filtration
removes mycelia (remains of the microorganisms), leaving the
filtered aqueous broth containing product and residual nutrients
ready to enter the product recovery phase.
There are three common methods of product recovery: solvent
extraction, direct precipitation, and ion exchange or adsorption.
Solvent extraction is a recovery process in which an organic
solvent is used to remove the pharmaceutical product from the
aqueous broth and form a more concentrated solution. With
subsequent extractions, the product is separated from any con-
taminants. Further removal of the product from the solvent can
be done by either precipitation, solvent evaporation, or further
extraction processes. Normally, solvents used for product
recovery are recovered and reused. However, small portions left
in the aqueous phase during the solvent "cut" can appear in the
plant's wastewater stream. The typical processing solvents used
in fermentation operations are benzene, chloroform,
1,1-dichloroethylene, and 1,2-trans-dichloroethylene. (42)
Direct precipitation consists of first precipitating the product
from the aqueous broth, then filtering the broth, and finally
extracting the product from the solid residues. Priority pollu-
tants known to be used in the precipitation process are copper
and zinc. (42) i
Ion exchange or adsorption involves the removal of the product
from the broth, using such solid materials as ion exchange resin,
adsorptive resin, or activated carbon. The product is recovered
from the solid phase with the use of a solvent; it is then reco-
vered from the solvent.
Steam is used as the major sterilizing medium for most equipment.
However, to the extent that chemical disinfectants may be used,
34
-------
they can contribute to priority pollutant waste loads.
a commonly used disinfectant.
Phenol is
Sometimes a fermentation batch can become infested with a phage,
a virus that attacks microorganisms. Although phage infestation
is rare in a well-operated plant, when it occurs, very large
wastewater discharges may be necessary in a short period of time.
Usually the batch is discharged early and its nutrient pollutant
concentration is higher than that of spent broth.
Another fermentation wastewater source is the control equipment
that is sometimes installed to clean fermentation waste off-gas.
The air and gas vented from the fermenters usually contain
odoriferous substances and large quantities of carbon dioxide.
Treatment is often necessary to deodorize the gas before its
release to the atmosphere. Some plants employ incineration
methods; others use liquid scrubbers. The blowdown from
scrubbers may contain absorption chemicals, light soluble organic
compounds, and heavier insoluble organic oils and waxes.
However, wastewater from this source is unlikely to contain
priority pollutants.
The pollution contribution of the spent beer arises from the fact
that the beer contains substantial food materials such as sugars,
starches, protein, nitrogen, phosphate, and other nutrients.
Methods for treating the fermentation wastes are generally
biological in nature. Although the spent beers, even in a highly
concentrated form, can be satisfactorily handled by biological
treatment systems, it is less likely to upset the system if the
wastes are first diluted to some degree. Dilution normally
results from the equalization of fermentation wastes with the
other waste streams. As a result, a satisfactory biological
reduction of the contaminants can be achieved.
The 308 data shows generally that wastewaters from Subcategory A
plants generally are characterized by high BOD, COD, and TSS
concentrations, large flows, and a pH range of about 4.0 to 8.0.
2. Biological and Natural Extraction
Many materials used as Pharmaceuticals are derived from such
natural sources as the roots and leaves of plants, animal glands,
and parasitic fungi. These products have numerous and diverse
pharmaceutical applications ranging from tranquilizers and
allergy relief medications to insulin and morphine. Also
included in this group is blood fractionation, which involves the
production of plasma and its derivatives.
35
-------
Despite their diversity, all extractive Pharmaceuticals have a
common characteristic: they are too complex to synthesize
commercially. They are either very large molecules and/or the
synthesis results in the production of several steroisomers only
one of which has pharmacological value. Extraction is an
expensive manufacturing process since it requires the collection
and processing of very large volumes of specialized plant or
animal matter to produce very small quantities of products.
The extraction process consists of a series of operating steps.
In almost every step, the volume of material being handled is
reduced significantly. In some processes,; the reductions may be
in orders of magnitude and the complex final purification
operations may be conducted on quantities of materials only a few
thousandths of the material handled in earlier steps. Neither
continuous processing methods nor conventional batch methods are
suitable for extraction processing. Therefore, a unique
assembly-line, small-scale batch processing method has been
developed. Material is transported in portable containers
through the plant in batches of 75 to 100 gallons. A continuous
line of these containers is sent past a series of operating
stations. At each station, operators perform specific tasks on
each batch in turn. As the volume of material being handled
decreases, individual batches are continually combined to
maintain reasonable operating volumes and the line moves more
slowly. When the volume is reduced to a very small quantity, the
containers used also become smaller, with laboratory-size
equipment used in many cases.
An extraction plant may produce one product for a few weeks;
then, by changing the logistical movement of pots and redefining
the tasks to be conducted at each station, a plant can convert to
the manufacture of a different product.
Residual wastes from an extraction plant essentially will be
equal to the weight of raw material, since the active ingredients
extracted are generally present at very low levels. Solid wastes
will represent the largest pollutant load; however, solvents used
in the processing steps will cause both air and water pollution.
The nature of the products of the pharmaceutical industry
dictates that any manufacturing facility maintain a standard of
cleanliness higher than that required for most industrial
operations. Since most of these plants are cleaned frequently,
detergents and disinfectants are normally found in the
wastewater. >
As in the fermentation process, a small number of priority
pollutants were identified as being used in the manufacturing of
extractive Pharmaceuticals. (41) The cations of lead and zinc are
36
-------
known to be used as precipitating agents. Phenol was identified
as an equipment sterlizing chemical as well as an active
ingredient. Otherwise, priority pollutants are found to be used
only as processing solvents. Some identified as solvents were
benzene, chloroform, and 1,2 dichloroethane.
Solvents are used in two ways in extraction operations. First,
they are used to remove fats and oils that would contaminate the
products. These "defatting" extractions use an organic liquid
that dissolves the fat but not the product material. Solvents
are also used to extract the product itself. Plant alkaloids,
when treated with an alkali, become soluble in such selected
organic solvents as benzene, chloroform, or 1,2 dichloroethane.
Ammonia is used in many extraction operations since it is
necessary to control the pH of water solutions from both animal
and plant sources to achieve separation of valuable components
from waste materials. Ammonium salts are used as buffering
chemicals and aqueous or anhydrous ammonia is used as an
alkalizing reagent. The high degree of water solubility of
ammonium salts prevents unwanted precipitation of salt; also,
ammonia does not react chemically with animal or plant tissue.
Such basic materials as hydroxides and carbonates of alkali
metals do not have these advantages.
The principal sources of wastewater from biological/natural
extraction operations are (a) spent raw materals (waste plasma
fractions, spent eggs, spent media broth, plant residues, etc.);
(b) floor and equipment washwaters; (c) chemical wastes (spent
solvents and the like); and (d) spills.
In general, the bulk of the spent raw materials is collected and
sent to an incinerator or landfill. Likewise, the nonrecoverable
portions of the spent solvents are incinerated or landfilled.
However, in both cases, portions of the residual materials find
their way into a plant's wastewater. Floor and equipment
washings and spills also contribute to the ordinary waste
discharge.
Although pollutant information for the biological/natural
extraction operations in the pharmaceutical data base was
limited, that which was available lent itself to a preliminary
analysis. Generally, wastewaters from Subcategory B plants are
characterized by low BOD, COD, and TSS concentrations; small
flows; and pH values of approximately 6.0 to 8.0.
3. Chemical Synthesis
Most of the compounds used as drugs today are prepared by
chemical' synthesis (generally by a batch process). The basic
37
-------
major equipment item is the conventional batch reaction vessel,
one of the most standardized equipment designs in industry.
Generally, the vessel is equipped with a motor-driven agitator
and an internal baffle. It is made of either stainless steel or
glass-lined carbon-steel and contains a carbon-steel outer shell
suitable for either cooling water or steam., Vessels of this type
are made in many different sizes, with capacities ranging from
0.02 to Tl.O m3 or more.
The basic vessels may be fitted with many different attachments.
Baffles usually contain temperature sensors to measure the
temperature of the reactor contents. An entire reactor may be
mounted on load cells to weigh accurately the reactor contents.
Dip tubes are available to introduce into the vessels reagents
below the liquid surface. One of the top nozzles may be fitted
with a floodlight and another with a glass cover to enable an
operator to observe the reactor contents. Agitators may be
powered by two-speed motors or by variable-speed motor drives.
Typically, batch reactors are installed with only the top heads
extending above the operating floor of the plant in order to
provide the operator with easy access for loading and cleaning.
With other suitable accessories, these vessels can be used in
many different ways. Solutions can be mixed, boiled, and chilled
in them. By addition of reflux condensation, complete reflux
operations are possible. By application of a vacuum, the vessels
become vacuum evaporators. Solvent extraction operations can be
conducted in them, and, by operating the agitator at slow speed,
they serve as crystallizers.
Synthetic pharmaceutical manufacture consists of using one or
more of these vessels to perform in a step-by-step fashion the
various operations necessary to make the product. Following a
definite recipe, the operator (or, increasingly, a programmed
computer) adds reagents; increases or decreases the flow rate of
cooling water, chilled water, or steam; and starts and stops
pumps to transfer the reactor contents into another similar
vessel. At appropriate steps in the process, solutions are
pumped through filters or centrifuges or are pumped into solvent
recovery headers or waste sewers.
The vessels with an assembly of auxiliary equipment are usually
arranged into independent process units; a large pharmaceutical
plant may contain many such units. Each unit may be suitable for
the complete or partial manufacture of many different
pharmaceutical compounds. Only with the highest volume products
is the equipment "dedicated" or modified to be suitable for only
one process.
38
-------
Each pharmaceutical is usually manufactured in a "campaign in
which one or more process unit is employed for a few weeks or
months to manufacture enough compound to satisfy its proDected
sales demand. Campaigns are usually tightly scheduled, with
detailed coordination extending from procurement of raw materials
to packaging and labeling of the product. For a variable period
of time, therefore, a process unit actively manufactures a
specific compound. At the end of this campaign, another is
scheduled to follow. The same equipment and operating personnel
are used to make a completely different product, utilizing
different raw materials, executing a different recipe, and
creating different wastes.
The synthetic Pharmaceuticals industry uses a wide variety of
priority pollutants as reaction and purification solvents (43).
Water was reported to be used more often than would be expected
in an industry whose products are organic chemicals. However,
benzene and toluene were the most widely used organic solvents
since they are stable compounds that do not easily take part in
chemical reactions. Similar ring-type compounds (xylene,
cyclohexane, pyridine, etc.) also were reported as being used in
the manufacture of synthesized Pharmaceuticals or resulting from
unwanted side reactions.
Solvents serve several functions in a chemical synthesis, They
dissolve gaseous, solid, or viscous reactants to bring all
reactants into close molecular proximity. They serve to transmit
heat to or from the reacting molecules. By physically separating
molecules from each other, they slow down some reactions that
would otherwise take place too rapidly and that would result in
excessive temperature increases and unwanted side reactions.
There are other less obvious uses of solvents, however. One of
these is the use of a solvent in the control of reaction
temperature. It is common practice in a batch-type synthesis to
select a solvent whose boiling point is the same as the desired
reaction temperature and which is compatible with the reaction.
Heat is then applied to the reaction mass at a rate sufficient to
keep the mixture continuously boiling. Vapors that rise from the
reaction vessel are condensed and the liquefied solvent is
allowed to drain back into the reaction vessel. Such refluxing
prevents both overheating and overcooling of the reactor contents
and can automatically compensate for variations in the rate of
release or eibsorption of chemical energy.
Essentially all production plants operate solvent recovery
facilities that purify contaminated solvent for reuse. These
facilities usually contain distillation columns and may also
include extraction facilities where still another solvent is used
to separate impurities. Many of the wastes from the synthetic
39
-------
pharmaceutical industry will be discharged from these solvent
recovery facilities. Aqueous wastes which may result from such
operations include residues saturated with the solvents
recovered.
Another cause of solvent loss is storage practices. Bulk storage
is usually in an unpressurized tank that is only partially
filled. The level of the liquid in the tank rises and falls as
liquid is added to or removed from the tank. The vapor in the
tank above the surface of the liquid is therefore exhausted when
the liquid level is rising; as the level falls, fresh air (or
nitrogen from a padding system) is introduced. Even if no liquid
is added or removed, the tank "breathes" as a result of
temperature and barometric pressure changes. Each time a tank
"exhales," the released vapor is saturated with solvent vapor;
rather large quantities of solvent can be lost to the atmosphere
through this mechanism.
Chemical synthesis operations also produce large quantities of
pollutants normally measured as BOD and COD. Wastewater is
generally produced with each chemical modification that requires
the filling and emptying of the batch reactors. These waste-
waters can contain the unreacted raw materials as well as some
solvents.
The effluent from chemical synthesis operations is the most
complex to treat because of the many types of operations and
chemical reactions (nitration, amination, halogenation,
sulfonation, alkylation, etc.). The production steps may
generate acids, bases, cyanides, metals, and many other
pollutants. In some instances, process solutions and vessel wash
waters may also contain residual solvents. Sometimes, this
wastewater is incompatible with biological treatment systems.
Although it is possible to acclimate the bacteria to the various
substances, there may be instances where certain chemical wastes
are too concentrated or too toxic to make this feasible. Thus,
it may be necessary to equalize and/or chemically pretreat a
process wastewater prior to conventional treatment.
Primary sources of wastewater from chemical synthesis operations
are (a) such process wastes as spent solvents, filtrates,
concentrates, etc.; (b) floor and equipment wash waters; (c) pump
seal waters; (d) wet scrubber spent waters; and (e) spills.
Wastewaters from Subcategory C plant can be characterized as
having high BOD, COD, and TSS concentrations; large flows; and
extremely variable pH, ranging from 1.0 to 11.0.
4. Formulation
40
-------
Although pharmaceutically active ingredients are produced in bulk
form, they must be prepared in dosage form for use by the
consumer. Pharmaceutical compounds can be formulated into
tablets, capsules, liquids, or ointments.
Tablets are formed in a tablet press machine by blending the
active ingredient, filler, and binder. Some tablets are coated
by tumbling with a coating material and drying. The filler
(usually starch, sugar, etc.) is required to dilute the active
medicinal to•the proper concentration, a binder (such as corn
syrup or starch) is necessary to bind the tablet particles
together. A lubricant (such as magnesium stearate) may be added
for proper tablet machine operation. The dust generated during
the mixing and tableting operation is collected and J-J usually
recycled directly to the same batch. Broken tablets are
generally collected and recycled to the granulation operatxon in
a subsequent lot. After the tablets have been coated and dried,
they are bottled and packaged.
Capsules are produced by first forming the hard gelatine shell.
These shells are produced by machines that dip rows of rounded
metal dowels into a molten gelatine solution and then strip the
capsules from the dowels after the capsules have cooled and
solidified. imperfect empty capsules are remelted and reused, if
possible, or sold for glue manufacture Most Pha™ceutical
companies purchase empty capsules from a few specialist
producers.
The active ingredient and any filler are mixed before being
poured by machine into the empty gelatine capsules. The filled
capsules are bottled and packaged. As in the case of tablet
production, some dust is generated. Although this is recycled
small amounts of waste dust must be disposed of. Some glass and
packaging waste from broken bottles and cartons also result from
this operation.
Liquid preparations can be formulated for injection or oral use.
in either case, the liquid is first weighed and then dissolved in
water Injectable solutions are bulk sterilized by heat or
filtration and then poured into sterilized bottles. Oral liquid
preparations may be bottled directly without the sterilization
steps.
Wastewaters are generated by general cleanup operations, spills,
and breakage. Bad batches may create a solid waste disposal
problem.
The primary objective of mixing/compounding/formulation
operations is to convert the manufactured products into a final,
usable form. The necessary production steps have typically small
41
-------
wastewater flows because very few of the unit operations use
water in a way that would cause wastewater generation. The
primary use of water in the actual formulating process is for
cooling water in the chilling units and for equipment and floor
wash.
Sources of wastewater from mixing/compounding/formulation
operations are (a) floor and equipment wash waters, (b) wet
scrubbers, (c) spills, and (d) laboratory wastes. The use of
water to clean out mixing tanks can flush materials of unusual
quantity and concentration into the plant sewer system. The
washouts from recipe kettles may be used to prepare the master
batches of the pharmaceutical compounds and may contain inorganic
salts, sugars, syrup, etc. Other sources of contaminated
wastewater are dust and fumes from scrubbers either in building
ventilation systems or on specific equipment. In general, these
wastewaters are readily treatable by biological treatment
systems.
An analysis of the pollutant information in the pharmaceutical
data base shows that wastewaters from Subcategory D plants
normally have low BOD, COD, and TSS concentrations; relatively
small flows; and pH values of 6.0 to 8.0.
D. RAW MATERIALS AND PRODUCTS
The pharmaceutical industry utilizes a vast array of raw
materials and processing agents. The diversity of feedstock is
attributable to the variety of products and the number of process
variations common to the industry. This review describes a
number of materials that can be used as feedstocks and processina
agents.
Fermentation operations use large quantities of nutrient
materials such as carbohydrates and proteins. Examples of some
raw materials are meat extractions and distillers extract.
Materials classified as priority pollutants which enter
fermentation operations are mainly metals, as reaction modifiers
au? j?rocessin9 agents in the fermenter, and organic solvents,
which are employed as extractive agents for product separation
and purification. The residues from the organic starting
materials plus mycelia contribute heavily to conventional BOD
loadings.
Biological and natural extraction processes can have a wide
variety of feedstocks including roots, leaves of plants, animal
glands or parasite fungi. These substances contribute to BOD
loadings; priority pollutant loadings are primarily due to
solvents used for extraction. These solvents can be any number
42
-------
of organic compounds with benzene and chloroform being among the
most widely used.
Chemical synthesis presents the broadest spectrum of starting
materials. Feedstocks can range from oxbile to dextrose. Given
the appropriate starting material there are many common synthetic
processes (as many as several hundred) by which the starting
material is transformed to the product. A number of solvents and
additives are required to complete the synthesis. Solvents are
usually inexpensive relative to the product and are used
liberally for this reason. These solvents are almost exclusively
organic and may be priority pollutants. Additives are used to
control reactions and many contain metals that are priority
pollutants.
Product recovery and purification from most of the processes used
to produce Pharmaceuticals expose a -variety of solvents and
extractive agents to the wastewater. These include hydrocarbons
and other organic compounds such as methylene chloride, benzene,
carbon tetrachloride, and chloroform. Reaction control, and in
some cases reactant requirements, call for the use of many metal
compounds listed as priority pollutants.
Many of the 126 priority pollutants appear in the industry's
wastewater. Most of them have their source in the raw materials
and processing agents employed. The organic solvent and metal
pollutants are almost completely accounted for by plant material
inputs.
In summary, chemical materials utilized and produced in the
pharmaceutical industry are numerous and diverse. They are used
as reactants, extractive solvents, catalysts, inhibitors,
diluents, and other purposes. In addition, other chemical
compunds may be identified as intermediates, products, and by-
products. Many of these materials are among those listed as
priority pollutants. In fact, the vast majority of the 126
priority pollutants listed are present somewhere in the industry
although not necessarily in wastewater. Appendix H summarizes
the usage and occurrence of priority pollutants as indicated by
308 responses.
E. CURRENT DIRECT DISCHARGER PERFORMANCE
1
BPT Compliance
Direct discharger wastewater effluents in the pharmaceutical
industry are currently subject to 1976 BPT performance standards.
A plant-by-plant analysis of 308 data for direct dischargers
indicates that although many plants are well within BPT limits, a
substantial number are not meeting the BPT level of 90 percent
43
-------
BOD removal and 74 percent COD removal.
rankings are shown in Table II1-4.
These performance
2- Current Performance Compliance with Proposed BPT
Current performance of some plants already meets the approximate
BCT limitations (see Table III-5) for BOD, COD, and TSS of 40,
360, and 40 mg/1, respectively. Tables II1-6 through II1-8 show
a ranking by effluent concentration and indicate a projected
compatibility with the projected design criteria for BCT and BAT
limitations.
Tables III-9 and 111-10 compare performance as judged by con-
centration criteria and by percent removal for BOD and COD. The
ranking derived for plants using either criterion are similar.
F. Comparison of Current Permits with 1976 BPT
Table Hl-ll presents the results of a comparison of current
permit limitations for direct dischargers with 1976 BPT
limitations for BOD, COD and TSS. Permit limitations (expressed
in Ibs/day) were compared to a Ibs/day value calculated from 308
data, using 1976 BPT design criteria (BOD 90%, COD 74%, TSS 52
mg/1), for each plant. The comparison shows that in general the
majority of current permit limitations for BOD and COD are more
stringent than, or at least equivalent to, the 1976 BPT
limitations. However, the majority of current permit limitations
for TSS are less stringent than 1976 BPT limitations.
44
-------
TABLE II1-1
PHARMACEUTICAL INDUSTRY
GEOGRAPHICAL DISTRIBUTION
Number of Percent of
T r^r*at* "i nn
EASTERN U.S.
Connecticut
Maine
Massachusetts
New Hampshire
Rhode Island
Vermont
REGION 1 Total
New Jersey
New York
Puerto Rico
Virgin Islands
REGION 2 Total
Delaware
Maryland
Pennsylvania
Virginia
West Virginia
District of Columbia
REGION 3 Total
Alabama
Georgia
Florida
Mississippi
North Carolina
South Carolina
Tennessee
Kentucky
REGION 4 Total
Til inois
Plants
368
8
0
7
0
1
' ' 1
1
17
76
43
44
2
165
2
7
26
7
2
0
44
3
6
8
2
12
3
10
5
49
38
Total Plants
79.2
1.7
0.0
1 .5
Of\
.0
0.2
0~ . '•)
. /
3.6
16.4
9.3
9 . 5
....... 0.4,
35.6
0.4
1 .5
5.6
1 .5
OA
. 4
Of\
. 0
9.4
0.6
1 .3
1 .7
' 0.4
2.6
0.6
2.2
1 . 1
10.5
8.2
Average
Number
Average
Plant
Employees Start-up
Per Plant
268
195
77
(2)
(2)
\ *• /
161
346
211
216
i •j
1 3
239
121
65
370
138
1 R1
1 */ 1
267
15
189
95
759
456
87
301
1*^
2
250
305
Year ( 1 )
1952
1963
1961
(2)
(2).
1960
1950
1943
1970
1956
1965
1938
1949
1950
1950
1958
1956
1967
1949
1971
1968
1940
1962
1951
45
-------
Indiana
Ohio
Michigan
Wisconsin
Minnesota
REGION 5 Total
18
14
15
4
4
3.9
3.0
3.2
0.9
0.9
664
203
423
54
41
1944
1929
1933
1957
—
93
20. 1
351
1943
WESTERN U.S.
Arkansas
Louisiana
Oklahoma
Texas
New Mexico
REGION 6 Total
Iowa
Kansas
Missouri
Nebraska
REGION 7 Total
Colorado
Utah
Wyoming
Montana
North Dakota
South Dakota
REGION 8 Total
Arizona
California
Neva
Hawaii
REGION 9 Total
Alaska
Idaho
Oregon
Washington
REGION 10 Total
96
2
2
0
12
0
16
3
4
17
4
28
5
1
0
0
0
0
6
1
38
1
0
40
0
0
2
4
20.8
0.4;
0.4i
0.0!
2.6'
'• 0.0
3.4
0.6
0.9
3.7
0.9
6.1 !
1 .1
0.2
0.0
0.0
0.0
0.0
1 .3 :
0.2
8.2
0.2
0.0
8.6
0.0
0.0 :
0.4
0.9
152
1558
9
—
127
-
129
77
123
108
201
117
96
(2)
_
_
_
-
162
(2)
139
(2)
-
137
^ ,
—
25
33
1962
1970
_
_
1967
-
1968
1963
1954
1943
1962
1951
1967
(2)
_
_
-
1968
(2)
1967
(2)
1967
_
_
_
—
1.3
30
(1) Since data concerning plant start-up year were not solicited
1955
46
-------
(2)
from the Supplemental 308 plants, the figures were calculated
using only the original 308 plants responses.
Employment and start-up year figures are not presented to
avoid disclosing individual plant data.
47
-------
Manufacturing
Subcategory
Combination
A only
A B
ABC
A B C D
A B D
A C
A CD
A D
B only
B C
BCD
B D
C only
C D
D only
Not Available
Total Plants
Individual
Manufacturing
Subcategory
A
B
C
D
Not Available
TABLE II1-2
SUBCATEGORY BREAKDOWN
Number of
Plants
4
1
2
8
4
3
10
5
21
12
9
23
47
42
271
2
464
Number of Plants
in Subcateqory
37
80
133
372
2
Total number of subcategories 624*
Percent of
Total
Plants
Percent of
Totals
6.0
12.8
21 .3
59.6
0.3
This represents the total number of subcategories covered by
the 464 manufacturing plants.
48
-------
TABLE III-3
PRODUCTION OPERATION BREAKDOWN
Number of Operations
Subcategory
Type of Operation
Batch
Continuous
Semi -continuous
Total Number of Operations
Percent of Total Operations
A
32
3
11
46
6.7
B
76
0
9
85
12.
C
129
14
19
162
4 23.
D
359
16
17
392
6 57.2
Total
596
33
56
685*
100.0
Percent
of Total
Oper.
87.0
4.8
8.2
100.0
Percent of Subcateqory
Which is Batch
69.6 89.4 79.6 91.6 87.0
* Since each individual subcategory within a plant may be comprised
of more than one type of operation, this figure will be greater
than the total number of subcategories.
NOTE: The above data apply to 462 manufacturing plants. For two
plants no information was available on their subcategories
and types of production operations.
49
-------
TABLE II1-4
DIRECT DISCHARGERS: COMPARISON OF PLANT PERFORMANCE
VS. 1976 BPT PERCENT REMOVAL "DESIGN" CRITERIA (BOD a) 90% & COD a) 74%)
(BASED ON 308 DATA)
Summary of Comparison
Meets design criteria, both parameters
Meets design criteria, but data incomplete
Does not meet criteria 13
Data lacking 36
Total Direct Dischargers
60
7
4
308 Long Term Avg.
Plant BOD
Number % Removal
308 Long Term Avg.
BOD COD COD
Rank % Removal Rank
Plants meeting design criteria: ;
12306
12307
12353
12038*
12248
12317
12026
^Partially meeting
12160
12463
12022
20297
Plants poorer than
12161
12015
20245
12132
12236
12104
12294
12338
20165
12239
12038*
99.0
97.5
96.5
96.1
95.9
95.8
95.0
design criteria,
99.1
94.1
93.2
94.7
design criteria
92.6
92.5
88.7
87.2
86.7
85.9
85.2
85.0
84.0
81 .9
80.1
2
3
4
5
6
7
8
but
1
9
10
8
92.1
96.5
94.4
87.9
87.0
89.9
77.7
lacking one
in one or more
12
14
14
15
16
17
18
19
20
21
22
36.56
69,72
94.5
95.77
79.32
74.52
79.89
_
79.11
81 .97
—
5
1
4
7
8
6
13
data item
i terns :
17
3
2
11
15
10
M
12
9
-.
50
-------
12471
20257
12407
Plants without % removal data:
12001
12006
12095
12097
12098
12117
12085
12089
12189
12194
12205
12283
12119
12261
12264
12267
12281
12459
23
24
25
12256
12298
12308
12339
12406
20319
75.78
12287
20037
20201
20246
20298
20370
14
12462
12014
12030
12057
12073
20402
Note: Underline indicates performance not meeting design criteria,
51
-------
TABLE II1-5
DIRECT DISCHARGERS: COMPARISON OF PLANT PERFORMANCE
vs. PROPOSED BCT and BAT CONCENTRATION DESIGN CRITERIA (BOD S 40 MG/L,
COD S 360 MG/L and TSS a) 40 MG/L)
(BASED ON 308 DATA)
Summary of Comparison
Meets design criteria, both parameters 9
Meets design criteria, but data incomplete 9
Does not meet design criteria ' 23
Data lacking ] 9
Total Direct Dischargers 60
308 Long Term Avg. 308 Long Term Avg.
Effluent Effluent
Plant BOD BOD COD COD
Number mg/1 Rank mq/1 Rank
Plants meeting design criteria:
12463
20201
12053
12248
12104
20246
12097
12132
20165
6
1
8
10
12
13
28
29
32
2
2
5
6
7
10
19
20
22
29
50
67
63
40
128
289
203
113
1
4
7
6
2
13
16
15
12
308 Long Term Avg.
Effluent
TSS TSS
mg/1 Rank
9
4
2
35
22
33
29
29
24
4
2
1
19
10
18
14
14
11
Partially meeting design criteria, but lacking one or more items
12089
12298
20319
20297
12001
12338
12407
12095
12406
13
15
15
20
21
30
54
Plants poorer than
12160 5
12119 7
12036 13
9
11
12
16
18
21
25
design criteria in one or
1
5 40 2
8 197 14
13 7
26 11
9 4
36 20
30 15
17 9
6 2
10 4
more items:
43_ 23
70 29
44 24
52
-------
12471
12307
12015
20037
12317
12283
12287
20245
12205
12161
12026
12022
20257
12462
12236
12294
12038*
12239
12098
14
18
19
20
32
35
56
56
60
72
93
105
143
145
149
208
244
284
693
11
u
15
16
22
24
26
26
28
29
30
31
32
33
34
35
36
37
38
83
489
107
10
1 1
5
8
9
22
23
19
18
20
21
24
17
26
38
Plants poorer than design criteria in one or more items:
39
12038** 114-0
12261
Plants with no effluent data:
4470
"9880
27
28
12006
12014
12117
20370
12073
12085
12281
12187
12194
20298
12264
12267
12057
457
565
12339
12459
12256
28
30
25
26
26
7
17
22
34
36
21
32
30
13
35
33
37
38
39
20402
12030
12308
*
**
Fermentation Wastes Only
Chemical Wastes Only
53
-------
TABLE II1-6
RANKING OF DIRECT DISCHARGERS BY EFFLUENT BOD CONCENTRATION
(DATA BASE: 308) ,
308 Long Term Avg,
E:
Plant No.
12160
12463
20201
12119
12053
12248
12104
12036
12089
20246
12471
12298
20319
12307
12015
20037
20297
12001
12097
12132
12338
12317
20165
12283
Design criterion
12407
12287
20245
12205
12161
12026
12022
20257
12462
12236
12294
12038*
12239
12098
ffluent BOD5_
mg/1
5
6
6
7
8
10
12
13
13
13
14
15
15
18
19
20
20
21
28
29
30
32
32
35
of 40 mg/1
45
56
56
60
72
93
105
143
145
149
208
244
284
693
Rank by BOD5_
Effluent Cone.
1
.2
2
4
5
6
7 ;
8
8
10 :
1 1
12 !
12
14 :
15
16 !
16
18 ;
19
20
21
22
22 ;
24
25
26
26
28
29 ;
so :
31
32
33
34
35
36
37
38
Rank by
% Removal
1
10
-
-
4
6
16
2
-
' -
22
-
-
3
13
-
9
-
-
15
19
7
20
—
25
-
14
—
12
8
1 1
24
—
16
18
5
21
-
% Removal
99.1
94.1
96.5
95.9
85.9
99.0
72.0
97.5
92.6
94.7
87.2
85.0
95.8
84.0
16.7
88.7
92.7
95.0
93.2
70.5
86.7
85.2
96.1
81 .9
54
-------
12038**
1 140
Plants with no BOD data;
12006
12014
12030
12057
12073
12085
12095
12117
12187
12194
12256
12261
39
12264
12281
12281
12298
**
23
12308
12339
12459
80.1
20298
20370
20402
Fermentation Wastes Only
Chemical Wastes Only
(Ranked as two separate plants, but counted as one.)
55
-------
TABLE II1-7
RANKING OF DIRECT DISCHARGERS BY EFFLUENT COD CONCENTRATION
(DATA BASE: 308)
308 Long Term Avg. Rank by COD
Effluent COD Effluent Cone. Rank
Plant No.
12463
12104
12119
20201
12287
12015
12248
12053
20245
12205
12307
12317
20165
20246
12036
12132
12097
12239
12462
20257
mq/1
29
40
40
50
51
54
63
67
74
81
83
107
112
128
197
203
289
290
297
329
by
% Removal
1
2
2
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
«
16
-
—
—
7
9
4
3
-
1
6
13
—
5
2
—
10
—
15
Design criterion of 360 ma/1
12236
12294
12161
12026
12038*
12339
12098
12038**
12261
Plants with
12001
12073
12187
12283
12459
20370
553
568
944
946
1453
2370
2886
4470
9880
no COD effluent data:
12014 12006
12085 12089
12194 12256
12298 12308
12471 20037
20402
21
22
23
24
25
16
27
28
29
12022
12095
12264
12338
20297
12
1 1
17
14
8
—
—
—
18
12030
12117
12267
12406
20298
12057
12160
12281
12407
20319
* Fermentation Waste Only
** Chemiral Wast-^ Onlw
% Removal
74.52
88.96
87.04
94.44
94.52
96.53
89.94
79.11
92.19
95.77
81 .97
75.78
79.32
79.89
68.30
77.69
87.91
36.56
56
-------
TABLE II1-8
RANKING OF DIRECT DISCHARGERS BY EFFLUENT TSS CONCENTRATION
(DATA BASE: 308)
308 Long Term Avg
Rank by TSS
Effluent TSS
Plant No.
12053
20201
12095
20319
12463
12406
12287
12089
12015
12407
12104
70165
12298
12294
12132
12097
12338
20245
20246
12248
20297
12022
12205
Design criterion
12160
12036
20037
12283
12317
12471
12119
12236
12307
12462
12239
12161
12038*
12026
12098
mg/1
2
4
6
9
9
10
13
13
15
17
22
24
26
28
29
29
30
32
33
35
36
38
40
43
44
47
50
50
59
70
90
90
97
174
196
306
326
336
Effluent Cone. Ra,nk by
mq/1
1
2
3
4
4
6
7
7
9
10
1 1
12
13
14
15
15
17
18
19
20
21
22
23
24
25
26
27
27
29
30
31
31
33
34
35
36
37
38
% Removal
1
—
4
—
—
3
—
—
7
14
—
13
—
—
—
—
8
—
—
—
11
—
^
2
5
—
—
' —
15
—
—
—
—
—
12
8
—
16
% Removal
99.5
96.5
97.0
89.7
43.3
48.9
85.0
75.5
99.0
93.7
36.6
50.8
86.5
5.1
57
-------
12038**
12261
457
567
Plants with no TSS data:
12001
12073
12194
12281
*
**
12057
12187
12267
20257
12256
12339
12459
39
40
12308
20370
20402
6
10
89.8
81 .6
20298
12014
12030
12006
12985
121 17
Fermentation Waste Only
Chemical Waste Only
58
-------
TABLE II1-9
RANKING OF DIRECT DISCHARGERS BY BOD PERCENT REMOVAL
(DATA BASE: 308)
Plant No.
308 Long Term Avg.
Effluent BOD
mg/1
12160
12036
12037
12053
12038*
12248
12317
12026
20297
12463
12022
12161
12015
Design
20245
12132
12236
12104
12294
12338
20165
12239
12038*
12471
20257
12407
*
**
5
13
18
8
244
10
32
93
20
6
105
72
19
criteria of 90% removal
56
29
149
12
208
30
32
284
1140
14
143
45
Fermentation Wastes
Chemical Wastes Onlv
Rank by BOD
Effluent Cone,
1
8
14
5
36
6
22
30
17
2
31
29
15
,27
20
34
7
35
21
23
37
39
11
32
25
Rank by
% Removal
1
2
3
4
5
6
7
8
9
10
1 1
12
13
14
15
16
17
18
19
20
21
22
23
24
25
% Removal
5
5
1
99.1
99.0
97
96
96
95.9
95.8
95.0
94.7
94.1
93.2
92.7
92.6
88.7
87.2
86.7
85.9
85.2
85.0
84.0
81 .9
80.1
80.1
70.5
16.7
59
-------
TABLE 111-10
RANKING OF PLANTS BY COD PERCENT REMOVAL
(DATA BASE: 308)
308 Long Term Avg.
]
Plant No.
12307
12132
20245
12053
12036
12317
12915
12038*
12248
12239
12294
12236
20165
12026
20257
12104
Design Criteria
12161
12261
affluent COD
mq/1 E
83
203
74
67
197
107
54
1453
63
290
658
553
113
946
329
40
of 74% removal
944
9880
Rank by
If fluent Cone.
11 f
16
9
8 ;
15 !
12 i
6 :
25
7
18 :
22 !
21 1
13
24
20
2
23 .
29 i
Rank by
% Removal
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
% Removal
96.53
95.77
94.52
94.44
92.19
89.94
88.96
87.91
87.04
81 .97
79.89
79.32
79.11
77.69
75.78
74.52
68.30
36.56
*Fermentation Wastes Only
60
-------
TABLE III-11
Ilant No-
12015
12022
12026
12036
12038
12053
12085
12097
12104
12117
12132
12161
12167
12205
12236
12248
12256
12261
12294
12307
12317
12339
12406
12459
12462
12471
BPT BPT
x
x
X
X
X
x
>BPT
x
X
x
>BPT
x
x
x
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
x
x
X
X
X
X
X
Kotes BPT: permit more stringent than BPT
Totals? BOD permits less stringent than EPT = 3
BOD permits equivalent,to BPT = j*
BOD permits more stringent than BPT 9
COD permits less stringent than BPT J
COD peririts equivalent to BPT jj
COD permits itore stringent than BPT 8
TSS permits less stringent than EPT .13
TSS permits equivalent to BPT 2
TSS permits more stringent than BPT j»
61
-------
FIGURE m-1
PHARMACEUTICAL INDUSTRY
GEOGRAPHICAL DISTRIBUTION
HAWAII
44-
• PUERTO RICO -«2
VIRGIN ISLANDS
-------
SECTION IV
INDUSTRY SUBCATEGORIZATION
A. INTRODUCTION
This section defines the subcategbries selected for evaluative
analysis and presents the rationale for their selection. The
subcategory breakdown utilized in this study was developed for
evaluative purposes. This method was found to be the most
practical means Of analyzing raw, waste .characteristics,
wastewater flow, and treatment technology alternatives. However,
at the end of the analysis, we determined that subcategories were
not necessary for regulatory purposes because the calculated
limits would not vary significantly between subcategories.
B. BASIS FOR SUBCATEGORIZATION
The existing BPT regulation divides the pharmaceutical industry
into subcategories based on the general type of manufacturing
process. Process method is an easily definable basis for
subcategorization and is well understood by those knowledgeable
about the industry. Characteristically only one process is used
for a given product or class of products although there are
sequential processing exceptions. Subcategorization based on
process therefore provides effective subcategorization by product
type as well. :
Both plant size and wastewater flow relate to process methods in
the sense that some processing methods (e;g., fermentation and
synthesis) are undertaken only in large-scale or highly complex
facilities. More direct product-oriented methods, such as
biological extraction or product formulation generally involve
small and less complex manufacturing facilities and less water
use.
The wastewater generated by most plants in the industry results
from more than one kind of process. Nonetheless, the existence
of single subcategory plants does permit wastewater
characterization according to process method. Process methods
are often distinct from one another in their effect on wastewater
characteristics (pollutant identities and loads and flow) because
of differences in the production modes involved and the use of
the campaign operation. Production mode may be batch or
continuous and in some cases semi-continuous, that is, with part
of the process being carried out on a batch basis (e.g. chemical
synthesis) and the other part of- the process being carried out
63
-------
continuously (e.g. product purification). The use of campaign
operation involves the use of the same equipment train to produce
different products. Both approaches to production are employed
where possible to reduce unit operating costs and the number of
certification analyses.
Fermentation and chemical synthesis processes are generally
conducted on a batch basis. Fermentation usually involves large
batches, while the batch size tends to vary considerably for
chemical synthesis processes. Chemical synthesis involving
several steps is usually conducted using the campaign operation
method. Biological extraction and product mixing and formulation
processes are generally carried out continuously.
The effect of differing uses of production approaches not only
affects wastewater characteristics on a plant to plant basis but
also affect the wastewater characteristics of individual plants
on a day to day basis. The effect of this induced variability on
wastewater characteristics and the resulting treatment
inefficiency can be ameliorated to some extent by flow
equalization prior to treatment.
C. SELECTED SUBCATEGORIES
The pharmaceutical industry subcategories
established for data analysis are:
selected
and
Subcategory A
Subcategory B
Subcategory C
Subcategory D
Fermentation
Biological Extraction
Chemical Synthesis
Mixing, Compounding, and Formulation
An additional Subcategory (Subcategory E - Research) was
identified earlier. However, since research does not fall within
SIC Codes 2831, 2833, or 2834 designated by the Consent Decree
and does not have wastewater characteristics warranting a
national regulation, it is not included in this study.
D. SUBCATEGORY CHARACTERISTICS
There are discernable differences among the subcategories when
viewed in terms of effluent concentration averages or ranges and
wastewater flow rates. However, diversity within each
Subcategory is often greater than between subcategories. As
explained below, this is a major reason for not subcategorizing
for regulatory purposes.
1. Fermentation is the basic processing method used in the
production of most antibiotics and steroids. The steps employed
are (a) preparation of a seed, (b) innoculation of the nutrient
64
-------
batch, (c) fermentation of the nutrient raw materials, and (d)
recovery of the product by such means as extraction,
precipitation, or ion exchange.
Fermentation processes are typically very large water users.
Spent beers are the major source of characteristically high BOD,
COD, and suspended solids levels in the wastewater.
2 Biological or natural extraction is the extractive removal
of therapeutic products from such natural sources as plant parts
(e.g., roots or leaves) animal parts (e.g., glands), or parasytic
fungi (e.g., molds).
In contrast to fermentation, biological extraction processes
are normally small-volume water users with lower BOD, COD, and
suspended solids levels.
3 Chemical synthesis is utilized widely in the manufacture of
many drugs in use today. Most production is in batch reactors
which can be used for a wide variety of process steps (heating,
cooling, mixing, evaporation, condensation, crystallization, and
extraction). Generally, these vessels are constructed of
glass-lined or stainless steel. Their versatility permits
multiple functions to produce many different compounds.
Chemical synthesis processes are characterized as relatively
large water users with high pollutant loadings. Also, a wide
variety of chemical pollutants can be expected.
4 In formulation (mixing, compounding, and formulation),
Pharmaceuticals are prepared in such useable forms as tablets,
Sapsules, liquids, and ointments. Active ingredients are
physically mixed with filler, formed into dosage quantities, and
packaged for distribution.
Formulation is normally a low-level water user (in many cases a
dry operation) with low pollutant levels.
5 Because most plants in the pharmaceutical industry include
operations in two or more subcategories and because common
treatment systems are used to treat combined wastes, raw waste
characteristics or treatment effectiveness often cannot be
differentiated by subcategory. For these reasons, much of tne
data analysis is limited to that portion of the data base which
describes the performance of single subcategory plants; the
remainder discusses the performance of mixed subcategory plants.
6. Variations in process routes employed by different producers
are common in the pharmaceutical industry. Process variations in
chemical synthesis plants manufacturing the same product occur
65
-------
because different starting materials and reaction dequences are
used. Two plants making the same product but using different
starting materials may use different reaction sequences. It is
possible that once a common intermediate compound is derived,
that the remaining processing steps will mirror each other. Even
if the same starting material is used by different plants, it is
possible, due to the complexity of a synthesis, that several
feasible routes to an end product exist. The decision as to
which route will be employed can depend on economics, patent
coverage, corporate history or even personal preferences.
In fermentation and material extraction processes the major
differences between processes will occur in the extraction
method. In many cases, extractions can be accomplished by any
number of solvents. Choice of a solvent will depend on
environmental impact, company history, economics, patents and
other factors. Due to the number of variables involved it is not
surprising that such processes vary widely between companies.
E. DECISION NOT TO SUBCATEGORIZE FOR REGULATORY PURPOSES
Although the industry was analyzed considering these process-
based subcategories, such distinctions were determined to be
unnecessary for the statement of limitations since:
(1) Most of the industry (in terms of total wastewater
flow) is composed of plants with operations in more than one
process subcategory, which combine the wastewater from all
process subcategories before it is treated for conventional and
nonconventional pollutants. In addition, the relative volumes of
wastewater from the different subcategory operations are subject
to considerable variation. Thus, wastewater in most plants is
not normally distinguishable by process origin. Under these
circumstances it is difficult to apply different limitations to
different subcategories.
(2) The broad product/process diversity within each
subcategory studied tends to exceed and obscure distinctions
characteristic of each subcategory. Differences in pollutant
loadings for plants within a subcategory may be greater than for
plants from different subcategories. Subcategorization schemes
along different product/process lines were considered but were
rejected as being too complex and not necessarily more accurate.
(3) The treatability of the wastewater from plants within
each subcategory is not characteristically related to the
subcategory. The conventional pollutant loadings for BOD and TSS
are generally amenable to reduction by biological treatment and
associated operations (clarification) regardless of their
subcategory source. It has also been demonstrated that reduction
66
-------
to identical pollutant levels is achievable for wastewater from
each of the different subcategories. Pollutant loadings may vary
within each subcategory and across subcategories but such
differences may be addressed by design and operating
modifications to the biological systems. The current BPT
regulation establishes identical limitations for each subcategory
covered.
(4) The existing subcategorization scheme is irrelevant to
the regulation , of toxic pollutants for this industry. The
occurrence of toxic pollutants in a plant's wastewater is not
dependent on its process subcategory designation but on the
particular mix of individual product/processes it engages in.
(5) The available performance data from which the
regulations are devised as well as the screening and verification
program results for toxic pollutants suggest that the industry
can be equitably regulated by a single set of limits.
67
-------
SECTION V
WASTE CHARACTERIZATION
A.
INTRODUCTION
The Agency, through an extensive data gathering effort, has
studied qualitatively and quantitatively the wastewaters of the
pharmaceutical industry. This effort provided the baseline data
necessary for determining the significant pollutants present in
the wastewaters of the pharmaceutical industry and subsequently
the regulatory scope for the pharmaceutical point source
category.
As a result of earlier studies, particularly the 1976
Development Document, the EPA had available a limited amount of
data which characterized the wastewater discharges of the phar-
maceutical manufacturing industry. However, not only were some
of these data old, but for the most part they were related only
to such "traditional" pollutant parameters as BOD, COD, and TSS.
Information on the 126 toxic pollutants or classes of toxic
pollutants was almost nonexistent. In order to fill this void,
the Agency instituted a number of programs aimed at gathering
from the pharmaceutical industry the necessary data on both toxic
and traditional pollutants. |
Wastewater
following:
characterization has been addressed considering the
(1) Traditional pollutants
(2) Priority pollutants I
(3) Wastewater flow ''
This section reviews the sources of data and describes the
results which provide the basis for the limitations and
standards.
B. TRADITIONAL POLLUTANTS
Traditional pollutants considered for regulation are BODS COD,
TSS, and pH. The reasoning behind their selection and the
omission of others is reviewed in Section VI. Three of these,
BOD, TSS, and pH are listed as conventional pollutant parameters
and one, COD, is listed as non-conventional.
1.
Sources of Data
68
-------
a. Previous studies - The 1976 Development Document, which
was part of the Rulemaking Package for the 1976 BPT, comprises
the main source of previously developed information.
b. 308 Survey - During 1978 the pharmaceutical industry
was surveyed to obtain wastewater data and related plant
information in support of this new rulemaking effort. The first
308 questionnaire was sent to member companies of the
Pharmaceutical Manufacturers Association (PMA). The content of
this questionnaire appears as Appendix B. The second phase of
this survey was aimed at the remainder of the industry, and the
questionnaire employed is in Appendix D. Substantial differences
in both the form and question content of these forms result from
shifts of program emphasis between the times of their
distribution. Recipients are listed in Appendices C and E.
Survey/response statistics are reviewed in Section II.
Traditional pollutant (BOD, COD, and TSS) levels, as indicated in
the 308 Portfolio data, are summarized in Appendix I, and flows
in Appendix J.
c. Long term data - A list of plants was selected for
further survey of long-term plant log data on end-of-pipe
treatment influents and effluents, with respect to BOD, COD, and
TSS. The development of a long-term data base, covering at least
a full year's data for each plant, was necessary to permit
establishment of a performance average for a representative group
of industry treatment plants in terms of both pollutant level and
effluent variability. A summary of long-term data is presented
in Table V-1.
A summary of plants covered by the long-term data program
follows. Some, but not all, of the plants also appear in the
screening/verification plant list, subsequently used in priority
pollutant analysis.
The flow values presented herein are long-term daily averages
developed from the log data submitted by each plant. These may
differ from flows reported in the 308 portfolio due to the
different time periods in which they were established and/or
different modes of operation during those time periods.
Plant 12015 is a Subcategory D plant which appears in both the
screening plants and the long-term data plants. Activated sludge
and activated carbon are used to treat 0.101 MGD of wastewater
from pharmaceutical manufacture.
Plant 12022 is a Subcategory A and C plant which is one of the
screening plants in addition to being a long-term data plant.
Plant 12022 discharges 1.45 MGD of wastewater from its treatment
69
-------
facilities which include activated sludge, trickling filters,
equalization, neutralization, and primary clarification.
Plant 12026 is a Subcategory C plant which is a screening plant,
a long-term data plant, and a verification plant. This plant
discharges 0.161 MGD of pharmaceutical process wastewater after
treatment with equalization, neutralization, activated sludge,
and a polishing pond.
Plant 12036 is a Subcategory A plant which is both -a screening
plant and a long-term data plant. This plant discharges 0.855
MGD of wastewater from pharmaceutical manufacture, which is
treated with activated sludge, trickling filters, an aerated
lagoon, and a final stabilization lagoon.
Plant 12097 is a Subcategory C and D plant which is a screening
plant as well as a long-term data plant. The chemical waste
treatment unit consists of equalization, neutralization,
physical-chemical treatment, filtration, and chemical
stabilization. This plant discharges 0.640 MGD of wastewater
from pharmaceutical processes.
Plant 12098 is a Subcategory D plant. Activated sludge is used
to treat pharmaceutical process wastewaters which amount to 0.005
MGD.
Plant 12117 is a Subcategory B and D plant. Activated sludge is
used in the wastewater treatment system to treat 0.101 MGD of
pharmaceutical process wastewater.
Plant 12123 is a Subcategory C and D plant which uses only
primary treatment to treat 0.932 MGD of wastewater from
pharmaceutical manufacture.
i
Plant 12160 is a Subcategory D plant. Pharmaceutical process
wastewater is treated with activated sludge. The flow of
wastewater is 0.029 MGD.
Plant 12161 is an Subcategory A, C, and D plant which appears as
both a screening plant and a long term data plant.
Pharmaceutical process wastewaters are treated by neutralization,
primary clarification, equalization, activated sludge, and
polishing ponds. The amount of wastewater discharged 1.65 MGD.
Plant 12186 is a Subcategory C and D plant. Activated sludge and
an aerated lagoon are used to treat 0.370 MGD of pharmaceutical
process wastewaters.
70
-------
Plant 12187 is a Subcategory C plant. The 1.07 MGD of
pharmaceutical process wastewaters is treated with a trickling
filter.
Plant 12235 is a Subcategory C plant. Primary treatment is the
only treatment used for pharmaceutical process wastewater. (This
plant was excluded from the variability analysis since it is not
a direct discharger).
Plant 12236 is a Subcategory C plant. This plant appears in the
screening plants, the verification plants, and the long-term data
plants. The 0.816 MGD of pharmaceutical process wastewaters is
treated with equalization, neutralization, primary sedimentation,
and activated sludge.
Plant 12248 is a Subcategory D plant. Activated sludge is used
to treat the 0.110 MGD of pharmaceutical process wastewater.
Plant 12257 is a Subcategory A, B, C, and D plant. This plant^is
in both the screening plants and the long-term data plants. The
treatment system components are equalization, neutralization, and
activated sludge. The amount of pharmaceutical process
wastewater discharged is 0.755 MGD.
Plant 12294 is a Subcategory C and D plant. Activated sludge is
used to treat the 0.118 MGD of pharmaceutical process wastewater.
Plant 12307 is a Subcategory D plant. Two biological treatments,
activated sludge and aerated lagoon, are used to treat the 0.002
MGD of pharmaceutical process wastewater.
Plant 12317 is a Subcategory D plant. Activated sludge is used
to treat the 0.740 MGD of pharmaceutical process wastewater.
Plant 12420 is a Subcategory B and D plant. This plant is
included in both the screening plants and the long-term data
plants. Activated sludge is used to treat the 0.164 MGD of
pharmaceutical process wastewater.
Plant 12439 is a Subcategory C and D plant. Plant 12439 is in
both a screening and long-term data plant. Process wastewaters
are treated with equalization, neutralization, primary
sedimentation, activated sludge, and an aerated lagoon. Long-
term flow data was not available.
Plant 12459 is a Subcategory D plant with a long-term data flow
of 0.049 MGD. The only method of wastewater treatment utilized
is an aerated lagoon.
71
-------
Plant 12462 is a Subcategory A plant with an average flow of
0.209 MGD. The wastewater treatment employed includes activated
sludge and aerated lagoon.
2- Results and Bases for Limits
Raw waste loads for plants reporting data under the 308 survey
are tabulated in Appendix I. These raw waste loads were compared
to 1976 BPT and proposed BCT, and were ranked according to (1)
effluent concentration and (2) percent removal for BOD, COD, and
TSS. These ranking tabulations are included earlier in Section
III as Tables III-4 through 111-10.
Averages of the raw waste concentrations of BOD and TSS were
developed for each subcategory as base case figures for the
calculation of cost estimates. However, these averages are not
intended to convey any significance other than as a calculation
tool (for further discussion, refer to Section VIII). They do
indicate relative average levels among the subcategories, but are
not used directly in establishing limits.
The development of plant-by-plant costs to accomplish proposed
BCT levels used 308 reported concentrations as the flag
indicating which plants are likely to require additional
treatment and to what extent. This is discussed in detail in
Section VIII.
Table V-l presents a summary of long term data. Among the direct
dischargers, 13 plants are identifiable as having reasonable
removal performances (equal to or,better than that required by
the existing regulation). These are summarized in Table V-2 with
a notation of performance in terms of percent removal and of
long-term average effluent concentrations for BOD, COD, and TSS.
The average performance of these plants serves as the basis for
developing statements of limits for BCT, BAT, NSPS, PSES and PSNS
as discussed in Sections XI, XII, XIII, and XIV. The development
of the statement of limits for the new TSS limitation is
presented in Section X.
Similarly, a further selection of long-term data plants was made
to serve as the basis for NSPS, which is discussed in Section
XIII. This was accomplished by exclusion of data from 3
additional plants whose performance was judged to be marginal as
indicated by percent removal of BOD. Table V-3 lists this
further group of selected plants and their data.
Statistical studies of this data were conducted to develop
variability factors reflecting changes in;performance occurring
from day to day and through the measured period of performance.
72
-------
The bases, methodology, and results of these variability analyses
are reviewed in Section IX,
C. Priority Pollutants
The Consent Agreement list of priority pollutants and classes of
priority pollutants potentially includes thousands of specific
compounds. However, for purposes of rulemaking, the Agency has
selected 129 specific pollutants for limited consideration.
These are listed in Table V-4.
Thirty-three priority pollutants are present in the wastewater of
at least one of the plants sampled. However, few of the priority
pollutants are individually widespread in their occurrence or
high in concentration. The significance of these facts as they
affect the choice of pollutants to be regulated is discussed in
Section VI.
1
Sources of Data
a 308 Portfolio Survey - The 308 Portfolio Survey was an
invaluable source of information for developing profiles of the
pharmaceutical manufacturing industry. Similarly, this survey
proved to be a major source of data for waste characterization
purposes. Not only did it provide more recent and detailed
information on traditional pollutant parameters and wastewater
flow characteristics, but the 308 Portfolio was the first major
source of data on the use and/or generation of priority
pollutants by this industry.
One purpose of the 308 survey was directed at quantifying the
nature and extent of priority pollutants in the pharmaceutical
industry. Of the 464 pharmaceutical manufacturing plants in the
comprehensive 308 Portfolio Data Base, 212 responded to the
questions concerning priority pollutants. Of the 115 different
priority pollutants identified, chloroform, methylene chloride,
phenol, toluene, and zinc were reported as being the most
frequently used as raw materials for manufacturing operations.
None of the priority pollutants were reported by even as many as
ten respondents as being intermediate or final products. Some
priority pollutants (primarily such pesticide-related compounds
as endrin and heptachlor) were reported as being analyzed in the
effluents of the manufacturing plants (most probably due to the
mixing of pharmaceutical and nonpharmaceutical wastewaters), but
not as being a raw material or a final product.
The 308 data base indicates that although the pharmaceutical
manufacturing industry uses and therefore might discharge a large
number of priority pollutants, broad occurrence of specific
chemical compounds is limited. Priority pollutant information
73
-------
submitted by the pharmaceutical manufacturing plants is presented
in Appendix H.
b. PEDCo Reports - Concurrent with the efforts to profile the
pharmaceutical manufacturing industry using the 308 Portfolio
survey, PEDCo Environmental, Inc. undertook a study to detail the
various manufacturing processes/steps that are used in the
production of fermentation, extractive, and synthesized
Pharmaceuticals.
In their studies, PEDCo examined recent industry data and
selected those products that comprise the major areas of
production for each of the three manufacturing subcategories
(i.e., A, B, and C). With these major product lines as a base,
they then consulted all available literature describing the step-
by-step procedures to be used in the production of each
substance. As a result, PEDCo was able to identify certain
priority pollutants that were known to be used by the
pharmaceutical industry. These pollutants are listed in Table V-
D *
Because of the size and complexity of the industry and the myriad
of products manufactured, it was not practical for a study of
this kind to identify every priority pollutant that could be
used. The competitive nature of the industry and the fact that
many products are produced under closely held processes make much
of the necessary data unavailable.
c. RTP Study - In December 1978, EPA's Office of Air Quality
Planning and Standards at Research Triangle Park published a
document (70) providing guidance on air pollution control
techniques for limiting emissions of volatile organic compounds
from the chemical formulation subcategory of the pharmaceutical
industry.
As part of this study, the Pharmaceutical Manufacturers
Association (PMA) surveyed selected pharmaceutical plants to
determine estimates of the ten largest volume volatile organic
compounds that each company purchased and the mechanism by which
they leave the plant (i.e., sold as product, sent to the sewer,
or emitted as an air pollutant).
Table V-6 presents a compilation of the results of this survey.
Of the twenty-six reporting companies, 25 indicated that their
ten largest volume volatile organics accounted for 80 to 100
percent of their total plant usage. (The other company stated
that the ten highest volume compounds only accounted for 50
percent of its total plant usage.) These 26 companies accounted
for 53 percent of the domestic sales of ethical Pharmaceuticals
in 1975.
74
-------
Included in the list of 46 compounds presented in Table V-6 are
seven priority pollutants. These compounds are methylene
chloride, toluene, chloroform, benzene, carbon tetrachloride,
1,1,1-trichloroethane, and 1,2-dichlorobenzene.
Table V-7 presents a summary and analysis of the data outlined in
Table V-6. Priority pollutants represent approximately 27
percent of the total volatile organic usage in the segment of the
industry analyzed. However, priority pollutants represent only
13 percent of the total mass discharge of volatile organics to
the plant sewers. This indicates a tighter control of the
discharge of toxic materials than of other organic materials.
Table V-7 also indicates that of the total quantity of all
volatile organic compounds discharged, only a fraction (16.7
percent) is discharged via wastewater. The priority pollutants
volatile organics are discharged with the wastewater in an even
lower proportion (9.7 percent).
In summary, the RTF report indicates that although the
pharmaceutical industry has a large involvement with volatile
organic materials, including some toxic compounds, there is
presently tight control over their discharge to the environment
via plant sewers.
d RSKERL/ADA Study - The Robert S. Kerr Environmental Research
Laboratory at Ada, Oklahoma (RSKERL/ADA) conducted for the
Effluent Guidelines Division (EGD) an applied research study
entitled "Industry Fate Study." (90) The purpose of this report
was to determine the fate of specific priority pollutants as they
pass through a biological treatment system. In the course of
this study, priority pollutants associated with the manufacture
of Pharmaceuticals at two industrial facilities were identified.
The results of these wastewater analysis are reported in Appendix
K. These priority pollutants are listed in Table V-8 with
similar data from the RTF Study, Pedco Reports, and
Screening/Verification Programs. RSKERL/ADA data are limited
since they are from only two plants. However, they do serve to
supplement the other data in Table V-8.
e. Wastewater Sampling Programs - Information on priority
pollutants from the aforementioned reports and surveys was
largely qualitative, although the 308 Portfolio did contain some
quantitative data. Moreover, those reports did not always
distinguish between pollutants used by a plant and pollutants in
the final effluent. To expand the data base the EPA initiated
the Screening/Verification Sampling Program under which a number
of plants representing the pharmaceutical manufacturing industry
were sampled for priority pollutants and for the traditional
pollutants (BOD5, COD, and TSS) in a two phase program. The
75
-------
first phase, called the screening phase, involved 26 plants and
covered a broad cross-section of the industry. This was followed
by a verification phase which limited the sampling to only five
carefully selected plants. Augmentation of the existing data
base with the analytical results of the Screening/Verification
Program along with the qualitative information from the other
studies provided the Agency with sufficient information with
which to characterize the industry's wastewaters.
The screening program was conducted to determine the presence or
absence of important priority pollutants in the wastewaters of a
number of pharmaceutical plants and to provide a quantitative
estimate of those present. The information was then used to
limit the search to specific priority pollutants for the
verification program and to identify plants likely to provide
information to accurately characterize the industry wastewaters.
Major processing areas and subcategory coverage, range of
wastewater flows, and an assortment of both in-plant and end-of-
pipe treatment technology/techniques were used as selection
criteria for the screening plants. Multiple subcategory plants,
as well as plants within only one subcategory, were deliberately
sought. Similarly, special effort was made to include plants
with wastewater flows less than 1000 GPD and more than 2.5 MGD.
Descriptions of the plants and of the sampling points are
presented in Appendix O.
Included in the screening group were nine direct dischargers,
seven indirect dischargers, three zero i dischargers and seven
plants which utilized moire than one mode of discharge. In the
latter group there were three plants that were both indirect and
zero dischargers, three plants that were both direct and zero
dischargers and one plant that utilized all three modes of
discharge.
Plant ID No. Subcateqorv
Plaht ID No. Subcateqorv
12015
12022
12026
12036
12038
12044
12066
12097
12108
12119
12132
12161
D
AC
C
A
ABCD
AD
BCD
CD
ACD .
AB
AC
ACD
12210
12231
12236
12248
12256
1 2257
12342
12411
1 2420
12439
12447
12462
BC
AD
C
D
ABCD
ABCD
ACD
BCD
BD
CD
ABCD
A
76
-------
12204
ABCD
12999
CD
The verification program was developed to confirm the presence of
the priority pollutants that were tentatively identified by the
screening program and to provide qualitative pollutant data with
a known precision and accuracy. The analytical results from
these episodes serve as a basis for technology selection and for
use in rulemaking.
Selection of the five plants for the verification program was
based in part on general criteria presented in Section II. A
criterion mentioned earlier and which weighed heavily in the
final selection process was the assortment of major priority
pollutants that were being used as raw materials for the
manufacture of Pharmaceuticals. Table VI-1 lists the priority
pollutants which appear in the waste streams of each of the
screening plants. Other plant specific characteristics that were
considered in the final selection process are summarized below on
a plant-by-plant basis.
Plant No. 12411. Plant 12411
rxou.u «w. .«.~. .. was found to have in its waste
streams three of the common priority pollutants for the industry
— methylene chloride, chloroform, and toluene. The presence of
these pollutants, a process area involving three subcategories,
utilization of a solvent recovery system, and pretreatment of
wastewater followed by aerated lagoon justified this plant for
verification sampling.
Plant No. 12038. This plant was selected for sampling in the
verification program because of its use of potential BAT
technology including activated carbon, aerobic biological
treatment, and thermal oxidation. The known presence of several
priority pollutants, including nitrosamines; the existence of a
large historical data base relating to nitrosamines; and the
inclusion of both pesticides and Pharmaceuticals in the
manufacturing operations at the plant were also considered in the
selection process.
Plant No. 12236. Limitation to one subcategory, reported flows
ofabout 0.81 MGD, use of cyanide as raw material, and treatment
of its wastewaters by activated sludge process qualified this
plant for the verification program. Also of interest were its
cyanide destruction and solvent recovery in-plant treatment
processes.
Plant No. 12026. A treatment train consisting of activated
sludge, aerated lagoon, and polishing pond after in-plant
treatment for solvent recovery were the reasons this plant was
77
-------
selected for verification sampling. It has a reported flow of
0.101 MGD and belongs in Subcategory C.
Plant No. 12097. Plant 12097 is a multiple subcategory (C, D)
plant with a reported flow of 0.035 MGD. Its use of cyanide in
production and a treatment system consisting of in-plant solvent
recovery, activated sludge, and physical-chemical treatment were
considered in selecting this plant.
2. Results of Screening/Verification Program
A plant-by-plant summary of the analytical
program is presented in Appendix G.
results from the
Table V-9 lists the traditional and priority pollutants that were
found in this program and the frequency at which they were found
to be present in the waste streams. Although a number of the
priority pollutants appeared in the waste stream, only a few of
them were sufficiently repetitive to cause concern. Pesticides
and PCBs were detected in one of the plants but were not due to
pharmaceutical-related activity.
Wastewater entering and leaving the end-of-pipe wastewater
treatment train were among the points in the waste stream that
were sampled in this program. Concentration levels for many of
the priority pollutants in the final effluent are relatively low.
The reasons for this are: (1) in-plant treatment and process
controls to minimize specific wastewater pollution (2) dilution
of concentrated process wastewater with other less concentrated
wastewaters and (3) incidental removal of some specific chemical
pollutants by end-of&pipe treatment.
D. Wastewater Flow Characteristics
In order to characterize the waste from plants in the
pharmaceutical industry, a determination was made from 308 data
of the total industry wastewater flow rate and its component
process subcategory flows for direct and indirect dischargers.
Total flow from plants with data is compared in Table V-10 with
the flows estimated for the subcategories. These are based on
single-subcategory plant total flow adjusted for the number of
occurrences for each subcategory. The averages of these flows
are also useful as base-case flows for cost analysis.
Approximately 70 percent'of the direct and ' indirect dischargers
(not including zero dischargers) within the 308 Data Base
reported wastewater flows totaling about 80 MGD. Of this, about
45 MGD is from the plants reporting direct discharges. A major
factor in both of these flow totals is the inclusion of Plant
78
-------
12256 which, due to a mixed discharge of large quantities of
once-through river water, reported a flow of 30 MGD.
Using the reported single-subcategory plant flows as a means of
estimating flow attributable to each subcategory, the plants not
Sporting flow are estimated to add another 13 MGD (93 MGD total
estimated discharge flow for the plants in the data base). Table
V-10 summarizes reported and estimated wastewater flows for the
industry as represented by the 308 Data Base; this information is
more comprehensively covered in Appendix J.
E. Precision and Accuracy Program
The Precision and Accuracy (P/A) Study is a fundamental,
continuing program to insure the reliability and validity of
analytical laboratory techniques. The P/A Program is not
utilized as a separate data base in support of the proposed
limitations, but is used primarily to substantiate the data
illustrated in Table V-ll.
Precision refers to the reproducibility among replicate
observations. In an Analytical Quality Control Program,
precision is determined not on reference standards, but by the
use of actual wastewater samples which cover a wide range of
concentrations and a variety of interfering materials usually
encountered by the analyst.
Accuracy refers to a degree of difference between observed and
actual values. Accuracy should also be determined on actual
wastewater samples routinely analyzed and, preferably, on the
same series as those used in the precision determinations.
Through this process, data obtained by analysis of multiple
samples were compared to demonstrate that (a) they Present
clearcut evidence that the analyst is indeed capable of analyzing
the samples for that particular parameter (i.e., he has the
standard method under control, and is capable of generating valid
data) and (b) the data can be used in the evaluation of daily
performance in reference to replicate samples, spiked samples,
and in the preparation of quality control charts.
This type of quality assurance program is applicable to and can
be adapted for all types of analytical procedures.
TRW and Radian performed on a split-sample basis for EPA a P/A
study on a series of 24-hour composite influent and ^effluent
samples collected from a single pharmaceutical manufacturing
plant (12236) representing Subcategory C (chemical synthesis).
Extraction of the non-volatile organic (NVO) sample for the basic
recovery study was performed using continuous liquid/liquid
79
-------
extractors. Volatile Organics (VGA) were analyzed using the
purge-and-trap procedure adopted for this study. Standard
spiking levels were used by both laboratories as specified by
EPA. The extract volumes were selected depending upon expected
concentration of the priority pollutants in the sample and the
established linear response range of the GC/MS instruments. All
pollutants detected in the samples are summarized in Table V-l1.
The values reported by the two laboratories for priority
pollutants are well within the detection limits of GC/MS
analysis, with the exceptions of methylene chloride, toluene, and
chloromethane. The values from the two laboratories are also
moderately close to each other. In some cases, methylene
chloride, toluene, and chloromethane were present in such high
concentrations that although reasonable recovery and quantitation
could be obtained, the results are not meaningful due to
instrument saturation. The high levels present for these
compounds apparently did interfere with the analysis of other
priority pollutants. Recoveries of 2,4-dimethylphenol,
benzidine, and the phthalates were low and erratic.
The detection of some of the priority pollutants could be the
result of contamination by sources in the field or laboratory.
It is common practice to equip automatic composite samplers with
polyvinyl chloride (tygon) tubing. Phthalates are widely used as
plasticizers to ensure that the tubing remains soft and flexible.
These compounds have a tendency to migrate to the surface of the
tubing and leach out into water passing through the sample
tubing. Results of analysis shown in Table V-n indicate the
phthalates vary between laboratories. Sample contamination is
possible and therefore, some of the results cannot be
conclusively attributed to the wastewater.
80
-------
TABLE V - 1
SUMMARY OF LONG TERM DATA
00
PLANT SUBCAT FLOWKGO IHBOD
12015 D
12022 A C
12026 C
12036 A
12097 CO
12098 D
12117 B
12123 CO
12160 D
12161 A CO
12186 CD
12107 C
12236 C
12248 0
12257 ABCD
1229* CD
12307 D
12317 0
12420 B D
12439 CD
12459 0
12462 A
100.93
1440.1
160.58
1092.1
63.99
5. 52
100.66
931.82
29.35
1653.3
37.49
1065
816.12
109.55
754.50
117.55
2.10
739.83
164.23
49.08
208.54
232.64
2141.6
3670
1570.8
1577.3
t
34.50
490.19
1538.9
"
.
741.97
294.44
2961.7
15S4.3
1003.7
^
69.50
1805
EFBOD
9.70
110.24
108.14
33.06
49.39
409.83
1.94
^
166.85
19.78
77.01
707.25
126.17
26.00
228.33
44.68
11.35
7.85
786.80
495.36
3.82
726.61
INBODLB EFBODLB
192.84
25830
4C69.7
14490
844.33
a
26.48
f
77.97
21142
,
t
5149.6
281.31
18750
1537.6
_
5985.6
.
B
18.05
3074.8
7.81
1303.3
135.42
293.61
30.64
12.81
1.73
t
41.80
276.37
27.05
6380.9
666.26
25.47
1439.5
43.66
0.21
43.65
1097.2
,
1.58
1272.6
IHCOD
552.68
.
7334.7
3542.3
1804.8
.
95.41
•
2160.4
4332.6
.
•
2009.7
473.90
a
3429.6
t
1102.3
.
. .
298.86
5168.2
EFCOD INCODLB EFCODLB
43.98
.
1221.8
444.49
37.61
,
24.49
.
516.69
850.24
447.54
«
501.90
95.05
.
232.29
106.39
42.34
.
971.20
112.79
2499.3
462.49
.
9700.6
32358
964.73
.
76.59
*
449.56
59231
.
.
13277
455.16
*
3332.3
.
6887.7
.
.
91.93
8666.5
35.44
•
1644.7
3919.7
20.42
.
20.34
*
137.51
11727
150.19
.
3451.8
90.90
.
228.94
2.13
254.80
. '
.
48.31
4247
IMTSS
123.76
.
87.94
1059.1
•
.
•
•
1615.2
795.94
•
.
.
.
1009.4
«
•
41.35
.
.
58.57
2012.9
EFTSS INTSSLB EFTSSLB
10.76 ~
e'4.85
283.68
78.14
18.11
392 . 08
16.00
•
115.41
31.55
119.25
60.50
61.96
60.42
715.27
59.21
32.30
9.84
966.40
.
16.74
2020.4
102.56
•
113.45
9812.4
•
.
•
.
282.17
10680
.
.
.
•
6306.4
•
.
247.66
•
.
23.71
3308.7
8.67
990.99
377.83
720.71
10.50
16.16
12.81
•
20.27
436.72
40.19
538.05
431.04
59.12
4403.8
60.53
0.60
59.53
1328.7
•
6.74
3391 .8
EFCN EFCNLB
0.03
0.02
0.25
0.02
0.15
1.72
Note: Influents & effluents in mg/L, LB = LB/DAY.
Period (.) indicates no data reported.
-------
TABLE V-2
LONG TERM DATA PLANTS SELECTED FOR BCT AND BAT
Long Term Avg. Effluent
Plant No.
12015
12022
12026
12036
12097
12117
12161
12236
12248
12294
12307
12317
12459
Type of Treatment
Biological
Biological
Biological
Biological
Biological
Biological
Biological
Biological
Biological
Biological
Biological
Biological
Biological
BOD%
Removal
95.8
94.9
97.1
97.9
96.9
94.4
98.7
83.0
91.2
97.2
ND
99.2
94.5
Cone, (mg/1)
BOD
j
110.2
108.1
33.1
49.4
1-9
19.8
126.2
26
44.7
11.4
7.8
3.8
COD
44.0
N/A
1222.0
444.5
37.6
24.5
850.1
501.9
95.9
232.3
106.4
42.3
112.8
TSS
10.8
84.9
283.7
78.1
18.1
16.0
31.6
62.0
60.4
59.2
32.3
9.8
16.7
N/A = Not available
ND = Not determined
82
-------
TABLE V-3
LONG TERM DATA PLANTS SELECTED FOR NSPS
Long Term Avg. Effluent
Plant No.
12015
12036
12097
12117
12161
12248
12294
12307
12317
12459
Type of Treatment
Biological
Biological
Biological
Biological
Biological
Biological
Biological
Biological
Biological
Biological
BOD%
Removal
95.8
97.9
96.9
94.4
98.7
91.2
97.2
ND
99.2
94.5
Cone, (mg/1)
BOD
9.7
33.1
49.4
1.9
19.8
26.0
44.7
11.4
7.8
3.8
COD
44.0
444.5
37.6
24.5
850.1
95.9
232.3
106.4
42.3
112.8
TSS
10.8
78.1
18.1
16.0
31.6
60.4
59.2
32.3
9.8
16.7
ND = Not determined
83
-------
TABLE V-4
LIST OF EPA-DESIGNATED PRIORITY POLLUTANTS
*No. Compound No.
IB acenaphthene 7OB
2V acrolein 71B
3V acrylonitrile 72B
4V benzene 73B
5B benzidine 74B
6V carbon tetrachloride 75B
7V chlorobenzene 76B
8B 1,2,4-trichlorobenzene 77B
9B hexachlorobenzene 78B
10V 1,2-dichloroethane 79B
11V 1,1,1-trichloroethane SOB
12B hexachloroethane 81B
13V 1,1-dichloroethane 82B
14V 1,1,2-trichloroethane 83B
15V 1,1,2,2-tetrachloroethane 84B
16V chloroethane 85V
17B bis(chloromethyl) ether** 86V
18B bis(2-chloroethyl) ether 87V
19V 2-chloroethylvinyl ether 88V
20B 2-chloronaphthalene 89P
21A 2,4,6-trichlorophenol 90P
22A parachlorometa cresol 91P
23V chloroform 92P
24A 2-chlorophenol 93P
25B 1,2-dichlorobenzene 94P
26B 1,3-dichlorobenzene 95P
27B 1,4-dichlorobenzene 96P
28B 3,3'-dichlorobenzidine 97P
29V 1,1-dichloroethylene 98P
30V 1,2-trans-dichloroethvlene 99P
31A 2,4-dichlorophenol 10OP
32V 1,2-dichloropropane 101P
33V 1,3-dichloropropylene 102P
34A 2,4-dimethylphenol 103P
35B 2,4-dinitrotoluene 104P
36B 2,6-dinitrotoluene 105P
37B 1,2-diphenylhydrazine 106P
38V ethylbenzene 107P
39B fluoranthene 108P
40B 4-chlorophenyl phenyl ether 109P
41B 4-bromophenyl phenyl ether 11 OP
42B bis(2-chloroisopropyl) ether 11 IP
43B bis(2-chloroethoxy) methane 112P
44V methylene chloride 113P
Compound
diethyl phthalate
dimethyl phthalate
benzo(a)anthracene
benzo(a)pyrene
3,4-benzofluoranthene
benzo(k)fluoranthane
chrysene
acenaphthylene
anthracene
benzo(ghi)perylene
fluorene
phenanthrene
dibenzo(a,h)anthracene
indeno(1,2,3-C,D)pyrene
pyrene
tetrachlorethylene
toluene
trichloroethylene
vinyl chloride
aldrin
dieldrin
chlordane
4,4'-DDT
4,4'-DDE
4,4'-ODD
alpha-endosulfan
beta-endosulfan
endosulfan sulfate
endrin
endrin aldehyde
heptachlor
heptachlor epoxide
alpha-BHC
beta-BHC
gamma-BHC
delta-BHC
PCB-1242
PCB-1254
PCB-1221
PCB-1232
PCB-1248
PCB-T260
PCB-1016
toxaphene
(lindane)
-------
45V methyl chloride
46V methyl bromide
47V bromoform
48V dichlorobromomethane
49V trichlorofluoromethane**
50V dichlorodifluoromethane**
51V chlorodibromomethane
52B hexachlorobutadiene
53B hexachlorocyclopentadiene
54B isophorone
55B naphthalene
56B nitrobenzene
57A 2-nitrophenol
58A 4-nitrophenol
59A 2,4-dinitrophenol
60A 4,6-dinitro-o-cresol
61B N-nitrosodimethylamine
62B N-nitrosodiphenylamine
63B N-nitrosodi-n-propylamine
64A peritachlorophenol
65A phenol
66B bis(2-ethylhexyl) phthalate
67B butyl benzyl phthalate
68B di-n-butyl phthalate
69B di-n-octyl phthalate
114M antimony (total)
115M arsenic (total)
116 asbestos (fibrous)
117M beryllium (total)
118M cadmium (total)
119M chromium (total)
120M copper (total)
121 , cyanide (total)
122M lead (total)
123M mercury (total)
T24M nickel (total)
125M selenium (total)
126M silver (total)
127M thallium (total)
128M zinc (total)
129B 2,3,7,8-tetrachloro-
dibenzo-p-dioxin (TCDD)
V - volatile organics
A - acid extractables
B - base/neutral extractables
P - pesticides
M - metals
** Deleted from the list of priority pollutants as per 46 FR 2264.
85
-------
TABLE V-5
SUMMARY OF PRIORITY POLLUTANT INFORMATION: PEDCo REPORTS
Priority Pollutants Identified As Used In;
Subcateqory AT
benzene
chloroform
1,1-dichloroethylene
1,2-trans-dichloroethylene
phenol
copper
zinc
Subcateqory B2
benzene
carbon tetrachloride
1,2-dichloroethane
chloroform
methylene chloride
phenol
toluene
cyanide
lead
mercury
nickel
zinc
Subcateqory C3
benzene
carbon tetrachloride
chlorobenzene
chloroethane
chloroform
1,1-dichloroethylene
1,2-trans-dichloroethylene
methylene chloride
methyl chloride
methyl bromide
nitrobenzene
2-nitrophenol
4-nitrophenol
phenol
toluene
chromium
copper
cyanide
lead
zinc
Total No. of Pollutants: 23
1 Reference No. 42
2 Reference No. 41
3 Reference No. 43
86
-------
TABLE V-6
COMPILATION OF DATA SUBMITTED BY THE PMA FROM
26 MANUFACTURERS OF ETHICAL DRUGS: RTP STUDY
Type of
Volatile Organic
Compound
Methylene Chloride
Skelly Solvent B'
Methanol
Toluene+
Acetone*
Dimethyl Formamide+
Ethanol
Isopropanol+
Amyl Alcohol"*"
Ethyl Acetate
Chloroform
Benzene"*"
Ethyl Ether
Methyl Isobutyl Ketone+
Carbon Tetrachloride
Xylene+
Methyl Ethyl Ketone
Trichloroethane
Hexane
Amyl Acetate
Isoprbpyl Acetate
Methyl Cellosolve
Butanol+
Isobutyraldehyde
Acetonitrile
Tetrahydrofuran
Isopropyl Ether
Acetic Acid
Acetic Anhydride
Annual Disposition (metric tons)
Annual
Purchase
10,000
1,410
7,960
6,010
12,040
1,630
13,230
3,850
1,430
2,380
500
1,010
280
260
1,850
3,090
260
135
530
285
480
195
320
85
35
4
25
930
1,265
Air
Emissions
5,310
410
2,480
1,910
1,560
1,350
1,250
1,000
775
710
280
270
240
260
210
170
170
135
120
120
105
90
85
40
30
-
12
12
8
Sewer
455
23
3,550
835
2,580
60
785
1,130
1,110
23
350
12
120
510
30
_
165
45
100
30
40
6
-
12
770
550
Incineration
2,060
980
1,120
1,590
4,300
380
915
1,150
480
150
-
1,510
1,910
60
100
230
5
-
_
4
-
-
Contract
Haul
2,180
410
1,800
770
120
200
470
0
80
175
80
30
—
140
™
475
-
130
—
~
•~
-
™
Disposal* Product
5
30 340
2,210
10,000
25 3,090
9
17
90
65
"~ ~"
3
~
-
-
110
•* "*
~
160
410
Solvent
Recovery
73,400
23,850
40,760
31 r\f\
,100
7,570
3,880
76,900
715
1,210
20,500
6^160
9t, f\f\
,400
'
25,670
311 r\
,_>1U
1,840
360
1,040
1 /. c
Llj
125
12
1,040
^00
J\J\J
-------
TABLE V-6
(Cont'd)
00
oo
Type of
Volatile Organic
Compound
Dimethylacetamide
Formaldehyde
Dimethylsulfoxide
1,4-Dioxane
o-Dichlorobenzene
Diethyl Carbonate
Blenda (Amoco)
Ethyl Bromide
Cyclohexylamine
Methyl Formate
Formamide
Ethylene Glycol
Diethylamine
Freons
Diethyl-ortho Formate
Pyridine
Polyethylene Glycol 600
Annual Disposition (metric tons)
Annual
Purchase
95
30
750
43
60
30
530
45
3,930
415
MO
60
50
7,150
54
3
3
Air
Emissions
7
5
4
2
1
1
_
_
_
_
_
_
50
6
_
_ -
-
Sewer Incineration
20
210 535
_ _
60
20
_ _
45
_ _
310
290
60
3
_
21
3 -
-
Contract
Haul
90
_
_
41
_
_
_
_
_
50
110
_
_
_
_
_
-
Disposal* Product
1
— —
— _
— —
7
530
3,930
60
30
_ _
_ _
7,145
33
— _ ' ~
3
Solvent
Recovery
«•>
4,760
—
7,060
«
7,170
1,130
_
60
300
_
«
_
_
TOTALS
85,170
19,190 14,880
17,480
7,350
72
27,700 441,320
Source - 26 member companies of the Pharmaceutical Manufacturers Association (PMA) reported these data
which they feel represent 85 percent of the volatile organic compounds used in their operations; these
reporting companies caccount for approximately 53 percent of the 1975 domestic sales of ethical
Pharmaceuticals.
*Deepwell or landfill.
+Annual disposition does not closely approximate annual purchase.
-------
TABLE V-7
SUMMARY OF VOLATILE ORGANIC COMPOUND EMISSION DATA: RTP STUDY
Amount:
Item;
Amount purchased (metric tons)
Amount discharged (metric tons)
Amount recovered within the
plant (metric tons)
Total amount used in plant
(sum of items 1 and 3)
(metric tons)
Percent recovered
Percent of total used that is
discharged
Percent of total used that is
discharged to sewer
Percent of total discharged that
is discharged to sewer
Total
Compounds
(total of 46)
85,170
86,142
441,320
526,490
83.8%
16%
2.7%
16.7%
Priority
Pollutants
(total of 7)
19,565
19,595
126,020
145,585
86.6%
13.5%
1.3%
9.7%
-------
Priority
Pollutant
TABLE V-3
SUMMARY OF MAJOR* PRIORITY POLLUTANTS IDENTIFIED
FROM MULTIPLE SOURCES OF INFORMATION
: Screening 6
RTP PEECo RSKERL/ 308 Verification
Study Reports ADA Portfolio Sampling Program
Acid Extractables
65 Phenol X
Ease Extractables
25 1,2-Dicblorobenzene X
Volatile Crqanics
4 Benzene X X
6 Carbon Tetrachloride X X
11 1,1,1 - Trichloroethane X
23 Chloroform X X
29 1,1-Dichloroethylene X
30 1,2-Trans-Cichloroethylene X
38 Ethylbenzene
44 Methylene Chloride X X
86 Toluene X X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
Ketals
119 Cfaroiriurr
120 Copper X
122 Lead X
123 Mercury
124 Nickel
128 Zinc X
ethers
121 cyanide XXX X
* For this table toxic compounds were defined as "major"
priority pollutants in accordance with the following criteria for
each data source:
B1P - The pollutant was reported by at least one plant (26 plants
reporting)
EEDCo - The pollutant was found in two or more subcategories (130
plants studied). i
BSKERL/ADA - The pollutant was reported by at least one plant (2
plant study).
308 - The pollutant was identified by 25 or more plants (464
plants surveyed).
Screening/Verification - The pollutant was detected at ten or
irore plants (26 plants sampled) .
90
-------
TARLE V-9
ANALYSIS OF PRIORITY POLLUTANT CONCENTRATIONS (ug/1)
Screeninq/Ver1fication Data Rase
Influent
Rased on Values Equal to or
Priority Pollutant Nui
Acid
?1
24
31
34
57
58
60
64
65
Rase
1
25
27
35
42
54
62
66
P
Extractahles
2,4, 6-tri chl orophenol
2-chl orophenol
2,4-dichlorophenol
2, 4-dimethyl phenol
2-nitrophenol
4-nitrophenol
4,fi-dinitro-o-cresol
pentachl orophenol
phenol
Neutrals
acenaphthene
1 , 2-di chl orobenzene
1,4-dichlorobenzene
2,4-dinitrotoluene
bis( 2-chl oroisopropyl )
ether
isophorone
N-nitrosodi phenyl amine
bis(2-ethylhexyn
Greater than (10 uq/1 1
Tiber of Number of
lants Observations Minimum Maximum
1
1
1
1
2
2
1
2
20
2
2
1
1
2
2
1
8
1
1
1
1
2
2
1
2
36
2
2
1
1
2
2
1
10
20
50
10
62
23
181
1,5
42
12
35
12
90
68
300
11
12
10
20
50
10
62
119
1600
15
62
51,000
92
20
90
68
448
1014
12
760
Median Mean
20
50
10
62
71
891
15
52
64
16
90
68
374
513
12
105
20
50
10
62
71
891
15
52
7529
64
16
90
68
374
513
12
157
Standard
Deviation
•
•
*
68
1003
•
14
15,499
40
6
.
.
150
709
•
222
91
-------
67
68
70
78
80
81
butyl benzyl phthalate
di-n-butyl phthalate
diethyl phthalate
anthracene
fluorene
phenanthrene
3
4
1
1
1
1
3
4
1
1
1
1
Volatile Orqanics
4
6
7
10
11
14
15
23
29
33
38
<((*
15
47
49
£5
86
87
benzene
carbon tetrachloride
chlorofcenzene
1 , 2-dichloroethane
1,1, 1-trichloroethane
1,1,2-trichloroethane
1,1,2,2-tetrachloro-
ethane
chloroform
1» 1-dichloroethylene
1,3-dichloropropylene
ethylbenzene
irethylene chloride
srethyl chloride
brornoform
trichlorof luorcmethane
tetrachlcroethylene
toluene
trichloroethylene
11
3
4
8
8
2
1
14
1
1
9
18
2
1
1
8
14
2
19
5
6
17
11
2
1
22
1
1
18
31
4
2
1
4
29
2
12
18
61
14
27
14
15
12
11
12
17
19
20
26
230
100
719
20
61
14
! 27
14
10,300
I 300
123,000
14,000
: 1,300
: 20
20
1620
230
' 100
18
20
61
14
27
14
120
18
3206
62
22
20
20
170
230
100
250
19
61
14
27
14
1586
81
36,405
2516
169
20
20
396
100
406
1
.
»
•
<*
3186
124
55,025
4944
383
1
0
470
.
•
11 42,000 24 3237 10,020
16 200,000 11,356 37,952
59 13,000 8,600 7,565 5,439
12 12 1.2 12
970 > 970 970 970
14 36 31 28 10
50 227,000 310 21,075 50,223
11 , 124 68 68 80
92
-------
88 vinyl chloride
Metals
114 antimony
115 arsenic
118 cadmiutr
119 chromium
120 copper
122 lead
*123 irercury
124 nickel
125 selenium
126 silver
127 thallium
128 zinc
ether
121 cyanide
130 ECD{mg/l)
131 COD (rag/1)
132 1SS(mg/l)
14
14
14
8
4
4
18
21
9
16
11
4
2
2
20
8
18
18
15
9
4
5
30
39
13
31
19
5
2
3
37
16
33
33
31
12
13
10
13
14
14
0.1
15
16
24
18
29
18
98
128
10
210
43
40
650
7030
500
0. 1
630
60
40
43
2070
540
11,300
25,900
3,480
27
31
32
39
63
39
28
32
40
140
1,090
2,641
218
45
29
25
117
571
119
3.9
103
31
32
34
363
153
2, 183
3,994
649
62
12
14
155
1689
139
9.6
146
17
11
14
475
135
2,688
4,868
837
93
-------
Effluent
Priority Pollutant
acid Extractahles
Number of Number of Standards
Plants Observations Minimum Maximum Median Mean Deviation
34
58
65
Ease
42
66
68
70
eo
2, 4-dirr.ethylphenol
4-nitrophenol
chenol
Keutral
bis (2-chloroisopropyl)
ether
bis (2-ethylhexyl)
phthalate
di-n-butyl tbtbalate
diethyl phthalate
fluorene
1
1
9
1
6
2
2
1
1
1
12
1
9
2
2
1
15
15
10
181
10
10
10
10
15
15
i
126
181
68
15
20
10
15
15
23
161
30
13
15
10
15
15
47
181
36
13
15
10
.
46
-
21
4
7
.
Volatile Organics
2
4
6
10
11
23
29
38
44
45
acrolein
benzene
carbon tetrachloride
1 ,2-dichloroethane
1,1, 1-trichloroethane
chloroform
1, 1-dichloroetyhlene
ethylbenzene
irtbylene chloride
aethyl chloride
1
1
2
5
4
6
1
3
14
2
1
1
2
9
6
7
1
3
21
4
100
120
16
22
10
14
180
14
12
100
100
i
120
61
500
33
150
180
22
8100
410
100
120
39
62
20
90
130
17
120
310
100
120
39
158
21
79
180
18
863
283
«
»
32
169
11
55
•
4
1852
139
-------
49 trichlorof luororrethane 1
85 tetrachloroethylene
66 toluene
67 tr.ichloroethylene
BetaIs
114 antimony
115 arsenic
118 cadmium
119 chromium
120 copper
122 lead
*123 mercury
124 nickel
125 selenium
126 silver
127 thallium
128 zinc
Cther
121 cyanide
**130 BOD
**131 COD
**132 TSS
*A11 non-remarked data considered
**Expressed in mg/1
1
1
4
1
2
3
1
13
13
9
11
8
2
1
2
17
6
13
13
13
1
1
4
1
5
6
1
21
25
14
19
16
5
1
5
32
11
25
30
29
420
18
100
14
20
10
40
10
14
13
0.1
19
12
40
10
13
30
10
216
0.1
420
18
315
14
51
20
40
304
106
400
1.3
300
56
40
129
2009
7700
1090
3293
1200
420
18
185
14
31
12
40
27
31
33
0.7
51
45
40
11
118
100
84
528
88
420
18
196
14
34
13
40
77
38
64
0.7
83
42
40
37
240
827
155
911
237
•
-
89
•
15
4
-
94
24
100
0.5
31
18
-'
52
378
2282
211
921
338
-------
TABLE V-10
ANALYSIS OF WASTEWATER FLOW CHARACTERISTICS
(BASIS: 308 DATA)
Direct Discharger Flow (All plants reporting data)
(Without Inclusion of Plant 12256)
Indirect Discharge Reporting Flow (178 plants)
Total Flow Reported
Total Single Subcategory Flow/No, plants (with data)
Subcat.
Subcat.
Subcat.
Subcat.
A
B
C
D
1 .
0.
8.
9.
30/3
67/15
80/34
80/131
=
=
=
=
0.435
0.045
0.260
0.075
45 MGD
(15)
35
80 MGD
Indirect Discharger Estimated Flow for Non-Reporting Plants
Subcat. A
Subcat. B
Subcat. C
Subcat. D
0.435 X 5 occurrences
0.045 x 16 occurrences
0.260 x 14 occurrences
0.075 x 90 occurrences
=
=
Estimated Unreported Flow
Total Discharge Flow Estimated for Data Base
(Without Inclusion of Plant 12256)
2.175 MGD
0.72
3.64
6.75
13
93 MGD
(63)
96
-------
TABLE V- 11
COMPARISON OF PRECISION & ACCURACY (P&A) DATA - PLANT 12236
of Other Data Sources
Priority Pollutants (ug/1)
Volatile Organics
44V Methylene Chloride
86V Toluene
45V Methyl chloride
23V Chloroform
4V Benzene
10V 1,2-Dichloroethane
30V Trans- 1,2-Dichloroethylene
38V Ethylbenzene
49V Trichlorofluoromethane
29V 1,1-Dichloroethylene
13V 1,1-Dichloroethane
Acid Extractables
65A Phenol
24A 2-Chlorophenol
57A 2-Nitrophenol
34A 2,4-Dimethylphenol
21A 2,4,6-Trichlorophenol
64A Pentachlorophenol
Base/Neutral Extractables
42B Bis(2-chloroisopropyOether
36B 2,6-Dinitrotoluene
56B Nitrobenzene
35B 2,4-Dinitrotoluene
70S Diethyl phthalate
68B bi-N-Butyl phthalate
67B Butyl benzyl phthalate
P&A Sample Analyses
Radian
Influent Effluent
916,000
24,000
33,000
24-29
7-9
57-83
4-6
19-25
ND
ND
ND
6-7
ND
ND
ND
ND
ND
• ND
ND
ND
ND
1
ND
-
-
-
-
ND
ND
ND
ND
ND
ND
ND
ND
ND
ND
—
1
ND
TRW
Influent Effluent
22,000
36,000
18,000
17-21
4
51-56
2
12-13
7
9-12
1
9-10
ND-2
ND
ND
T
T-l
ND
1-4
ND-T
ND
ND
12-13
ND
2-3
T
13
T
T
ND
ND
ND
T-l
T
T-l
ND-1
1
T
ND-1
T
3
2
1
13-25
1
*^on
Screening
Influent Effluent
40,000 200
33,000 1350
1,300
30
40
12
190
i
ipartauii m. v»m«^ ^—-— — —
Verification 30s
Influent
14,000-80,000
56,000-71,000
8,000-13,000
10
10-27
68-650
10-12
10-16
Effluent
15,000-8,100
10 reported as used
100,410
10
10 reported as used
62-300
10
10
ND = not detected
T = trace or less than 1
- = no data
-------
A.
SECTION VI
SELECTION OF POLLUTANT PARAMETERS
INTRODUCTION
The priority (toxic) and traditional (conventional and
nonconventional) pollutants characterized in Section V are
discussed in this section in light of their occurrence in
pharmaceutical industry wastewaters and their effects on the
environment.
B. TRADITIONAL POLLUTANTS
The Clean Water Act of 1977 (P.L. 95-217) requires the
Administrator to establish effluent limitations and standards for
traditional pollutants. Among these, the conventional parameters
of biochemical oxygen demand (BOD), total suspended solids (TSS),
pH, and oil and grease and the nonconventional parameters of
chemical oxygen demand (COD), total organic carbon (TOO, color,
ammonia, nitrogen, and phosphorus were considered. Those chosen
as representative of specific and persistent pollution problems
across the industry were BOD, TSS, COD and pH.
These pollutant parameters were identified in 100 percent of the
plants for which data were obtained. Pollutant levels in
treatment influent and untreated effluent streams are frequently
high, particularly in Subcategories A and C (fermentation and
synthesis, respectively).
Other conventional parameters subject to regulation under the
Administrator's discretion are oil and grease, pH, and fecal
coliform. Although they do appear as problems in some plant
process wastewater, oil and grease is not sufficiently widespread
nor severe enough to justify regulation. Fecal coliform is not
of significance in the industrial wastewater effluents of this
industry. Similarly, the nonconventional parameters of color,
phosphorus and various forms of nitrogen are not judged to
present a frequent enough problem to justify regulation. TOC is
considered to be so closely related to BOD and COD that separate
attention is not necessary. The BPT pH range (6.0 - 9.0) will be
continued in all other direct discharge regulations.
1. Biochemical Oxygen Demand
BOD is the quantity of oxygen required for .the biological and
chemical oxidation of waterborne substances under ambient or test
conditions. Substances that may contribute to the BOD include
carbonaceous organic materials usable as a food source by aerobic
organisms; oxidizable nitrogen derived from nitrites, ammonia,
98
-------
and organic nitrogen compounds that serve as food for specific
bacteria; and such chemically oxidizable materials as ferrous
iron, sulfides, sulfite, and similar reduced-state inorganics
that will react with dissolved oxygen or that are metabolized by
bacteria.
The BOD of a waste adversely affects the dissolved oxygen
resources of a body of water by reducing the oxygen available to
fish, plant life, and other aquatic species. Total exhaustion of
the dissolved oxygen in water results in anaerobic conditions and
the production of such undesirable gases as hydrogen sulfide and
methane. The reduction of dissolved oxygen can be detrimental to
fish populations, fish growth rate, and organisms used as fish
food. A total lack of oxygen due to excessive BOD can result in
the death of all aerobic aquatic inhabitants in the affected
area.
Water with a high BOD indicates the presence of decomposing
organic matter and associated increased bacterial concentrations
that may degrade water quality and minimize potential uses of the
water. This organic material promoting a high BOD can also
increase algal concentrations and cause blooms.
The BOD5 (5-day BOD) test is widely used to estimate the oxygen
requirements of domestic and industrial wastes and to evaluate
the performance of waste treatment facilities. To test for BOD,
complete biochemical oxidation of a given waste may require a
period of incubation too long for practical analytical test
purposes. For this reason, the 5-day period has been accepted as
standard and the test results have been designated as BOD5.
Despite its relative complexity, this test is widely accepted for
measuring potential pollution because it is the best available
method for evaluating the deoxygenation effect of a waste on a
receiving water body.
The BOD test measures the weight of dissolved oxygen utilized by
microorganisms as they oxidize or transform the gross mixture of
chemical compounds in the wastewater. The degree of biochemical
reaction involved in the oxidation of carbon compounds is related
to the period of incubation. BOD5 normally measures only 60 to
80 percent of the total carbonaceous biochemical oxygen demand of
the sample, but, for most purposes, this is a reasonable estimate
of ultimate BOD.
When measuring BOD either by the Winkler dissolved oxygen
titration method or by the dissolved oxygen probe determination,
measured BOD at lower levels of approximately 2 mg/1 give a
deviation of about ±33 percent even under the most careful
laboratory conditions. At higher concentrations (above 100 mg/1,
for example), the deviation is about ±15 percent.
99
-------
2- Total Suspended Solids
Suspended solids in wastewater are normally measured as total
suspended solids. They can include both organic and inorganic
materials. The inorganic materials may include sand, silt, clay,
and, possibly, toxic metal compounds. The organic fraction may
include such materials as grease, oils, animal and vegetable
waste products, fibers, microorganisms (algae, for example), and
many other dispersed insoluble organic compounds. These solids
may settle rapidly and form bottom deposits that are often a
mixture of both organic and inorganic solids.
Solids may be suspended in water for a time and then settle to
the bed of the stream or lake. They may be inert; they may be
slowly biodegradable materials; or they may be rapidly
decomposable substances. While in suspension, they increase the
turbidity of the water, reduce light penetration, and thereby
impair the. photosynthetic activity of aquatic plants. After
settling to the stream or lake bed, the solids can form sludge
banks which, if largely organic, create localized dead areas in
the water body and result in anaerobic and undesirable benthic
conditions. Aside from any toxic effect attributable to
substances leached out by water, suspended solids may kill fish
and shellfish by causing abrasive injuries, by clogging gills and
respiratory passages, by screening light, and by promoting and
maintaining the development of noxious conditions through oxygen
depletion. Suspended solids also reduce the recreational value
of the water.
i
The precision of the TSS determination varies directly with the
concentration of suspended matter in the sample. At 15 mg/1, the
deviation is shown to be ±33 percent; at 242 mg/1, the deviation
is ±10 percent; and at 1707 mg/1, the deviation is ±0.76 percent.
There is no satisfactory procedure for determining the accuracy
of the TSS method on wastewater samples since the true initial
concentration cannot be determined.
3. Chemical Oxygen Demand
i
COD is a chemical oxidation test devised as an alternate method
of estimating the total oxygen demand of a wastewater. Since the
method relies on the oxidation-reduction system of chemical
analyses rather than on biological factors, it is more precise,
accurate, and rapid than the BODS test. The COD test is widely
used to estimate the total oxygen demand (ultimate rather than 5-
day BOD) required to oxidize the compounds in a wastewater. It
is based on the fact that with the assistance of certain
inorganic catalysts, strong chemical oxidizing agents under acid
conditions can oxidize most organic compounds.
100
-------
The COD test measures organic matter that exerts an oxygen demand
and that may affect public health. It is a useful analytical
tool for pollution control activities. Most pollutants measured
by the BOD5 test can be measured by the GOD test. In addition,
pollutants more resistant to biochemical oxidation can also be
measured as COD. COD is a more inclusive measure of oxygen
demand than BOD5 and results in higher oxygen demand values than
BOD5.
The COD of a wastewater normally exceeds BOD5 since it is usually
constituted of those materials contributing to the BOD level plus
those more resistant to biochemical oxidation. ^^
consideration of COD and BOD measurements can indicate the
relatively biodegradability of the pollutants and the levels of
the chemical pollutants not easily bio-oxydized. The correlation
between the COD and BOD concentrations in a specific plant waste
resulting from a particular operation is applicable only to that
waste. Furthermore, the level of organic pollutants as indicated
by COD do not correlate with the level of individual priority
pollutants.
Compounds more resistant to biochemical oxidation are of great
concern because of their slow, continuous oxygen demand on the
receiving water and also because of their potentially harmful
effects on the health of humans and aquatic life. Many of these
compounds result from industrial discharges; some of the
compounds have been found to have carcinogenic, mutagenic, and
similar adverse effects. Concern about these compounds has
increased as a result of demonstrations that their long life in
receiving waters (the result of a low biochemical oxidation rate)
allows them to contaminate downstream water intakes. The
commonly used systems of water purification are not effective in
removing these types of materials and such disinfection as
chlorination may convert them into even more hazardous materials.
The COD test when performed by the dichromate reflux procedure
will account for 95 to 100 percent of the theoretical values for
most organic compounds. However, there are some compounds of the
aromatic family (benzene, toluene, and pyridine, for example)
that are not oxidized by this procedure.
C. PRIORITY POLLUTANTS
The frequency and level of priority pollutant occurrence in the
wastewaters of the industry were considered in order to determine
the manner in which these pollutants might be regulated. The
diversity of process and materials employed by the industry
brings about a broad presence, with virtually every toxic
pollutant compound listed in the modified comprehensive
settlement agreement present in at least one plant. However,
101
-------
none are present in the effluent in all
part of the industry.
or even a predominant
Under the provisions of Paragraph 8 of the Settlement Agreement
in Natural Resources Defense Council, Inc. v. Train, 8 EEC 2120
(D.D.C. 1976), modified 12 ERC 1833 (D.DTcT1979) (1)(2)
guidance is provided to the Agency on exclusion of specific
priority pollutants, subcategories, or categories from
regulations under the effluent limitations guidelines, standards
of performance and pretreatment standards. This paragraph is
excerpted below:
"8(a) The Administrator may exclude from regulation under
the effluent limitations and guidelines, standards of
performance, and/or pretreatment standards contemplated by
this Agreement a specific pollutant or category or
subcategory of point sources for any of the following
reasons, based upon information available to him:
(i) For a specific pollutant or a subcategory or
category, equally or more stringent protection is already
provided by an effluent, new source performance, or
pretreatment standard or by an effluent limitation and
guideline promulgated pursuant to Section(s) 301, 304, 306
307(a), 307(b) or 307(c) of the Act;
(ii) For a specific pollutant, except for pretreatment
standards, the specific pollutant is present in the effluent
discharge solely as a result of its presence in intake
waters taken from the same body of water into which it is
discharged and, for pretreatment standards, the specific
pollutant is present in the effluent which is introduced
into treatment works (as defined in Section 212 of the Act)
which are publicly owned solely as a result of its presence
in the point source's intake waters, provided however, that
such point source may be subject to an appropriate effluent
limitation for such pollutant pursuant to the requirements
of Section 307;
(iii) For a specific pollutant, the pollutant is not
detectable (with the use of analytical methods approved
pursuant to 304(h) of the Act, or in instances where
approved methods do not exist, with the use of analytical
methods which represent state-of-the-art capability) in the
direct discharges or in the effluents which are introduced
into publicly-owned treatment works from sources within the
subcategory or category; or is detectable in the effluent
from only a small number of sources within the subcategory
and the pollutant is uniquely related to only those sources;
or the pollutant is present only in trace amounts and is
102
-------
neither causing nor likely to cause toxic effects; or_ is
present in amounts too small to be effectively reduced by
technologies known to the Administrator; or the pollutant
will be effectively controlled by the technologies upon
which are based other effluent limitations and guidelines,
standards of performance, or pretreatment standards; or
(iv) For a category or subcategory, the amount and the
toxicity of each pollutant in the discharge does not justify
developing national regulations in accordance with the
schedule contained in Paragraph 7(b).
(b) The Administrator may exclude from regulation under
the pretreatment standards contemplated by this Agreement
all point sources within a point source category or point
source subcategory:
(i) If 95 percent or more of all point sources in the
point source category or subcategory introduce into
treatment works (as defined In Section 212 of the Act) which
are publicly owned only pollutants which are susceptible to
treatment by such treatment works and which do not interfere
with, do not pass through, or are not otherwise incompatible
with such treatment works; or
(ii) if the toxicity and amount of the incompatible
pollutants (taken together) introduced by such P°injusou^ces
into treatment works (as defined in Section 212 of the Act)
that are publicly owned is so insignificant as not to
justify developing a pretreatment regulation..."
Pollutants Excluded from Direct Discharger Regulations
Table VI-1 lists the occurrence,, frequencies and levels found in
the screening plant data for the priority pollutants addressed by
the Consent Decree. The priority pollutant data provided in the
308 data base was used to help develop the group of plants which
were then screened for priority pollutants. However,^these data
were not used to support Paragraph 8 exclusion of priority
pollutants found in the S/V study because many of the 308
priority pollutant responses were incomplete _ or.. •?*. J
non-quantitative nature. This was due in part to the fact that
many plants have not performed a priority pollutant scan of their
wastewater. The 308 priority pollutant data were used to exclude
those which were uniquely related to individual sources or occur
as the result of non-pharmaceutical operations.
Compounds numbered 17B, 49V, and 50V have been deleted^by 46 FR
10723 and 46 FR 2266. The remaining list of priority pollutants
was considered under the individual subparagraphs of Paragraph 8.
a.
103
-------
The compounds that can be excluded under each provision are
tabulated in Tables VI-2 through VI-5, with those which can be
excluded by more than one provision being noted by an asterisk
( ''. In addition a few pollutant compounds can be excluded bv
combinations of provisions (Table VI-5).
Table VI-2 lists compounds whose incidental removal is likely to
be brought about by technologies instituted to meet other
limitations. A significant example is phenol whose
biodegradability makes it likely that substantial removal will be
accomplished by activated sludge, aerated lagoons, or other
biological treatment systems targeted for BOD removal. Air
strippable volatiles are also likely to be removed by the passage
of aeration air and high surface atmospheric exposure.
Table VI-3 lists pollutants with levels of occurrence
insufficient to justify regulation. Some are present at no more
than trace amounts ( at or below the detection limits) and others
at levels below or essentially the same as removal capabilities
of applicable technologies. Those compounds with sufficient
volatility and low solubility to be effectively steam stripped
can be removed to no better than about 50-100 micrograms per
liter Ug/1). Earlier consideration by the'Agency (98) of the
treatability of a number of the more significant priority
pollutants indicates the following typical treatability criteria
expressed on a 5-day maximum basis:
8B 1,2,4-Trichlorobenzene
11V 1,1,1-Trichloroethane
13V 1,1-Dichloroethane
23V Chloroform
25B 1,2-Dichlorobenzene
26B 1,3-Dichlorobenzene
27B 1,4-Dichlorobenzene
44V Methylene Chloride
55B Naphthalene
86V Toluene
4V Benzene
69B Di-n-Octyl Phthalate
50-100
500-600
500-600
500-600
400-500
400-500
400-500
500
400-500
400
400
100
Metals removal effectiveness is indicated in Table VI1-2 Table
VI-3 shows the priority pollutants which were excluded based on a
comparison of these treatability levels with the screening
verification effluent data in Appendix G.
Also included in Table VI-3 are a number of phthalates whose
presence is likely the result of sample contamination by sampling
equipment.
104-'
-------
those pollutants which are present in amounts
- t
s
plants at treatable levels.
The one priority pollutant detected at sufficient levels and
?reqSency control by direct dischargers is cyanide.
b. Pollutants Excluded from Regulation under Pretreatment
Standards
u, o/i^ (n\ of i-he Settlement Agreement allows for the
discharging pharmaceutical plants.
105
-------
TABLE VI-1
SUMMARY OF PRIORITY POLLUTANT OCCURRENCE
SCREENING PLANT DATA
No. of Occurrences
Detected i
No.*
IB
2V
3V
4V
5B
6V
7V
8B
9B
10V
11V
12B
13V
14V
15V
16V
17B***
18B
19V
20B
21A
22A
23V
24A
25B
26B
27B
28B
29V
30V
31A
32V
33V
34A
35B
36B
37B
38V
39B
Compound
acenaphthene
acrolein
acrylonitrile
benzene
benzidine
carbon tetrachloride
chlorobenzene
1,2,4-trichlorobenzene
hexachlorobenzene
1,2-dichloroethane
1,1, 1-trichloroethane
hexachloroethane
1, 1-dichloroethane
1 , 1 ,2-trichloroethane
1,1,2,2-tetrachloroethane
chloroethane
bis(chloromethyl) ether
bis(2-chloroethyl) ether
2-chIoroethylvinyl ether
2-chloronaphthalene
2, 4, 6-trichlorophenol
parachlorometa cresol
chloroform
2-chlorophenol
1 , 2-dichlorobenzene
1 , 3-dichlorobenzene
1 , 4-dichlorobenzene
3,3'-dichlorobenzidine
1, 1-dichloroethylene
1-2-trans-dichloroethylene
2, 4-dichlorophenol
1 ,2-dichloropropane
1 , 3-dichloropropylene
2, 4-dimethylphenol
2,4-dinitrotoluene
2, 6-dinitrotoluene
1,2-diphenylhydrazine
ethylbenzene
fluoranthene
Influent
(25)**
4 (16%)
15 (60%)
1 (4%)
3 (12%)
5 (20%)
5 (20%)
8 (32%)
4 (16%)
4 (16%)
2 (8%)
1 (4%)
1 (4%)
16 (64%)
1 (4%)
2 (8%)
1 (4%)
5 (20%)
1 (4%)
1 (4%)
2 (8%)
1 (4%)
1 (4%)
12 (48%)
Effluent
(20)**
3 (15%)
1 (5%)
4 (20%)
4 (20%)
1 (5%)
1 (5%)
9 (45%);
2 (10%)
1 (5%)
1 (5%)
2 (10%)
Above 500
ug/L in
Effluent (20)**
1
Max. Effluent
Level
ug/L
120
16
500
33
20
110
180
15
160
106
-------
TABLE VI-1 (continued)
No. of Occurrences
Detected
No.*
40B
41B
42B
43B -
44V
45V
46V
47V
48V
49V***
50V***
51V
52B
53B
54B
55B
56B
57A
58A
59A
60A
61B
62B
63B
64A
65A
66B
67B
68B
69B
7 OB
71B
72B
73B
74B
75B
76B
77B
78B
79B
SOB
81B
82B
Compound
4-chlorophenyl phenyl ether
4-bromophenyl phenyl ether
bis(2-chloroisopropyl) ether
bis(2-chloroethoxy) methane
methylene chloride
methyl chloride
methyl bromide
bromoform
dichlorobromomethane
trichlorofluoromethane
dichlorodifluoromethane
chlorodibromomethane
hexachlorobutadiene
hexachlorocyclopentadiene
isophorone
naphthalene
nitrobenzene
2-nitrophenol
4~nitrophenol
2,4-dinitrophenol
4,6-dinitro-o-cresol
N-nitrosodimethylamine
N-nitrosodiphenylamine
N-nitrosodi-n-propylamine
pentachlorophenol
phenol
bis(2-ethylhexyl) phthalate
butyl benzyl phthalate
di-n-butyl phthalate
di-n-octyl phthalate
diethyl phthalate
dimethyl phthalate
benzo(a) anthracene
benzo(a) pyrene
3, 4-benzof luoranthene
benzo(k) fluoranthane
chrysene
acenaphthylene
anthracene
benzo(ghi) perylene
fluorene
phenanthrene
dibenzo(a,h) anthracene
Influent
(25)**
3 (1296)
17 (68%)
1 (496)
1 (4%)
1 (4%)
2 (8%)
1 (4%)
1 (4%)
3 (1296)
3 (12%)
1 (4%)
2 (8%)
14 (56%)
10 (40%)
2 (8%)
3 (12%)
1 (4%)
2 (8%)
1 (4%)
1 (4%)
Effluent
(20)**
2(100%)
15 (75%)
1 (5%)
1 (5%)
1 (5%)
4 (20%)
8 (40%)
4 (20%)
1 (5%)
Above 500
ug/L in
Effluent (20)**
2
Max. Effluent
Level
ug/L
2600
44
15
15
120
68
15
20
107
-------
TABLE VI-1 (continued)
No. of Occurrences
Detected
No.* Compound
83B indeno(l,2,3-C,D)pyrene
84B pyrene
85V tetrachloroethylene
86V toluene
87V trichloroethylene
88V vinyl chloride
89P aldrin
90P dieldrin
91P chlordane
92P 4,4'-DDT
93P 4,4'-DDE
94P 4,4'-DDD
95P alpha-endosulfan
96P beta-endosulfan
97P endosulfan sulfate
98P endrin
99P endrin aldehyde
lOOP heptachlor
101P heptachlor epoxide
102P aipha-BHC
103P beta-BHC
104P gamma-BHC (lindane)
105P delta-BHC
106P PCB-1242
107P PCB-1254
108P PCB-1221
109P PCB-1232
HOP PCB-1248
111P PCB-1260
112P PCB-1016
113P toxaphene
114M antimony (total)
115M arsenic (total)
116 asbestos (fibrous)
117M beryllium (total)
118M cadmium (total)
119M chromium (total)
120M copper (total)
121 cyanide (total)
122M lead (total)
123M mercury (total)
124M nickel (total)
125M selenium (total)
Influent
(25)**
* (16%)
16 (64%)
3 12%)
Effluent
(20)**
Above 500
ug/L in
Effluent (20)**
(10%)
(25%)
(10%)
Max. Effluent
Level
ug/L
18
1350
11
10 (40%)
5 (20%)
it- (16%)
8 (32%)
23 (92%)
24 (96%)
11 (44%)
13 (52%)
16 (64%)
14 (56%)
7 (28%)
3 (15%)
3 (15%)
2 (10%)
5 (25%)
15 (75%)
16 (80%)
10 (50%)
9 (45%)
12 (60%)
9 (45%)
3 (15%)
90
30
2.0
40
304
63
7700
400
1.58
310
56
108
-------
TABLE VI-1 (continued)
No. of Occurrences
Detected Above 500 Max. Effluent
No.*
126M
127M
128M
129B
Compound
silver (total)
thallium (total)
zinc (total)
2,3,7,8-tetrachloro-
dibenzo-p-dioxin (TCDD)
Influent
(25)**
7 (28%)
5 (20%)
21 (8*%)
Effluent ug/L in
(20)** Effluent (20)**
3 (15%)
4 (20%)
17 (85%)
Level
UR/L
40
29
403
. * V - volatile organics
A - acid extractables
B - base/neutral extractables
P - pesticides
M - metals
** Indicates number of plant streams.
*** Deleted from further consideration by 46 FR 10723 and 46 FR 2266.
109
-------
TABLE VI-2
PRIORITY POLLUTANTS EXCLUDED FROM DIRECT DISCHARGER REGULATIONS
BASED ON
CONTROL BY OTHER LIMITATION TECHNOLOGIES
Paragraph 8 (a) (i) "For a specific pollutant effectively controlled by the
technology upon which are based upon other effluent
limitations and guidelines, standards of performance, or
pretreatment standards ..."
4V benzene
11V* 1,1,1-trichloroethane
13V* 1,1-dichloroethane
85V tetrachloroethylene
86V toluene
87V* trichloroethylene
57 A* 2-nitrophenol
58A* 4-nitrophenol
59A* 2,4-dinitrophenol
65A phenol
25B* 1,2-dichlorobenzene
26B* 1,3-dichlorobenzene
27B* 1,4-dichlorobenzene
55B* naphthalene
(Air stripping and/or biodegradation)
(Air stripping)
(Air stripping)
(Air stripping)
(Air stripping and/or biodegradation)
(Air stripping)
(Biodegradation)
(Biodegradation)
(Biodegradation)
(Biodegradation)
(Biodegradation)
(Biodegradation)
(Biodegradation)
(Biodegradation)
* Indicates exclusion under two or more separate provisions of
Paragraph 8.
V - Volatile organics
A - Acid extractables
B - Base/neutral extractables
P - Pesticides
M- Metals
110
-------
TABLE VI-3
PRIORITY POLLUTANTS EXCLUDED FROM DIRECT DISCHARGER REGULATIONS
BASED ON
LOW-LEVEL PRESENCE
Paragraphs (a) (iii) "For a specific pollutant-present only in trace
amounts "and is neither causing nor likely to cause toxic
affects; or is present in amounts too small to be effectively
reduced by technologies known to the Administrator..."
6V* carbon tetrachloride
7V chlorobenzene
11V* 1,1,1-trichloroethane
13V * 1,1 -dichlor oethane
14V* 1,1,2-trichloroethane
15V * 1,1,2,2-tetrachloroethane
16V* chloroethane
19V* 2-chloroethylvinyl ether
30V * 1,2-trans-dichloroethylene
32V* 1,2-dichloropropane
33V* 1,3-dichloropropylene
38V* ethylbenzene
46V* methyl bromide
47V* bromoform
48V* dichlorobromomethane
51V* chlorodibromomethane
85V* tetrachloroethylene
87V* trichloroethylene
88V* vinyl chloride
21A* 2,4,6-trichlorophenol
22A* parachlorometa cresol
24A* 2-chlorophenol
31 A* 2,4-dichlorophenol
34A* 2,4-dimethylphenol
37A* 1,2-diphenylhydrazine
57 A* 2-nitrophenol
58A 4-nitrophenol
59 A* 2,4-dinitrophenol
64A* pentachlorophenol
65A phenol
IB* acenaphthene
5B* benzidine
8B* 1,2,4-trichlorobenzene
9B* hexachlorobenzene
12B * hexachloroethane
18B* bis(2-chloroethyl) ether
2 OB* 2-chloronaphthalene
25B* 1,2-dichlorobenzene
26B* 1,3-dichlorobenzene
27B* 1,4-dichlorobenzene
28B* 3,3-dichlorobenzidine
35B* 2,4-dinitrotoluene
36B* 2,6-dinitrotoluene
39B* fluoranthene
40B* 4-chlorophenyl phenyl ether
^1B* 4-bromophenyl phenyl ether
43B* bis(2-chloroethoxy) methane
52B* hexachlorobutadiene
53B* hexachlorocyclopentadiene
54B* isophorone
55B* naphthalene
56B* nitrobenzene
61B* N-nitrosodimethylamine
62B* N-nitrosodiphenylamine
63B* N-nitrosodi-n-propylamine
66B** bis(2-ethylhexyl) phthalate
67B** butyl benzyl phthalate
68B** di-n-butyl phthalate
69B** di-n-octyl phthalate
70B** diethyl phthalate
7IB** dimethyl phthalate
72B* benzo(a)anthracene
73B* benzo(a)pyrene
74B* 3,4-benzof luoranthene
75B* benzo(k)fluoranthane
76B* chrysene
77B* acenaphthylene
78B* anthracene
79B* benzo(ghi)perylene
SOB* fluorene
8 IB* phenanthrene
82B* dibenzo(a,h)anthracene
83B* indeno(l,2,3-C,D)pyrene
84B* pyrene
129B* 2,3,7,S-tetrachloro-dibenzo-p-
dioxin (TCDD)
114M antimony (Total)
115M arsenic (Total)
111
-------
TABLE VI-3 (CONT'D.)
PRIORITY POLLUTANTS EXCLUDED FROM DIRECT DISCHARGER REGULATIONS
BASED ON
LOW-LEVEL PRESENCE
117M* beryllium (Total)
118M* cadmium (Total)
119M chromium (Total)
120M copper (Total)
122M lead (Total)
123M mercury (Total)
124M nickel (Total)
125M* selenium (Total)
126M* silver (Total)
127M thallium (Total)
* Indicates exclusion under two or more separate provisions of Paragraph 8.
** Phthalates likely resulting from sample contamination.
V - Volatile organics :
A - Acid extractables
B - Base neutral extractables
P - Pesticides :
M - Metals ;
112
-------
TABLE VI-*
PRIORITY POLLUTANTS EXCLUDED FROM DIRECT DISCHARGER REGULATIONS
BASED ON
INFREQUENT OCCURRENCE
Paragraph 8 (a) (iii) "For a specific pollutant—detectable in the effluent
from only a small number of sources within the subcategory
and the pollutant is uniquely related to only those sources..."
2V acrolein
3V acrylonitrile
6V* carbon tetrachloride
(tetrachloromethane)
7V* chlorobenzene
10V* 1,2-dichloroethane
13V* 1,1-dichloroethane
14V* 1,1,2-trichloroethane
15V* 1,1,2,2-tetrachloroethane
16V* chloroethane
19V* 2-chloroethyl vinyl
(mixed)
29V 1,1-dichloroethylene
30V* 1,2-trans-dichloroethylene
32V* 1,2-dichloropropane
33V* 1,3-dichloropropylene
(1,3-dichlor opr opene)
38V* ethylbenzene
45V methyl chloride
(chloromethane)
46V* methyl bromide
(bromomethane)
47V* bromoform
(tribromomethane)
48V* dichlorobromomethane
51V* chlorodibromomethane
85V* tetrachloroethylene
87V* trichloroethylene
88V* vinyl chloride
(chloroethylene)
21 A* 2,4,6-trichlorophenol
22A* parachlorometa cresol
24A* 2-chlorophenol
31A* 2,4-dichlorophenol
34A* 2,4-dimethylphenol
37 A* 1,2-diphenylhydrazine
58A* 4-nitrophenol
59A* 2,4-dinitrophenol
60A 4,6-dinitro-o-cresol
64A* pentachlorophenol
IB* acenaphthene
5B* benzidine
8B* 1,2,4-trichlorobenzene
9B* hexachlorobenzene
12B* hexachloroethane
1 SB* bis(2-chloroethyl) ether
20B* 2-chloronaphthalene
25B* 1,2-dichlorobenzene
26B* 1,3-dichlorobenzene
27B* 1,4-dichlorobenzene
28B* 3,3-dichlorobenzidine
35B* 2,4-dinitrotoluene
36B* 2,6-dinitro toluene
39B* fluoranthene
40B* 4-chlorophenyl phenyl ether
41B* 4-bromophenyl phenyl ether
42B bis(2-chloroisopropyl) ether
43B* bis(2-chloroethoxy) methane
52B* hexachlorobutadiene
53B* hexachlorocyclopentadiene
54B* isophorone
55B* naphthalene
56B* nitrobenzene
61B* N-nitrosodimethylamine
62B* N-nitrosodiphenylamine
63B* N-nitrosodi-n-propylamine
72B* benzo(a)anthracene
73B* benzo(a)pyrene
74B* 3,4-benzofluoranthene
75B* benzo(k)fluoranthene
76B* chrysene
77B* acenaphthylene
78B* anthracene
79B* anthracene
SOB* fluorene
SIB* phenanthrene
113
-------
TABLE VI-4 (CONT'D.)
PRIORITY POLLUTANTS EXCLUDED FROM DIRECT DISCHARGER REGULATIONS
BASED ON
INFREQUENT OCCURRENCE
82B*
83B*
S4B*
129B*
89P**
90P**
9 IP**
92P**
93P**
95P**
96P**
97P**
98P**
99P**
100P**
101P**
102P**
103P**
104P**
105P**
106P**
107P**
108P**
109P**
HOP**
HIP**
112P**
113P**
117M*
118M*
125M*
126M*
dibenzo(a,h) anthracene
indeno(l,2,3-C,D)pyrene
pyrene
2,3,7,8-tetrachloro-dibenzo-p
dioxin(TCDD).
aldrin
dieldrin
chlordane
4,^-DDE
alpha-endosulfan
beta-endosulfan
endosulfan sulfate
endrin
endrin aldehyde
heptachlor
heptachlor epoxide
alpha-BHC
beta-bhc
gamma-BHC (lindane)
delta-BHC
PCB-1242
PCB-1254
PCB-1221
PCB-1232
PCB-124S
PCB-1260
PCB-1016
toxaphene
beryllium (Total)
cadmium (Total)
selenium (Total)
silver (Total)
* Indicates exclusion under two or more separate provisions of Paragraph 8.
** Infrequent presence due to operations on site other than pharmaceutical.
V - Volatile organics
A - Acid extractables
B - Base neutral extractables
P - Pesticides
M - Metals
-------
TABLE VI-5
PRIORITY POLLUTANTS EXCLUDED FROM DIRECT DISCHARGER REGULATIONS
BASED ON
PRESENCE IN AMOUNTS TOO SMALL TO BE EFFECTIVELY REDUCED
BY TECHNOLOGIES KNOWN TO THE ADMINISTRATOR
23V chloroform
^W methylene chloride
128M zinc (Total)
M- Metals
V - Volatile organics
115
-------
TABLE YI-6
POLLUTANTS EXCLUDED FROM PRETREATMENT STANDARDS
No.
Compound
No. of Occurrences
in Indirect
Wastewaters
1W
15V
16V
19V
32V
33V
48V
51V
88V
IB
5B
8B
9B
12B
18B
20B
25B
26B
27B
28B
35B
36B
37B
39B
40B
41B
42B
43B
52B
53B
54B
55B
56B
61B
62B
63B
66B
67B
68B
1,1, 2-trichloroethane
1,1,2,2-tetrachloroethane
chloroethane
2-chloroethylvinyl ether
1 ,2-dichloropropane
1 ,3-dichloropropylene
dichlorobromomethane
chlorodibromomethane
vinyl chloride
acenaphthene
benzidine
1,2,4-trichlorobenzene
hexachlo robenzene
hexachloroethane
bis(2-chloroethyl) ether
2-chloronaphthalene
1 ,2-dichlorobenzene
1,3-dichlorobenzene
1,4-dichlorobenzene
3,3'-dichlorobenzidine
2,4-dinitrotoluene
2,6-dinitrotoluene
1 ,2-diphenylhydrazine
fluoranthene
4-chlorophenyl phenyl ether
4-bromophenyl phenyl ether
bis(2-chloroisopropyl) ether
bis(2-chloroethoxy) methane
hexachlorobutadiene
hexachlorocyclopentadiene
isophorone
naphthalene
nitrobenzene
N-nitrosodimethylamine
N-nitrosodiphenylamine
N-nitrosodi-n-propylamine
bis(2-ethylhexyl) phthalate
butyl benzyl phthalate
di-n-butyl phthalate
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
5*
0
0
Max. Indirect
Wastewater
Concentration
12
12
2700*
Basis For
Exclusion
Infrequent
it
it
ti
it
" & low level
it
ti
it
ii
ti
it
ii
it
it
ti
it
it
" & low level
Phthalate occurrence likely the result of sample contamination by sample tubing.
116
-------
TABLE VI-6 (Continued)
No.
69B
7 OB
71B
73B
74B
75B
76B
77B
78B
79B
SOB
81B
82B
83B
84B
129B
89P
90P
91P
92P
93P
94P
95P
96P
97P
98P
99P
100P
101P
102P
103P
104P
105P
106P
107P
108P
109P
HOP
HIP
112P
113P
114M
115M
117M
118M
119M
Compound
di-n-octyl phthalate
diethyl phthalate
dimethyl phthalate
benzo(a) pyrene
3,4-benzofluoranthene
benzo(k) f luoranthane
chrysene
acenaphthylene
anthracene
benzo(ghi) perylene
fluorene
phenanthrene
dibenzo(ajh) anthracene
indeno(l,2,3-C,D) pyrene
pyrene
2,3,7,8-tetrachloro-
dibenzo-p-dioxin (TCDD)
aldrin
dieldrin
chlordane
alpha-endosulfan
beta-endosulfan
endosulfan sulfate
endrin
endrin aldehyde
heptachlor
heptachlor epoxide
alpha-BHC
beta-BHC
gamma-BHC (lindane)
delta-BHC
PCB-1242
PCB-1254
PCB-1221
PCB-1232
PCB-1248
PCS-1260
PCB-1016
toxaphene
antimony (total)
arsenic (total)
beryllium (total
cadmium (total)
chromium (total)
No. of Occurrences
in Indirect
Wastewaters
o'
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0.
0
0
6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7
3
2
3
11
Max. Indirect
Wastewater Basis For
Concentration Exclusion
Infrequent
• n
n
n
n
n
n
n
" - • ' ' n
ii
•'•••' ' ' •' 'n
' ' ; ii
n
n •
n
n
n
"-"••'•. n
n
n
210 treatable level
£13 n " n
2 ii " "
32 ii ii '•
650 " " "
117
-------
TABLE VI-6 (Continued)
No.
120M
122M
123M
124M
125M
126M
127M
128M
116
Compound
copper (total)
lead (total)
mercury (total)
nickel (total)
selenium (total)
silver (total)
thallium (total)
zinc (total)
No. of Occurrences
in Indirect
Wastewaters
11
8
7
8
3
2
10
Max. Indirect
Wastewater
Concentration
150
286
50
630
30
522
Basis For
Exclusion
treatable level
118
-------
TABLE VI-7
POLLUTANTS CONSIDERED FOR PRETREATMENT STANDARDS
No. of Occurrences
No.
121
2V
3V
4V
6V
7V
10V
11V
13V
23V
29V
30V
38V
*W
47V
85V
86V
87V
Compound
cyanide
Volatile Organics:
acrolein
acrylonitrile
benzene
carbon tetrachloride
chlorobenzene
1 ,2-dichloroethane
1 , 1 , 1 -tr ichloroethane
1 , 1-dichloroethane
chloroform
1 , 1-dichloroethylene
1 ,2-trans-dichloroethylene
ethylbenzene
methylene chloride
bromoform
tetrachloroethylene
toluene
trichloroethyiene
in Wastewaters
5
2
1
6
1
2
2
4
3
6
2
1
3
9
1
1
6
1
Max. Wastewater
Concentration Level
(ug/L)
590
100
100
580
300
11
290
360,000
27
1,350
10
550
21
890,000
12
2
1,050
7
119
-------
SECTION VII
CONTROL AND TREATMENT TECHNOLOGY
A. INTRODUCTION
This section addresses the technologies currently used or
available to remove or reduce wastewater pollutants generated by
the pharmaceutical manufacturing industry. Although wastewater
flow and raw waste load will vary from plant to plant, they are
expected to be treatable by the techniques presented herein.
Many possible combinations of in-plant and EOF systems exist that
are capable of achieving the pollutant reduction levels
anticipated. However, each individual plant must make the final
decision concerning the specific combination of pollution control
measures best suited to its particular situation.
In identifying appropriate control and treatment technologies,
the Agency assumed that each manufacturing plant had installed or
would install the equipment necessary to comply with limitations
based on BPT. Those treatment technologies currently in place in
the industry, as reported in 308 responses, are presented by
plant in Appendix L. Thus, the technologies described below are
those which can further reduce the discharge of pollutants into
navigable waters or POTW systems. They are divided into two
broad classes: in-plant and end-of-pipe (EOF) technologies.
Since the ultimate receiving point of a plant's wastewater can be
critical in determining the overall treatment effort required,
information on ultimate discharge is also supplied.
B. IN-PLANT SOURCE CONTROL
The intent of in-plant source control is to reduce or eliminate
the hydraulic and/or pollutant loads generated by specific
sources within the overall manufacturing process. By
implementing controls at the source, the impact on and
requirements of subsequent downstream treatment systems can be
minimized.
Many of the newer pharmaceutical manufacturing plants are
designed with the reduction of water use and subsequent mini-
mization of contamination as part of the overall planning and
plant design criteria. Improvements also have been made in
existing plants to better control their manufacturing processes
and other activities and the consequent environmental effects.
Some examples of in-plant source controls that have been
effective in reducing pollution loads are as follows:
120
-------
(1) Production processes have been modified or combined and
reaction mixtures have been concentrated to reduce waste
loads as well as increase yields. Processes have also been
reviewed and revised to reduce the number of toxic
substances used.
(2) Efforts are made to concentrate and segregate wastes at
their source to minimize or eliminate wastes where possible.
New process equipment is designed to produce effluents
requiring no further treatment.
(3)
Several techniques have been employed to reduce the volume
of fermentation wastes discharged to end-of-pipe treatment
systems. One approach involves concentrating "spent beer"
wastes by evaporation and then dewatering and drying waste
mycelia. The resulting dry product in some instances has
sufficient economic value as an animal feed supplement to
offset part of the drying cost.
(4) Several plants have installed automatic TOC-monitoring
instrumentation or both pH' and TOC monitoring to permit
early detection of process upsets that may result in
excessive discharges to sewers.
(5) The recovery of waste solvents is a common practice among
plants using solvents in their manufacturing processes.
However, to further reduce the amount of waste solvent
discharge, plants have instituted such measures as (a)
incineration of solvents that cannot be recovered eco-
incineration of "bottoms" from solvent
and (c) design and construction of solvent
solvents beyond the economical
nomically, (b)
recovery units,
recovery columns to strip
recovery point.
(6) The use of barometric condensers can result in significant
water contamination, depending upon the nature of the
materials entering the discharge water stream. In addition,
barometric condenser use very high quantities of water,
which results in substantial increases in the total amount
of process-exposed wastewater. An outstanding example of
this is plant 12256 which utilizes more than 20 MGD of once-
through barometric condenser water. As an alternative,
several plants are using surface condensers to reduce
hydraulic or organic loads.
(7) Several plants are using a recirculation system as a means
of greatly reducing the amount of contaminated water being
discharged from water-sealed vacuum pumps.
121
-------
(8) Reduction of once-through cooling water by recycling through
cooling towers is used in numerous plants and results in
decreased total volume of discharge.
(9) Separation of manufacturing area stormwater is practiced
throughout the industry and often facilitates the isolation
and treatment of contaminated runoff.
(10) Spill prevention is recognized in the industry as a
critical aspect of pollution control. In addition to
careful management of materials and methods, such preventive
steps as impoundment basins are utilized in many cases.
(11) Wash waters can be reduced or eliminated in many situations
by use of dry cleanup methods. Containment control and
removal of either liquid or solid dry process wastes can
often be accomplished using little or no water. This
particular approach can possibly ;completely eliminate
wastewater discharge, especially ;in Subcategory D
(Formulation) plants, where washwater is often the only
wastewater source.
C.
IN-PLANT TREATMENT
Besides implementing source controls to reduce or eliminate the
waste loads generated within the manufacturing process, plants
may also employ in-plant treatment directed at removing certain
pollutants before they are combined with the plant's overall
wastewaters and thus diluted.
This concept of in-plant treatment of a segregated stream is of
major importance. First, treatment technologies can be directed
specifically toward a particular pollutant. Also, since
wastewater treatment and pollutant removal costs are strongly
influenced by the volume of water to be treated, the costs
involved in treating a segregated stream are considerably less
than they would be in treating combined wastewater.
Additionally, chemicals other than those being treated are less
likely to interfere with the treatment technology if treatment
occurs before commingling. Further, lower EOF effluent levels
can be attained due to dilution of the treated segregated stream.
In-plant treatment processes can be visualized as end-of-pipe
treatment for a particular production process or stage within the
plant itself, designed to treat specific waste streams. Although
in-plant technologies can remove a variety of pollutants, their
principal applications are for the treatment of toxic or priority
pollutants. In the pharmaceutical manufacturing industry, three
122
-------
classes of priority pollutants are of particular importance. As
indicated in Section V, the major priority pollutants are
solvents, metals, and cyanide. Thus, the discussions presented
below on in-plant technologies concern the treatment of these
three classes of pollutants. '
The 308 Portfolio data base was the principal source of
information relating to the use of in-plant treatment in the
pharmaceutical industry. Most of this information came from the
Supplemental 308 Portfolio responses. In addition, while not
specifically requested in the original 308 Portfolio, some in-
plant treatment information was obtained from the original 308
Portfolio plants. It was gathered via three mechanisms: a) some
plants provided on the questionnaire "additional" data or
comments relative to in-plant treatment; b) a small amount of
information was gathered by direct contact with plant personnel;
and c) the wastewater sampling programs discussed in Section II
identified the use of a few in-plant technologies. (At the time
of the original 308 mailing, data on in-plant treatment was not
thought to be a critical item. This philosophy was changed prior
to the Supplemental 308 mailing.)
Table VII-1 presents a summary of in-plant treatment technologies
identified from the various data bases along with the number of
plants that employ each process. A listing of each plant's
treatment system, including in-plant treatment, .is presented in
Append i x L.
1
Cyanide Destruction Technologies
Cyanide destruction is employed in the pharmaceutical industry,
as noted by the 308 responses (table VII-.l), by limited direct
inquiry, and by information from the S/V program.
Present cyanide treatment processes demonstrated to be effective
are based upon two fundamental approaches, chemical oxidation and
high pressure and temperature techniques. Chemical oxidation is
a reaction in which one or more electrons are transferred from
the chemical being oxidized to the chemical initiating the
transfer (oxidizing agent); as a result of the valence change,
the oxidized substance can then react to form a more desirable
compound. The latter treatment is the application of high tem-
perature and pressure to break down chemical bonds; the end
result is that more tolerable substances are formed (e.g. C02 and
N02). Under some circumstances, cyanide ions may combine with
several metals to form inert complexes which may interfere with
removal of both the cyanide and the metal. Of the commonly
encountered metals, chromium, manganese, and iron form inert
complexes, while nickel and mercury form labile complexes;
123
-------
Cyanide Complexes
Inert
Cr
Mn
Fe
Labile
Ni
Hg (CN)4-2
Although they are classified as inert, cyanide will be released
from the inert complexes over an extended period of time.
However, this time period may exceed the residence time in the
cyanide destruct unit and cyanide from these complexes would not
be destroyed. The labile complexes will present no interference
in cyanide removal.
An evaluation of cyanide limitations practically achievable by
the various technologies must consider the following:
(1) Theoretical reaction equilibrium limits. These are
generally extreme and therefore not a controlling factor.
(2) Conditions under which cyanate reversion can occur.
(3) Competitive reactions resulting
consumption.
in increased oxidant
(4) Chemical interferences such as iron complexing and
processing alternatives necessary to avoid them.
the
(5) Physical interferences which might hamper
availability and design methods to overcome them.
reactant
(6) The extent to which equalization dilution after
treatment lowers cyanide in the final effluent. In most plant
situations this results in a substantial concentration reduction
allowing limitation levels at end-of-pipe which might be
difficult to reach directly.
a. Chlorination
Destruction of cyanide by oxidation either with chlorine gas
under alkaline conditions or with sodium hypochlorite is a very
common method of treating industrial wastewaters containing
cyanide. Although more costly, sodium hypochlorite is less
hazardous and is simpler to handle. Oxidation can be
approximated by the following two-step chemical reaction:
Cl* + NaCN + 2 NaOH = NaOCN + 2 NaCl + H,O
124
-------
3C1
6NaOH + 2NaOCN = 2 NaHC0
N
6 NaCl
2 H0
Cyanide is oxidized to cyanate completely and rapidly at a pH of
about 9.5 to 10.0. Usually 30 minutes are required to insure a
complete reaction. The oxidation of cyanide to cyanate is
accompanied by a marked reduction in volatility and a
thousandfold reduction in toxicity.
However, since cyanate may revert to cyanide under some
conditions, additional chlorine is provided to oxidize cyanate to
carbon dioxide/bicarbonate. At pH levels around 9.5 to 10.0,
several hours are required for the complete oxidation of the
cyanate, but only one hour is necessary at a pH between 8.0 .and
8.5. Also, excess chlorine must be provided to break down
cyanogen chloride, a highly toxic intermediate compound formed
during the oxidation of cyanate.
Although stoichiometric oxidation of one part of cyanide to
cyanate requires only 2.73 parts of chlorine, in practice 3 to 4
parts of chlorine are used. Complete oxidation of one part
cyanide to carbon dioxide and nitrogen gas theoretically requires
6.82 parts of chlorine, but nearly 8 parts are normally necessary
in practice. The chlorine required in practice is higher than
the theoretical amount because other substances in the wastewater
compete for the chlorine.
Soluble iron interferes seriously with the alkaline chlorination
of cyanide wastes. Iron and cyanide form a stable complex which
is impervious to chlorine oxidation. Similar difficulties result
from formation of nickel cyanides. Ferrocyanides are reported
treatable by alkaline chlorination at temperatures of 71 C
(160 F) and at a pH of about 12.0.
Ammonia also interferes with the chlorine oxidation process since
the chlorine demand is increased by the formation of chloramines.
When cyanide is only being oxidized to cyanate, it is usually not
economical to remove the ammonia by breakpoint chlorination,
which requires almost 10 parts of chlorine per part of ammonia.
Complete cyanate formation can be accomplished by allowing an
extra 15 minutes contact time. When complete oxidation of the
cyanide is to be accomplished, the ammonia must be removed by
breakpoint chlorination so a free chlorine residual can be
maintained to break down the cyanogen chloride.
An example of a cyanide destruction system using chlorination is
shown in Figure VII-1 .
Because of some of the advantages of the chlorination process,
this technology has received widespread application in the
chemical industry as a whole. First, it is a relatively low cost
125
-------
system and does not require complicated equipment. It also fits
well into the flow scheme of a wastewater treatment facility.
The process will operate effectively at ambient conditions and is
well suited for automatic operation, thus minimizing labor
requirements. This technique is used by pharmaceutical processes
manufacturers who use cyanide in chemical synthesis.
The chlorination process, however, does have limitations and
disadvantages. For example, toxic, volatile intermediate-reaction
products can be formed. Thus, it is essential to properly
control the pH to ensure that all reactions are carried to their
end point. Also, for waste streams containing other oxidizable
ma.tter, the chlorine may be consumed in oxidizing these materials
and may interfere with the treatment of the cyanide. Finally,
for those systems using gaseous chlorine, a potentially hazardous
situation exists when it is stored and handled.
The oxidation of cyanide-bearing wastewaters by using chlorine
under basic conditions is a classic technology. However, its use
by the pharmaceutical industry is limited to a few plants. From
the EPA's Effluent Guidelines Division's study to develop BAT
regulations for the electroplating industry (109), it was found
that cyanide levels around 40 ^g/1 are achievable by in-plant
chlorination processes, as long as reaction interferences are not
present. The presence of interfering substances in
pharmaceutical manufacturing wastewater may, in fact, prevent the
attainment of these levels using the alkaline chlorination
method.
In addition, the Draft Development Document for the Inorganic
Chemicals Industry (71) indicates that the free cyanide level
after chemical oxidation treatment is generally below 100 ug/1.
An important consideration relative to th^ reported attainable
effluent level and the variety of pharmaceutical wastewaters
encountered is the presence of constituents which interfere by
complexing or competing for the chlorine oxidizing agent. The
extent to which the various materials foiuid in pharmaceutical
wastewater may interfere with chlorine oxidation is not known.
i
Chemical oxidation of cyanide is currently the most prevalent
technique used by pharmaceutical plants to destroy cyanide.
However, the available data from plants using this method does
not permit an adequate evaluation of the cyanide destruction
capability of this technique as applied to pharmaceutical
wastewater. ;
b. Ozonation
Ozone (allotropic form of oxygen) is a good oxidizing agent and
can be used to treat process wastewaters; that contain cyanide.
126
-------
In fact, ozone oxidizes many cyanide complexes (for instance,
iron and nickel complexes) that are not broken down by chlorine.
Ozonation is primarily used to oxidize cyanide to cyanate.
With traces of copper and manganese as catalysts, cyanide is
reduced to very low levels, independent of starting
concentrations and form of the complex. The oxidation of cyanide
by ozone to cyanate occurs in about 15 minutes at a pH of 9.0 to
10.0, but the reaction is almost instantaneous in the presence of
traces of copper. The pH of the cyanide waste is often raised to
12.0 in order that complete oxidation occurs before the pH drops
to 8.0 in the process.
Oxidation of cyanate to the final end products, nitrogen and
bicarbonate, is a much slower and more difficult process unless
catalysts are present. Therefore, since ozonation will not
readily effect further oxidation of cyanate, it is often coupled
with such independent processes as dialysis or bio-oxidation.
The ozonation treatment process is beginning to receive more and
more usage. Its initial applications in treating metal finishing
wastewater have shown it to be quite effective for cyanide
removal. Like chlorination, the ozonation process is well suited
to automatic control and will operate effectively at ambient
conditions. Also, the reaction product (oxygen) is beneficial to
the treated wastewater. Since the ozone is generated onsite,
procurement, storage, and handling problems are eliminated.
The ozonation process does have drawbacks. It has higher capital
and operating costs than chlorination and similar toxicity
problems; also, as with chlorination, increased ozone demand is
possible if other oxidizable matter is present in the waste
stream. Finally, in most cases the cyanide is not effectively
oxidized beyond the cyanate level.
c. Alkaline Hydrolysis
Removal of cyanide from process wastewaters can be accomplished
without the use of strong oxidizing chemicals. For the alkaline
hydrolysis system, the principal treatment action is' based upon
the application of heat and pressure. In this process, a caustic
solution is added to the cyanide-bearing wastewaters to raise the
pH to between 9.0 and 12.0. Next, the wastewater is transferred
to a continuous reactor where it is subjected to temperatures of
about 165°C to 185°C (329°F to 365°F) and pressured from
approximately 90 to 110 psia. The breakdown of cyanide in the
reactor is generally accomplished with a residence time of about
1.5 hours.
127
-------
An example of an alkaline hydrolysis system for tres::ng cyanide-
bearing wastewaters is shown in Figure VI1-2.
The absence of specific chemical reactants in this process
eliminates procurement, storage, and handling problems. As with
other cyanide processes, alkaline hydrolysis is well suited to
automatic control. '
In the pharmaceutical industry, wastewaters with large amounts of
cyanide content are more likely to be treated by alkaline
hydrolysis, for economic reasons.
As in the case of chlorination, only a limited amount of data is
available regarding the pharmaceutical industry's use of alkaline
hydrolysis for cyanide treatment. The data available from these
plants, however, indicated that the cyanide levels reached by
this technology are similar to those achieved by the chlorination
process. Long term performance data has been submitted by one
plant (12236) which uses this method to destroy cyanide in its
wastewater. The available data indicate that an average effluent
value of 200 ug/1 is achievable for cyanide. It should be
emphasized that this is an achievable effluent level and not
necessarily what is achievable directly as result of the
treatment of pharmaceutical wastewater by the alkaline hydrolysis
technique.
2. Metals Removal Technologies
This discussion of metals removal technologies is presented even
though the Agency is not proposing effluent guidelines
limitations for metals. It is intended to aid permit writers and
others who may, at some point, have an interest in the
performance of these technologies. Metals removal technologies
are reported to be in place by the 308 responses.
Proven metals treatment technologies are based upon precipitation
and filtration. Based on the solubility products (Ksp) quoted
for insoluble metal salts (113), the concentration of metal ions
in a saturated solution can be calculated. This concentration
represents the theoretically achievable levels.
Compound Ksp nQ/l
Cu S
Ni S
Zn S
Hg S
Cu(OH).,
Ni(OH)2
6 x 10-3«
2 x 10-25
1 .6 X 10-25
3.5 x 10-52
3.5 x
1 .5
10~19
x 10-15
x 10-10
x 10-*
x 10-5
x 10~18
25
400
128
-------
Zn(OH)2
Cr(OH)3
1.8 x TO-14
6.7 x 10~31
1 x 10-3
6 x 10-1
Comparison of theoretically achievable treatment levels of metal
priority pollutants to the other proposed regulation levels
(i.e., metal finishing) shows that sulfide precipitation is
theoretically capable of removing the metals to levels several
orders of magnitude lower than the levels that are practically
achieved. Hydroxide precipitation can result in the theoretical
levels of metals which are lower then the levels generally
achievable by hydroxide precipitation as practiced.
Thus, in most cases, the solubility level will not be the
controlling factor in establishing minimum levels. Practical
limits of removal are set by other circumstances, many of which
are peculiar to particular treatment processes. The efficiency
of physical removal of precipitate solids by such means as
filtration or clarification is limited by such particle
characteristics as particle size and stability, which are
functions of pH and other chemicals present. Many metal cations
are subject to chemical complexing that transforms them into an
unprecipitable species, causing interference with their removal.
Treatment system performance under industrial operating
conditions is indicated in Table VII-2. The levels shown are
estimates of practical attainable long-term average effluent
concentrations for priority pollutant metals. Of the six metals
of special interest in this study, copper, chromium, lead, and
nickel are generally amenable to reductions to approximately 500
ng/l at the point of metals treatment. Although zinc reductions
to about 500 ^g/1 are reported, 1,200 »q/l may be a more
realistic limit for the zinc content of wastewater since a higher
final concentration is also reported for all three treatment
methods. Mercury concentration, though not treatable by alkaline
precipitation, may be reduced to around 50 ug/1 after sulfide
precipitation and filtration.
a. Chemical Reduction
Chromium and some other metals must be reduced from their high
valence states before they can be precipitated. This is
accomplished by chemical reduction, a reaction in which one or
more electrons are transferred from the chemical initiating the
transfer (reducing agent) to the chemical being reduced.
The main application of chemical reduction in the treatment of
industrial wastewater is in the reduction of hexavalent chromium
to trivalent chromium. Chromium is a common metal contaminant in
the industry is wastewaters and its chemical reduction is
employed as an in-plant treatment by the industry. The reduction
129
-------
enables the trivalent chromium in conjunction with other metal
salts to be separated from solution by precipitation. Sulfur
dioxide, sodium bisulfite, sodium metabisulfite, and ferrous
sulfate are strong reducing agents in aqueous solution and are
therefore useful in industrial waste treatment facilities for the
reduction of hexavalent chromium to trivalent chromium.
The chemical reduction of chromium wastes by sulfur dioxide is a
well-known and widely accepted treatment technology in numerous
plants employing chromium or other high valence ions in their
manufacturing operations. An example of how this system treats
process wastewaters containing chromates is presented in Figure
VI1-3. The reactions involved may be illustrated as follows:
3SO2 + 3H20
3H2S03 + 2H
3H2S03
Cr2(S04)3 + 5H20
This reaction is favored by a low pH;, a value of 2.0 to 3.0 is
normally required for situations requiring complete reduction.
At pH levels above 5.0, the reduction rate is slow. Such
oxidizing agents as dissolved oxygen and ferric iron interfere
with the reduction process by consuming the reducing agent. The
sulfate precipitate can be removed by filtration or
clarification.
Chemical reduction has been used quite successfully to treat
large concentrations of hexavalent chromium (e.g. from metal
finishing operations). This method is well suited to automatic
control and may be used when conditions are ambient.
Chemical reduction, however, is not without some limitations.
Careful pH control is required for effective reduction. In
addition, when waste streams contain other reducible matter, the
reducing agent may be consumed, depleting that available for
treatment of the metals. Also, for those systems using sulfur
dioxide, a potentially hazardous situation exists when it is
stored and handled. Data indicate that chromium levels below 500
vg/1 can be achieved from in-plant chromium reduction processes.
(109) ;
b. Alkaline Precipitation
The solubility of metal hydroxides, in most cases, is a function
of pH and therefore the success of metal hydroxide precipitation
treatment is heavily dependent on the pH level of the solution.
In order to achieve optimum formation of solid metal hydroxides
the pH of the wastewater must be adjusted to the range (usually
moderately alkaline) found to be most effective for the metal(s)
130
-------
involved. This is accomplished by measured addition of
the wastewater with concurrent pH monitoring.
1ime to
Following the attainment of optimum pH conditions the solid metal
hydroxides are coagulated (using coagulating agents) in a
clarifier and deposited as sludge. Proper clarifier design and
good coagulation are important prerequisites for efficient metals
removal by alkaline precipitation.
If substantial sulfur compounds are present in the wastewater,
caustic soda (sodium hydroxide) may be used instead of lime to
prevent calcium sulfate formation which would increase sludge
volume. Treatment chemicals for adjusting pH prior to
clarification may be added to a rapid mix tank, to a mix box, or
directly to the clarifier, especially in batch clarification. If
such metals as cadmium and nickel are in the wastewater, a pH in
excess of 10.0 is required for effective precipitation. This pH,
however, is unacceptable for discharged wastewater; therefore,
the pH must be reduced by adding acid. The acid is usually added
as the treated wastewater flows through a small neutralization
tank prior to discharge.
An example of a metals removals system using alkaline preci-
pitation is shown in Figure VI1-4.
There are several advantages to the use of alkaline
precipitation. In the first place, it is well demonstrated
wastewater treatment technology. It is well suited to automatic
control and will operate at ambient conditions. Also, in many
instances, preceding treatment steps adjust the waste (especially
pH) to aid the alkaline precipitation process. The end result is
that the costs associated with this technology may be
substantially lower than those for other processes. However,
this method is subject to interference when mixed wastes are
treated. In addition, this process generates relatively high
quantities of sludge that also require disposal.
Alkaline precipitation is a classic technology being used by many
industries, although its use by the pharmaceutical industry has
been limited. The EPA study to develop BPT regulations for the
electroplating industry (109) indicated that the alkaline
precipitation process is capable of achieving the following
approximate levels: 300 ug/1 for chromium and zinc, 200 ug/1 for
copper, TOO ug/1 for lead, and 500 ug/1 for nickel.
c. Sulfide Precipitation
In this process, heavy metals are removed as a sulfide
precipitate. Sulfide is supplied by adding a very slightly
soluble metal sulfide that has a solubility somewhat greater than
131
-------
that of the sulfide of the metal to be removed. Normally,
ferrous sulfide is used. It is fed into a precipitator where
excess sulfide is retained in a sludge blanket that acts both as
a reservoir of available sulfide and as a medium to capture
colloidal particles.
The process is applicable for treatment of all heavy metals. The
process equipment requirement required includes a pH adjustment
tank, a precipitator, a filter, and pumps to transport the
wastewater. The filter is optional and may be a standard,
dual-media pressure filter.
A variation of the process utilizes sulfide for reducing
hexavalent chromium. Ferrous sulfide at a pH of 8.0 to 9.0 acts
as an agent to reduce the hexavalent chromium and then
precipitates it as a hydroxide in one step. Hexavalent chromium
wastes do not have to be isolated and pretreated by reduction to
the trivalent form.
With respect to the generated sludge, sulfide sludges have been
found to be less subject to leaching than hydroxide sludges.
However, sulfide precipitation produces sludge in greater volumes
(requiring more available storage space) and requires greater
expenditures for chemicals than does alkaline precipitation.
Pollutant levels after treatment with sulfide precipitation are
very similar to the pollutant levels after alkaline
precipitation.
3. Solvent Recovery and Removal
Solvents are used extensively in the pharmaceutical manufacturing
industry. Because such materials are expensive, most
manufacturers try to recover them in opder to purify them for
reuse whenever possible. Solvent recovery operations typically
employ such techniques as decantation, evaporation, distillation,
and extraction. The feasibility and extent of recovery
purification are governed largely by the quantities involved and
by the complexity of solvent mixtures' to be separated. If
recovery is not economically practicable, the used solvents may
have to be disposed of by means of incineration, landfilling,
deep-well injection, or contract disposal.
Even when an effort is made to recover solvents, some wastewater
contamination can be expected. Removal of small quantities of
organic solvents from the segregated wastewater can be
accomplished by such techniques as steam stripping or carbon
adsorption. Further removal of solvents from combined
end-of-pipe wastewater may result from biological treatment or
from surface evaporation in the treatment system.
132
-------
a. Steam Stripping
Steam stripping is a variation of distillation in which steam is
used as both the heating medium and the driving force for the
removal of volatile materials. Steam is added at the bottom of a
tower and the wastewater being treated is fed either at the
middle or near the top of the unit. As the steam passes through
the wastewater, volatile materials are vaporized and removed with
the steam exiting from the top of the tower.
Some steam .stripping processes employ columns packed with
materials that are inert and corrosion resistant. Packing
materials have shapes that maximize the surface area for a given
volume. Materials of construction for packing include steel,
porcelain, stoneware, and plastic. In tray towers, the column
contains a series of trays that contain bubble caps or sieve
perforations to allow for liquid-vapor contact.
The tower bottoms contain only trace quantities of volatile
materials. Tower overheads contain the volatile materials
removed along with steam. Subsequent condensation results in an
immiscible organic layer that is recovered and an aqueous layer
that is returned to the column. If more than one compound has
been removed, further separation possibly may be desired for
recovery. Separation techniques include selective condensation,
extraction, and distillation. If the organic distillate removed
is not recovered, it may be disposed of by such methods as
incineration, landfilling, deep-well injection, or contract
disposal.
An example of a steam stripping unit for removing solvents from
process wastewaters is shown in Figure VI1-5.
Steam stripping of organic-bearing wastewaters has been used in
pharmaceutical manufacturing and in other industries. A
preliminary study (72) by the EPA's Organic Chemical Branch has
shown that steam stripping used as an in-plant technology can
produce very low pollutant levels for benzene,
1,2-dichloroethane, chloroform, jnethylene chloride, toluene, and
many other similar compounds. The starting concentration does
not strongly influence either the cost of treating a given
quantity of water or the achievable effluent concentrations. A
level of about 50 »/g/l can be reached for the volatile organic
solvents used in commercial practice.
Steam stripping technology is known to be in-place at a number of
pharmaceutical plants. However, adequate data has not yet been
received which would confirm the Agency's estimates of the
pollutant reduction capability of this technology.
133
-------
b* Activated Carbon Adsorption
Adsorption is defined as the adhesion of dissolved molecules to
the surface of solid bodies with which they are in contact.
Granular activated carbon particles have two properties that make
them effective and economical adsorbents. First, they have a
high surface area per unit volume which results in faster, more
complete adsorption. Second, they have a high hardness value
which lends itself to reactivation and repeated use.
The adsorption process typically is preceded by preliminary
filtration or clarification to remove insolubles. Next, the
wastewaters are placed in contact with carbon so adsorption can
take place. Normally, two or more beds are used so that
adsorption can continue while a depleted bed is reactivated.
Reactivation is accomplished by heating the carbon between 870°C
to 9800C (1600°F to 180QOF) to volatize and oxidize the adsorbed
contaminants. Oxygen in the furnace is normally controlled at
less than 1 percent to avoid loss of carbon by combustion.
Contaminants may be burned in an afterburner.
Carbon adsorption is primarily designed to remove dissolved
organic material from wastewater although it can, to some extent
remove chromium, mercury and cyanide. A discussion of the
technical and economic feasibility of activated carbon adsorption
technology may be found in "Treatability of Priority Pollutants
in Wastewater by Activated Carbon" by S. T. Hwanq and P.
Fahrenthold, EPA report, 1979.
The potential use for this technology by the Pharmaceutical
Industry is limited. Concentrations of most of the toxic
pollutants (metals, volatile organics and cyanide) characteristic
of pharmaceutical wastewater are all reduced more effectively and
with less cost by the previously discussed technologies than by
activated carbon adsorption. Phenols, the other group of
pollutants found in pharmaceutical wastewater are biodegradable
and their concentrations can be reduced by improved biological
treatment. Carbon adsorption is particularly applicable in
situations where organic material in low concentrations not
amenable to treatment by other technologies must be removed from
wastewater.
The equipment necessary for an activated carbon adsorption
treatment system consists of a preliminary clarification and/or
filtration unit to remove the bulk of the solids, two or three
columns packed with activated carbon, and pumps and piping. When
on-site regeneration is employed, a furnace, quench tanks, a
spent carbon tank, and a reactivated carbon tank are generally
required. Contract regeneration at a central location is
frequent commercial practice.
13*
-------
An example of an activated carbon adsorption unit is shown in
Figure VII-6.
Carbon adsorption systems are compact, will tolerate variation in
influent concentrations and flow rates and can be thermally
desorbed to recover the carbon for reuse. Economic application
of carbon adsorption is limited to the removal of low pollutant
concentrations. Competititive adsorption of non-target
constituents, as well as blinding by suspended solids, can cause
interference.
D. END-OF-PIPE TREATMENT
In-plant treatment processes are used to treat specific
pollutants in segregated waste streams; end-of-pipe (EOP)
technologies usually are designed to treat a number of pollutants
in a plant's overall wastewater discharge. The types and/or
stages of EOP treatment are primary treatment, secondary
treatment, and tertiary treatment. Depending on the nature of
the pollutants to be removed and the degree of removal required,
combinations of the available technologies are used.
As in the case of in-plant treatment, the 308 Portfolio Data Base
was the principal source of information for identifying the use
of EOP treatment by the pharmaceutical industry. inis
information was requested by both 308 Portfolio mailings. As a
cross-check for accuracy and completeness, the 308 Portfolio
responses were compared with information available from the other
data bases.
Table VI1-3 presents a summary of the EOP technologies identified
by the various data bases, along with the number of plants that
employ each process. A listing of each plant s end-of-pipe
treatment system is presented in Appendix L.
1• Primary Treatment
Primary (physical/chemical) treatment refers to those processes
that are nonbiological in nature. Primary treatment involves (a)
the screening of the influent stream to remove large solids and
(b) gravity separation to remove settleable solids and floating
materials. Commonly used primary treatment technologies in the
pharmaceutical industry are coarse solids removal, primary
sedimentation, primary chemical flocculation/clarification, and
dissolved air flotation.
In selecting EOP treatment processes for consideration as BAT,
BCT, NSPS, PSES, and PSNS technologies, only those that would
follow primary treatment were examined.
135
-------
2. Secondary and Tertiary Treatments
Secondary (biological) treatment is the principal method by which
many pharmaceutical manufacturing plants are now meeting existing
BPT regulations. This is one of the first steps toward
compliance with future BAT, BCT, and NSPS guidelines. Biological
treatment could also be an important technology in meeting future
Although it is discussed as a single EOF treatment alternative,
biological treatment actually encompasses a variety of specific
technologies such as aerated lagoons, activated sludge,
trickling filters, and rotating biological contactors. Since
there are numerous publications available that describe all
aspects of the operations (advantages, limitations, and other
pertinent facts), discussions of these specific treatment
processes will be presented only in moderate detail in this
report. Although each has its own unique characteristics, they
are all based on one fundamental principle: the reliance on
aerobic and/or anaerobic biological microorganisms for the
removal of oxygen-demanding compounds.
An aerated lagoon is one example of a treatment facility which
utilizes aerobic biological processes. It is essentially a
stabilization basin to which air is added either through
diffusion or mechanical agitation. The air provides the oxygen
required for aerobic biodegradation of the organic waste. If
properly designed, the air addition will provide sufficient
mixing to maintain the biological solids in suspension so that
they can be removed in a secondary sedimentation tank. After
settling, sludge may be recycled to the head of the lagoon to
ensure the presence of a properly acclimated seed. When operated
in this manner, the aerated lagoon is analogous to the activated
sludge process. The viable biological solids level in an aerated
lagoon is low when compared to that of an activated sludge unit
The aerated lagoon relies primarily on detention time for the
breakdown and removal of organic matter; aeration periods of 3 to
8 days are common.
The activated sludge process is also an aerobic biological
process. The basic process components include an aerated
biological reactor, a clarifier for separation of biomass, and a
piping arrangement to return separated biomass to the biological
reactor. The aeration requirements are similar to those of an
aerated lagoon in that aeration provides the necessary oxygen for
aerobic biodegradation and mixing to maintain the biological
solids in suspension. The available activated sludge processes
that are used in the treatment of wastewaters include
conventional, step-aeration, tapered-aeration, modified-aeration,
contact-stabilization, complete-mix and extended-aeration.
136
-------
A trickling filter is a fixed-growth biological system where a
thin-film biological slime develops and coats the surfaces of the
supporting medium as wastewater makes contact. The film consists
primarily of bacteria, protozoa, and fungi that feed on the
waste. Organic matter and dissolved oxygen are extracted and the
metabolic end products are released. Although very thin, the
biological slime layer is anaerobic at the bottom so hydrogen
sulfide, methane, and organic acids are generated.
These materials cause the slime to periodically separate (slough
off) from the supporting medium and be carried through the system
with the hydraulic flow. The sloughed biomass must be removed in
a clarifier. Trickling filters are classified by hydraulic or
organic loading as "low rate" or "high rate." Low-rate filters
generally have a hydraulic loading rate of 1 to 4 million
gal./acre/day (or an organic loading rate of 300 to 1,000 Ib.
BOD5/acre-ft./day), a depth of 6 to 19 ffet, and no
recirculation. High-rate filters have a hydraulic loading rate
of 10 to 40 million gal./acre/day, an organic loading rate of
1,000 to 5,000 Ib. BOD5/acre-ft./day, a depth of 3 to 10 feet,
and a recirculation rate of 0.5 to 4.0. High-rate filters can be
single or two stage. The medium material used in trickling
filters must be strong and durable. The most suitable medium in
both the low-and high-rate filters is crushed stone or gravel
graded to a uniform size.
The rotating biological contactor (RBC) process consists of a
series of disks constructed of corrugated plastic plates and
mounted on a horizontal shaft. These disks are placed in a tank
with contour bottom and immersed to approximately 40 percent ot
the diameter. The disks rotate as wastewater passes through the
tank and a fixed-film biological growth similar to that on
trickling filter media adheres to the surface. Alternating
exposure to the wastewater and the oxygen in the air results in
biological oxidation of the organics in the wastes. Biomass
sloughs off (as in the trickling filter) and is carried out in
the effluent for gravity separation. Direct recirculation is not
generally practiced with the rotating biological disks.
There are a few other biological treatment techniques not
specifically mentioned in this section which utilize either
aerobic or anaerobic biodegradation or both. These are
stabilization ponds, anaerobic lagoons and facultative lagoons.
In facultative lagoons, the bacterial reactions include both
aerobic and anaerobic decomposition.
Besides the direct utilization of these treatment processes,
biological treatment also encompasses two other approaches; in
this report, they are referred to as biological enhancement and
biological augmentation. Generally, these variations are
137
-------
accomplished by (a) modifications made in the conventional
biological treatment itself or (b) conventional processes
combined into a multistage system. Examples of biological
enhancement are pure oxygen activated sludge and biological
treatment with powdered activated carbon. Biological
iCSUl/ b\ trickling filter/activated sludge,
h- ge/ ,,rotatin(3 biological contactor, aerated
hing pond, or any combination of two or more
conventional biological treatment processes.
The differences in performance inherent in differences in number
°Lj!Jages .^Jt on the applicability of plug-flow/back-mix
effects. A true plug-flow system, such as a narrow channel
lagoon, approaches equivalence to an infinity of stages if the
food/microorganism (F/M) ratio is maintained. This tends to
beneficially maximize the availability of nutrients, a function
of the concentration of biodegradable pollutants. A fully back-
mixed system (as an activated sludge unit tends to be) operates
throughout at its exit concentration. It is thus a distinct
finite stage incremental with any stage before it or after it. '
In practice, these distinctions are not clearcut. Since there is
some back-mixing even in a channelled lagoon, separations of
units or even of cells within one unit may be beneficial. Also,
iJLJ^t mixed systems, the concentration gradient established is
sufficient for some increase in the effective nutrient
microorganSm
.,,~,* sy?temf' design factors other than the concentration-
induced driving force may overshadow the concentration gradient
and prevent simple performance correlation.
Comprehensive consideration of the criteria affecting bio-
reaction performance suggests the following to be significant:
(1) Influent concentration of pollutants.
i
(2) Resistive characteristics of the BOD pollutants and the
resultant K value (i.e., how easily the BOD is biodegraded) .
(3) Presence of potential interfering pollutants
constituents toxic to the microorganisms).
(e.g.,
(4) Bio-reaction characteristics and concentration of
microorganisms present.
the
(5) Dissolved oxygen content and distribution at
the point of adequate 02 availability.
least to
138
-------
(6) Sludge recycle as it may affect microorganism
availability and character as represented by the F/M ratio.
(7)
Contact efficiency of pollutants and microorganisms,
_. .... r- n _ _ i_ J_ ^ — —. ~. M J V1T \ 7C? O
as
may be induced by agitation, flow pattern, and MLVSS.
(8) Availability and balance of nutrients, including
nitrogen and phosphate.
(9) Required target effluent.
(10) Temperature (e.g., seasonal effects)
The proper design of biological systems in addition to developing
optimum operating criteria, must also take into account how much
of the system's potential capacity will be used so that an
optimum modification approach will be available The most
economical approach may be simple adjustments of operating
variables to exploit existing capacity fully. The adjustments
mav require such minor changes as increasing agitation, power
input, or sludge recycle rate or, at the extreme, may require the
addition of an independently functioning system. In many cases
the optimum upgrade may be a combination of existing component
units integrated with balanced new units. This is likely to
result in a system complex dictated in part by performance
requirements and in part by equipment already in place.
Some examples of typical augmented biological configurations are
shown in Figure VI1-7.
Tertiary treatment usually means any treatment following the
biological or other secondary treatment system. The treatment
technologies are quite varied and are normally applied for the
removal of such pollutants as a specific priority pollutant
class, nitrogen, color, and so forth. Some tertiary treatment
processes are also applicable to in-plant or primary treatment
schemes. The location in the overall treatment concept
determines whether the operation is a tertiary treatment.
Bioloqical treatment systems are mainly intended to reduce the
level of the traditional pollutants BOD and COD. Some priority
pollutants may be removed incidentally, even though not targeted
by the treatments.
Biological treatment removal efficiency is a function of
treatment intensity, detention time, and such system
characteristics .as bioreaction rate constant, biomass
concentration (as represented by food/microorganism ratio), and
biomass contact efficiency. The configuration of the system is
139
-------
important since it affects these factors, but the effectiveness
is not necessarily benefitted by splitting the bioreaction into a
number of steps. In a plug-flow (non-backmixed) system there is
a continuation of reaction and little inherent effect of staging
as in certain separation techniques and driving force systems.
There may be reaction rate advantages in a back-mixed system
which might accrue from staging but these must be evaluated for a
specific system considering microorganism availability, contact
efficiency and other factors.
Economic concerns often dictate a design which uses (a) one
biotechnique in preference to others (b) more than one technique
as the reaction progresses (e.g., activated sludge and trickling
filter) or (b) various arrangement configurations. However,
these design choices are highly site and waste specific, and
generalizations should be avoided in the comparison of systems
and in the choice a particular treatment configuration.
One of the Agency's data-gathering programs requested long-term
traditional pollutant data from the industry. As opposed to the
screening/verification data obtained by a few days of sampling
and the annualized 308 Portfolio data, the long-term data
consisted of raw daily or weekly influent and effluent data that
covered a period of one year and was obtained from 22 plants
having some type of biological treatment. Therefore, for
purposes of predicting what the industry:can achieve in the way
of traditional pollutant control by biological enhancement, the
long-term data selected were the best available. Summaries of
the long-term data are presented in Table V-l.
The thirteen plants chosen from among the 22 pla'nts (see section
IX for explanation of plant selection) that submitted raw daily
or weekly data indicate what existing sources can achieve in the
way of traditional pollutant control. These plants have achieved
performance in almost all cases which is greater than that
required by the existing regulation for BOD5. and COD. Total
suspended solids performance was better than the average
performance of all plants with biological treatment systems.
3. Solids Removal
Removal of solids from EOF wastewater can occur at several points
in the treatment sequence. Grit removal by screening,
filtration, or sedimentation is often necessary as a preliminary
step in primary treatment. After secondary biological treatment,
it is generally necessary to complete the removal of sludge and
other solids by means of clarification, filtration, or a special
operation such as flotation.
140
-------
Further solids removal occurs in tertiary treatment stages, e.g.,
incidentally by retention of wastewater in polishing ponds.
a. Clarification
Clarification is a method of removing suspended or colloidal
solids by means of gravity sedimentation. Since the settling
rate of suspended solids is dependent on particle size and
density (the smaller the particle size and the closer the density
to that of water, the slower the settling rate), flocculant or
coagulant aids somkimes must be added to promote bridging
between particles and to render them more settleable. A slow
settling rate and the stability of colloidal mixtures make
chemical destabilization and agglomeration of
colloids/suspensions necessary.
Clarifiers are usually large containment vessels that have a
continuous water throughput. A conventional clarification system
utilizes a -rapid mix tank to mix chemicals with the entering
water; the wastewater is then subjected to slow agitation
Provision for the removal of settled solids is also a necessary
part of the system.
Typical clarifiers are shown in Figure VII-8.
b. Filtration
Filtration is a basic solids removal technology in water and
wastewater treatment. Silica sand, anthracite coal garnet and
similar granular inert materials are among the most common media
used in this technology, with gravel serving as a support
material. These media may be used separately or in various
combinations. Multimedia filters may be arranged in relatively
distinct layers by balancing the forces of gravity, flow and
buoyancy of the individual particles. This is accomplished by
selecting appropriate filter flow rates, media grain size, and
media densities.
The most common filtration system is the conventional gravity
filter. It normally consists of a deep bed of granular media in
an open-top tank. The direction of flow through the filter is
downward and the flow rate is dependent solely on the hydrostatic
pressure of the water above the filter bed. An°ther type of
filter is the pressure filter. In this case, the basic approach
is the same as a gravity filter, except the tank is enclosed and
pressurized.
As wastewater is processed through the filter bed, the solids
collect in the spaces between the filter particles.
Periodically, the filter media must be cleaned. This is
141
-------
accomplished by backwashing the filter (reversing the flow
through the filter bed). The flow-.rate for backwashing is
adjusted in such a way that the bed is expanded by lifting the
media particles a given amount. This expansion and subsequent
motion provides a scouring action which effectively dislodges the
entrapped.solids from the media grain surfaces. The backwash
water fills the tank up to the level of a trough below the top
lip of the tank wall. The backwash is collected in the trough7
fed to a storage tank, and recycled into the waste treatment
stream. The backwash flow is continued until the filter is
clean.
!
An example of a filtration unit is shown in Figure VI1-9.
c. Flotation ,
Flotation is an optional method of clarification utilized to
treat some industrial waste in which the suspended solids have
densities less than that of water. Air-assisted flotation may be
applied to some systems with solids slightly heavier than water.
As with conventional clarifiers, flocculants are frequently
employed to enhance the efficiency of flotation.
E. ULTIMATE DISPOSAL
In any evaluation of control and treatment technologies, one of
the most important considerations is the ultimate disposal
methods used by the industry. Whether a plant is a direct
discharger to surface waters, an indirect discharger to POTW's
or a zero discharger can be a critical factor in determining what
technologies are most appropriate for controlling its waste
discharge. Table VII-4 summarizes the methods used by the
pharmaceutical manufacturing industry for the ultimate disposal
of its process wastewaters. This table was prepared from a
listing of each plant's individual disposal methods (See Appendix
Approximately 13 percent of the 464 manufacturing plants have
direct discharges. Seven of these plants also have indirect
discharges, while another nine use zero discharge methods for
some of their smaller waste streams. The majority of the
industry are indirect dischargers. Almost 63 percent of the
plants in the 308 Portfolio Data Base discharge to POTW's. Seven
of these plants also have direct discharges, but another 25 use
zero discharge techniques for some of their smaller waste
streams. Over 25 percent of the manufacturing plants use only
such zero discharge methods as contract disposal, evaporation
ocean dumping, recycling, and so forth. Seventy-five percent of
the zero dischargers were classified as such because they
generated no process wastewaters requiring disposal
142
-------
TABLE VII-V
SUMMARY OF IN-PLANT TREATMENT PROCESSES
In-Plant Technology
Cyanide Destruction
Chromium Reduction
Metals Precipitation
Solvent Recovery
Steam Stripping
Other Technologies
Evaporation
Neutralization
Number of Plants
6
1
3
29
7
19
9
5
-------
TABLE VII-2
CONCENTRATIONS FOR
THE PRIORITY POLLUTANT METAT.R
Final Concentration d/a/l)*
Metal
Antimony
Arsenic
Beryllium
Cadmium
Copper
Chromium III
Lead
Mercury
Nickel
Silver
Selenium
Thallium
Zinc
Lime
Settling
800-1500
500-1000
100-500
100-500
500-1000
100-500
300-1600
-
200-1500
400-800
200-1000
200-1000
500-1500
i
Lime Sulflde
Filter Filter
400-800
I
500-1000 50-100
10-100
50-100 10-100
400-700 50-500
50-500
50-600 50-400
10-50
100-500 50-500
100-400 50-200
100-500
100-500
400-1200 20-1200
References
1 16
118,
116
117,
124,
117,
121,
113,
119,
126
1 18,
122,
120,
118,
120,
116
116
114,
120, 121
118, 123,
125
1 18, 1 19,
123, 124, 125
1 15, 118,
120, 121,
120, 121,
124
121, 128
123, 124
121, 126
118, 123.
124
*Estimated achievable levels reported in the Inorganic Chemicals
references iel°Pment D°<^nt
-------
TABLE VI1-3
SUMMARY OF-END-OF-PIPE TREATMENT PROCESSES
(Data Bases 308)
p»,q-of-Pipe Technology
Equalization
Neutralization
Primary Treatment
Coarse Settleable Solids Removal
Primary Sedimentation
Primary Chemical Flocculation/Clarification
Dissolved Air Flotation
Biological Treatment
Activated Sludge
Pure Oxygen
Powdered Activated Carbon
Trickling Filter
Aerated Lagoon
Waste Stabilization Pond
Rotating Biological Contactor
Other Biological Treatment
Physical/Chemical Treatment
Thermal Oxidation
Evaporation
Additional Treatment
Polishing Ponds
Filtration
Multimedia
Activated Carbon
Sand
°thelecondaryn2hemical Flocculation/Clarif ication
Secondary Neutralization
Chlorination
Number of Plants
.60
79
61
41
37
11
3
74
51
1
2
9
23
9
1
1
17
3
5
40
10
16
7
2
5
17
5
4
10
treatment processes were not available.
-------
TABLE VII-4 :
SUMMARY OF WASTEWATER DISCHARGES
Method of Discharge
Number of Plants
in the Industry
Number of Plants
Direct Only
Direct with minor Zero
Discharge
Total Direct Dischargers
Indirect Only
Indirect with minor Zero
Discharge
Total Indirect Dischargers
Combined Direct/Indirect
Dischargers
SUBTOTAL
Zero Dischargers
TOTAL
NOTE: Subcategory counts will
of multiple subcategory
44
9
251
21
not equal
plants.
i
53
272
7
/
332 ,
132
'
464
industry
FATE OF WASTEWATERS AT ZERO DISCHARGE PLANTS (TOTAL
Discharge Method Dischargers
No process Wastewater
Contract Disposal
Deep Well Injection
Evaporation
Land Application
Ocean Dumping
Recycle/Re-use
Septic System
Subsurface Discharge
98
7
o
7
6
2
2
6
4
Direct
w/Zero
3
i
t
i
i
•3
•J
1
1
fi
u
fl
u
_g
"^ 7 fff feA Ut* *^
A B
6 A
4
3 A
4
9 8
17 53
• 7 p
/ O
24 61
21
2
11 H
_2 _9
37 80
totals because
INDUSTRY)
Indirect
w/Zero
7
/
3
C
Iyt A
4 2
21
68 20
1C 1
5 1
83
107
27
134
Total
132
25
-------
FIGURE VH-1
CYANIDE DESTRUCTION SYSTEM - CHLORINATION
(oe
FEED)
8
00
-------
FIGURE VH-2
CYANIDE DESTRUCTION SYSTEM - ALKALINE HYDROLYSIS
CAUSTIC FEED
1
•*=•
00
INFLUENT
F-EED
TANK
STEAM IN STEAM OUT
REACTOR VESSEL
HEAT
EXCHANGER
FLASH
TANK
RECOVERED
MATERIALS
EFFLUENT
-------
FIGURE Vn-3
CHROMIUM REDUCTION SYSTEM
ACID FEED
VD
1UFLUEK1T
-*-
so, FEED
a
do
,-
CMJST1C FEED
U
U
T
'
EFFLUEMT
TO KLUDGE DISPOSAL
CONTACT
-------
FIGURE VII-4
METALS REMOVAL SYSTEM -ALKALINE PRECIPITATION
LIME FEED
ALUM F£ED
EFFLUENlT
P15POSAL
SOLIDS COklTACT
FILTER. UlsilT
-------
Condenser
Aqueous Layer
Organic Layer
(Product, Recycle)
Manometer
FIGURE VH-5
STEAM STRIPPING UNIT
-------
'l:^^^.':':^''':^:i:^:Y^
SURFACE
WASH
CARBON
BED SURFACE
CARBON
INLET &
OUTLET
SAND
GRAVEL
FILTER BLOCK
WATER OUTLET
FIGURE VH-6 !
ACTIVATED CARBON ADSORPTION UNIT
152
-------
BPT System
FIGURE VII-7
EXAMPLES OF AUGMENTED BIOLOGICAL SYSTEMS
Activated Sludge
Aeration Basin
Effluent
Sludge Disposal
Ui
BPT System
Rotating Biological Contactors
Effluent
Sludge Disposal
Polishing Pond
BPT System
Effluent
-------
\
10
SLUDGE
EFFLUENT
INFLUENT
(a)CIRCULAR CENTER-FEED CLARIFIER WITH
A SCRAPER SLUDGE REMOVAL SYSTEM
INFLUENT
EFFLUENT
7-> SLUDGE
(b)CIRCULAR RIM-FEED, CENTER TAKE-OFF CLARIFIER WITH A
HYDRAULIC SUCTION SLUDGE REMOVAL SYSTEM
INFLUENT
EFFLUENT
SLUDGE
(cJCIRCULAR RIM-FEED, RIM TAKE-OFF. CLAR I F I ER
FIGURE VH-8 i
TYPICAL CLARIFIER CONFIGURATIONS
154
-------
FLOAT-
CONTROL
VALVE
EFFLUENT[
FIGURE VII-9
FILTRATION UNIT
155
-------
SECTION VIII
COST, ENERGY, AND NON-WATER QUALITY ASPECTS
A.
INTRODUCTION
This section addresses the costs, energy requirements, and non-
water quality environmental impacts associated with the control
and treatment technologies.
There is substantial variability within the industry and within
each subcategory as to products, process methods, plant size,
wastewater flow, raw waste characteristics, and waste treatment
methods employed. Therefore, it is appropriate to evaluate the
impact of limitations on an individual plant basis.
Treatment costs are largely a function of wastewater flow rate
and pollutant loadings. Choice of treatment methods is also of
importance and is dependent on wastewater quality, effluent
target, and site considerations. In-plant treatments are, of
course, largely dictated by which specific pollutants are to be
removed. ,
It is not feasible to develop exact individual requirements for
every plant because of the lack of data on site specific
considerations and bioreaction treatability (K rates). Instead,
an approach has been taken which assumes conservative (high side)
valuation of these considerations across the board.
Capital, operating, and maintenance costs were developed and
applied to each of the processing subcategories for a variety of
in-plant treatment and end-of-pipe (EOF) systems. The resultant
annualized costs were then generalized to variations in
wastewater flow, raw wasteload, and effluent limitation levels.
Cost "sensitivity" curves show the effect of these variables on
annualized costs and investments; tabulations of individual plant
costs indicate specific cost details.
The costs considered are those costs likely to be required over
and above the capital and operating costs associated with BPT
guidelines technology. In other words, the costs noted are those
incremental to what is necessary to meet current BPT
requirements. Since all plants within the industry are not
precisely in compliance with BPT (many being significantly better
or worse), an alternative statement of costs was considered in
the plant-by-plant analysis projecting actual upgrade
requirements relative to performance capabilities indicated at
the time of the 308 questionnaire (1977). A series of six cases
156
-------
reflecting the various target level options as well as starting
bases (BPT or actual) were developed.
B. COST DEVELOPMENT
1. Approach
Treatment costs were developed for the direct and indirect
dischargers in the 308 Data Base. Raw waste loads and flow rates
were reviewed to determine the required treatments for in-plant
streams, wastewater effluents to surface waters, and flows to
various POTW's. Average flows and raw waste loads were estimated
for each subcategory to serve as bases for cost development.
Individual plant costs were then determined by adjustment of base
costs for flow and RWL, allowing for economies of scale.
Adjustment of investment components in proportion to an
exponential ratio is generally acknowledged to best reflect
economies of scale. Cost extensions were applied directly to
plants with sufficient flow and concentration data,. For plants
with insufficient data costs were indirectly applied by assuming
requirements similar to plants with data.
Investment and operating costs for individual plants were
developed by adjustment of applicable subcategory model plants to
account for specific wastewater flow and concentrations of the
subject plants. Mixed subcategory plants containing A and/or C
were evaluated based only on those subcategories since their
flows were judged to predominate. If both A and C process were
used, an average of the cost models was used. If B and/or D
processes were employed, their cost models were employed, either
individually or averaged. It should be noted that the
sensitivity of an individual plant cost to the choice of
subcategory model is not great since the models are substantially
similar on comparable flow and loading bases.
The base costs to meet proposed design requirements for
limitations were developed for average conditions for each
subcategory as presented in Table VIII-1. This was done by
establishing representative values for wastewater flow rates and
traditional pollutant loadings for subcategories A, B, C, and D;
costs were then determined for each of the end-of-pipe and
in-plant treatment alternatives for these representative flows
and loadings. Since these base costs are not used directly but
only as calculation bases for adjustment to specific plant
situations, the base values of flow and concentration are not
critical.
Investment and operating costs were developed by means of the
Catalytic Treatment Model. It applies end-of-pipe and in-plant
treatment alternatives to influent, effluent, and flow conditions
157
-------
stated for each case. Because of distinctive processing
techniques and materials employed, not all priority pollutants
are likely to be associated with all; subcategories (e.g.,
reactant and catalyst chemicals are not likely to be found in
Subcategory D wastewaters). However, they tend to appear in the
same range of concentrations in those subcategories in which they
do occur. Paragraph B.2. (Case Definition) summarizes the
judgment made as to subcategory occurrences of priority of
pollutants. Cost development is limited to those instances of
likely occurrence. i
As indicated in Section V, the priority pollutant loadings for
the individual subcategories are effectively represented by the
median values from all plants in the Screening/Verification data
base. These concentrations of priority pollutants were not found
to vary markedly among subcategories, due in part to the
necessity of relying on unsegregated stream data. For the total
industry, raw waste concentrations of 13 of the most commonly
found priority pollutants are presented in Table VIII-2.
Following the development of the base costs for the various
flow/loading levels, each of the plants was analyzed for flow and
concentration data, end-of-pipe and in-plant treatment
requirements, and incremental cost impacts. Of the direct
dischargers, 18 plants lacked sufficient data to directly apply
the treatment costs. The indirect dischargers include 33 plants
with sufficient data, 144 plants with flow data only, and 105
plants with insufficient flow and concentration data.
Additionally, the available concentration data for the indirect
dischargers was normally presented for the total flow to the
POTW, which includes process, sanitary, noncontact cooling, and
other wastewaters. Further calculations were required to
determine the concentration in process wastewater prior to mixing
and the consequent estimate of treatment cost if applied to this
segregated stream only.
For plants with sufficient data, the current effluent
concentration was compared to a target level, and further percent
removal was calculated. The percent removal was related to an
incremental number of "treatment stages1" and a cost/capacity
extension of the treatment costs was applied. Initially, the
cost for one stage was extended from the appropriate base case;
that cost was then adjusted to reflect any incremental stages
required.
A similar approach was applied to the plants with only flow data.
The incremental stage requirement, however, was calculated as a
constant based on the plants with sufficient data. Average
additional percent removals, average flows, and probabilities of
r;t);tequired treatment) were incorporated into the base cases.
158
-------
Exponential ratio cost adjustments were made based on the ratio
of plant flow to base flow. The costs for these plants can be
combined to provide part of the total industry cost estimate.
The costs for plants with insufficient flow and concentration
data were calculated and applied in a similar fashion with two
exceptions. First, the average flow was calculated for all
plants with flow data (including plants with flow data only and
plants with sufficient data on flow and concentrations). Second,
costs were determined for this average set of conditions.
Without any individual capacity adjustment, these costs were
applied as a constant to all plants with insufficent data. These
costs are applicable to an average plant situation and the sum of
these average plant costs is included in the total industry cost
estimate.
The probabilities of treatment being required for the direct and
indirect dischargers were, calculated from the plants with
sufficient data. These probabilities reflect the percentage of
total plants not meeting specified targets. The probabilities of
required treatment (both end-of-pipe and in-plant) for the direct
and indirect dischargers were calculated from the plants with
sufficient concentration data. These probabilities reflect the
percentage of total plants hot meeting specified targets as
defined for each case.
Direct discharge plants with flows of 3,000 gallons per day or
less were assigned costs for hauling to an off-site centralized
contract treatment plant rather than on-site treatment costs.
Hauling for such flows was found to be a more economical
alternative. This is illustrated by Figure VIII-24, which shows
that the cost curves with flow variation cross at about this
level.
For situations where a plant was classified as a direct and an
indirect discharger, costs were applied to each waste treatment
segment. The total plant costs were derived from the summation
of direct, indirect, and in-plant treatment costs. Zero
dischargers are not affected by this proposal. Therefore, no
costs are developed for these plants.
2. Assumptions, Bases, and Limitations
This section describes assumptions regarding current performance
levels and design criteria which were used in developing cost
cases. These cost cases were then used to estimate the loss that
would be incurred by plants in complying with the anticipated
regulations.
a. Case Definition
159
-------
BCT target levels for two levels of concentration and one level
of percent removal were considered for direct dischargers. Two
comparison starting levels are covered, one, equivalent to BPT (90
percent removal) and the other reported actjual performance at the
time of the 308 responses. One level of pretreatment of indirect
discharge (200 mg/1 of BOD) was considered. A single set of
limits for priority pollutants was considered for both direct and
indirect discharges. Thus we developed six distinct cost cases
each comprehensively covering the cost impacts for all plants.
Case variations studied cover three potential BCT effluent design
criteria limitations for direct discharge:
(1). 40 mg/1 BOD, 40 mg/1 TSS
(2). 20 mg/1 BOD, 30 mg/1 TSS
(3). 95 percent removal BOD, 40 mg/1 TSS
Upgrade costs for direct dischargers were developed from two
starting bases. BPT performance and actual performance. BPT
performance of 90 percent removal of BOD was not fully achieved
at the time of the 1977 308 questionnaire. Some plants met and
even exceeded that level, but many more did not.
Cost cases are set forth as follows for direct dischargers:
OPTION CASES BASED UPGRADE FROM
ON EOP DESIGN CRITERIA LIMITS BPT
40 mg/1 BOD
40 mg/1 TSS
20 mg/1 BOD
30 mg/1 TSS
95% Removal BOD
40 mg/1 TSS
Case I
Case II
Case III
UPGRADE FROM
ACTUAL REPORTED
Case IV
Case V
Case VI
The costs of each treatment case were developed for all direct
dischargers using the data supplied by the plants (flows and
influent and effluent concentration values). In cases where
concentration data was not supplied, average values were used for
influent and effluent concentrations and the costs were derived
in the same manner as the costs based on known influent and
effluent concentrations. The technology options chosen as the
control bases for the traditional pollutants (to be regulated by
BCT, BAT, and NSPS) do not equate exactly to any of the six
option cases described because they require the attainment of
different effluent target levels for BOD5_, COD, and TSS than
160
-------
specified above. However, the overall technology bases (varying
decrees of biological enhancement or augmentation as required) of
these regulations are only different in that they involve
slightly different design requirements to accommodate the
different target concentration levels. Plant-by-plant costs for
the chosen BCT/BAT option were developed by allowing for
necessary design modifications to Option Case IV. The costs were
then calculated for all direct dischargers requiring treatment
uparading based on data submissions. New source costs were
estimated for an average new source direct discharger using an
adjustment of Option Case V. In addition, pretreatment costs
were estimated for indirect dischargers assuming plants would
discharge effluent containing 200 mg/1 or less of BOD5 to POTWsj
All costs are included in the technical record of this
rulemaking. \
In-plant treatment requirements developed to meet revised BPT,
PSES, and PSNS for the treatment most probably applicable to each
process subcategory in each plant are:
Steam Stripping
Subcategory of Volatiles
Fermentat ion
B
Biological
Extraction
Chemical
Synthesis
Yes
Yes
Yes
No
Cyanide
Destruction
No
No
Yes
No
Formulation
There are exceptions to the exclusions set forth in this listing
(e g., the use of cyanide-related materials in the Vitamin-B12
manufacture via fermentation) (42); however, for purpose of cost
approximation, treatment for removal of priority pollutants is
considered whenever actual effluent data reported for a given
plant exceeds the following values:
All volatile organics
Cyanide
EOP Value
1200
200
(all values in micrograms/1iter)
161
-------
Removal methods for priority pollutants for which specific
processing costs were developed include steam stripping for
volatile organics, alkaline precipitation for most metals,
chromium reduction, and oxidative destruction of cyanide. Other
priority pollutants can be removed by methods which are generally
cost equivalent to the methods which have been costed. These
pollutants include phenol, mercury, and other metals. The
not analyzed here
exchange, sulfide
techniques which might be employed, although
for cost detail, might include ion
precipitation, and thermal oxidation.
Costs for in-plant treatment of toxic volatile organics and
cyanide were developed for individual plants when a comparison of
the data submitted with the above effluent target values
indicated that treatment for cyanide and/or toxic volatile
organics was required. Costs were also estimated for plants that
did not supply effluent priority pollutant data by assuming that
the above target values and average raw waste values were
applicable to these plants. Although the Agency will not develop
limitations on metals in this rulemaking, costs for metals
precipitation and chromium reduction (developed on a basis
similar to that used the cyanide destruction and steam stripping
cost development) are included in the technical record. The
components of all in-plant costs are discussed in the ensuing
subsections.
b.
Cost Factors
i
The following major capital and operating cost factors were
throughout the costing effort:
used
(1) Land - The cost estimates presented do not include land
costs. The cost of land is variable and site dependent and
cannot be estimated on a national basis. For in-plant
systems, the necessary equipment usually can be placed in
existing structures near the source stream being treated.
For end-of-pipe systems, the total area required is
indicated.
(2) Piping and Pumps - Where required, piping and pumps are
assumed to be 20 percent of basic equipment costs.
(3) Delivery and Installation - These costs are assumed to be 50
percent of total equipment costs.
(4) Engineering and Contingency - These costs are assumed to be
30 percent of total installed costs.
(5) Energy - Electricity costs are assumed to be $0.04 per KWh-.
Annual power costs for mixing and pumping are computed as
162
-------
(6)
(7)
(8)
(9)
(Total horsepower) x (8760 hr/yr) x (0.746 KW/hp) x
($0.04/KWh).
Operating Labor - A rate of $10/hr including taxes and
fringe benefits is assumed.
Maintenance - Maintenance costs are assumed to be 3 percent
of total capital costs.
Sludge Disposal - This cost (including transportation) is
assumed to be $0.30 per gallon.
Capital Amortization -
percent at 10 years.
This
figure is estimated at 10
-
News Record Construction Index number was
--
2670 and the
an Plant Cost Index number was 2 0.6 .See
Appendix N tor tabulation of these indices.) Capital costs
for such major equipment items as tanks, clarifiers,
filters, mixers, sludge thickeners, and vacuum filters were
obtained from equipment manufacturers and from a ^tewater
treatment cost data base Catalytic, Inc. developed for the
Effluent Guidelines Division (131, 132).
c. Cost Sensitivity Bases
Additional assumptions and bases necessary for derivation of the
cost variations are:
(1) Investment costs vary with the 0.7 exponential power of
wastewater throughput.
(2) Break points or discontinuities in equipment sizes (as they
vary with flow or performance) are not considered since they
are likely to be plant specific and potentially misleading.
A smoothed transition form of capacity and investment data
is preferred and used.
(3) Sludge-dewatering equipment size or disposal volume is
directly proportional to quantity of sludge generated.
Disposal costs are constant per unit of sludge handled.
(4) Within the ranges considered, labor cost is considered to be
constant and independent of equipment size or throughput.
(5) Treatments requiring the addition of pH-adjustment chemicals
utilize such chemicals in proportion only to the amount of
water treated.
163
-------
(6) Treatments based on chemical reaction of pollutants are
considered to require reactant-treatment chemicals in direct
proportion to the amount of pollutant removed.
(7) Cost Factors applied to investment, labor, and other costs
remain valid within the range of data and results presented.
d. Plant-by-Plant Cost Bases
The bases on which the plant-by-plant costs were developed are:
(1) Treatment Stages - Treatment systems costs are estimated in
relation to the base costs determined by BRISC/Catalytic.
The extent of treatment is defined as a stage of
biotreatment and is assumed to :be equivalent to be
approximately 85 percent BOD removal.
(2) Treatment Choice - Activated sludge is used as a cost basis
for biological treatment. Although it is not expected to be
the treatment selected for every case, it is the most
broadly applicable technology and should be a conservative
cost representation of other treatment methods (e.g.,
aerated lagoons, trickling filters, etc.).
(3) Bio-reaction Kinetics - The degree of biological treatment
is developed as a function of percent BOD removal required
to meet target performance. The bio-reaction is considered
to be first order, with a constant K value equal to the
conservative value of 1 used in the base study.
(4) Extent of Treatment - Since detention time and the
consequent holdup volume of the system is directly
proportional to the number of "stages", system investment
cost also can be related. The counting of "stages" is an
artificial calculation convenience used to compare extent of
treatment by comparison to an arbitrary standard treatment
extent, chosen at about 85 percent BOD5_ removal for the
purposes of these calculations. Investment was taken to
vary as the 0.7 exponent both of the system throughput rate
and of the number of stages. For the sake of simplicity,
those system parts (pumps, piping, instrumentation, and the
like) not varying with holdup are not estimated separately.
(5) Throughput Effect - Wastewater flow rate is also considered
to influence system capacity proportionately and therefore
is also scaled by 0.7 exponent.
(6) Low-Flow Alternative - A few plants among the direct
dischargers indicate flows to be low enough to require
exhorbitant additional treatment cost per unit of volume.
164
-------
(7)
(8)
(9)
(10)
In such cases, the alternative of hauling the small volumes
of wastewater to a POTW or to a neighboring industrial
treatment facility is substituted. The break point between
these methods is approximately 3,000 GPD.
TSS Removal - Costs developed for biological treatment
systems include secondary TSS removal. However, there are a
few direct dischargers for which biotreatment is not needed
but TSS treatment is. A separate TSS removal is estimated
and included in such cases. Because of the small magnitude
of these costs and the uncertainty of applicability, no
estimates of supplemental TSS costs were made for the plants
with insufficient data.
Direct Discharge Data Projection - Flow data are reported
for most direct discharge plants. However, performance data
in terms of influent and effluent BOD concentrations are not
available in the 308 data for a substantial number of
plants. If either influent or effluent data (not both) are
missing, current BPT compliance performance at 90 percent
removal is assumed. If both are missing, an average level
of treatment based on known treatment plants and a
probability of biotreatment being required are used to
estimate a probability-weighted cost for each plant.
Indirect Discharge Data Reported Projection - Data reported
forindirect discharge plants are not as complete as the
data for direct dischargers. Flow data as well as BOD
concentrations are lacking for many plants. Where
concentration only is missing, treatment requirements and
costs are scaled t6 individual volumes based on a
"representatively average" plant that supplied complete
data. Where flow also is not known, an average plant is
developed from those with data, and its costs are used to
estimate an average set of costs applied to all of the
plants without data.
In-Plant Data Projection - In-plant treatment data are
subject" to"considerable uncertainty since wastewater flows
and concentrations are reported on an end-of-pipe or a
combined influent basis. Thus flows and local priority
pollutant concentrations before combination and equalization
are not available. Based on reasonable processing mix, an
estimate was made that, for a typical plant, 10 percent of
the total process wastewater is subject to each of the
in-plant treatments applicable. It is to be expected that
actual plants will vary substantially above and below this
proportion. Average treatment costs are developed based on
those plants with data. These averages are factored by the
probability of a treatment being required for plants without
165
-------
data and
plants.
the resultant costs have been developed for these
The application of a probability of treatment as well as the
estimated wastewater proportion prevents reliance on the
accuracy of individual plant costs so calculated. These
cost effects should be relied on only as an estimate of
cumulative effects for the plants without data.
3. In-Plant Treatment Costs
In-plant treatment is directed at removing certain pollutants
from specific waste streams before the water is combined with
other wastewaters. The costs of in-plant treatment alternatives
allocated to any pharmaceutical plant must be based upon the flow
of the process wastewater stream bearing the specific pollutant
or pollutants of interest. To prepare costs for the subcategory
base cases, the flow rate of the process waste stream to be
treated by in-plant treatment systems was assumed to be 10
percent of a plant's total wastewater flow since in-plant flows
are seldom reported individually. In addition, it was assumed
that the entire mass loading for each case of the subject
pollutant (calculated from the data in' Table VIII-2) was
contained in the process waste stream. The major priority
pollutants found in pharmaceutical wastewaters were cyanide,
metals, and solvents. Therefore, cost estimates were developed
for treating these three classes of pollutants.
a. Cyanide Destruction
Cyanide has been identified in the wastewaters of a number of
pharmaceutical plants. Table VIII-3 contains the equipment cost
bases and energy requirements for oxidation with hypochlorite in
an alkaline environment. :
I
Capital cost items are presented in Table VII1-4 and include
detention tanks, mixers, piping and pumps, and automatic chemical
feed systems. The annual operating costs for base conditions and
variations are shown in Tables VII1-5 and VII1-6. To estimate
the annual cost of chemicals, it was assumed that 1.2 Ibs of
hypochlorite ($0.60/lb) and 1.4 Ibs of caustic ($0.12/lb) were
added to each 1000 gallons of wastewater treated.
b. Chromium Reduction
Chromium in wastewaters can occur in either a hexavalent or a
trivalent state. Hexavalent chromium is extremely soluble while
trivalent chromium forms an insoluble hydroxide. Therefore, the
first step in the treatment of chromium is the reduction of the
hexavalent ions to the trivalent state. This usually is
166
-------
accomplished with sulfur dioxide at low pH values; however, other
reducing agents can be used.
The pH of the wastewater containing the trivalent chromium is
adlusted to the range (8 to 10) where chromium hydroxide is
precipitated and removed by clarification. The procedure
generally is performed on a batch basis for systems below 15
gallons per minute and on a continuous basis for larger ^systems.
Table VII1-7 presents the equipment cost bases and energy
requirements for chromium reduction systems. Adjustment of pH
and clarification are included as part of the systems cost.
Tables VIII-8 through VIII-11 present the capital and operating
costs for base conditions and variations. Chemical requirements
for the systems presented include 0.45 Ibs of sulfur dioxide ($0
,15/lb). 0.45 Ibs of sulfuric acid ($0.06/lb), and 2 Ibs of
caustic ($0.12/lb) for each 1000 gallons of wastewater treated.
c. Metal Precipitation
Metal removal generally is accomplished by pH adjustment in the
range of 8 to 10. After, the metal hydroxide precipitates formed
bv the pH adjustment are removed by clarification. There are a
variety of chemicals that can be used to aid in the precipitation
and clarification process; however, the data presented in Tables
VI11-12 and VI11-13 are based upon lime and alum addition since
they are commonly used. Sulfide precipitation, similar in cost,
is also frequently employed.
Table VII1-12 presents the design bases and energy requirements
for metal precipitation. Solids-contact-type clarifiers were
used for costing purposes. These units include a flash mix zone,
a flocculation zone, and a settling zone in one unit.
Since metals removal by precipitation requires very little head
loss, most systems will be operated by the head already available
in the wastewater effluent line. The miscellaneous energy
requirements shown in Table VIII-12 include those for chemical
addition and sludge removal.
Table VIII-13 presents the capital cost items for the base case
for the systems outlined, while Tables VIII-14 through VIII-16
show the annual operating costs for base conditions and
variations. Capital amortization (capital recovery plus
interest) is the largest portion of annual cost.
d. Steam Stripping
A study (72) conducted by EPA on the applicability of steam
stripping for treating wastewaters containing organic priority
167
-------
pollutants shows that this technology is a feasible in-plant
treatment method for the pharmaceutical manufacturing industry
and is in fact currently in use.
Since no other specific cost data were available, the preliminary
figures reported in that study are used in this document. Table
VIII-17 presents capital and annual operating costs for steam
stripping. As work continues in this area, more detailed cost
information can be developed and incorporated into the analysis.
4. End-of-Pipe Treatment Costs
Bi?i°iiCal treatment was found to be the principal end-of-pipe
method in use by the majority of pharmaceutical mcinufacturing
plants now seeking to meet existing BPT limitations guidelines.
This treatment alternative consists of such specific technologies
as activated sludge systems, trickling filters, rotating
biological contactors, lagoons, etc. In addition, variations in
the application of these specific technologies can improve
biological treatment. Modifications and combinations of
conventional biological treatment processes are referred to as
biological enhancement and augmentation.
a. Biological Treatment
For the purpose of developing costs, combinations of biological
treatment processes were considered for biological treatment.
The assumption was made that a conventional biological process
would be added to a BPT system already in place. For costing
purposes, those plants lacking effluent data were assumed to be
meeting the existing BPT (90 percent removal) limitations.
Data analyses conducted during this study indicate a significant
number of plants utilizing biological treatment can achieve
effluent levels of 40 mg/1 BOD and 40 mg/1 TSS (an improvement
over BPT systems in many cases).
Table VIII-18 presents equipment cost bases and energy
requirements for activated sludge systems designed for four
subcategory base levels developed for cost calculation purposes.
Capital cost items are presented in Table VIII-19 and include
typically such auxiliary equipment as aeration basins, aerators,
nutrient-addition equipment, clarifiers, and sludge-handling
facilities. The total annual costs for base conditions and
variations are shown in Table VII1-20.
Rotating biological contactors (RBC's) were another type of
biological treatment considered. RBC systems were sized for each
of the base conditions and were based upon the data in Table
168
-------
base
ecaep o,
Capital cost items and annual °P*«ting costs for base
conditions and variations are presented in Table VIII 24 ana
include excavation, grading, compaction, . an imper vjous liner^ and
Iolis9^?n?f %?ea^f sho ?d 1hn
thf present value of such costs is judged to be
For nlant-bv-plant cost evaluation, activated sludge treatment
was considered to be representative of the various biological
modification of existing systems, although ^"btedly feasible
in many cases, because site-specific knowledge of each plant was
not available.
b. Biological Treatment and Filtration
Filtration can be used as a polishing step following Biological
treatment for increased solids removal. Analyse sindi cate that
effluent concentrations of 20 mg/1 BOD and 30 mg/1 TSS are
achievable with biological treatment and filtration ot
pharmaceutical wastewaters.
Table VI I 1-25 presents equipment cost bases and energy
VIII-27.
Cost estimates were also prepared .for filtration units following
RRP easterns The RBC units were sized for the desired eftiuent
aualitv increasing the total RBC surface area above those shown
Tn Table vm-!T? The same dual media filters as those Provided
iith activated sludge systems are specif led in Table VIII-28
Capital and total annual costs for base conditions and variations
are given in Table VIII-29.
169
-------
c- Low-Volume Wastewater Hauling
°Perati°ns making up the pharmaceutical
3 large number of Plants wifch small volume
dlscharges. Many of these flows are so small that the
cost of conventional treatment, expressed as cost per unit of
wastewater flow, would be comparatively quite llrge Most
lanJS aP indirect dischargers to a POTW and have no
"astewater treatment. However, a few may be located
this is not practical. In such1 situations, it may be
t0 fl?d a means of consolidating such small volumes
w <-er v?lume system (e.g., hauling the wastewater to a
POTW or other combined treatment system).
An analysis of wastewater hauling costs is presented in Figure
VIII-24 and is supported by Table VIII-30. A range of hauling
mifef CanSeP™nent*? by Parameters of round-trip hauls of 50
hiJTfnn^fS • ? ^ S a^e Considered. Investment for wastewater
hauling is included, as is destination cost of treatment The
current criterion of $.36 per pound of pollutant (1980) is taken
cost reasonable aPProximation of a combined system treatment
armmn<- moderately small flows of wastewater might be
accommodated by intermediate-scale methods, such as small
package-type treatment units or evaporation ponds? Since these
approaches are expected to be intermediate in cost and in mlny
?S5? -A involve .site-specific circumstances, they are nSt
individually analyzed. Hauling costs are considered to set an
upper, conservative limit for small volumes.
a£ti5??]3r«i!!3!!lln8! aS opP°sed to a standard treatment .such as
activated sludge, becomes advantageous at about 3,000 gallons per
5. Cost Sensitivities
tr?jtment cost with wastewater flow, raw waste
mo effluent concentration level are recognized by
means of the cost sensitivity curves shown in Figures VIIl-i
SfSyS,. VIII~24' Subcategories are presented as plrlmetrically
distinct curves. The cost axes are stated as annual cost of
pT«S ? °r4-au COSt per thousand gallons of wastewater treated.
Flow rate must be considered because of its effects on treatment
plant investment and annual costs. i.i««uneni.
Biological treatment systems are directed toward removal of BOD
?emoval.a related manner^ COD, also with supplemental solids
170
-------
In-plant treatment is directed primarily toward reduction of
priority pollutants. Cost sensitivities developed for treatment
systems in both areas cover the following:
(1) Activated Sludge, Annual Treatment Cost vs. Wastewater
Flow.
(2) Activated Sludge With Supplemental Treatment, Annual
Treatment Cost vs. Wastewater Flow.
(3) RBC System, Annual Treatment Cost vs. Wastewater Flow.
(4) RBC System With Supplemental Treatment, Annual Treatment
Cost vs. Wastewater Flow.
(5) Polishing Pond, Annual Treatment Cost vs. Wastewater Flow.
(6) Cyanide Destruction, Annual Treatment Cost vs. Wastewater
Flow.
(7) Cyanide Destruction, Annual Treatment Cost vs. Influent CN
Concentration.
(8) Cyanide Destruction, Unit Treatment Cost vs. Wastewater
Flow.
(9) Cyanide Destruction, Unit Treatment Cost vs. Influent CN
Concentration.
(10) ChromiumReduction, Annual Treatment Cost vs. Wastewater
Flow.
(11) Chromium Reduction, Unit Treatment Cost vs. Wastewater Flow.
(12) Chromium Reduction, Annual Treatment Cost vs. Influent Cr
Concentration.
(13) Chromium Reduction, Unit Treatment Cost vs. Influent Cr
Concentration.
- (14) Chromium Reduction, Annual Treatment Cost vs. Effluent Cr
Concentration.
(15) Chromium Reduction, Unit Treatment Cost vs. Effluent Cr
Concentration.
(16) Metals Precipitation, Annual Treatment Cost vs. Wastewater
Flow.
171
-------
(17) Metals Precipitation, Unit Treatment Cost vs. Wastewater
Flow.
(18) Metals Precipitation, Annual Treatment Cost vs. Influent
Metals Concentration.
(19) Metals Precipitation, Unit Treatment Cost vs. Influent
Concentration.
i
(20) Metals Precipitation, Annual Treatment Cost vs. Effluent
Metals Concentration. ;
(21) Metals Precipitation, Unit Treatment Cost vs. Effluent
Metals Concentration.
(22) Steam Stripping, Annual Cost vs. Flow;Rate and Steam Cost.
(23) Steam Stripping, Unit Cost vs. Flow Rate and Steam Cost.
(24) Wastewater Hauling Costs vs. Wastewater Flow.
C. ANALYTICAL COSTS FOR MONITORING PRIORITY POLLUTANTS
In addition to the cost of treatment facilities to remove
priority pollutants, the cost of monitoring the priority
pollutants discharged must be considered. An estimate of these
costs is shown in Table VII1-31.
The basis for these costs assumes a typical slate of eleven
priority pollutants to be monitored by the example plant: five
volatiles (including acid extractables), five metals, and
cyanide. This slate cannot cover all plant situations, for
purpose of costing; but it is judged to be representative of the
priority pollutants most commonly found in the industry's
wastewater. Muouty &
Several methods of analysis are available for each category of
pollutant. For volatiles and extractables, the methods are gas
chromatography (GC), high-pressure liquid chromatography (HPLC),
and gas chromatography with mass spectroscopy (GC/MS). Of these
methods, GC and HPLC were judged to be appropriate for routine
use, as they are considerably less expensive than GC/MS. A GC/MS
run would be made at intervals for confirmation of the GC or HPLC
results and for identification of any unexpected priority
pollutants. An interval of one GC/MS for every ten samples was
selected as reasonable. Which method, GC or HPLC, might be used
for routine analysis would depend on the specific pollutants
present and established analytical capabilities. However, the
172
-------
costs are very similar. Extractables would be analyzed using the
same methods employed for volatile organics, but preceded by
appropriate extraction.
A colorimetric test was selected for cyanide analysis. Two tests
were considered for metals analysis: Inductively Coupled Plasma
(ICP) and Atomic Absorption (AA). A cost range for each element
analyzed was established covering these methods.
Costs of the applicable analyses are expected to vary with a
number of site-and location-specific factors. For example, the
cost of analysis would vary with the cost-of-living if the area
where the plant is located. The cost of analysis would also vary
from lab to lab, since each lab sets its own prices. The number
of pollutants analyzed would also be a factor. For this reason,
a range of costs is presented along with a weighted average. The
costs given are based on quotations from labs in Baton Rouge,
Louisiana, and U.S. Bureau of Labor Statistics for various U.S.
cities.
Once the total cost per analysis has been calculated, the
required frequency of analysis is established. Factors to be
considered in setting frequency include the volume of outflow,
the compliance history of the plant, the variability history, the
nature of the product/processes and priority pollutants of the
plant, and the equalization pattern of the plant s treatment
system. The frequencies selected for study were daily, weekly,
monthly, and a three-day series once per month. Costs based on
each of these patterns are included in Table VIII-31.
Finally, another monitoring cost determinant is the number of
outfall analyses which must be covered. Some outfalls may be
combined if waste characteristics are similar and if a high level
of priority pollutants is not likely to cause individual
monitoring concern. The cost presented is per individual sample,
be it from an individual outfall or a composite.
D. ENERGY CONSIDERATIONS
The energy consumption impact of further limitation on wastewater
quality in the pharmaceutical industry is largely limited to
power requirements for additional pumps, agitators, and so forth.
One exception is the substantial steam requirement (relative to
pollutant removed) for steam stripping removal of volatile
organics or other solvent recovery technologies based on
volatilization.
Incremental energy consumption is reflected within the additional
costs noted for each plant. Availability of power or steam where
173
-------
needed is not judged to be a prevalent problem,
of the relatively modest demand.
largely because
To the extent that regulatory limits on priority pollutants may
encourage changes in manufacturing techniques, there may be some
specific changes in energy utilization. These are expected to be
minor. Examples are recycle and reuse of process contact water
and substitution of techniques other than direct contact
barometric legs for vacuum systems.
E. NON-WATER QUALITY ASPECTS
Although these proposed limitations cover effluent wastewater
quality from the pharmaceutical industry, the effect such
regulations might have on other aspects of environmental quality
must be considered. These include RCRA wastes ("solid wastes")
and air emissions.
1. RCRA Wastes
RCRA wastes generated by the pharmaceutical industry fall into
four general categories: sludges, waste solvents, infectious
wastes, and returned rejected goods. (129)
a. Sludges
Sludges are generated by in-plant and end-of-pipe technologies
and range from the relatively innocuous sludge of aerated lagoons
and activated sludge units to sludge cakes of high metal content
(the amount of which will not be affected by these regulations).
Sludge from biological treatment and general process waste (e.g.,
mycelia from fermentation) is usually landfilled. A current
trend in the industry is to reprocess waste mycelia and market it
as an animal feed supplement.
Sludge production rates for base-case plants are shown for each
treatment process in the cost bases tables. The amount of sludge
produced by pharmaceutical plants will vary markedly from site to
site. However, these estimates are high and are expected to be
equal to or higher than the actual amounts experienced by any
given production site. Based upon these factors, it is expected
that any additional sludge production will be minimal, especially
when compared to the large quantities of sludge produced by the
basic in-place technology.
b. Waste Solvents
Waste solvents, such as toluene, methylene chloride, benzene, and
carbon tetrachloride, are a substantial part of RCRA wastes from
the pharmaceutical industry. Solvents which might be separated
174
-------
from wastewater by steam stripping would contribute a modest
increment to such wastes. For the most part, waste solvents are
disposed in approved hazardous waste disposal sites. However,
because of RCRA considerations this method will more than likely
decline. Another and more attractive form of disposal for waste
solvents is incineration, either direct or by incorporation into
a fuel system. These systems are designed to completely oxidize
organic solvents and eliminate the need for landfill.
Chanaes in process in the pharmaceutical industry generally
require FDA approval. Because of potential process
contamination, solvent recovery would normally fall into such a
change category, effectively restricting recycle, at least into
pharmaceutical processing.
The latest estimates available (1980) showthe pharmaceutical
industry already generates approximately 52,000 dry U.S. tons per
year of waste solvents(43). A toxic solvent limitation (PSES)
would have the effect of increasing the quantity of waste
solvents subject to RCRA disposal. The Agency estimates that if
a toxic solvent pretreatment standard were promulgated,^ an
increase of about 9300 tons/yr of waste solvents requiring RCRA
disposal would result, assuming no recycle.
c. Infectious Wastes, Returned and Rejected Goods
This category covers a wide spectrum of solid waste materials.
Because of their infectious nature, the wastes must undergo
treatment that will insure destruction of pathogenic agents. The
two methods most commonly used in the pharmaceutical industry for
the treatment of infectious waste are autoclaving and
incineration.
Returned and rejected goods from formulation, test animal
carcasses, bedding, and other disposable materials are
incinerated and/or landfilled, depending upon whether they are
suspected of carrying infectious agents.
Any new effluent limitations will have no effect on the disposal
of infectious agents and other solid wastes since these wastes
are not generaged by wastewater treatment.
2. Air Emissions
The various types of air emissions which may emanate from a
pharmaceutical manufacturing site include solvents, particulates,
combustion gases, and odors. However, these regulations will
onlv affect the emissions of wastewater-borne solvents to air,
and hence only the effect of these emissions has been considered.
175
-------
The technology options likely to be selected for controlling
traditional pollutants and cyanide beyond existing BPT may, in
some cases, increase to a small extent the air emissions of
wastewater-borne volatile solvents. In particular, plants which
may choose to use aerated biological treatment systems, such as
aerated lagoons, may have some increase in emission via
incidental air stripping.
This may or may not result in local;air pollution problems
depending on the nature and amount of volatile organics in the
untreated wastewater. However, no significant direct effect on
air quality is anticipated as a result of any effluent guidelines
limitations and standards that may be proposed in this
rulemaking.
176
-------
TABLE VIII-1
RAW WASTE LOADS FOR SUBCATEGORY BASE CASES
TRADITIONAL POLLUTANTS
Traditional Pollutant
BOD, mg/1
Ibs/day >
COD, mg/1
Ibs/day
TSS, mg/1
Ibs/day
t
2
8
5
18
1
3
A
,440
,850
,180
,800
,030
,740
B
1,270
480
2,050
770
520
200
2
4
5
11
1
C
,190
,750
,160
,200
740
,600
1
1
2
1
D
,630
,020
,780
,740
370
230
Wastewater Flow
435,000
45,000
260,000
75,000
Notes:
1. Wastewater concentrations (mg/1) were developed using the
results of the screening and verification programs.
Twenty-six individual plants comprise this data base with
subcategory breakdown as noted in Table I 1-2.
2. BOD, COD, and TSS concentrations are the mean of the
results in the screening and verification data base for
each of the three pollutants. The mean concentrations are
based on the data from all plants that had that particular
type of operation (Example: data from an ABC plant were
used in the A, the B, and the C determinations).
3. The averages tabulated above include mixed subcategory data.
177
-------
TABLE VII1-2
TYPICAL PRIORITY POLLUTANT CONCENTRATIONS USED
FOR BASE CASE IN-PIANT COSTS*
Pollutant »q/l
Acid Extractables
Phenol
Volatile Orqanics
Benzene
Chloroform
Ethylbenzene
Methylene Chloride
Toluene
Metals
Chromium
Copper
Lead
Mercury
Nickel
Zinc
Other
Cyanide
180
100
150
20
320
515
45
85
50
8
50
250
280
Concentration values are based on earlier analysis and do
not duplicate medians of Table V-6 but are used only as a
typical, hypothetical calculation base and introduce no
discrepancy since cost variation with concentration is
accounted for in individual plant costs, based on 308 data
for each plant.
178
-------
TABLE VII1-3
CYANIDE DESTRUCTION
EQUIPMENT COST BASES AND ENERGY REQUIREMENTS
Subcategory C - 26,000 GPD Base Case
Description
Mean flow, gal/day
Type of Operation
Detention Tank(s), gal
Mixer(s), hp
Mixing Req., kWh/yr
Hypochlorite Feed
Rate, Ib/yr
Caustic Feed Rate,
Ib/yr
Pumping Req., kWh/yr
Manpower Req., h/yr
26,000
Continuous
One, 600
One, 0.25
1 ,600
11,500
13,300
2,000
500
179
-------
TABLE VII1-4
i
CYANIDE DESTRUCTION
CAPITAL COSTS
(dollars)
Subcategory C - 26,000 GPD Base Case
Description
Detention Tank(s) $ 2,000
Mixer(s) 800
Hypochlorite Feed 9,500
System
Caustic Feed System 9,500
pH and ORP Control 10,000
Systems
Equipment Cost 38,200
Installation 19,100
Engineering 8,800
Contingency 8,900
Total Capital Cost $75,000
180
-------
26.000 GPP . x 2
TABLE VII1-5
CYANIDE DESTRUCTION
TOTAL ANNUAL COSTS
(Dollars/Year)
VARIATION WITH FLOW
Subcategory C - 26,000 GPD Base Case
Description
Flow Variation X 1/2
Chemicals
Hypochlorite
Caustic
Energy
Labor
Maintenance
Capital Amortization
Total Annual Cost
$/l,000 Gal.
$ 3,500
800
100
5,000
1,500
7,650
$18,500
$ 3.90.
$ 6,900
1,600
200
5,000
2,300
12,000
$28,000
$ 2.95
$13,800
3,200
400
5,000
3,600
18,800
$44,800
$ 2.36
181
-------
TABLE VII1-6
j
CYANIDE DESTRUCTION
TOTAL ANNUAL COSTS
(Dollars/Year)
VARIATION WITH INFLUENT CN CONCENTRATION
Subcategory C - 26,000 GPD Base Case
Effluent Concentration = 40 ug/1
Description
Influent Concentration
(ug/1)
Chemicals
Hypochlorite
Caustic
Energy
Labor
Maintenance
Capital Recovery plus
Return
Total Annual Cost
$71,000 Gal.
161 Base 322
644
$ 3,500
1,600
200
5,000
2,300
12,080
$24,600
$ 2.59
$ 6,900
1
1,600
200
5,000
2,300
12,000
$28,000
$ 2.95
$13,800
1,600
200
5,000
2,300
12,000
$34,900
$ 3.68
182
-------
TABLE VIII-7
CHROMIUM REDUCTION
EQUIPMENT COST BASES AND ENERGY REQUIREMENTS
Subcateqory C
Mean flow, gal/day
Type of Operation
Detention Tank(s), gal
Mixers, hp
Mixing Req., kWh/yr
Clarifier Dia., ft
S02 Feed Rate, Ib/yr
Acid Feed Rate, Ib/yr
Caustic Feed Rate,
Ib/yr
Pumping Req., kWh/yr
Manpower Req., h/yr
Sludge Produced,
Ib/yr dry solids
26,000 GPD Base Case
26,000
Continuous
One, 1,200
2 sections
One, 0.5
One, 0.25
4,800
8
4,300
4,300
19,000
2,000
500
4,800
183
-------
Description
Detention Tank(s)
Mixers
Acid and
Feed Systems
pH and ORP
Control Systems
Caustic Feed System
Clarif ier
Piping and Pumps
Equipment Cost
Installation
Engineering
Contingency
Total Capital Cost
TABLE VIII-8
CHROMIUM REDUCTION
CAPITAL COSTS
(Dollars)
Subcateqorv C
26,000 GPD Base Case
$ 4,500
2,500
19,000
10,000
i
9,500
i
27,000
13,500
86,000
43,000
19,500
19,500
$168,000
184
-------
Flow (GPD)
Chemicals
S02
Acid
Caustic
Energy
Labor
Maintenance
Sludge Disposal
Capital Recovery plus
Return
Total Annual Cost
$/l,000 Gal.
TABLE VII1-9
CHROMIUM REDUCTION
TOTAL ANNUAL COSTS
(Dollars/Year)
VARIATION WITH FLOW
Subcategory C - 26,000 GPD Base Case
13,000 Base Case 52,000
$ 325
125
1,150
150
5,000
3,250
1,750
17,780
$29,530
$ 6.22
$ 650
250
2,300
300
5,000
5,100
3,500
27,900
$45,000
$ 4.74
$ 1,300
500
4,600
600
5,000
8,000
7,000
43,800
$70,800
$ 3.73
185
-------
TABLE VIII-10
CHROMIUM REDUCTION .
TOTAL ANNUAL COSTS
(Dollars/Year)
VARIATION WITH FLOW
Subcategory C - 26,000 GPD Base Case
Effluent Concentration ~ 300 ug/1
Influent Cone, (mg/1)
Chemicals
S02
Acid
Caustic
Energy
Labor
Sludge Disposal
Capital Recovery plus
Return
Total Annual Cost
$71,000 Gal.
0.90
1 .1
1 .35
$ 650
250
2,300
300
5,000
3,500
27,900
$45,000
4.74
$ 650
250
' 2,300
300
5,000
i 14,000
27,900
$55,500
5.85
$ 650
250
2,300
300
5,000
24,500
27,900
$66,000
6.95
186
-------
TABLE VI11 -.11
CHROMIUM REDUCTION
TOTAL ANNUAL COSTS
(Dollars/Year)
VARIATION WITH EFFLUENT CONCENTRATION
Subcategory C - 26,000 GPD Base Case
Influent Concentration - 450 ug/1
Effluent Cone, (ug/1)
Chemicals
S02
Acid
Caustic
Energy
Labor
Maintenance
Sludge Disposal
Capital Recovery plus
Return
Total Annual Cost
$/l,000 Gal.
TOO
200
300
$ 650
250
2,300
300
5,000
5,100
8,200
27,900
$49,700
$ 5.24
$ 650
250
2,300
300
5,000
5,100
5,800
27,000
$47,300
$ 4.98
$ 650
250
2,300
300
5,000
5,100
3,500
27,900
$45,000
$ 4.74
187
-------
TABLE VII1-12
METAL PRECIPITATION
EQUIPMENT COST BASES AND ENERGY REQUIREMENTS
Description
Mean flow, gal/day
Type of Operation
Clarifier Dia., ft
Filters Dia., ft
Lime Feed Rate, Ib/yr
Alum Feed Rate, Ib/yr
Misc. Energy Req., kWh/yr
Manpower Req., h/yr
Sludge Produced,
Ib/yr dry solids
Subcateqorv A Subcateoorv C
43,500 26,000
Continuous Continuous
10
Two, 3
13,200
2,600
500
500
15,900
8
Two, 3
7,900
1,600
300
500
9,500
138
-------
TABLE VIII-13
METAL PRECIPITATION
CAPITAL COSTS
(Dollars)
Description
Clarifier, Solids
Contact Type
Lime and Alum
Feed Systems
Filtration Units
Piping
Equipment Cost
Installation
Engineering
Contingency
Total Capital Cost
Subcateaorv A Subcateaory C
32,000
27,000
22,000
20,000
8,400
$ 92,400
$ 46,000
20^700
20,700
19,000
30,000
7,600
$ 83,600
$ 41,000
18,000
18,000
$180,000
$163,000
189
-------
TABLE VIII-14
METAL PRECIPITATION
Flow (GPD)
Chemicals
Lime
Alum
Energy
Labor
Maintenance
Capital Recovery
Plus Return
Total Annual
Cost
$71,000 Gal.
TOTAL ANNUAL COSTS
I do liars/year)
VARIATION WITH FLOW
Subcategories A & C
21
$
5
3
. 5
•y
18
$33
$ 4
,750
275
100
25
,000
,450
,750
,700
,300
.19
A
43,500
$ 550
200
50
5,000
5,400
11,500
29,300
$52,000
$ 3.27
87,000
$ 1,100
400
100
5,000
8,500
23,000
46,000
$84,100
$ 2.65
13,000
$ 175
50
25
5,000
3,150
3,400
17,100
$28,900
$ 6.09
C
26,000
$ 350
100
50
5,000
4,900
6,800
26,800
$44,000
$ 4.64
52,00
$ 70
20
10
5,00
7,70
13,60
42,00
$69,30
$ 3.65
190
-------
r
TABtE VIII-15
METAL PRECIPITATION
TOTAL ANKUAL COSTS
(dollars/year)
VARIATION WITH INFLUENT CONCENTRATION
Effluent cone. * 1.1 mg/1
Sufccategories A 6 C
influent Conc«
(mg/1)
Chemicals
lime $
Alum
Energy
labor
Maintenance
Sludge Disposal
Capital Recovery
Plus Return
Total Annual
Cost $
$/ 1,000 Gal. $
3.0
550
200
50
5,000
5,400
6,700
29.300
47,200
2.97
=A=
4.36
$ 550
200
50
5,000
5,400
11,500
29,300
$52,000
$ 3.27
7.00
$ 550
200
50
5,000
5,400
20,800
29,300
$61,300
$ 3.86
• - . :
3.0
$ 350
50
50
5,000
4,900
4,000
26,800
$42,200
$ 4.45
C
4.36
$ 350
100
50
5,000
4,900
6,800
26,800
$44,000
$ 4.64
7.0
$ 350
100
50
5,000
4,900
12,300
26,800
$49,500
$ 5.22
191
-------
TABIE VIII-16
METAX PRECIPITATIOH
TOTAL ANNUAL COSTS
(dollars/year)
VARIATION WITH EFFLUENT CONCENTRATION
Influent Cone. = 4.36 mg/1
Sutcategories A 6 C
Effluent Cone.
(Jrg/1)
Chemicals
lime $
Alum
Energy
labor 5,
Maintenance 5 ,
Sludge Disposal 13,
Capital Recovery
Plus Return 29,
Total Annual
Cost $54,
5/1,000 Gal. $ 3.
0.5
550
200
50
000
400
600
300
100
41
j A
1-j
$ 550
200
50
5,000
5,400
11,500
29.300
$52,000
* 3.27
2.0
$ 550
200
50
5,000
5,400
8,300
29.300
$48,800
$ 3.07
0.5
$ 350
50
50
5,000
4,900
3,100
26.800
i
$45,300
$ 4.47
C
1.1
$ 350
100
50
5,000
4,900
6,800
26.800
$44,000
$ 4.64
2.0
$ 350
100
50
5,000
4,900
4,900
26,800
$42,100
$ 4.44
192
-------
TABLE VIII - 17
STEAM STRIPPING
COST DATA
Capital Cost, Dollars
Description
Process Equipment
Steam Stripper with 20 trays,
4 ft. I.D. Feed rate = 200,000
Ibs/hr (400 gpm)
Physical Plant
207% of equipment cost
Engineering and Construction
30% of the total equipment cost
Direct Plant Cost
Fixed Capital
120% of direct plant cost
Working Capital
15% of fixed capital
Total Capital Cost
Steam
$3/1,000 Ibs. steam
0.1 Ibs steam/lb feed
Steam for Feed Heating
70 C to 100 C
0.056 Ibs stecim/l b feed
Electricity
$0.04Awh
Labor
$10/hr.
Operating time = 8,000 hr/yr
Maintenance
3% of capital cost
Capital Recovery plus Return
16.3% of capital cost
(57,600 GPD)
Base x 0.1
$ 22,000
46,000
20,000
h
88,000
106,000
16,000
$122,000
(288,000 GPD)
Base x 0.5
$ 63,000
130,000
58,000
251,000
301,000
45,000
$346,000
(576,000 GPD)
Base Flow
$ 98,000
203,000
90,000
391,000
469,000
71,000
$ 540,000
1,152,000 GPD
Base x 2.0
$ 154,000
318,000
142,000
614,000
737,000
111,000
$ 848,000
Annual Cost, Dollars/1,000 gal
2.50
1.40
2.50
1.40
2.50
1.40
2.50
1.40
0.33
4.20
0.33
0.84
0.33
0.42
0.33
0.21
0.18
1.05
0.10
0.60
0.08
0.47
0.06
0.37
Total Cost, $/l,000 GAL $ 9.66/
1,000'GAL
$ 5.T7/
1,000 GAL
5.20/
1,000 GAL
$ 4.87/
1,000 GAL
$/yr. $203,OOOAr- $6G7,000/Yr.
Note: Costs have been adjusted to January 1978 dollars.
Ref.: Contractor's Engineering Report Pharmaceutical Industry.
193
$l,093,000/Yr. $2,048,OOOAr.
-------
TABLE VIII-18
ACTIVATED SLUDGE SYSTEM
EQUIPMENT COST BASES
•
Description
Mean flow, gal/day 435
Detention Time, days
AND
~S "
,000
2.2
Aerators, hp Four, 60
Nutrient Addition, Ibs/day
Ammonia
Phosphorous
Lime
Ferric Chloride
Clarifiers, Dia., ft Two,
Sludge THickener Surface
Area, ft2
Vacuum Filter Area, ft2
Energy Req. , kwh/yr 1,625,
Sludge Produced,
Ibs/day dry solids
Area Req., ft2 61,
32
6
30
8
30
28
19
000
130
000
t
ENERGY REQUIREMENTS
Subcateaorv
B :
45,000
i
0.2
Two, 5
1 .4
0.3
Two, 10
i
_
-
104,000
6
13,000
Base Case
C D
260,000 75,000
1.2 , 0.3
Four, 30 Two, 5
16 1.4
3 0.3
17
4.5
Two, 24 Two, 12
20
10
845,000 111,000
85 8
35,000 13,000
194
-------
TABLE VII1-19
ACTIVATED SLUDGE SYSTEM
CAPITAL COSTS
Cost. Dollars, for
Description
Activated Sludge Unit
Aeration
Nutrient Addition
Clarification
Sludge Thickening
Vacuum Filtration
Sludge Storage
Piping (installed)
Installed Cost
Engineering
Contingency
Total Capital Cost
A
$ 420,000
218,000
13,000
180,000
33,000
142,000
—
151 ,000
1 ,157,000
174,000
174,000
$ 1,505,000
B
$ 12,000
40,000
1,000
75,000
-
. • - -
18,000
22,000
168,000
25,000
25,000
$ 218,000
Subcateaorv Base Cases
C
$ 290,000
154,000
7,000
120,000
24,000
132,000
-
108,000
835/000
125,000
125,000
$ 1,085,000
D
$ 34,000
40,000
1,000
96,000
—
-
18,000
28,000
217,000
33,000
33,000
$ 283,000
195
-------
TABLE VII1-20
ACTIVATED SLUDGE SYSTEM
Description
Chemicals
Energy
Labor
Maintenance
Sludge Disposal
Capital Amortization
TOTAL ANNUAL COSTS
Cost, Dollars, for Subcateqory Base Cases
A B
$ 2,600 $ 200
65,000 4,200
110,000 80,000
45,200 6,500
5,700 7,900
246,500 35,200
C
$ 1,400
33,800
110,000
32,600
3,700
176,500
D
$200
4,400
80,000
8,500
10,500
46,400
Total Annual Cost $ 475,000 $ 134,000 $ 358,000 $ 150,000
196
-------
TAfllE VIII-21
EQUIPMENT COST BASES AND ENERGY BEOUIREMEMS
Cescriction
Mean Flow, gal/day
Kunber of BBC Units
Shaft Lengths, ft
Total BBC Surface Area, ft2
Energy Beq. , kwh/hr
Clarifiers, Dia., ft
Manpower Beq., h/yc
Sludge Produced,
Ibs/day dry solids
Sludge Dewatering
Manpower Beq. , h/yr
Energy Beq., kwh/yr
Area Beq., ft2
A
435,000
Four
20
304,000
130,000
Two, 30
2,000
220
Yes
1500
195,000
30,000
Sufccateaorv
B
45,000
One
10
24,000
13,000
Two, 10
2,000
20
NO
-
-
2,500
Ease Cases
C
260,000
Three
20
228,000
98,000
Two, 24
2,000
130
Yes
1500
115,000
20,000
D
75,000
One
20
65,000
33,000
Two, 12
2,000
40
No
—
-
4,000
197
-------
TABLE VIII-22
CAPITAL
AND TOTAL ANNUAL COSTS i
Capital Costs
($)
sutcateqorv Base Cases
Cescription
BEC Units, Steel Tankage,
Insulated covers
Clarifiers
Sludge Dewatering
Sludge Storage
Piping
Equipment cost
Installation
Engineering
Total Capital Cost
Energy
labor
Maintenance
Sludge Disposal
Capital Amortization
Total Annual Cost
A
$ 205,000
120,000
96,000
-
42.000
163,000
232,000
104,000
S 903,000
$ 13,000
35,000
27,100
9,600
147.300
* 232,000
I :
$ 40,000
50,000
1
8,000
10.000 ;
108,000
54,000
24,000
C
$ 155,000
80,000
84,000
-
32.000
351,000
176,000
79,000
$ 210,000 $ 685,000
Annual Costs *£/vrl
$ 600 ;
20,000
6,300
5,300
34.800
$ 67,000
$ 8,500
35,000
20,600
5,700
112.200
$ 182,000
£
S 50,000
64,000
-
12,000
13,000
139,000
70,000
31,000
$ 271,000
S 1,400
20,000
8,100
10,500
44.000
$ 84,000
198
-------
TABLE VII1-23
POLISHING POND
Description
Mean Flow, gal/day.
Detention Time, days
Excavated Volume, yd3
Lined Area, ft2
Basin Width at Top, ft
Square basin, Is3 slope
Freeboard = 1 ft
Water depth = 8 ft
Sludge depth » .1 ft
Manpower Req., h/yr
Area Req., ft2
COST BASES
A
435,000
5.5
15,000
40,000
230
slope
•^
:t
200
62,000
Subcateqory
B
45,.000
3.3
1,000
3,300
80
200
10,000
Base Cases
C
260,000
5.0
8,000
22,000
175
200
40,000
D
75,000
4.0
2,000
5,700
100
200
14,000
199
-------
TABLE VII1-24
POLISHING POND
CAPITAL AND TOTAL
Description A
Excavation, Grading, $ 135,000
Compaction
Impervious Liner 26,000
(installed)
Piping (installed) 24,000
Installed Cost 185,000
Engineering 28,000
Contingency 28,000
Total Capital Cost $ 241,000
Labor $ 2,000
Maintenance 7,200
Capital Amortization 38,800
Total Annual Cost $ 48,000
200
ANNUAL COSTS
Capital
Subcateqory
B
$ 9,000
2,200
1,700
12,900
2,000
2,100
$ 17,000
Annual
$ 2,000
500
2,500
$ 5,000
f-
Costs ($)
Base Cases
C
$ 72,000
14,300
12,900
99,200
14,900
14,900
$ 129,000
Costs ($/vr)
$ 2,000
3,900
21,100
$ 27,000
D
$ 18,000
3,700
3,300
25,000
4,000
4,000
$ 33,000
$ 2,000
1,000
5,000
$ 8,000
-------
TABLE VII1-25
ACTIVATED SLUDGE SYSTEM
WITH FILTRATION
EQUIPMENT COST BASES AND ENERGY REQUIREMENTS
Description
Mean Flow, gal/day 435,
Detention Time, days
Aerators, hp Six,
Nutrient Addition, Ibs/day
Ammonia
Phosphorous
Lime
Ferric Chloride
A
000
8
125
32
6
Clarifiers, Dia. ,' ft Two, 30
Number of Dual Media
Filtration Units
F i 1 1 er D i ameter s , f t
Sludge THickener Surface
Area, ft z
Vacuum Filter Area, ft2
Energy Req., kwh/yr 5,600
Sludge Produced,
Ibs/day dry solids
Area Req., ft2 165
Two
10
*\ f\
20
10
,000
90
,000
Subcateoorv Base Cases
_ — B - — ^— -
45,000 260,000
1 5.5
Two, 7.5 Four, 75
1.4 16
— — O
0.3 3
Two, 10 Two, 24
Two Two
3 8
- 20
•" *• V
- 10
130,000 2,340,000
20 60
17,000 74,000
D
75,000
1
Two, 7.5
1.4
0-1
. o
Two, 12
Two
4
~
140,000
20
17,000
201
-------
TABLE VII1-26
ACTIVATED SLUDGE SYSTEM
Description
Activated Sludge Unit
Aeration
Nutrient Addition
Clarification
Dual Media Filtration
Sludge Thickening
Vacuum Filtration
Sludge Storage
Piping (installed)
Installed Cost
Engineering
Contingency
Total Capital Cost $
WITH FILTRATION
!
CAPITAL COSTS
Cost, Dollars, for Subcateaorv
A
$ 778,000
465,000
13,000
180,000
180,000
24,000
132,000
-
266,000
2,038,000
306,000
306,000
$ 2,650,000
B
I
$ 63,000
44,000|
1,000
75,000
54,000:
-
-
44,000
i
43,000:
324,000
48,000
48,000
$ 420,000
C
$ 508,000
245,000
7,000
120,000
120,000
24,000
132,000
-
174,000
1,330,000
200,000
200.000
$ 1,730,000
Base Cases
D
$ 86,000
44,000
1,000
96,000
63,000
-
-
44,000
50,000
384,000
58,000
58f 000
$ 500,000
,202
-------
Description
Chemicals
Energy
Labor
Maintenance
Sludge Disposal
Capital Recovery
plus Return
TABLE VII1-27
ACTIVATED SLUDGE SYSTEM
WITH FILTRATION
TOTAL ANNUAL COSTS
Cost. Dollars, for Subcategorv Base Cases
$ 2,500
224,000
130,000
79,500
4,000
432,000
$ 200
5,200
100,000
12,600
26,300
68,700
$ 1,200
93,600
130,000
51,900
2,600
280,700
$ 200
5,600
100,000
15,000
26,300
81,900
Total Annual Cost $872,000 $213,000 $560,000 $229,000
203
-------
TABLE VII1-28
ROTATING BIOLOGICAL CCNTACTgB IRECj SYSTEM
HITH FILTRATION
EQUIPMENT COSI
EASES AND ENERGY RKnilTBRMK-WTc
i
Suhcateuorv Base Cases
Cescriction
Rean Flow, gal/day
Kuirber of REC Units
Shaft Lengths, ft
Sotal RBC Surface Area, f
Energy Reg., Jcwh/hr
Clarifiers, Dia., ft
Kumber of Dual Media
Filtration Units
filter Diameters, ft
Hdnpower Reg., h/yr
Sludge Produced,
Ibs/day dry solids
Sludge Dewatering
Manpower Reg., h/yr
Energy Reg., kwh/yr
Area Reg., ft*
A
435,000
Four
25
t* 442,000
260,000
Two, 30
Two
10
4,500
300
Yes
1500
265,000
31,000
B
45,000
One
20
65,000
33,000
Two, 10
Two
3
4,500
30
No
-
-
3,000
c
260,000
Four
20
364,000
195,000
Two, 24
Two
8
4,500
180
Yes
1500
160,000
21,000
D
75,000
One
20
65,000
33,000
Two, 12
Two
4
4,500
50
No
_
— ,
4,500
204
-------
TABLE VIII-29
— ' KITH
CAPITAL AND
Descriction
BBC Units, Steel Tankage, $
Insulated Covers
Clarifiers
Filtration Units
Sludge Dewatering
Sludge Storage
Equipment cost
Installation
Engineering
Total Capital Cost $ 1
Energy
labor
Maintenance
Sludge Disposal
4*-kw£ 4- -.1 Am<-bii"+- i •* a*" \ fin
J-ILTRATIOK
TOTAL ANNUAL COSTS
Capital Costs
Sufccategory Base
A I
235,000 $ 50,000
120,000 50,000
120,000 36,000
108,000
12,000
641,000 163,000
321,000 82,000
144,000 37,000
(SI
Cases
C
$ 205,000
80,000
80,000
92,000
—
503,000
251,000
113,000
,250,000 $ 319,000 $ 980,000
Annual Costs (S/vr)_ —
$ 21,000 $ 1,«00
60,000 45,000
37,400 9,600
13,100 7,900
203.500 52.100
$ 14,200
60,000
29,400
7,900
159.500
D
$ 50,000
64,000
42,000
—
18,000
191,000
96,000
43,000
$ 3,73,000
{ 1,400
45,000
11,200
13,100
61.300
Total Annual Cost
Kumber of
$ 335,000 3 116,000
$ 271,000
$ 132,000
205
-------
O
O\
Description
Tank Trailer Leased)
Hauling Charges^)
Extra Hauling Charges^)
Annual Hauling Cost
Capital Amortization^)
Total Annual Hauling Cost
Treatment Cost(5)
Total Annual Cost
$/l,000 Gal
TABLE Vra-30
WASTEWATER HAULING/TREATMENT COSTS
. Annual Cost, $
50 Miles Round Trip
200 Miles Round Trip
1000GPD
9,000
17,000
5,000
31,000
5,000
36,000
5,000
2000GPD
9,000
35,000
8,000
52,000
5,000
57,000
10,000
3000GPD
9,000
52,000
11,000
72,000
5,000
77,000
15,000
1000GPD
9,000
29,000
5,000
43,000
5,000
48,000
5,000
2000GPD
9,000
57,000
8,000
74,000
5,000
79,000
10,000
3000GPD
9,000
86,000
11,000
106,000
5,000
111,000
15,000
41,000
112
67,000
92
92,000
53,000
145
89,000
122
126,000
115
(1) Long Term lease for 6,000 gallon trailer with insulation and heating facilities.
(2) Based on New Jersey hauling rates weighted for inter- and intrastate, 50 mi. round trip - $.57/100 Ib. and 200
(3)
(4)
mi. round trip - $.94/100 Ib.
Extra charges for dead head loads, truck pump rental, driver detention time, and other misc. charges.
20 year and 15% amortization of loading facilities and tank capital cost of $25,000.
(5) Based on average D subcategory loading and POTW treatment cost at $1.00-1.50/lb of BOD removed.
-------
TABLE VHt31
ANALYTICAL COSTS FOR MONITORING
PRIORITY POLLUTANTS
METHOD
VGA (5) GC or HPLC
GC/MS
Cyanide Colormetric
Sub-total
° Metals (5) ICP
AA
COST PER COST PER
ANALYSIS* ANALYSIS*
- RANGE WEIGHTED AVG.
$ $
75-105 90
125-185 160
25-50 27
10-19 11
(per element)
15-25 17
(per element)
ANN!)
COST PER
SAMPLE
MONITORED** S
$
90
16
J7
143
55
ANNUAL COSTS PER OUTFALL OR OUTFALL/COMPOSITE
3-DAY
DAILY WEEKLY SERIES MONTHLY
AMPLE SAMPLE EACH MONTH SAMPLE
$/YR $/YR $/YR S/Yr
Total with Metals
198
52,200 7,fOO
72,300 10,300
5,100
7,100
1,700
2,400
* Costs from contracting laboratory contacts, adjusted for geographical distribution of industry.
** Bases
- Assumes one screening/confirmation GC/MS required for every ten samples.
- Typical for five organics and five metals.
*** If outfalls are composited each composite counts as one outfall analysis.
-------
80Z
ANNUAL TREATMENT COST ($1000/YR.)
•a,-dj.!ijTjiB:!:i±
H * f ?•*•?•*•*• 44.tf»4.+4'4">
-W-^SWtuWJHiT
*:::^\t-Tff-*"?rH'i-ft'f"r-r*-»-*4">->-*"'-
...... J. i • 11 ' ~T~r-rTTTT "T* rTT'i
r::t±5!;4.|l|fRf|5±:
^ii: :n43±Hii4liiil:!z: j
^fjOjouJ.j..j..,. .Si 'i.;.;.;.: 4^Zti^x
-H-ffH-|--- •*.•.*+ -4rJ f*.t.:tTI
*±f''
rte?|: .Tiflttfttttr
trrftrf-ffft ?! I i.i~'i-
fit amHErlE t:':i
3fflHT!WPra*
Si't«;.f.rf7'H-jjjfHrtjfcgj;t
-------
I I
"T
K ^pfqure VlTTT. Activated sludge with "supplemental treatment.^
.L • -, .5.. ; | Annual treatment cost vs. wastewater flow. \- \
—^ r
500
200
900
600
300
200
300 400 500
VIASTE WATER FLOW RATE (1000 GPD)
-------
012
ANNUAL TREATMENT COST ($1000/YR.)
-------
500
I
\
RBC system witTIuppTemental'treatment. Annual treatment cost vs. j.
wastewatertflow. | j—f ; •*" I j * i i ] j "
j
~~T
EFFLUENT BOD 20 mg/u , »
400
t/i
s
300
200
600
800
WASTE"WATER FLOW RATE (tooo GPD)
-------
isning pondannual treatment
.__. ^ ^ £
200
400
600
FLOW RATE (1000 GPD)
212
800
1 000
-------
ANNUAL TREATMENT COST ($1000/YR.)
t 4 !
-------
CO
<=>
CJ
N)
Figure VIII-7.
des"tructlon annual treatment cost vs. influent CN concentration'.5
-HK-~J"H •! 9 **jJ** J * * i «"*-*
i^fH-H-M^V^fff*--
^ . r T - • -T-1—-r-;"S"" • i"( •; : : T r v-*-» *~*-*,+^*.»., ^.^^,
"f-- •> j >-J-rH'j-n-Htt-n '- !' i-H-H-H+4-i
£trl.i.!-.i:->i r r :i •! tr!-;-H-M-r ft it j! 11 <*-- -t—!
00
200
300
400
500
600
700
00
INFLUENT CONCENTRATION (mg/L)
-------
15
-1 •':- "'"{Figure VIlf-8.™ Cyanide destruction "unit treatment cost vs. wastewater flow.
ft i n*: i1' "H™i r; T r 7 viiiiLlJ fi .IT"",
| J! * * 1 • ^^^.J^^^^J^^ 4 *, ^(^ hv «^*^**J ^ *4v^*v«[ v^A**^ *^^ * ny ~c^v*^, I^W-4- **-*« *-i* *-<> I ^*v*^t~^v««" ««*-*«. *• * * ^'f *v*^MW^^«« «i™**-| ^ * <~|~p-o»«-»^:
12
V)
o
..., : J • ^^
10
20
30
40
50
60
70
80
WASTE WATER FLOW RATE (1000 GPD)
-------
9TZ
UNIT TREATMENT COST (DOLLARS/1000 GAL.)
-------
100
80
•5 60
CO cZ
40
20
Figure VIII-10. Chromium reduction annual treatment cost vs. wastewater flow
*^ j. ... ..i a .<• . Jff J
w^~^-*™— I ^^.4^~*j-'-<*
10
20
30 , 40 50
WASTEWATER FLOW RATE (1000 GPD)
60
70
80
-------
UNIT TREATMENT COST (DOLLARS/1000 GAL.)
t-o
0
CO
a
CJ1
CD
3
-------
» t
gure VIII-12. Chromium reduction
annual treatment
< cost vs. influent
' Cr concentration.
1 . 0
INFLUENT CR (mg/L)
219
-------
treatment
concentration
.30 .45
1.0 1.2 1.4
INFLUENT CR (mg/L)
220
-------
_ ~ —~_ L_ I—I—.!
Tigure VIII-14. Chromium reduction annual treatment
•cost vs. effluent Cr concentration.
"~i— '~
60
s
IXJ
C3
CJ
40
20
0.10
0. 20
0.30
EFFLUENT CR (mg/L)
221
0.40 0.45
-------
12
10
HTf
itili
ziii i.i I'll
In'
J
Figure VIII-15. Chromium reduction unit treatment
vs> eff1uent £r concentration. I I' |-
' IT i ^ ., . 1 .
".",."." ™,!i'™'!zi°l-!" j * 1 $ t ti""^.
0.10
0. 20
0.30
0.40 0.45
EFFLUENT CR (mg/L)
222
-------
00
80
§60
40
20
i
Figure VIII-16. Metals precipitation annual treatment cost vs. wastewater flow.
10
20
30
40
50
60
70
WASTE WATER FLOW RATE (1000 GPD)
-------
tzz
UNIT TREATMENT COST (DOLLARS/1000 GAL.)
-------
ANNUAL TREATMENT COST ($1000/YR.)
N)
"5s
-------
11
10
"«"*• *'*"*"'"**«^**^—s«^.^.j.4.-l--»>a.i..lvn^s»>l..faj^ !.„ ™*^hN(vAX tmi*. *<.**. |«™ «^™, ,™J i ^H<4^>^4r^
Figure VIII-19. Metals precipitation unit treatment { M <
ffiWr^ii44:, w&Ui|:cost yS> influent concentration. *v ' Jl r
*-^^-iww***-**f**-i-i« * ft^. ^ ^yJ,-™ +.: i ^.^,
•"»«".{.-!.,, l| 3»-i3 i' . fr.1
^f!1,,'}, I ' »} ,.»•
s?h,v. , I ] , -v
3
INFLUENT TOTAL METALS (mg/L)
226
-------
V """ 7
1 ^ !->-!•
" FiguVeTviII-20". Metals~pfecipitation annual treatment
cost vs. effluent metals concentration.
' T . _ _.!_-... |.-.|—- .(_-, ^^ -^
I. I
i .0
2 . 0
4. 0
EFFLUENT TOTAL METALS (mg/L)
227
-------
Metals precipi tat
cost vs. effluent metal
treatment
concentration
2-0 4.0
EFFLUENT TOTAL METALS (mg/L)
228
-------
ANNUAL TREATMENT COST (51000/YR.)
e »
~
-------
Steam stripping
and steam cost.
200
400 600 800
WASTE WATER STRIPPED (1000 GAL./DAY)
230
1 000
-------
Figure" Ylll^ATwastewater!hauling costs vs. wastewater f 1 ow.
' °°~*~ *' ' ....—r
Vfr fl.sfr * * * ^^«^«^^W--'
* *:•*: 1 * **
I I
• |:.-»-"4- *• —i
44- 444 t
i-" 'I' "4*-"
i <.<•<• !*• * t
Z^tnvw^. v*^>v««i^y«l™a,»**« *«~f~*w
! :. *'., U r.::i*.
FLOWRATE (1000 GPD)
231
-------
SECTION IX
ANALYSIS OF LONG TERM DATA FOR POLLUTANTS OF CONCERN
This section describes the analysis of long term BOD5., COD, TSS
and cyanide data submitted to EPA by pharmaceutical plants
utilizing biological treatment systems and in-plant cyanide
destruction. The first part of this section details which plant
data were used to develop the suggested limitations and discusses
reasons for the deletion of some of the submitted data. Data
verification procedures are described as well as the contents of
the limitations data base. The second part of this section
describes the statistical methodology used to calculate the daily
maximum and 30-day average maximum variability factors.
A. Description of Data
EPA conducted statistical analyses of long term effluent
monitoring data from the pharmaceutical industry to establish
revised BPT and new BCT, BAT and NSPS effluent limitations
guidelines and pretreatment standards (PSES and PSNS). These
guidelines are in the form of daily maximum and 30-day average
maximum effluent limitations for the conventional pollutants TSS
and BOD5., the nonconventional pollutant COD and the toxic
pollutant cyanide.
The major objectives of the study were to quantify the day-to-day
variability of treated process effluent and to provide
appropriate variability factors to be used in conjunction with
appropriate long term performance averages to construct new
limitations guidelines. The specific methodologies for
calculation of these variability factors are presented in the
statistical appendices of the report Pharmaceutical Effluent Data
Analysis conducted by SRI International, EPA Contract 68-01-6062,
Task 1.
1. Plant Data Used in Limitations Development
Long term self-monitoring daily data were submitted to EPA by 22
pharmaceutical manufacturing plants. Information concerning the
data collection is contained in the report entitled "Contractor's
Engineering Report for the Development of Effluent Limitations
Guidelines and Standards for the Pharmaceutical Manufacturing
Industry Point Source Category" prepared for the Effluent
Guidelines Division of the U.S. EPA by the Burns and Roe
Industrial Service Corporation (1980).
In order to preserve source confidentiality, each plant was
assigned the five digit identification number assigned in the
232
-------
^08 Portfolio Survey . In conjunction with the plant
etica?ion nSmbers are listed^he manufacturing |"£«™
The plant Identifiers and subcategories
Idicated.
are shown in Table IX-1 .
All but one of the 22 plants included in the study employ BPT
treatmen? systems (i.e. biological systems). The lone exception
is Slant 12123, which is an indirect discharger.
represenXuvfof Bd" treatment '»•*"*»
be
representtveof a properly designed -»J ^-^ biolo,ic.l
system. These omissions are explained as follows:
Plant 12098 The data from this plant did not in<=iu*f
S .
high effluent concentrations has been assumed. The
Jxplain the less than BCT level of performance by this
Plant 12187
This plant did not provide influent data for BOD5, COD and TSS as
well as effluent COD data. The high effluent average BOD|
concentration (707.3. mg/1) indicates that, in order for the
pl2St"s treStment system to be properly designed and operated an
average influent BODS concentration several times greater than
233
-------
that observed in any other Subcategory C plant must have existed,
a highly unlikely possibility. -Therefore, in the absence of any
other data this high average effluent BOD5. value can only be
explained by either improper design or inadequate operation of
the treatment system.
Plants 12160 and 12462 !
These plants show poor long term average percent reduction for
both BOD and COD (68 percent and 67 percent, respectively, for
BOD and 60 percent and 52 percent, respectively, for COD). The
current BPT regulation requires a 90 percent reduction in BOD and
a 74 percent reduction in COD from raw waste levels. In addition
both plants show high long term average effluent TSS levels.
These long term performance data are not representative of proper
BCT treatment. *
The remaining 13 plant data sets were used to derive BCT and BAT
limitations and variability factors. One plant (12236), which
achieved a less than 90 percent average reduction for BOD (83
percent), was still included in the BCT-BAT data set because it
was a significantly better overall performer than the four
deleted plants.) For purposes of calculating NSPS standards and
variability factors, we further eliminated 3 of the 13 plant data
sets. The performance of three plants (12022, 12026 and 12236)
was nudged to be demonstrably inferior to that of the other ten
Si«ntf and therefore these plant data sets were excluded from the
NSPS data set group. While two of the three plants (12022 and
12026) have average long term BOD removal percentages greater
than 90 percent, their performance regarding COD and TSS was
considerably inferior to that of the NSPS plants. The
performance of the third plant, 12236, was considerably below
that of the other ten plants from the standpoints of percent
reduction and final effluent concentration. Although one plant
in the NSPS data set (12307) did not provide influent data, it
was retained because its effluent pollutant levels were deemed
acceptable. Finally, only plant 12236 provided acceptable long
term cyanide destruction performance data, and this data was used
to develop BPT (BAT) cyanide limitations and variability factors.
I
2* Pata Verification Procedure
In order to identify values that may have been coding errors or
that possibly reflected physical breakdown of the plant treatment
system, graphic displays of daily pollutant values versus date of
sample were generated. Data values found to deviate greatly from
neighboring values were listed as possible transcription errors
or observations reflecting physical breakdown of the plant
treatment system. As a result of this procedure, some values
were corrected and others were deleted because they reflected
234
-------
in statistical Appendix B of the report cited for EPA contract
68-01-6062, Task 1.
3. C22l±!±± 2f. JJ!£ Pharmaceutical Long. Term Data Base
In addition to implementing corrections ^as granted
and effluent pollutant loadings in mass ^charge units (
were computed
concentrations
flctortsK^ShrdatrbasrSontalnrtSrioliowing Information:
(1) Plantt The five digit plant identifier code.
(2) SUBCAT: The plant subcategory (EPA classification
based on specific nature of plant activity).
(3) DATE: The date on which each observation was taken.
(4) FLOW MGD: The flow in million gallons per day through
the plant treatment facility.
(5) INBODs Influent biological oxygen demand to the
treatment plant (mg/1).
(6) EFBODs Effluent biological oxygen demand from the
plant (mg/1).
(7) INCOD: Influent chemical oxygen demand (mg/1).
(8) EFCOD: Effluent chemical oxygen demand (mg/1).
(9) INTSS: Influent total suspended solids (mg/1).
(10) EFTSS: Effluent total suspended solids (mg/1).
(11) EFCN: Effluent cyanide (ug/1).
Also, for analysis purposes, the following variables
computed:
were
(1) FLOWKGD: Flow in thousand gallons per day.
(2) INBODLB: Influent biological oxygen demand (Ib/day).
235
-------
(3) EFBODLB: Effluent biological oxygen demand (Ib/day).
(4) INCODLB: Influent chemical oxygen demand (Ib/day).
(5) EFCODLB: Effluent chemical oxygen demand (Ib/day).
(6) INTSSLB: Influent total suspended solids (Ib/day).
(7) EFTSSLB: Effluent total suspended solids (Ib/day).
(8) EFCNLB: Effluent cyanide (.001 Ib/day).
no»« listinf.of the data ^se used in determining the
pollutant specific variability factors is available in
68-01-6062* "115' A °f ^ reP°rt Cited f°r EPA contract
B' Definition and Use of Variability Factors
The pollutant effluent level from a physical treatment process is
subject to a certain degree of inherent day-to-day fluctuation.
Limitations should account for this variability while at the same
time incorporate an acceptable level of treatment performance
a?hievable Affluent limitations are determined Is
a™,, f °S •? ~?ng term avera9e performance and a factor
accounting for daily effluent variability.
a factor is defined as the ratio of the
estimated 99th percentile of the distribution of pollutant values
<~ *.£ estimated mean value of the distribution. The mean used
is the arithmetic average of aM the daily values for a specific
pollutant which were not deleted on the basis of being erroneous
or descriptive of aberrant performance.
variability factors were calculated using
i methods on the long term data available from
plants. These pollutant-specific variability factors
were then combined across plants to obtain an overall variability
factor for a given pollutant. The concentration variability
da^0rwaoa^"iajed,1fr?ln fc?e reP°fted dailV effluent concentration
data, was used to derive limitations on effluent concentrations.
?a!S _d?-?charge variability factors were calculated from the
1 fl°W V°1Ume and th€ dail* concentration
«e 14 an5 30 day average maximum) variability factors
used in limitations development are discussed in the ensuing
suDsections.
236
-------
a. Daily Variability Factors. Several approaches were used to
estimate the — 99th percentile distribution of daily values. One
tpprSacS fit! a'paraSetric distribution to the data set and then
estimates the 99th percentile using the fitted distribution.
?hree dfStributions we?e examined in this study: the normal
distribution, the two parameter lognormal distribution and the
three parameter lognormal distribution. The normal (or Gaussian)
distribution has a symmetric bell shape and is characterized by
?wo parameters, its mean and its standard Deviation The two
parameter lognormal distributions in the distribution of a
variable whose logarithm has a normal distribution; it is
charactSri^by the same two parameters This Distribution was
examined because it corresponds closely to the observable skewed
behavio? of the variables in this data set, (I.e., the occurrence
of a la'rae "tail" of observations toward the higher pollutant
values). The three parameter lognormal distribution is similar
to the two parameter distribution but it contains an additional
oarameter which allows a constant shift to be applied to all the
vtlSeV of the distribution. Due to the difficulty in • estimating
the three parameter lognormal distribution, two different methods
of fitting this distribution to the data were used. The methods
68-01-6062, Task 1 .
Another approach investigated for estimation of the 99th
pe?centile of the daily pollutant values assumes no parametric
distribution and hence is referred to as "nonparametric. The
estimate is referred to as a 50 percent tolerance level estimate
of the 99th percentile. For calculation procedures, see
Statistical Appendix D of the report cited for EPA contract 68-
oT-6062" task 1 in order to calculate nonparametric tolerance
estimates, a minimum number of data values are required
specifically a 50 percent tolerance estimate of the 99tn
pelcentile can be calculated only if 69 or more data values are
available.
The final approach considered is a combination of parametric and
nonparametri? methodologies. The data values above the 90th
nercentile (upper 10 percent were assumed to follow an
Ixponentill distribution. The fitted exponential distribution
SSTthen used to estimate the 99th percentile of daily pollutant
values? This estimate is referred to as the "ta ^exponential'
assumption and was suggested by the skewness exhibited by the
data. Since the variance associated Wlfch the tail-exponential
99th percentile estimate can be shown to be less than the
variance of the nonparametric estimate for a given sample size,
this estimate was calculated only if 69 or more samples were
237
-------
\
available. (See Statistical Appendices E & G of the earlier
cited SRI report for procedures and references).
In order to compare and assess the fits of the assumed
distributions to the plant-specific pollutant data sets,
statistical goodness-of-fit tests were applied. Two general
tests, the Kolmogorov-Smirov and the Anderson-Darling were used
to test each distribution: normal two and three parameter
lognormal, and tail exponential. A specific test of normality,
the D Agostiro test, was also used to test the fit of the data to
the normal and lognormal distributions. The Watson test of
exponentiality was applied to test the tail-exponential fit.
Overall comparisons of the goodness-of-fit of each distribution
to the data for each variable were made by combining the tests at
each plant via Fisher's combined test of significance. The
results and procedures are described in Statistical Appendix F of
the earlier cited SRI report. In summary, the following
conclusions are evident from the overall assessment of
distribution fit:
j
(1) In most cases, the normal distribution does not fit the
observed data.
(2) The lognormal (2- and 3-parameter) distributions fit the
data moderately well, and considerably better than the normal
distributions. Of these, the 3-parameter lognormal, fitted by
the MMLE method provided the best overall fit.
(3) The tail-exponential distribution, providing a sufficient
number of observations is available, fits the data
acceptably and certainly more effectively than the other
distributions. The instances of apparent lack of fit can
reasonably be attributed to statistical fluctuation.
[ I II 1 ,,j , "' JB1'1, ',• ,' j!; '''„ •': » .1, 'ii'ii, ". v,
Since the nonparametric estimate assumes no distributional form
the question of goodness of fit is not at issue.
Many of the plants did not provide sufficient information to
calculate either the tail-exponential qr the nonparametric
estimate (i.e. sample sizes were less thain 69). Because it was
important to utilized as much plant-specific information as
possible a variability factor was ; calculated for each
plant/variable combination according to the best procedure
consistent with the amount of data available.
For each variable at each plant, the best procedure is defined as
follows:
(1) If 69 or more pollutant values are available, then utilize
the tail-exponential estimate unless goodness-of-fit tests
238
-------
reject tail-exponentiality. Otherwise use the nonparametric
estimate.
(2) If 69 or more pollutant values are not available, use the 3-
parameter lognormal MMLE fitting procedure.
For each pollutant the average of the selected variability
factors (weighted by the number of observations at each plant)
was computed (See Statistical Appendix H of the earlier cited SRI
report for formulas). These average daily maximum variability
factors (concentration and mass based), along with minimum and
maximum factors plant variability and the number of plants used
in the calculation of the average factors is found in Table IX-2.
b. Monthly Variability Factors
A 30-dav average variability factor is defined as the ratio of
the estimated 99th percentile of the distribution of 30-day
averages of daily pollutant values to the estimated long term
mean value. A 30-day average is the arithmetic mean of 30 daily
measurements; the sets of measurements used in determining each
monthly average are assumed to be distinct. The long-term mean
is the long term arithmetic mean of 30 day averages and is the
same as the long term mean of the daily pollutant values.
The 30-day variability factors were developed on the basis of a
statistical result known as the Central Limit Theorem. _The
Theorem states that, under general and nonrestnctive
assumptions, the distribution of a sum of a number of _random
variables, say n, is approximated by the normal distribution.
The approximation improves as the number of variables, n,
increases. The Theorem is quite general in that no particular
distributional form is assumed for the distribution of the
individual variables. In most applications (as in determining
the 30-day limitations) the Theorem is used to approximate the
distribution of the average of n observations of a random
variable. The result is important because it makes it possible
to compute approximate probability statements about the average
in a wide range of cases. For instance, it is possible to
compute a value below which a specified percentage (e.g. 95 or 99
oercent) of the averages of n observations are likely to fall.
Most textbooks state that 25 or 30 observations are sufficient
for the approximation to be valid although in many cases 10 or 15
are adequate. In applying the Theorem to the determination of
30-dav limitations, we approximate the distribution of the
average of 30 observations drawn from the distribution of daily
measurements..
239
-------
Various forms of this Theorem exist and are applicable for
different situations. A key assumption in the most familiar form
of the Central Limit Theorem is that the individual measurements
are independent. That is, it is assumed that measurements made
on successive days or any fixed number of days apart are
statistically independent or not related. This assumption of
independence is rarely satisfied in an absolute sense in effluent
data. In many cases, however, the assumption is satisfied to a
degree sufficient to yield a suitable result. In the case of the
pharmaceutical data, there is evidence of dependency in the data
that should be incorporated into \ the determination of
limitations. The Central Limit Theorem can still be used in
developing variability factors in the case of dependent data but
some of the necessary calculations must be modified to account
for the dependency and more samples (i.e. larger n) may be
required for the approximation to be adequate. In the case of
positive dependence (the usual situation with effluent data) the
modifications will result in a larger variance of the mean than
would be obtained if independence is assumed. This in turn
results in a larger limitation for the mean than would be
obtained if independence is assumed. The technical details of
the Central Limit Theorem including computational formulae and
results obtained for the pharmaceutical data are described in
Chapter V and Statistical Appendix I of the earlier cited SRI
report. The average 30-day variability factors (weighted by the
number of observations at the plant) was computed and these
values, along with minimum and maximum variability factors and
the number of plants used in the calculating of the averaae
factors, are presented in Table IX-3. Both concentration and
mass based variability factors are shown.
c. Applicability of Variability
Levels of Plant Operation
Factors at New Performance
• u^?®E J° evaluate the applicability of the calculated
variability factors when applied to plants operating at generally
lower levels of pollutant concentration, the plant-specific daily
variability factors and the 30-day variability factors for each
variable were plotted versus the mean concentratAon of the
pollutant for each plant (see Figures VI-1-1throughVI-2-8 of
the cited SRI Task 1 report), contractor's report). Similarly,
iL-r^?^- t0f elaluatf the applicability of the calculated
variability factors to plants operating! at higher pollutant
reduction percentages, plant-specific variability factors were
plotted versus the average percentage reduction of the pollutant
at each plant (see Figures VI-3-1 through Vl-4-8 of the cited SRI
report). No trends are generally observable in either set of
plots, except for the somewhat greater scatter of the dailv
factors based on smaller numbers of observations
240
-------
As a further check, the Spearman rank correlation, a measure of
monotonic (not necessarily linear) association, was computed in
each case. The Spearman correlations are shown in Tables VI-1
and VI-2 of the above cited report. Spearman correlations were
not calculated for cyanide since cyanide values were used from
one plant. Based on these analysis, there exists little or no
association of variability factors with the mean pollutant level
or percent reduction. As long as similar control technologies
are employed this result suggests that the computed variability
factors are indeed appropriate for plants operating at different
performance levels.
d. Regulatory Limitations
For each pollutant, concentration and mass discharge effluent
limitations were determined by multiplying a pollutant s
across-plant or average variability factor by its across-plant
long term average. As with the across-plant variability factor,
the across-plant long term average was determined by weighting
the individual plant's long term average by their pollutant
specific sample sizes. Daily maximum and 30-day average maximum
concentration limitations (in concentration and mass discharge
units) along with the across-plant long term averages and
variability factors are shown for all the pollutants to be
regulated in Table IX-4. The respective type of limitation or
standard to which the long term averages and variability factors
apply is also indicated.
-------
Table IX-1 '.
PLANT IDENTIFIERS AND SUBCATEGQRIES
IN THE PHARMACEUTICAL LONG-TERM DATA BASE
PLANT CODE NO.
12015
12022
12026
12036
12097
12098
12117
12123
12160
12161
12186
12187
12236
12248
12257
12294
12307
12317
12420
12439
12459
12462
SUBCATEGORIES
D
AC
C
A
CD
A
B
CD
D
ACD
CD
C
C
C
ABCD
CD
D
D
BD
CD
D
A
242
-------
Table IX-2
DAILY VARIABILITY FACTORS
Concentration Data
Pollutant
BCT and BAT Plants
BOD
COD
TSS
NSPS Plants
BOD
COD
TSS
Cyanide
Number
of
Plants
13
12
13
10
10
10
Weighted
Average
VF
4.53
3.03
5.07
4.43
3.43
5.60
3. 1
Min
VF
2.58
1 .92
2.35
2.58
2.20
2.56
Max
VF
Mass Discharge Da
Number Weighted
of Average Mi
Plants VF VF
16.25
6.95
7.60
16.25
6.95
7.60
13
12
13
10
10
10
1
4.65
3.30
5.15
4.64
3.55
5.74
3.34
2,
2
2,
2,
2,
2,
Note: VF = variability factor
243
-------
Table IX-3
30-DAY VARIABILITY FACTORS
Concentration Data
Pollutant
BCT and BAT Plants
BOD
COD
TSS
NSPS Plants
BOD
COD
TSS
Cyanide
Number
of
Plants
4
5
6
3
4
5
Weighted
Average
VF
2.04
1 .96
2.04
2.78
1 ,
2,
70
07
Min
VF
1 .56
1 .48
1 .71
1 .56
1 .48
1 .71
Max
VF
2.59
2.25
2,70
2.04
2.25
2.70
Mass Discharge Da|
Number Weighted
of Average Mil
Plants VF VF|
4
5
6
3
4
5
1 .81
2.04
1 .77
2.09
1 .80
1 .79
2.16
2.0
Note: VF « variability factor
-------
Table IX-4
LONG TERM AVERAGE-CONCENTRATIONS, VARIABILITY FACTORS AND LIMITATIONS
Regulation
BCT
BAT
BCT
NSPS
NSPS
NSPS
Pollutant
BOD
COD
TSS
BOD
COD
TSS
Mean
Pollutant
Level (mq/1)
55.48
338.0
50.94
28.51
263.7
34.73
D
Variability
Factor
4.53
3.03
5.07
4.43
3.23
5.60
ailv
Limitation
Value (ma/1)
252
1024
258
126
853
195
Var
Fa
BPT, BAT and
NSPS
Cyanide
.207
3.1
.643
245
-------
SECTION X
BPT
A . Summary
1 . General
The factors considered in defining best practicable control
technology currently available (BPT) include: (1) the total cost
of applying the technology relative to the effluent reductions
that result, (2) the age of equipment and facilities involved,
(3) the processes used, (4) engineering aspects of the control
technology, (5) process changes, (6) nonwater quality
environmental impacts (including energy requirements), and (7)
other factors, as the Administrator considers appropriate. In
general, the BPT level represents the average of the best
existing performances of plants within the industry of various
ages, sizes, processes, or other common characteristics. When
existing performance is uniformly inadequate, BPT may be
transferred in from a different subcategory or category. BPT
focuses on end-of -process treatment rather than process changes
or internal controls, except when these technologies are common
industry practice.
The existing BPT regulation requires all subcategory plants to
reduce their raw waste BOD5. loading by 90 percent and their raw
waste COD loading by 74 percent. It also requires subcategory B,
D, and E plants to achieve a monthly maximum average of no more
than 52 mg/1 for TSS. The latter requirement has been found to
be an overly stringent one for the technology basis of BPT.
Amended limitations are proposed based on additional data.
Reflecting what is actually achievable by that technology. EPA
is also proposing new cyanide limitations based on the use of
cyanide destruction technology currently by the industry.
. of limitations are being proposed. The first set, the
TSS limitations, are to replace the existing TSS limitations for
subcategory B, D, and E plants with limitations which will apply
to subcategory A - E plants. The second set of limitations are
new and will apply to all A, B, C, D, and all mixed subcategory
plants but not to E only plants. In addition, current BPT
limitations for BOD5_ and COD Based on a percent reduction
calculation are revised to allow dischargers the option of
meeting specific BCT and BAT concentration based limitations,
whichever is less stringent.
2. Limitations
246
-------
BPT limitations are summarized in Table X-l below.
TABLE X-l
BPT EFFLUENT LIMITATIONS
Pollutant
TSS mg/1
Cyanide ug/1
BOD5_ mg/1
COD mg/1
30-Day Average Maximum
217
375
113 or existing BPT
570 or existing BPT
Daily Maximum
643
BPT Limitations for
No changes are being made in the existing
BOD5_, COD and pH (codified at 40 CFR 439).
B. IDENTIFICATION OF BPT .
1. Prior Regulations
BPT was originally promulgated for the pharmaceutical
manufacturing industry as an interim final regulation in November
of 1976. The regulation divides the industry into five
subcategories: fermentation (A), biological extraction (B),
chemical synthesis
-------
Limitations on the discharge of cyanide are necessary not only to
control the effluent discharge of cyanide, a toxic pollutant, to
surface waters but also to prevent interference with the
operation of in-plant biological treatment systems.
3. Methodology Used |
a. TSS Limitation
An analysis of th current treatment performance of direct
discharging plants serves as the basis for the modification .and
extension of the existing TSS limitation. ;The TSS Limitation for
subcategories B, D, and E in the existing regulation stipulate a
30 day maximum average of 52 mg/1 based on :a long term average of
18 mg/1. The NPDES permits issued, before that regulation was
issued as well as the available 308 and long term daily data
indicate this level is overly stringent.
i
Compliance with this limitation is generally achieved mostly by
plants that generate low raw waste levels of TSS (mostly
formulation (D) only plants). For the industry as a whole,
compliance with the TSS level could in fact force BOD5_ and COD
removal in excess of that required under the 1976 regulation.
Therefore the 1976 TSS limitation is hot reasonable as a
performance criterion for BPT.
I
Accordingly, the Agency has decided to propose a less stringent
limitation which will apply to all plants covered by the existing
regulation. This limitation will be a more in keeping with the
demonstrated performance of BPT systems.
I
This amended limitation is derived from data submitted by direct
discharging plants in the 308 and long term daily data surveys.
The long term average performance with respect to TSS Of 41
plants which have in-place some type of biological treatment
provides the immediate data base for the limitation. This group
of performance values has been specifically chosen because the
group of plants submitting them is most representative of all
direct discharging pharmaceutical plants in terms of
manufacturing processes and treatment employed. Table IX-1 lists
the TSS average values used to compute the new long term average,
the identification numbers of plants submitting them, their
process wastewater flows, their manufacturing subcategory(s) and
the actual source of the value. Table IX-2 compares the
subcategory breakdown of the plants in the new TSS limitation
group with that of the entire direct discharger population.
I
When both long term daily and 308 data were available, long term
daily average value was used in preference to the 308 value for
TSS because the long term daily value for the TSS was supported
24-8
-------
by a significant number of observations which make possible a
more accurate judgement about the solids removal achieved by the
plant's treatment system. The one notable exception was in the
case of data from plant 12462. This plant submitted average TSS
values of 97 and 2022 mg/1 in the 308 and long term daily
surveys, respectively. The value of 2022 mg/1 was not used
because it reflects negative removal of TSS by the treatment
system. In all other cases, the 308 value did not differ
significantly from the long term daily average value. The TSS
value of 97 is also a long term average value since the 308
survey participants were requested to supply annual averages.
The new long term average concentration for TSS Is 75 mg/1. When
multiplied by the appropriate variability factor, this results in
the amended 30 day average maximum limitation. The variability
factor (2.89) used is identical to the one used in the
development of the existing TSS limitation. This factor was used
in preference to the one calculated from the long term data since
most of the averages (25 of 41) used to compute the TSS
limitation base average were from 308 submissions. These dtata
submissions are not supported by daily or weekly values and,
therefore, it was not possible to calculate a 30-day average
maximum variability factor from the available data that would be
representative of the average of performance of all 41 plants.
In addition, all 41 data submissions describe the performance of
treatment systems that were installed in response to or
coincidentally with the development of the existing regulation.
The TSS variability factor calculated for the original limitation
is therefore considered appropriate for use in setting the
amended BPT TSS limitation.
b. Cyanide Limitations
About 7 to 10 percent of all pharmaceutical plants may use and
generate waterborne cyanide waste on a regular or intermittent
basis. Cyanide destruction units are in-place in several plants
and long term data was requested which describes the performance
of these units. Two plants provided data on the performance of
cyanide control technology. However, one plant was an indirect
discharger that provided much less extensive data and therefore
data from this plant was not used in developing cyanide
limitation for direct dischargers.
The 30-day and daily maximum limitations are derived from data
submitted by plant 12236 on the performance of its alkaline
pyrolysis cyanide destruction unit. The concentration results
submitted are final effluent values and do account for dilution
by other 'non-cyanide process wastewater. These limitations make
no distinction as to the form of the cyanide in the effluent
(complexed or noncomplexed). The Agency will request additional
249
-------
data on the performance of cyanide destruction technology in this
rulemaking.
The statistical treatment of the daily cyanide data was discussed
in Section IX. !
c. Alternative BPT,
Limitations
BODS and
COD
Concentration-based
The revised alternative concentration-based limitations for BOD5_
and COD are proposed to d to revise the existing BPT regulation
to allow plants with low raw waste loads[the option of meeting
the concentration-based limitations proposed BCT and BAT
limitations. This proposal will eliminate the possibility that
for any plant BPT could be more stringent than BCT and/or BAT.
These proposed limitations are stated in terms of 30-day average
maximums as were the original BPT percent reduction limitations.
4. Engineering Aspects of BPT
A technical review and evaluation of the treatment technologies
employed in the industry presented in Section VII Indicates that
the industry makes use of a variety of in-plant and end-of-pipe
technologies. In-plant controls consist of solvent recovery,
steam stripping, metals precipitation and cyanide destruction.
Filtration of mycelia from fermentation wastewater (required by
the existing BPT regulation) will reduce the nutrient BOD5_
loading before combination with other wastewater. In some cases,
the mycelia are a recoverable by-product. The end-of-pipe
treatment technologies employed in the industry include primary
clarification, neutralization and neutralization and equalization
followed by secondary biological treatments such as activated
sludge, aerated lagoons and trickling filters and finally by
tertiary treatments such as polishing ponds'.
Generally, the industry
material and wastes which
generated. However, some
often necessary before
biotreatment technologies
lagoons, and trickling
filtration.
engages in theiprocessing of organic
are strongly acid lor alkaline are not
neutralization of equalized influent is
secondary treatment. The secondary
used include activated sludge;, aerated
filters, bellowed by clarification or
5.
Cost in Relation to Benefits
The implementation costs for the amended BPT regulations will be
incurred by plants which must install cyanide destruction
equipment. No implementation costs or Ibs of TSS removed can be
attributed to the new TSS limitation for two reasons. First, as
to subcategories B, D, and E the regulation does not require any
250
-------
new treatment. Second, the costs for subcategories A and C
plants are either attributable to compliance with the current
BOD5. and COD percent reduction limitations or are not required
because the limitations can be met by changes in treatment system
operation.
On the basis of the information available from the 308 survey and
the S/V program, 6 plants will incur a total of $628,000 in
annual costs and $1,740,000 in investment costs (1980 dollars).
We estimate that these regulations will result in the removal of
17,000 Ibs/year of cyanide from the effluent of pharmaceutical
plants.
6. Nonwater Quality Environmental Impact
The four general categories of RCRA wastes generated by the
pharmaceutical industry are sludges, waste solvents, infectious
wastes and returned goods. None of these is expected to be
increased significantly as a result of this amended regulation.
Sludge from biological treatment can mostly be landfilled as can
separable solid process waste such as mycelia from fermentation.
Implementation of BPT in-plant cyanide destruction is
expected to affect air emissions.
not
The energy consumption and energy costs of BPT implementation are
expected to be small. The increases in energy needs are largely
limited to additional power requirements for pumps and agitators
needed for cyanide destruction systems. These requirements tend
to be very small in scale.
251
-------
TABLE X-l
EFFLUENT TSS PERFORMANCE OF DIRECT DISCHARGERS
(308 & Long-Term Data)
PLANT NO.
12053
12463
20319
12406
12317
12015
12089
12287
20201
12117
12407
12459
12097
12104
20165
12298
12132
12338
20245
12307
12161
20246
20297
12205
12036
20037
12283
12294
12294
12471
12248
12187
12236
12119
12022
12462
12160
12239
12026
12038*
12098
SUBCATEGORY
D
BD
D
C
D
D
BD
D
D
BD
C
D
CD
D
BC
D
AC
D
AC
D
ACD
C
C
D
A
D
D
CD
CD
B
D
C
C
AC
AC
A
D
D
C
ABCD
D
DATA
SOURCE
308
308
308
308
L.T.
L.T.
308
308
308
L.T.
308
L.T.
L.T.
308
308
308
308
308
308
L.T.
L.T.
308
308
308
308
308
308
L.T.
L.T.
308
L.T.
L.T.
L.T.
308
L.T.
308
L.T.
308
L.T.
308
L.T.
FLOW
(MGD)
0.004
0.057
0.003
0.370
0.740
0.101
0.155
0.131
0.002
0.101
0.731
0.049
0.064
0.367
0.004
0.003
1.000
0.001
0.500
0.002
653
250
0.001
0.030
.128
0.043
0-013
6.118
0.118
0.043
0.110
1.065
0.816
0.032
.300
0.170
0.006
0.002
0.161
0.855
0.006
1
1
1
1
AVERAGE
EFFLUENT TSS
(mq/L)
2
9
9
10
10
11
13
13
14
16
17
17
18
22
24
26
29
30
32
32
32
33
36
40
44
47
50
59
59
59
60
61
62
70
85
97
115
174
284
340
392
252
-------
12261 C 308
Total Flow = 13.237 MGD
Plant Avg. Flow = 0.323 MGD
Flow-Weighted TSS Avg. = 65 mg/1
Plant Avg. TSS =75 mg/1
0.051
567
Plants lacking effluent TSS data;
12001
12006
12014
12030
12057
12073
12085
12194
12235
12256
12264
12267
12281
12308
12339
20257
20298
20370
20370
20402
Plant with TSS data but without biotreatment:
12095
*Provable process flows only; incinerator scrubber water and
other diluting flows not included.
TABLE X-3
SUBCATEGORY BRACKDOWN OF TSS GROUP PLANTS COMPARED TO ALL DIRECT DISCHARGES.
% Subcateaorv Plants TSS Group All Direct Dischargers
A
B
C
D
Mixed
4.9
2.4
19.5
43.9
26.3
3.2
1 .6
19.7
45.9
29.5
253
-------
SECTION XI I
BEST CONVENTIONAL POLLUTANT CONTROL TECHNOLOGY
CURRENTLY AVAILABLE
A. Summary
1 . GENERAL
The 1977 Amendments added Section 301 (;b) (2) (E) to the Act
establishing "best conventional pollutant control technology"
(BCT) for discharges of conventional pollutants from existing
industrial point sources. Conventional pollutants are those
defined in Section 304(a)(4) [biological oxygen demanding
pollutants (BOD5J, total suspended solids (TSS), fecal coliform,
and pH], and any additional pollutants defined by the
Administrator as "conventional" [oil and grease, 44 FR 44501,
July 30, 1979].
BCT is not an additional limitation but replaces BAT for the
control of conventional pollutants. In addition to other factors
specified in section 304(b)(4)(B), the Act requires that BCT
limitations be assessed in light of a two part
"cost-reasonableness" test. American Paper Institute v. EPA, 660
F.2d 954 (4th Cir. 1981). The first test; compares the cost for
private industry to reduce its conventional! pollutants with the
costs to publicly owned treatment works for similar levels of
reduction in their discharge of these pollutants. The second
test examines the cost-effectiveness of additional industrial
treatment beyond BPT. EPA ' must find that limitations are
"reasonable" under both tests before establishing them as BCT.
In no case may BCT be less stringent than BPT.
2.
LIMITATIONS
BCT limitations are summarized in Table XI-1 below:
TABLE XI-1
Pollutant
BOD (mg/1)
TSS (mg/1)
pH
Range
30-Day Average
Maximum
i
113 '
110
Daily Maximum
252
291
B.
6.0 - 9.0
Identification of BCT
254
-------
1. Methodology BCT limitations which are more stringent than
existingBPT limitations for a given industrial category or
subcategory must satisfy a two part "cost reasonableness test.
The first part of the test involves a comparison of the average
annual removal cost incurred by direct discharging plants in
upgrading from existing BPT to BCT level performance regarding
the treatment of conventional pollutants with an analogous POTW
removal cost figure. The latter figure, $0.42/lb in 1980
dollars, is an estimate of the incremental removal costs incurred
by an average POTW which has upgraded from secondary to advanced
secondary treatment. If the average industry category or
subcategory removal cost is less than this figure, the more
stringent BCT limitations meet the requirement of the first part
of the test. The second part of the test entails calculation of
the ratio of the removal cost incurred in upgrading from BPT to
BCT to the removal cost incurred in upgrading from a raw waste or
treatment in-place (at the time of BPT promulgation) status to
existing BPT. The choice of status depends on the reliability of
the data available. (The raw waste status was used in this
rulemaking, based on that criterion). This ratio is then
compared to an incremental cost ratio 1.43 (which has been
obtained by dividing the average annual removal costs incurred by
a POTW in upgrading from a secondary to an advanced secondary
treatment level by the average annual removal costs incurred in
upgrading from a primary to a secondary treatment level.) If an
industry category or subcategory meets the requirement of the
first part of the test and the calculated incremental ratio is
less than 1.43, then the cost of the BCT limitations are
considered reasonable. If the calculated figures are greater
than the benchmark figures in either case, BCT limitations must
be raised until the calculated figures are less than the
benchmark figures in both cases.
2.
Costs
The plant-by-plant incremental annual costs for upgrading from
BPT to BCT performance levels were assigned using an incremental
treatment stage approach. First, the average effluent BOD
concentration from the plant's 308 as long term data submission
was compared to the anticipated BCT long term data average for
BODS 55 mg/1. Then .an estimate was made of the number of
treatment stages which had to be added to a plant's existing
biological treatment system to produce a long term effluent BOD
of 55 mg/1. These treatment stages are equivalent to increases
in unit capacities within the system (greater equalization,
aerated lagoon or clarifier capacity). All cost increments
assume an activated sludge type of treatment, the most expensive
of the three types considered (the others being RBC's and ponds).
Costs for plants discharging less than 3000 gpd were based on the
assumption that they would haul their concentrated wastewater
255
-------
(see Table VIII-30) to comply with the limitations rather than
upgrade existing biological treatment, an extremely cost
ineffective solution at these low flow rates. All costs were
computed in 1980 dollars. These estimates are conservative,
because many plants may be able to improve removal by adjusting
the operation of existing treatment stages, thus saving costs.
An updated (1980) version of a graph of annual treatment costs
versus flow (see original document (55)) was used to estimate
annual costs for BPT (biological treatment) systems. This graph
was obtained by plotting subcategory moqlel plant annual costs
versus flow. This technique was considered;appropriate in view
of the number of mixed subcategory plants.
3. Pollutant Loading Reduction Calculations
The annual conventional (BOD and TSS) pollutant loading
reductions to be achieved upon upgrading from existing BPT to BCT
level performance were calculated in following manner. The
average long term BOD and TSS concentrations submitted in the 308
or long term data surveys were multiplied by the respective
variability factors in the existing BPT regulation, 3.0 and 2.89,
to obtain the 30-day maximum average concentrations. (Generally,
long term data average concentrations were used when available
because they were derived from data which were readily
verifiable). Thirty-day average maximum concentrations were used
because the POTW benchmark figures were calculated using this
type of concentration limitation. Thereafter, the 30 day average
maximum concentrations (mg/1) were multiplied successively by the
average process wastewater flow (MGD), 365 days per yecir, and a
conversion factor (8.34) to give the annual BOD5_ and TSS load
from the plant's BPT system. In a similar manner the plant's BCT
annual loading was calculated using the long term averages and 30
day variability factors derived from the BCT plant data set (13
sets of long term data) in Section IX. The plant's BCT loading
was then subtracted from the existing BPT loading to determine
the incremental removal obtainable by upgrading from BPT to BCT
level performance. The individual incremental loads for all
plants in the test group were summed to give the aggregate
incremental removal for all plants tested. This aggregate was
used for both parts of the cost test.
i
The other number required for the second part of the cost test,
cost of BPT removal, was calculated using raw waste and effluent
annual averages from 308 and long term data. (A variability
factor of 1.0 was assumed and applied to the average raw waste
concentrations to generate 30 day average maximum
concentrations). When 308 and long term data average
concentrations were not available, average raw waste
concentrations characteristic of the plant's manufacturing
256
-------
activities (in the case of TSS) or raw waste concentrations
derived by assuming BPT compliance (e.g. 90 percent method in the
case of BOD5) were used. The calculations were performed in the
same manner~as the previously described calculations. Individual
BPT loadings for plants were subtracted from the raw waste
loadings. The results were summed to give the total removal by
BPT technology for all plants tested.
4. Test Criteria Results
EPA performed the BCT cost test using data from 28 of the 60
known direct dischargers in the pharmaceutical industry. Thirty-
two plants submitted data which indicate that they are currently
in compliance with the proposed BCT limitations for BOD5_ and TSS.
(Therefore, no costs as pollutant reductions are attributable to
these plants). If the 28 plants pass the BCT cost test, the
industry passes. The tests were performed using the submitted
concentration and flow data except in cases where insufficient
data were available as in the case of 18 plants. In these
instances the calculations were performed using industry average
effluent concentrations for BOD5_ and TSS and plant-by-plant
estimated upgrade costs based on these industry average effluent
concentrations.
Before discussing the results, one exception to the above
procedure requires explanation. One plant, 12256, indicated that
it had an effluent flow rate of 30 MGD. This flow was composed
of both treated process effluent and once-through stream water
which is used for barametric condensation. Since it was not
possible to determine the actual flow rate of the treated
effluent from actual manufacturing operations, it was assumed
that ten percent of the 30 MGD flow is from manufacturing and the
costs and pollutant reductions were calculated accordingly. This
flow (3.0 MGD) is equivalent to that of the average large plant
in the industry. A set of criteria was also calculated for the
group of 27 plants that did not include plant 12256. This
procedure was employed so as not to bias the results of the BCT
test for the whole industry. Costs and removals calculated for a
30 MGD plant are highly cost effective since this flow is over
twice that of the reported total flow from all the remaining 27
plants.
Initially, two sets of BCT criteria were calculated. The
calculation of one set of criteria assume that all 18 plants in
the insufficient data group will incur costs and achieve
pollutant reduction as a result of the BCT limitations. The
calculations for the other set assume only 24 percent of the
plants or 35 percent of the flow in this group will incur costs
and achieve pollutant reductions as a result of the new
limitations. These percentages reflect the segment of plants who
257
-------
have submitted data which are not in compliance with the proposed
BCT limitations. The two sets of criteria were calculated to be
$0.38/lb. and 0.87 and $0.37/lb and 0.86, respectively. EPA
considers the latter set of criteria, $0.37/lb. and 0.86 (the one
obtained usirig the percentage estimate for!costs and removals) as
the more reliable indicator because many of the 18 plants in the
insufficient data group are small formulating facilities which
are not likely to require additional treatment.
Thereafter, four additional sets of criteria were calculated.
One set of criteria was calculated for the 28 plant group
(including plant 12256) and another set was calculated for the 27
plant group (without plant 12256). These two sets of
calculations assumed the aforementioned percent non-compliance.
The results for each set were $0.37/lb. and 0.86 and $0.38 and
0.82, respectively. Finally, two sets of criteria were
calculated for the 28 and 27 plant groups assuming 100% non-
compliance with proposed BCT. These results were $0.38/lb. and
0.84 and $0.40/lb. and 0.83 for the 28 and 27 plant groups,
respectively.
Based on the comparison of these calculated criteria to the BCT
cost test benchmark figures ($0.42/lb. and 1.43), the proposed
BCT limitations meet the requirements of. the BCT "cost
reasonableness test" regardless of which set of criteria are used
as the comparison criteria. A subsequent analysis and discussion
of the test as applied confirm this conclusion.
j
As part of its confirmatory analysis EPA presents the BPT and BCT
costs and removals as well as the criteria results for 10 plants
who have submitted data which indicate that they are not
currently achieving BCT level performance. Table XI-2 lists the
identification numbers of these plants along with the calculated
incremental removals achieved by BPT and to be achieved by BCT
and the estimated costs of these loading reductions. Table XI-3
lists the plant identification numbers, their manufacturing
subcategory classification(s), the test criteria on a plant by
plant basis and the overall results. The 10 plants in this test
group were specifically chosen further analysis because they
submitted data which could be used to calculate actual BCT cost
test criteria (estimations had to be made in a few cases) and
their data indicated that they were below the anticipated BCT
performance requirements. The average industry criteria
calculated for this plant group are $0.36/lb and 0.81. These
values confirm the overall result for the industry.
The above analysis uses existing BPT performance as the measure
of BPT removal. Because not all plants are exactly at the levels
required by the existing BPT regulation, we also considered
whether the BCT cost test results would be different using the
258
-------
existing BPT regulation, as opposed to actual performance data.
The existing BPT regulation requires that all direct dischargers
achieve a 90% reduction from BOD5_ levels and that subcategory B,
D and E plants comply with a maximum monthly average of 52 mg/1
for TSS. In order to calculate BCT cost criteria using the
existing BPT regulation (as opposed to existing BPT performance)
as a base point, some changes had to be made in the in the
identity of the plants in the test group. Two plants (12098 and
12187) were dropped because raw waste BOD5_ data was not provided,
and a third (12160) was dropped because a 90 percent BPT
reduction of its BOD5. raw waste concentration would bring it into
compliance with the BCT limitation. Five other plants (12132,
12161, 12294, 12307 and 12317) were added because 90% BOD
reduction costs and concentrations can be estimated with the data
they submitted.
The calculation of BCT criteria for this group of 12 plants
involves significant difficulties. In the first place, it is not
possible to establish effluent TSS concentrations that exist
after a 90% reduction in raw waste BOD and therefore average
values must be used for plants that do not have a TSS limitation
(9 plants). Consequently, the BCT criteria derived for this
plant group will be based to a large extent on artificial
performance. Secondly, the BPT TSS limitation in effect for some
plants in the test group (3) is more stringent than the
anticipated amended BPT and BCT limitations. Attributing costs
and removals to meeting this soon-to-be deleted limitation is not
reasonable nor is it necessarily consistent with the intent of
the Clean Water Act concerning BCT. Finally, this exercise would
require that the costs incurred by the 3 plants to meet their
existing BPT TSS limitation be separated from the costs required
to meet BCT BOD5. limits. This is not feasible, however, since
the upgrading costs are developed based on average effluent BOD5_
concentrations and not effluent TSS concentrations. Biological
treatment systems are designed to meet a target BOD5. effluent
level and if the system is operated properly roughly equivalent
effluent levels of TSS will result. The data from plants already
meeting the anticipated BCT limits show this to be the case.
Nonetheless, BCT criteria for this 12 plant group using the
existing BPT regulation as a base point were calculated by
assuming TSS average concentrations of 18 mg/1 and 178 mg/1 (the
non-regulated subcategory average), respectively, for plants with
and without a TSS limitation. No attempt was made to separate
the costs of BPT/TSS compliance from the BCT upgrade costs. The
criteria results, $0.38/lb and 0.49, should be interpreted in
light of the approximations used to obtain them.
Finally, since we are proposing to amend the existing BPT
regulation, we considered whether those changes could alter the
259
-------
results of the BCT cost test. The planned amended BPT regulation
will be the same as the existing BPT regulation except that the
current mg/1 TSS limitation for B, D and E subcategory plants
will be replaced by a limitation based on a long term average
concentration of 75 mg/1 which will apply to all plants and all
operations in subcategories A - E.
The calculation of the test criteria iis similar to the
calculation just described except that all 12 plants were
assigned a TSS concentration of 75 mg/1. :The criteria results
$0.54 and 0.76 are of questionable validity because the plant by
plant removal calculations are based on contrived BPT performance
for TSS.
The results obtained from these exercises support the Agency's
conclusion concerning the BCT cost test for the pharmaceutical
industry. These results also support the Agency's contention
that the procedure used to calculate the BCT criteria for
comparison to the BCT benchmark figures represents the most
effective use of the data available. ;
4. Technology Basis for BCT
The treatment, technologies employed by the industry were
evaluated to determine the pattern for technology addition.
Primary clarification, neutralization and equalization may be
followed by secondary biological treatments such as activated
sludge, aerated lagoons or trickling filters and finally by
tertiary treatment such as polishing ponds. After consideration
of these various technologies, the Agency decided that the
technology basis for the BCT limitations wi;il be add-on activated
sludge. Activated sludge is both commonly used and effective,
and any requirement to achieve improved effluent quality as
measured by the conventional pollutant parameters BOD and TSS may
be accommodated by either increasing the capacity of existing
activated sludge units or by adding new units. The adoption of
add-on activated sludge technology as the basis for BCT
limitations does not, of course, preclude the use of other
technologies to achieve the requisite effluent quality.
Effluent limitations based on the performance of these
technologies may be either on a percentage basis or a
concentration basis. The reasoning behind the use of a
concentration basis for effluent limits is as follows:
a. Markedly higher loadings do not inherently indicate
proportionately more difficult treatment. In fact,
removal of a pound of BOD equivalent, for example, is
generally much easier at higher concentrations than at
lower concentrations.
260
-------
b. A greater removal of pounds of pollutant per dollar
expended will generally be accomplished by further
treatment of higher concentration streams, an approach
not encouraged by percent removal limitations but
consistent with concentration limits.
c. Other industry regulations are based on concentration
limits and implementation of the regulation would be
facilitated by this approach.
d. Dilution in order to meet concentration limits can
avoided by permit recognition of applicable flows.
be
EPA also considered two other technology options as the basis for
BCT. Option (2) for advanced biological treatment entails the
addition of specific design units (activated sludge, RBC's or
polishing ponds) to existing biological treatment systems.
Biological systems employing these additional units can achieve
long term effluent performance levels of 20 mg/1 BOD5. and 30 mg/1
TSS with appropriate treatment system design and operation. The
other option considered (3) was advanced biological treatment
that could produce long term average effluent concentrations of
28 mg/1 BOD5. and 36 mg/1 TSS. Similarly, this treatment
performance can be achieved by the addition of activated sludge
digestors, rotating biological contactor units or polishing ponds
to existing biological systems. Option 3 is a lower cost option
than option 2 because of its less stringent design requirements.
Both options were evaluated using the BCT "cost reasonableness"
test as required by the Clean Water Act in the same manner as the
selected option was evaluated. The results for the POTW
benchmark criterion were $.54/lb. and $.53/lb., respectively, for
options 2 and 3. These values are both greater than the $.42/lb.
benchmark criterion stipulated for the first part of the test and
therefore the Agency has rejected these options for BCT on the
basis of the "cost reasonableness" statutory requirement. The
failure of these options to pass the cost test is due to the fact
that a significant number of plants are achieving effluent
quality in terms of BOD5. and TSS that is close to that required
by these options and further upgrading would be relatively cost
ineffective for these plants.
5. Regulated Pollutants
Conventional pollutants to be regulated by BCT are BOD5., TSS and
pH. These pollutants were also regulated under the 1976 BPT. No
other conventional pollutants were found to present significant
problems in the wastewaters of the industry. A more detailed
review of the selection of pollutant parameters for regulation is
presented in Section VI.
261
-------
*>• Profile of Industry Facilities
An in-depth profile of the Pharmaceutical Industry is provided in
Section III of this document. In this section the major
manufacturing operations are evaluated in terms of wastewater
generating characteristics and priority pollutant usage. While
there is significant operational diversity within each
manufacturing subcategory and from one subcategory to the next,
and while the raw waste loads .generated may differ with respect
to the composition and concentration of pollutants, the waste
load generated by pharmaceutical plants are nonetheless
consistently amenable to treatment by biological systems. This
is evidenced by the large number of mixed subcategory which
employ one biological system to treat wastes from all their
manufacturing operations. Moreover, the methods of treatment
employed by single subcategory plants do not vary markedly from
subcategory to subcategory. The 308 and long term daily data
submitted provide adequate justification for proposing one set of
limitations for all plants covered by this!study.
7. Engineering Aspects of_ BCT
A technical review and evaluation of treatment technologies
employed in the industry, presented in Section VII indicates use
of a variety of treatment technologies, both in-plant and end-of-
pipe. Filtration of mycelia from fermentation wastewater offers
an opportunity for a major reduction in nutrient BOD loading
before combination with other wastewaters and also, in some
cases, a recoverable by-product.
Since the manufacturing operations entail the handling of mostly
organic materials, waste loads which are decidedly acid or
alkaline are usually not encountered. However, some
neutralization of equalized influent before secondary treatment
is often necessary. The secondary biotreatment systems used
include activated sludge, aerated lagoons, and trickling filters,
with clarification or filtration following.
8. Variability
The variability of wastewater effluent in the industry is a
result of variations in three general factors. The first is in
raw waste loads and concentrations, resulting from process
variation and from phasing of batch and campaign production. The
second is in wastewater flow, resulting from variations in
production rate and operating techniques. The third is in
treatment efficiency which is affected by seasonal ambient
conditions and operating variations.
262
-------
EPA conducted statistical analyses of long-term effluent
monitoring data to determine BAT, BCT, and NSPS limitations in
the form of daily maximum effluent limitations and 30-day average
maximum effluent limitations for traditional pollutants
(conventional pollutants TSS and BOD5_ and the nonconventional
pollutant, COD) and the toxic pollutant, cyanide. In addition,
allowable mass-based variability factors were also determined.
The specific methodologies for calculation of these variability
factors are discussed in Chapter IX. Variability factors are
calculated for each pollutant in terms of both daily and 30-day
average levels.
As mentioned above, the 1976 "Development Document" established
five manufacturing subcategories of pharmaceutical products and
activities for regulatory purposes A through E. The statistical
analyses presented are herein for the set of all pharmaceutical
plants. As stated earlier, plants operating solely in
subcategory E (Research) were not studied as part of the
investigation. The contribution of research activities to the
effluent of plants also engaged in activities in the first four
subcategories was deemed to be negligible.
9. Cost in Relation to Benefits
The cost of BCT implementation is considered to be the cumulative
implementation costs for those plants not already meeting the new
limits (including estimated costs for plants that supplied
insufficient data) at the time.of the data surveys. These costs
(investment and operating) were developed on a conservative basis
for treatment module units wherever reported performance did not
meet average long term performance of 55 mg/1 for BOD and 51 mg/1
for TSS. Estimates based on the average costs for plants not
meeting the new limitations were projected for plants submitting
insufficient data, assuming that the rate of compliance (76-6)
found for the plants who submitted complete data applies to these
plants. The total annual and investment costs may amount to
$7.72 million and $19.4 million, respectively, for direct
dischargers. Actual expenditures are expected to be
substantially less due to site specific opportunities for
improvement of wastewater treatment operations.
BOD discharge by industry direct dischargers will be reduced by
an estimated 4,727,000 Ib. per year and TSS discharge by an
estimated 1,756,000 Ib. per year. These discharge reductions
were calculated on a long term average concentration basis and
include an estimated contribution from plants from whom
insufficient data was received. These discharge reductions
reflect reductions achievable from actual performance levels as
reported in the 308 and long term data surveys.
263
-------
10. Nonwater Quality Environmental Impact
The four general categories for RCRA wastes generated by the
pharmaceutical industry are sludges, waste solvents, infectious
wastes, and returned and rejected goods. ! Only one of these,
sludges, is expected to be significantly increased by
technologies expected to be employed under BCT.
Sludge from biological treatment can mostly be land-filled, as
would separable solid process waste 'such as mycelia from
fermentation.
Implementation of BCT level technology is not expected to affect
air emissions significantly. :
The energy consumption and cost effect of BCT implementation are
slight. Increases in energy needs are largely limited to
additional power requirements for pumps, agitators, etc., and are
not generally a large requirement. Costs of incremental energy
needs are included in the cost studies. ;
1! • Guidance to Enforcement Personnel i
The regulatory limits set forth earlier >in this section are
expressed in terms of concentration. In stating permit limits,
it is anticipated limits will be set based both on concentration
and on loading, e.g., pounds per day. The conversion requires
consideration of flow and unit conversion according to:
Maximum Loading (Ib/day) = Maximum Day Concentration (mg/1)
X Maximum Applicable Flow (MGD)
X 8.34 Ib x;liters
mg|x MG
264
-------
TABLE XI-2
Incremental BPT and BCT Annual Costs and Removals
Plant t
12022
12026
12038
12098
12160
12187
12236
12239
12462
20257
BPT Cost ($)
6,400,000
1,400,000
4,500,000
200,000
400,000
5,200,000
4,400,000
150,000
1,500,000
300,000
24,450,000
BPT Removal (Ibs)
9,954,000
1,641,000
22,881,000
52,000
113,000
17,721,000
2,176,000
6,000
698,000
22,000
55,264,000
BCT Cost ($)
1,044,000
275,000
1,243,000
156,000
203,000
1,539,000
715,000
89,000
387,000
171,000
5,822,000
BCT Removal (Ibs
581,000
455,000
5,407,000
39,000
54,000
6,747,000
845,000
7,000
1,080,000
22,000
16,237,000
265
-------
Plant
TABLE XI-3
BCT Cost Test Criteria
12022
12026
12038
12098
12160
12187
12236
12239
12462
20257
AC
C
ABCD
D
D
C
C
C
A
C
Subcateqorv(s)
BCT Cost ($/lb)
0.66
0.60
i
0.23
3,98
3.73
0.23
0.85
12.84
0.36
7.93
Overall Ave. = 0.36*
Calculated from totals in Table XI-2.
BCT/BPT Ratio
1.03
0.71
1.17
1 .04
1.06
0.78
0.42
0.47
0. 17
0.54
Overall Ave. 0.81*
266
-------
SECTION XII
Best Available Technology Economically achievable
A. Summary
1 .
GENERAL
As a result of the Clean Water Act of 1977, the achievement of
BAT has become the principal national means of controlling
wastewater discharges of toxic pollutants. The factors
considered in establishing the best available technology
economically achievable (BAT) level of control include the costs
of applying the-control technology, the age of process equipment
and facilities, the process employed, process changes, the
engineering aspects of applying various types of control.
techniques, and non-water quality environmental considerations
such as energy consumption, solid waste, generation, and air
pollution (Section 304(b)(2)(B)). In general, the BAT technology
level represents, at a minimum, the best economically achievable
performance of plants of shared characteristics. Where existing
performance is uniformly inadequate, BAT technology may be
transferred from a different subcategory or industrial category.
BAT may include process changes or internal controls, even when
hot common industry practice.
The statutory assessment of BAT "considers" costs, but does not
require a balancing of costs against effluent reduction benefits
(see Weyerhaeuser v. Costle, ;11 SRC 2149 (D.C. Cir. 1978)).
However, in assessing the proposed BAT, EPA has given substantial
weight to the reasonableness of costs. The Agency has considered
the volume and the nature of discharges, the volume and nature of
discharges expected after application of BAT, the general
environmental effects of the pollutants, and the costs and
economic impacts of the required pollution control levels.
Despite this expanded consideration of costs, the primary
determinant of BAT is effluent reduction capability using
economically achievable technology.
2. Limitations
BAT limitations are summarized in Table X-l below.
Pollutant
Table X-l
BAT LIMITATIONS
30-Day
Average Maximum
Daily
Maximum
267
-------
COD (mg/1) 570 1024
Cyanide (mg/1) 0.375 .643
B. Identification of BAT
[
1. Prior Regulations
The Agency has not previously proposed or promulgated BAT
effluent limitation guidelines for the pharmaceutical
manufacturing industry. Suggested limitations were published in
the 1976 Development Document for information purposes.
2. Regulated Pollutants
I
The only priority pollutant sufficiently evident in the industry
and requiring BAT limitation was cyanide. The nonconventional
pollutant COD will also be regulated. !
3. Methodology Used j
The first part of EPA's priority pollutant study of the
pharmaceutical industry involved a review of the priority
pollutant information provided in the 308 portfolio responses
concerning the manufacturing use and wastewater discharge of
priority pollutants. This information was evaluated to determine
what priority pollutants were commonly discharged as a result of
pharmaceutical manufacturing operations. Those priority
pollutants known to be present in wastewater as a result of non-
pharmaceutical manufacturing operations (e.g., pesticide
manufacturing) or which were present in only one instance (as a
result of unique site-specific operations) were rejected as
candidates for regulation at that point. After developing a
group of commonly discharged priority pollutants (cyanide, toxic
solvents, metals, and phenols), the Agency then selected as group
of plants for sampling in the S/Y program, j The purposes of this
program were to determine the levels j.p.f these pollutants
discharged and the degree to which the raw waste levels of these
pollutants were reduced by treatment in-place.
EPA found 34 toxic pollutants in the wastewater of pharmaceutical
plants who were in the S/V program. 33 of] these pollutants have
been excluded from direct discharger regulations by the
provisions of paragraph 8 of the Consent Decree. A detailed
discussion of the rationale for these exclusions and the
exclusions of the pollutants not found\ in the S/V program is
contained in Section VI of this document. !The remaining toxic
pollutant, cyanide, was found at levels and;frequencies requiring
regulatory control (see Section X).
268
-------
A. Cyanide
Where toxics are present at levels and frequencies requiring
regulation but insufficient technological justification exists
fo? levels more stringent than BPT, BAT levels should be set at
BPT levels for such toxics. In regard to the BAT control of
cyanide in the pharmaceutical industry, EPA has concluded that
further reduction of cyanide from the BPT level has not been
adequately demonstrated by technologies for cyanide destruction.
Therefore, the Agency is proposing BAT limitations to control
cyanide which are equal to the BPT limitations.
B.
COD
In addition to controlling toxic pollutants, BAT may be
appropriate for the control of nonconventional P°Jl"tant
pSamlters. One such parameter, COD has been^ fj«n* «J high
concentrations in the raw waste of direct discharging
pharmaceutical plants. This pollutant parameter is a measure of
the non-biodegradable or slowly biodegradable organic* in
wastewater. The discharge of COD is currently being controlled
by percent reduction limitation of the existing BPT regulation.
In its analysis of the 13 plant BCT data set discussed in Section
IX the Agency was able to derive a long term average
concentration of COD based on data submitted from 12 of the 13
nlants This average performance together with the daily and 30-
day average variability factors (see Section IX for methods of
calculation) were combined to provide COD daily maximum and 30-
day maximum average limitations. This performance is
characteristic of what is achievable by BCT biotreatment systems
in regard to the control of COD. These systems are also judged
to be the "best available and economically achievable.
4. Technology Basis for BAT
The technology basis for BAT is a combination of cyanide
destruction (part of the technology basis for BPT and add-on
activated sludge (the technology basis for the BCT limitations).
Shile Sost Plants will be able to meet the COD limitations by
proper operation of adequately designed and operated biological
treatment to which any required activated sludge capacity has
been added, some plants because of their heavy use of certain
refractory organic materials (e.g., solvents and some synthetic
Starting materials) may be required to carefully control the
amounts of these substances that enter their wastewater in order
to meet these limitations. In some instances this may require
appropriate stream segregation and treatment or disposal or
changes in process operations.
269
-------
EPA also considered other technology options for the control of
COD. Specifically, EPA considered the two advanced biological
treatment options that were also considered for BCT (See Section
XI). These options were rejected for BAT control of COD after an
evaluation of the available treatment in terms of the processes
which generate COD in the pharmaceutical industry indicated that
these technology options would require a level of COD reduction
which is not achievable generally achievable by existing direct
dischargers.
5. Costs and BMP Considerations
i
Cost considerations relating to COD limitations are intimately
involved with the costs for BOD5 and TSS removal addressed by the
BCT cost analysis, as the same technology which achieves BCT
limits will achieve the COD limits under BAT. A discussion of
the BCT costs may be found in Section XI(. Therefore, there are
no incremental costs for COD control attributable to BAT. In
addition, no costs are expected as aresult of the BAT
limitations on cyanide discharge since any;costs to be incurred
are attributable to the BPT regulation. i
No BMPs (Best Management Practices) beyond those required by the
existing BPT regulation are proposed in this rulemaking.
6. Guidance to Enforcement Personnel
Although cyanide is the only priority pollutant to be limited by
this regulation, enforcement personnel are urged to limit other
priority pollutants at specific plants where they are identified
as discharged in treatable quantities. Permit writers should
study the product/process mix employed by each facility to
determine whether toxic pollutants may be discharged in
manufacturing operations. The priority pollutants used in
various pharmaceutical manufacturing operations are presented in
the PEDCo reports (41, 42, 43). Raw materials and process
materials are the two key areas of priority pollutant usage. A
good understanding of these areas as they ! pertain to a given
facility is necessary before any decision can be made about
imposing additional controls on toxic pollutants not controlled
by BAT. I
i •; •
Referring to screening and verification ;data will also provide
the permiters with information on priority !pollutant levels in a
plant's discharge. Careful note should be made of both influent
and effluent concentrations of toxic compounds so that the
process and non-process dilution effects can properly be'
accounted for. i
270
-------
Although the most efficient removals of toxic pollutants are
performed at the in-plaht treatment level, end-of-pipe
technologies are effective in removing substantial amounts of
priority pollutants as well. In-plant treatment for the removal
of toxic metals and solvents (metal precipitation and steam
stripping) has been found to be very effective when applied to
streams containing high concentrations of these pollutants (see
Section VII). The performance capabilities of these technologies
should be carefully considered when site-specific limitations are
to be imposed.
A review of permit limits may be required if changes in the
materials or processes occur. Such changes may require that
limitations on toxics discharge be eased or made more stringent
or completely eliminated. In some cases, new limitations may be
necessary. Any changes in operations reported by the permit
holder should alert the permit writer to the possibility of new
limitations.
271
-------
SECTION XIII !
NEW SOURCE PERFORMANCE STANDARDS
A. Summary
1. General
The basis for new source performance standards (NSPS) under
Section 306 of the Act is the best ; available demonstrated
technology. At new plants, the opportunity exists to design the
best and most efficient production processes and wastewater
treatment facilities. Therefore, Congress directed EPA to
consider the best demonstrated process changes, in-plant
controls, and end-of-pipe treatment technologies that reduce
pollution to the maximum extent feasible.
2. Limitations
NSPS limitations are summarized in Table XII-1, below:
Table XIII-1
NEW SOURCE PERFORMANCE STANDARDS
Pollutant
Range
30-Day Average Max
Daily Maximum
BOD5_ (mg/1)
COD (mg/1)
TSS (mg/1)
Cyanide (mg/1)
EH 6.0
- 9.0
51
449
72
0.375
126
853
195
0.643
B. Identification of NSPS :
1. Methodology Used
i
a. BODS, COD and TSS
NSPS for BOD, COD and TSS were derived froip the data of a more
select group of plants than that group.whose data was used to
develop BCT and BAT limitations. This more select group was
established by deleting data from three plants. The performance
of these plants (12022, 12026 and 12236) was considered
significantly inferior to that of the other 10 plants in the BCT
(BAT) group from the standpoint of both removal .efficiency and
final effluent concentration (see discussion in Section IX) and
therefore inappropriate in light of the statutory requirements
272
-------
for NSPS. The effluent data points
were used to develop a long term
parameter. 30-day average maximum
factors for each pollutant parameter
from these 10 plants as described
multiplied by the long term average
pollutant parameters equal the 30
maximum limitations.
b. Cyanide
from the remaining 10 plants
average for each pollutant
and daily maximum variability
were derived from the data
in Section IX. These factors
values for the individual
day maximum average and daily
The cyanide NSPS are identical to those derived for the BPT, BAT
and PSES regulations. Data is not yet available to the Agency
which indicates that more stringent levels of cyanide control can
be achieved by new sources.
2. Regulated Pollutants
Pollutants regulated for NSPS are those also regulated under BPT
guidelines. These are the conventionals BOD5_, TSS, and pH, the
nonconventional pollutant COD, and the toxic pollutant cyanide.
A more detailed review of the selection of pollutant parameters
for regulation is presented in Section VI.
3. Engineering Aspects
End-of-pipe treatment systems can be designed to attain the long
term average concentrations for BOD, COD and TSS which form the
bases of NSPS for these pollutant parameters. Several plants .in
the long term and 308 data bases have provided data along with
descriptions of their end-of-pipe systems that demonstrate that
these standards are achievable. Biological treatment systems
which have capacities that allow for sufficient aeration and
retention time and which employ equalization of waste loads prior
to biotreatment are quite capable of producing effluent which
meets these standards. The fact that different wastes from
various manufacturing operations may have different K factors
(biodigradability constants) associated with them has been and
can be accounted for by on-site treatment system design and does
not necessitate separate standards for different subcategories of
plants.
EPA also considered two other technology options as the basis for
NSPS. One option was identical to the technology option chosen
for BAT (namely enhanced biological treatment and in-plant
cyanide control). After a review of the technology available to
treat wastewater from pharmaceutical manufacturing operations,
the Agency concluded that this option did not provide
sufficiantly stringent control of traditional pollutants (BOD5,
COD and TSS) in terms of the demonstrated performance of
273
-------
available treatment systems in the industry and new sources could
achieve a more stringent levels of control with proper treatment
system design. The second option considered (also considered for
BAT) involved specified design treatment levels (20 mg/1 BOD5_, 30
mg/1 TSS and 270 mg/1 COD) for enhanced biological treatment.
After review of the best demonstrated available technology in the
industry, the Agency concluded that this technology option was
insufficiently demonstrated in the industry to warrant its
selection.
!
In addition to being able to design better performing end-of-pipe
treatment systems, new sources may also design manufacturing
operations and install appropriate in-plant controls in such a
way as to limit the amount of waste that must be treated end-of-
pipe. Provision may also be made for the recycle and reuse of
water, solvent recovery and reuse and other resource and
materials conserving practices by incorporation of these
functions into the design of the plant. The ability to practice
resource recovery and reuse is not always available to existing
sources because of on-site structural limitations.
EPA considered the feasibility of attaining the new source
performance standards at new sites from the standpoint of the
technology basis (i.e., enhanced biological treatment). The
Agency concluded that these standards wiauld not impose any
unachievable technological requirements on new sources beyond
those already met by existing sources. We j also 'considered the
effect of the NSPS technological basis ohexistingsources who
might expand on-site pharmaceutical operations or start new ones.
The Agency concluded that the new source standards applicable to
these new pharmaceutical operations at existing sites would^also
not impose technological requirements that are not currently
being satisfied by existing source direct dischargers.
4. Total Capital and Annual Costs and Incremental Pollutant
Reduction
The total capital and annual costs of new source wastewater
treatment technology for an average mixed subcategory
pharmaceutical source are estimated to be $3.9 million and $1.5
million, respectively. These costs for an average new source are
estimated to be 38 percent greater than the costs incurred by the
average existing source in meeting BCT/BAT, Average pollutant
reductions for BOD5_, TSS and COD by an new source will be 18%
greater than that achieved by an existing source.
27k
-------
SECTION XIV
PRETREATMENT STANDARDS FOR NEW AND EXISTING SOURCES
A. Summary
1. General
Section 307(b) of the Act requires EPA to promulgate pretreatment
standards for existing sources (PSES) that must be achieved by a
data specified by EPA which is not later than three years from
promulgation. PSES are designed to prevent the discharge from
presently operating facilities of pollutants that pass through,
interfere with, or are otherwise incompatible with the operation
of POTWs.
Section 307(c) of the Act requires EPA to promulgate pretreatment
standards for new sources (PSNS) at the same time that it
promulgates NSPS. New indirect dischargers, like new direct
dischargers, have the opportunity to incorporate the best
available demonstrated technologies including process changes,
in-plant control measures, and end-of-pipe treatment and to use
plant site selection to ensure adequate treatment system
installation. PSNS are designed to prevent the discharge from
new facilities of pollutants that pass-through, interfere with,
or are otherwise incompatible with the operation of POTWs.
The Clean Water Act of 1977 states that pretreatment is required
for pollutants, such as heavy metals, that pass through POTWs in
amounts that would violate direct discharger effluent limitations
or limit POTWs1 sludge management .alternatives, including the
beneficial use of sludges on agricultural lands. The legislative
history of the 1977 Act indicates that pretreatment standards are
to be technology-based, analogous to the best available
technology for removal of toxic pollutants. The general
pretreatment regulations (40 CFR Part 403) which serve as the
framework for these proposed pretreatment regulations can be
found in 40 FR 27736 (June 26, 1978).
2.
Standards
Standards controlling cyanide discharge will be proposed. These
standards are shown below in table XIV-1 and are identical for
existing and new sources.
Table XIV-1
PRETREATMENT STANDARDS FOR NEW AND EXISTING SOURCES
Pollutant
30 Day Maximum Average
Daily Maximum
275
-------
Cyanide (mg/1)
0.375
0.643
Additional standards for total volatile or>ganics (TTVO) are being
considered and are also discussed below.
B. Identification of_ Pretreatment Standards
1.. Methodology Used
a. Cyanide
308 submissions indicate that 31 of the 278 indirect dischargers
use cyanide in their manufacturing operations (batch and
continuous). S/V data indicate that pharmaceutical plants
wastewater may contain high concentrations of cyanide as a result
of process operations. High concentrations of cyanide will
interfere with the operation of biological treatment systems
which are utilized by POTWs and various ranges of cyanide
concentrations have been shown to pass through the treatment
systems of municipal plants (117). High concentrations of
cyanide in the POTW sludge will also limit the alternatives
available for its management. Consequently, PSES and PSNS for
the control of cyanide discharge are deemed appropriate. The
cyanide destruction technology and data which form the basis for
BPT and BAT cyanide limitations may also be used to prevent pass-
through, etc. by indirect sources and therefore is used as the
basis for PSES and PSNS. I
b- TTVO (Total Toxic Volatile organics)
Although a Paragraph 8 exclusion of direct discharges from
limitations controlling the discharge of toxic volatile organics
has been recommended for BAT. and NSPS, such an exclusion from
regulation is not appropriate for indirect dischargers.
Information from the 308 data base shows that 155 indirect
discharging plants use priority pollutant solvents in their
manufacturing operation. An extropolation of the S/V flow
weighted mean TTVO raw waste concentration (232 mg/1) to these
plants results in a TTVO loading of 19.5 million pounds per year.
This loading is significant in that only 12 plants have indicated
having treatment in-place which can reduce raw waste
concentrations of these pollutants, e.g., steam stripping and
aerated equalization.
Generally, POTWs with secondary treatment do reduce their
influent concentration of volatile organics to some extent. Data
from the 40 plant POTW study (133) indicate that POTWs may remove
68.5% (mass based) of the raw waste TTVO found in the S/V
program. However, the biological treatment systems of direct
276
-------
discharaers in the S/V program were able to achieve an overall
mals baled average removal rate of 96.1% for a very similar mix
of solvents' It was also found that the POTW removal rates of
Tndividual commonly found toxic solvents were less in most cases
than the direct discharger removal rates of the same solvents. A
comparison of these removal rates along with the percent by
weight of the various solvents found in the S/V sampling program
is presented in Table XIV-2.
The Aaencv's interpretation of the pass-through provision of
30?(bt If the Act asLmes that pass through at POTWs occurs as a
result of a pollutant discharge from an industrial category when
t-h! nercent removal of that pollutant achieved by the BAT
trSatSSt sSstSS is greater than that achieved by POTWs. The
available data viewed in light of this interpretation suggest
that prltreaLen? standards controlling the Discharge of toxic
solvent pollutants may be required to prevent pass through of
these substances at POTWs.
The recommended technology for reducing the concentration of
volatile organics in wastewater is steam stripping. The
performance capability of steam stripping technology has been
discussed in Section VII of this document. The employment of
this technology on a selected In-plant basis would drastically
reduce the current discharge of toxic solvents- from indirect
discharges Although a few plants (6) have indicated that they
hive stSm strippers in-place, data has not been made available
which SSSld allow derivation of standards for TTVO. When such
performance data is received a decision on how the discharge of
toxic solvents by indirect dischargers can be regulated will be
made Therefore, pretreatment standards controlling the
discharge of TTVO are not specified in this rulemaking. However,
If Suring this rulemakingwe obtain appropriate data concerning
the performance of steam-stripping to derive standards, we will
include a TTVO standard in the final regulation.
c. Other Toxics
EPA also considered the effect that other toxic pollutants, which
were found in significant concentrations in the wastewater of
pharmaceutical plants, would have on the operation of POTWs. One
group of pollutants, phenol and the various phenol type
pollStants, is adequately biodegraded by the biological treatment
lystems of direct dischargers and the evidence available from the
40-plant POTW study (117) indicates that the .con?entrations of
these pollutants as discharged by pharmaceutical plants can be
adequately reduced by the secondary treatment works of POTWS.
The concentrations of toxic metals discharged by Direct
discharaina pharmaceutical plants are low enough that no pass
through or interference problems result from this discharge at
277
-------
POTWs. Therefore, no pretreatment standards are required to
control the discharge of toxic metals, phenol and phenol related
pollutants from pharmaceutical plants.
1. Regulated Pollutants
Only cyanide will be controlled by pretreatment standards in this
rulemaking. These standards will apply to end-of-pipe discharges
and will limit total cyanide (complexed and free).
1
2. Engineering Aspects ;
Cyanide can be controlled on an in-plant basis by the cyanide
destruction systems discussed in Section VII. Process streams
containing high cyanide concentrations can be selectively treated
for cyanide and the effluent from cyanide destruction can then be
combined with other wastewater streams.
i
4. Variability
The cyanide effluent standards to be proposed for indirect
dischargers are 30-day maximum average and daily maximum
standards. These standards are identical to the BPT and BAT
limitations as well as the new source standards (NSPS) for
cyanide and account for variations in raw waste loads and flows.
5. Cost and Nonwater Quality Aspects
The annual and investment costs to indirect dischargers for
meeting the cyanide standards are $880,000 and $323,000,
respectively. Increases in energy use as a result of these
standards are expected to be very small and no increase in wastes
to be disposed of under RCRA is anticipated.
*>• Guidance to Enforcement Personnel \
-•• ' • [*:" :., .:,•'.' ., • . ,
Enforcement personnel are referred to Sections VI, IX and X and
an earlier part of this section for information concerning the
development of these standards. : ;
278
-------
TABLE XIV-2
:OMPARISON OF POTW AND DIRECT DISCHARGER REMOVAL RATES FOR SOLVENTS
% by Wat. in Raw Waste Direct Discha
POTW Removal Rate, % Removal Rate,
•roxic ooiveiii. wj.
Btethylene
• chloride
ll , 1 , 1-trichloro-
• ethane
•Toluene
Ichlorobenzene
Ichloroform
Ifithylbenzene
ll ,2-Dichloro-
1 ethane
Isenzene
•Methyl
• chloride
Bothers
»J/ T tA Gill h»0
59.3
23.0
8.9
4.2
1.8
1.2
0.9
0.3
0.3
0.1
58
87
90
67
61
84
91
71
92
-
92
**
98
100
94
85
95
69
100
-
|*Other solvents found at least once include tetrachloroethylene,
Jui-dichloroethane, 1,1-dichloroethylene, carbon tetrachloride,
trichloroethylene, chloroethane, 1,2-trans-dichloroethylene,
ll,1,2-trichloroethane and bromoform.
J '• • ' ~ . • •'.''.-".',•'.
**Influent concentrations are to low to make accurate removal
rate estimates.
279
-------
1.
2.
3.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
SECTION XV
REFERENCES
Anderson, Dewey R., et al, "Pharmaceutical Wastewater:
Characteristics and Treatment," Industrial Wastes. March/
April 1971, pp. 2-6.
APHA Project Staff, Factbook '76, Prescription Drug Industry
Pharmaceutical Manufacturers Association, 1976.
APHA Project Staff, Handbook of Nonprescription Drugs.
Aerican Pharmaceutical Association, Washington, B.C., 1977.
Breaz, Emil, "Drug Firm Cuts Sludge Handling Costs," Water
and Wastes Engineering,, January 1972, pp. 22-23. "
Burns and Roe submittal to the U.S. EPA, "Burns and Roe Review
of TRC Data Base," May 8,1978 revised June 7, 1978 .
Burns and Roe submittal to the U.S. EPA, "Preliminary
Profile," February 15, 1978.
Burns and Roe submittal to the U.S. EPA, "Profile Report No.2
308 Portfolio, Subcategory A Report," June 2, 1978.
Burns and Roe submittal to the U.S. EPA, "Profile Report No
3, Industry Population," June 22, 1978.
Burns and Roe submittal to the U.S. EPA, "Profile Report No
4, Fate of Industry Wastewater, " August; 18,1978.
Burns and Roe submittal to the U.S. EPA,"Profile Report No.5
Treatment Technology," September 8, 1978.
Burns and Roe submittal to the U.S. EPA!, " Profile Report No
6A, Production Data by Plant Site," August 30, 1978.
Burns and Roe submittal to the U.S. EPA! "Summary Report No.
1, Pharmaceutical Manufacturing Data Base Acquisition "
February 14, 1978. !
Burns and Roe submittal to the U.S. EPAi "Summary Report No.
1A, 308 Portfolio Development, Pharmaceutical Manufacturing,"
May, 1978. y'
Burns and Roe submittal to the U.S. EPAk "Summary Report No.2,
308 Portfolio Computerization, Phase I, Pharmaceutical
280
-------
Manufacturing," February 24, 1978.
15. Burns and Roe submittal to the U.S. EPA, "Summary Report
No. 3, Industrial Subcategorization, Review of Alterna-
tives," February 14, 1978.
16. Burns and Roe submittal to the U.S. EPA, "Summary Report
No. 4, Pharmaceutical Manufacturing Point Source Category
Definition," February 14, 1978.
17. Burns and Roe submittal to the U.S. EPA, "Summary Report
No. 5, 308 Portfolio Computerization, Phase II, Pharma-
ceutical Manufacturing," April 21, 1978.
18. Burns and Roe submittal to the U.S. EPA, "Screening Plants
Coverage of Pharmaceutical Products," letter transmitted,
December 12, 1978.
19. Burns and Roe submittal to the U.S. EPA, "308 Treatment
Plant Performance Data," letter report dated December 11,
1978.
20. Burns and Roe submittal to the U.S. EPA, "Profile Report
No. 1A," June 15, 1978.
21. Crane, Leonard W., "Activated Sludge Enhancement: A Viable
Alternative to Tertiary Carbon Adsorption," Proceedings of
the Open Forum on Management of Petroleum Refinery Waste-
water, June 6-9, 1977.
22. Dlouhy, P.E. and Dahlstrom, D.A., "Continuous Filtration in
Pharmaceutical Production," Chemical Engineering Progress,
Vol. 64, No. 4, April 1968, pp. 116-121.
23. Dunphy, Joseph F. and Hall, Alan, "Waste Disposal: Settling
on Safer Solution for Chemicals," Chemical Week, March 8,
1978, pp. 28-32
24. Echelberger, Wayne F., Jr., "Treatability Investigations for
Pharmaceutical Manufacturing Wastes," presented at the ASCE
National Environmental Engineering Conference, Vanderbilt
University, July 13-15, 1977.
25. Federal Register, Vol. 41, No.31 - Friday, February 13, 1976,
pp. 6878-6894.
26. Federal Register, Vol. 41, No. 106 - Tuesday, June 1, 1976,
pp. 22202-22219.
27. Federal Register, Vol.41, No. 223 - Wednesday, November 17,
281
-------
28.
29.
30.
31 .
32.
33.
34.
35.
36.
37.
38.
40.
1976, pp. 50676-50686.
Federal Register. Vol. 42, No. 20 - Monday, January 31, 1977
pp. 5697.
Federal Register. Vol. 42, No. 24 - Friday, February 4, 1977,
pp. 6813-6814. j
Federal Register. Vol. 42, No. 148, - Tuesday, August 2, 1977,
pp. 39182-39193. !
Federal Register. Vol. 42, No. 191, - Monday, October 3, 1977,
pp. 53804-53820.
i
Fox, Jeffrey L., " Ames Test Success Paves Way for Short-Term
Cancer Testing," Chemical and Engineering News. December 12,
1977, pp. 34-46.
i • • • •
Grieves, C.G., et al, "Powdered Carbon Improves Activated
Sludge Treatment," Environmental Management. October 1977,
pp. 125-130.
Humphrey, Arthur E., "Current Developments in Fermentation,"
Chemical Engineering. December 9, 1974, pp. 98-112.
Lawson, C.T., and Hovious, J.L., "Realistic Performance
Criteria for Activated Carbon Treatment of Wastewaters from
the Manufacture of Organic Chemicals and Plastics," Union
Carbide Corporation, February 14,1977.
Lund, Herbert F., Industrial Pollution Control Handbook.
McGraw-Hill. " £-
Marek, Anton C., Jr., and Askins, William, "Advanced
Wastewater Treatment for an Organic Chemicals Manufacturing
Complex," U.S./U.S.S R. Symposium on Physical/Chemical
Treatment, November 12-14, 1975.
I
i
Mohanrao, G.J., et al, "Waste Treatment at a Synthetic Drug
Factory in India," Journal Water Pollution Control
Federation. Vol. 42, No.8, Part 1, August 1970, ppTl 530-1543.
Natural Resources Defense Council, et al
8 E.R.C. 2120 (D.D.C. 1976).
vs Train,
41. PEDCo Environmental submittal to the U.S. EPA, "The Presence
of Priority Pollutants in the Extractive Manufacture of
Pharmaceuticals," October 1978.
282
-------
42. PEDCo Environmental submittal to the U.S. EPA, "The Presence
of Priority Pollutant Materials in the Fermentation
Manufacture of Pharmaceuticals," no date.
43. PEDCo Environmental submittal to the U.S. EPA, "The Presence
of Priority Pollutants in the Synthetic Manufacture of
Pharmaceuticals," March 1979.
44. Shumaker, Thomas P., "Carbon Treatment of Complex Organic
Wastewaters," presented at Manufacturing Chemists Associ-
ation, Carbon Adsorption Workshop, November 16, 1977.
45. Stracke, R.J., and Bauman, E.R., "Biological Treatment of a
Toxic Industrial Waste - Performance of an Activated Sludge
and Trickling Filter Plant: Salisbury Laboratories."
46. Struzeski, E.J., Jr., "Waste Treatment in the Pharmaceuticals
Industry/Part 1," Industrial Wastes July/August 1976,
pp. 17-21.
47. Struzeski, E.J., Jr., "Waste Treatment in the Pharmaceuticals
Industry/Part 2," Industrial Wastes September/October 1976,
pp. 40-43.
48. Stumpf, Mark R., "Pollution Control at Abbott", Industrial
Wastes, July/August 1973, pp. 20-26.
49. "Super Bugs Rescue Waste Plants," Chemical Week Novem-
ber 30, 1977, p. 47 (unauthored).
50. The Directory of Chemical Producers - U.S.A., Medicinals.
. Stanford Research Institute, Menlo Park, CA.
51. The Executive Directory of U.S. Pharmaceutical Industry,
Third Edition. Chemical Economics Services, Princeton, NJ.
52. U.S. EPA, "Assessment of the Environmental Effect of the
Pharmaceutical Industry," Contract No. 68-03-2510, December
1978. :'.'-'
53. U.S. EPA, "Characterization of Wastewaters from the Ethical
Pharmaceutical Industry," Report No. 670/2-74-057, July
1974.
54. U.S. EPA, "Control Techniques for Volatile Organic Emissions
from Stationary Sources," Contract No. 68-02-2608, Task 12,
September, 1977.
55. U.S. EPA, "Development Document for Interim Final Effluent
Limitations Guidelines and Proposed New Source Performance
283
-------
56.
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
Standards for the Pharmaceutical Manufacturing Point Source
Category," Report No. 440/1-75/060, December 1976.
U.S. EPA, "Development Document for Proposed Existing Source .
Pretreatment Standards for the Electroplating Point Source
Category," Report No. 440/1-78/085, February 1978.
U.S. EPA, Draft of "Pretreatment Standards for Ammonia,
Phenols, and Cyanides", Contract No. 68-01-3289, March 1976.
U.S. EPA, "Pharmaceutical Industry: Hazardous Waste Gen-
eration, Treatment, and Disposal," Report No. SW-508, 1976.
U.S. EPA, "Preliminary Evaluation of Sources and Control of
the Wastewater Discharges of Three High Volume Pharmaceutical
Production Processes," Contract No. 68-03-2870, November 1977.
U.S. EPA, "Sampling and Analysis Procedures for Screening of
Industrial Effluents for Priority Pollutants," April 1977.
U.S. EPA, "Waste Treatment and Disposal Methods for the
Pharmaceutical Industry," Report No. 330/1-75-001, February
1975. y
Willey, William J., and Vinnecombe, Anne T., Industrial
Microbiology. McGraw-Hill, 1976. :
Windholz, Martha, The Merck Index 9th Edition.
Co., Rahway, NJ7 1976.
Merck and
Wu, Yeun C. and Kao, Chiao F., "Activated Sludge Treatment
of Yeast Industry Wastewater," Journal Water Pollution
Control Federation Vol. 48, No. 11, November 1976, pp.2609-2618
DeWalle, F.B., et al, "Organic Matter Removal by Powdered
Activated Carbon Added to Activated Sludge," Journal Water
Pollution Control Federation. April 1977.
Grieves, C.G., et al, "Powdered Activated Carbon Enhancement
of Activated Sludge for BATEA Refinery Wastewater Treatment,"
Proceedings of the Open Forum' on Management of Petroleum
Refinery Wastewater, June 6-9, 1977. ;
Grulich, G., et al, "Treatment of Organic Chemicals Plant
Wastewater with DuPont PACT Process," presented at AICHE
Meeting, February 1972.
Heath, H.W., Jr., "Combined Powdered Activated Carbon -
Biological ("PACT") Treatment of 40 MGD Industrial Waste,"
presented to Symposium on Industrial Waste Pollution Control
284
-------
69.
70.
71 .
72.
73.
74.
75.
76.
77.
78.
79.
80.
at ACS National Meeting, March 24, 1977.
Button, D.C., and Robertaccio, F.L., U.S. Patent 3,904,518,
September 9, 1975.
U.S. EPA, "Control of Volatile Organic Emissions from the
Manufacture of Synthesized Pharmaceutical Products," Report
No. 450/2-78-029, December 1978.
U.S. EPA, "Draft Development Document Including the Data Base
for Effluent Limitations Guidelines (BATEA), New Source
Performance Standards, and Pretreatment Standards for the
Inorganic Chemicals Manufacturing Point Source Category,"
Contract No. 68-01-4492, April 1979.
Hwang, Seong T., and Fahrenthold, Paul, "Treatability of the
Organic Priority Pollutants by Steam Stripping," presented at
A.I.Ch.E, meeting, August 1979.
Burns and Roe submittal to the U.S EPA, "Executive Summary of
Effluent Limitations Guidelines for the Pharmaceutical
Industry," July 1979.
Burns and Roe submittal to the U.S. EPA, "Supplement to the
Draft Contractors Engineering Report for the Development of
Effluent Limitations Guidelines for the Pharmaceutical
Industry," July 1979.
Fox, C.R., "Removing Toxic Organics from Wastewater,
Engineering and Process, August 1979.
Chemical
Boznowski, J.H., and Hanks, D.L., "low-energy Separation
Processes," Chemical Engineering, May 7, 1979, pp.65-71.
Heist, James A., "Freeze Crystallization," Chemical
Engineering, May 7, 1979, pp. 72-82.
Hanson, Carl, "Solvent Extraction-An Economically Competitive
Process," Chemical Engineering, May 7, 1979, pp. 83-87.
Region 2 S&A Chemistry Section memo to William Telliard of
Effluent Guidelines, "Quantitative Organic Priority Pollutant
Analyses-Proposed Modifications to Screening Procedures for
Organics," December 12, 1978.
Arthur D. Little submittal to the U.S EPA, "Economic Analyses
of Interim Final Effluent Guidelines for the Pharmaceutical
Industry," August 1976.
81. Arthur D. Little submittal to the U.S. EPA, "Preliminary
285
-------
Economic Assessment of the Pharmaceutipal Industry for BATEA
Effluent Limitation Guidelines Studies/1 February 1978.
82. Office of Quality Review to Robert B. Schaffer of Effluent
Guidelines Division, "Treatability of "65" Chemicals Part B-
Adsorption of Organic Compounds on Activated Charcoal,"
December 8, 1977.
\
83. Waugh, Thomas H., "Incineration, Deep Wells Gain New
Importance," Science, Vol. 204, June 15, 1979, pp. 1188-1190.
84. Wild, Norman H., "Calculator program for Sour-Water-Stripper
Design," Chemical Engineering. February 12, 1979, pp. 103-113.
85. M & I preliminary submittal to the U.S. EPA, "A Demonstrated
Approach for Improving Performance and Reliability of
Biological Wastewatch Treatment Plants," December 1977.
86. U.S. EPA, "Control of Volatile Organic Emissions from
Manufacture of Synthesized Pharmaceutical Products," Report
No. 450/2-78-029, December 1978. i
87. Swan, Raymond, "Pharmaceutical Industry Sludge: Drug Makers
Face Waste Management Headache," Sludge, July-August 1979,
pp. 21-25.
88. Robins, Winston K., "Representation of Extraction
Efficiencies," Analytical Chemistry Vol. 51, No. 11, September
1979, pp. 1860, 1861. l ,
i
89. Dietz, Edward A., and Singley, Kennetl? F., "Determination of
Chlorinated Hydrocarbons in Water by H^adspace Gas
Chromotography," Analyical Chemistry Vol. 51, No. 11,
September 1979, pp. 1809-1814.
90. U.S. EPA, "Indicatory Fate Study," Report No. 600/2-79-175,
August 1979. !
91. U.S. EPA, "Biological Treatment of High Strength Petrochemical
Wastewater," Report No. 600/2-179-172, August 1979.
92. U.S. EPA, "Activated Carbon Treatment of Industrial
Wastewaters: Selected Technical Papers," Report No.
600/2-79-177, August 1979.
I
93. U.S. EPA, "Biodegradation and Treatability of Specific
Pollutants," Report No. 600/9-79-03, October 1979.
!
94. Interagency Regulatory Liasion Group, "Publications on Toxic
Substances: A Descriptive Listing," 1979.
286
-------
95. Federal Register, Vol. 44, No. 233 - Monday, December 3, 1979,
pp. 69464-69575.
96. Engineering-Science, Inc. submittal to the U.S. EPA,
"Effectiveness of Waste Stabilization Pond Systems for Removal
of the Priority Pollutants," December 1979.
97. U.S. EPA, "Seminar for Analytical Methods for Priority
Pollutants," May 1978.
98. Strier, Murray P., "Pollutant Treatability: A Molecular
Engineering Approach", Vol. 14,No. 1., January 1980, pp. 28-31.
99. U.S. EPA, "Fate of Priority Pollutants in Publicly Owned
Treatment Works - Pilot Study," Report No. 440/1-79-300,
October 1979.
100. Malina, Joseph F., Jr., "Biodisc Treatment," no date.
101. Gloyna, Earnest F., and Tischler, Lial F., "Design of Waste
Stabilization Pond Systems," presented at International
Association on Water Pollution Research/ Conference on
Developments on Land Methods of Waste Treatment and
Utilization, October 1978.
Gulp, Ressell L., "GAG Water Treatment Systems," Publics
Works, February 1980, pp. 83-87. ., ; .
Lawson, C.T., and Hovious, V.C., "Realistic Performance
Criteria for Activated Carbon Treatment of Wastewaters from
the Manufacture of Organic Chemicals and Plastics," Union
Carbide Corporation, February 14, 1977.
102.
103.
104.
105,
106,
107
U.S. EPA, "Development of Treatment and Control Technology for
Refractory Petrochemical Wastes," Report No. 600/2-79-080,
April 1979.
Pharmaceutical Manufacturers>.Association, "Administrative
Officers of the Member Firms and Associates of the PMA,"
October 1976.
Manufacturing Chemists Association submittal to Paul
Fahrenthold of Effluent Guidelines Division, "Comments on the
Molecular Engineering Approach to Effluent Guideline
Development," January 23, 1979.
Chemical Manufacturers Association submitted to the U.S. EPA
"CMA Comments on EPA's Proposed Leather Tanning and Finishing
Effluent Limitations Guidelines and Standards," March 27,
287
-------
1980.
108. U.S. EPA, "Ambient Water Quality Criteria," Criteria and
Standards Division, unpublished draft ;report.
109. U.S. EPA, "Development Document for Effluent Limitations
Guidelines and New Source Performance iStandards for the
Copper, Nickel, Chromium, and Zinc Segment of the
Electroplating Point Source Category," Report No.
440/1-74-003a, March 1974.
110. Walk, Haydel and Associates, Inc., "Summary Report for the
Pharmaceutical BAT/Priority Pollutant Orientation Study,"
Contract No. 68-01-6024, Work Assignment No. 3, May 20, 1980.
111. Considine, Douglas M. (ed.), Chemical and Process Technology
Encyclopedia, McGraw Hill Book Co., New York, N.Y., 1974.
112. Hawley, Gessner G., The Condensed Chemical Dictionary,
9th edition, Van Nostrand Reinhold Co., New York, N.Y., 1977.
113. Calspan Corp. Addendum to Development Document for Effluent
Limitations Guidelines and New Source Performance Standards.
Major Inorganic Products Segment of Inorganic Chemicals
Manufacturing Point source Category. Contract No. 68-01-
3281, 1978. I
114. Coleman, R.T., J.D. Colley, R.F. Klausmeiser, D.A. Malish,
N.P. Meserole, W.C. Micheletti, and K Schwitzgebel.
Treatment Methods for Acidic Wastewater Containing
Potentially Toxic Metal Compounds. EPA Contract No. 68-02-
2608, U.S. Environmental Protection Agency, 1978. 220 pp.
115. Colley, J.D., C.A. Muela, M.L. Owen, N.P. Meserole, J.B.
Riggs, and J.C. Terry. Assessment of Technology for Control
of Toxic Effluents from the Electric Utility Industry. EPA
600/7-78-090. U.S. Environmental Protection Agency, 1978.
116. Hannah, S.A., M. Jelus, and J.M. Cohen. Removal of Uncommon
Trace Metals by Physical and Chemical Treatment Processes.
Journal Water Pollution Control Federation 49(11): 2297-
2309, 1977. 1
117. Larsen, H.P., J.K. Shou, and L.W. Ross.; Chemical Treatment
of Metal Bearing Mine Drainage. Journal Water Pollution
Control Federation 45(8): 1682-1695, 1973.
118. Maruvama. T., S.A. Hannah, and J.M. Cohen. Metal Removal by
Physical and Chemical Treatment Processes. Journal Water
Pollution Control Federation 47(5):962-975, 1975.
288
-------
119.
120.
121 .
Nilsson, R. Removal of Metals by Chemical Treatment of
Municipal WAste Water. Water Research 5:51-60, 1971.
Patterson, J.W., and R.A. Minear. Wastewater Treatment
Technology. Illinois Institute of Technology, 1973.
Patterson, J.W. Wastewater Treatment Technology. Ann Arbor
Science Publishers, Inc. Ann Arbor, Micigan, 1975.
122. Patterson, J.W., H.E. Allen, and J.J. Scala. Carbonate
Precipitation for Heavy Metals Pollutants. Journal Water
Pollution Control Federation 49(12):2397-2410, 1977.
123. Schlauch, R.M., and A.C. Epstein. Treatment of Metal
Finishing Wastes by Sulfide Precipitation. EPA-600/2-75-
049, U.S. Environmental Protection Agency, 1977. 89 pp.
124.
125
126,
127
128.
129,
130,
131
Scott, M.C. Sulfex - A New Process Technology for Removal of
Heavy Metals from Waste Streams. The 32nd Annual Purdue
Industrial Waste Conference, Lafayette, Indiana, 1977. 17
pp.
Scott, M.C. Heavy Metals Removal at Phillips Plating, WWEMA
Industrial Pollution Conference, St. Louis, Missouri, 1978.
16 pp.
Sorg, T.J. O.T. Love, and G.S. Logsdon. Manual of Treatment
Techniques for Meeting the Interim Primary Drinking Water
Regulations. EPA-600/8-77-005. U.S. Environmental
Protection Agency, 1977. 73 pp.
U S. EPA, "Development Document for Porposed Effluent
Limitations Guidelines, New Source Performance Standards,
and Pretreatment Standards for the Inorganic Chemicals
Manufacturing Point Source Category", Contract No. 440/1-
80/007-6, June 1980.
Sabade'll, J.E. Traces of Heavy Metals in Water Removal
Processes and Monitoring. EPA-902/9-74-001. U.S.
Environmental Protection Agency, 1973.
U.S. EPA, "Analytical Methods for the Verification Phase
of the BAT Review, " June 1977.
The Research Corporation of New England submittal to the
U.S. EPA, "Assessment of the Environmental Effect of the
Pharmaceutical Industry, " December 1978.
Catalytic Inc., Computerized Wastewater Treatment Model
prepared for U.S. EPA 1980).
289
-------
132. Catalytic Inc., Submittal to Burns and Roe, "Computer
Print Out - Pharmaceutical ANalysis," Jan. 29, 1980.
i
133. U.S. EPA, "Fate of Priority Pollutants in Publicly
Owned Treatment Works," - Interim Report", October 1980,
290
-------
SECTION XVII
LEGEND OF ABBREVIATIONS
AA
A.C.
AE
atm
avg.
BADCT
BAT (BATEA)
bbl.
BCT
B-N
BOD5
BPT (BPCTA)
Btu
°C
C.A.
cal.
cc
cfm
cfs
cm
CN
COD
cone.
cu.m.
deg.
DO
E.Col.
Eq.
op-
Fig.
F/M
fpm
fps
ft
g
gal.
GC
GC/MS
gpd
gpm
atomic absorption
activated carbon
Acid extractables
atmosphere
average
Best Available Demonstrated Control
Technology
Best Available Technology Economically
Achievable :
barrel
Best Conventional Control Technology
Base - Neutral Extractables
Biochemical Oxygen Demand, five day
Best Practicable Control Technology
Currently Available
British Thermal Unit
degrees Centigrade
carbon adsorption
calorie
cubic centimeter
cubic feet per minute
cubic feet per second
centimeter
cyanide
Chemical Oxygen Demand
concentration
cubic meter
degree
dissolved oxygen
Escherichia coli - coliform bacteria
equation
degrees Fahrenheit
Figure
Food to microorganisms ratio
(Ibs BOD/1bs MLSS)
feet per minute
feet per second
foot
gram
gallon
Gas chromatography
Gas chromatography/Mass
Spectrophotometry
gallon per day
gallon per minute
291
-------
hp
hp-hr
HPLC
hr
in
kg
KW
KWh
1
1/kkg
Ib
m
M
mg
MGD
mg/1
min
ml
MLSS
MLVSS
mm
MM
mole
mph
MPN
mu
NH3-N
N03-N
NPDES
NSPS
02
P04
P.
pH
POTW
PP.
ppb
ppm
PSES
psf
psi
PSNS
RBC
R.O.
rpm
horsepower
horsepower-hour
High Pressure Liquid Chromatography
hour
inch |
kilogram ;
kilowatt
kilowatt hour
liter :
liters per 1000 kilograms
pound
meter
thousand
milligram
million gallons per day
milligrams per liter
minute
milliliter •
mixed liquor suspended solids
mixed liquor volatile suspended
solids
millimeter
million
gram molecular weight
mile per hour
most
millimicron ;
ammonia nitrogen
nitrate nitrogen
National Pollutant Discharge
Elimination System
New Source Performance Standards
Oxygen ;
phosphate
page
potential hydrogen or hydrogen-ion
index (negative logrithm of the
hydrogen-ion concentration)
Publicly Owned Treatment Works
pages
parts per billion
parts per million
Pretreatment Standards for Existing
Sources
pounds per square foot
pounds per square inch
Pretreatment Standards for New Sources
Rotating Biological Contactor
reverse osmosis
revolution per minute
292
-------
RWL
sec.
Sec.
SIC
SOx
sq.
sq. ft.
SS
STP
SRWL
TDS
TKN
TLM
TOC
TOD
TSS
VOA
vol
wt
yd
u
ug
ug/1
raw waste load
second
Section
Standard Industrial Classification
Oxides of Sulfur (e.g. sulfate)
square
square foot
suspended solids
standard temperature and pressure
standard reiw waste load
total dissolved solids
total Kjedahl nitrogen
median tolerance limit
total organic carbon
total oxygen demand
total suspended solids
Volatile Organic Analysis
volume
weight
yard
micron
microgram
microgram per liter
note: symbols for chemical elements and compounds are in accordance
with IUPAC and standard chemical nomenclature.
293
-------
SECTION XVI
ACKNOWLEDGMENTS
Acknowledgment is made to all Environmental Protection Agency
personnel contributing to this effort. Specifically, the
development of this report was under the direction of the
following personnel:
Robert Schaffer
Jeffrey Denit
Devereaux Barnes
Paul Fahrenthold
Robert Bellinger
James Gallup
Michael Kosakowski
Joseph Vitalis
Dan Lent
Susan Delpero
Frank Hund
Former Director, Effluent
Guidelines Division
Director, Effluent
Guidelines Division
Deputy Division Director,
Effluent Guidelines Division
Chief, Organic Chemicals Branch
Acting Chief, Wood Fibers and
Product's Branch
Chief, Office of Quality Review
Project Officer
Project Officer
Project! Officer
Chemical Engineer
Project Officer
In addition, the Organic Chemicals Branch would like to extend
its appreciation to the following individuals for significant
input into the production of this Development Document while
serving as members of the EPA pharmaceutical working group which
provided detailed review, advice and assistance:
Rob Ellis - Economic Project Officer
Jean Noroian - Economic Project Officer
Susan Green - Economic Project Officer
John Ataman - Economic Project Officer
Kathleen Ehrensberger - Economic Project Officer
Henry Kahn - Statistical Project Officer
Russ Roegner - Statistical Project Officer
William Kaschak- MDSD Project Officer
Rich Silver - MDSD Project Officer
Ruth Wilbur - MDSD Project Officer
Richard Healy - MDSD Project Officer
Susan Lepow - OGC Attorney
Catherine Winer- OGC Attorney
Bruce Newton - Enforcement Division
The following members of the Burns and
Corp., technical staff made significant
base development and technical analysis:
294
Roe Industrial Service
contributions to the data
-------
Arnold S. Vernick -
Barry S. Langer
Jeffrey A. Arnold -
Tom H. Fieldsend
Thomas Gunder
Vaidyanathan Ramaiah-
Mark Sadowski
Mary Surdovel
Jeffrey Walters
Samuel Zwickler
Manager, Environmental
Engineering
Project Manager
Project Engineer
Environmental Engineer
Environmental Engineer
Environmental Engineer
Environmental Engineer
Environmental Engineer
Environmental Engineer
Senior Supervising Engineer
Walk, Haydel and Associates, Inc. provided technical support for
this regulatory effort through the following members of its
technical staff:
J.S. Beaver
Forrest E. Dryden
E. Jasper Westbrook
Richard Melton
Ronald Rossi
Miles Sieffert
Efrain Toro
Fred J. Zak
Paul R. Schneider
Anita Junker
Administrative Project Manager
Technical Manager
Technical Program Coordinator
Project Engineer
Project Engineer
Project Engineer
Project Engineer
Project Engineer
Environmental Scientist
Environmental Technologist
The assistance of Mrs. Kaye Storey, Mrs. Glenda Nesby, Ms. Carol Swann
the Word Processing Center of Effluent Guidelines Division in the
typing of this report is specifically noted.
The assistance of all personnel at EPA Regional Offices and
State environmental departments who participated in the data
gathering efforts is greatly appreciated.
The assistance of PEDCo, Cincinnati, Ohio, is also
acknowledged for their technical input and text preparation used in
the process description portion of Section II.
Acknowledgment is made to all of the pharmaceutical plants
that participated in the sampling programs included in this
study.
Acknowledgment is made to the environmental committees of
the Pharmaceutical Manufacturers Association (PMA) for their
assistance during the course of this project.
The efforts of The Research Corporation of New England (TRC)
in developing and maintaining an open literature data base are also
acknowledged.
295
-------
-------
APPENDIX A
Glossary
-------
-------
APPENDIX A
GLOSSARY
Abatement. The measures taken to reduce or eliminate pollution.
Absorption. A process in which one material (the absorbent) takes
up and retains another (the absorbate) with the formation of a
homogeneous mixture' having the attributes of a solution.
Chemical reaction may accompany or follow absorption.
Acclimation. The ability of an organism to adapt to changes in
its immediate environment.
Acid. A substance which dissolves in water with the formation of
hydrogen ions.
Acidulate. To make somewhat acidic.
Act. Clean Water Act of 1977, PL 95-217.
Activated Carbon. Carbon which is treated by high temperature
heating with steam or.carbon dioxide producing an internal porous
particle structure.
Activated Sludge Process. A wastewater purification process in
which microorganisms absorb dissolved or suspended organic matter
and secrete enzyme to digest and utilize this matter The term
"activated sludge" applies to the flocculant growths formed as
the microorganisms grow and reproduce.
Active Ingredient. The chemical constituent in a medicine which
is responsible for its activity.
Adsorption. A method of treating wastes in which a material
(designated "adsorbent") chemicals or ^organic Batter not
necessarily responsive to clarification or biological treatment
by adherence on the surface of solid bodies.
Advanced Waste Treatment. Any treatment method or process
employed following biological treatment to increase the removal
of pollution load, to remove substances that may be deleterious
to receiving waters or the environment or to produce a- high-
quality effluent suitable for reuse in any specific manner or for
discharge under critical conditions. The term tertiary .treatment
is commonly used to denote advanced waste treatment methods.
Aeration. (1) The bringing about of intimate contact between air
and . a—liquid by one of the following methods: spraying the
-------
liquid ih the air, bubbling air through the liquid, or agitation
of the liquid to promote surface absorption of air. (2) The
process or state of being supplied or impregnated with air; in
waste treatment, a process in which liquid from the primary
clarifier is mixed with compressed air and with biologically
active sludge.
Aerobic. Ability
oxygen is present.
to live, grow, or take place only where free
Algae. Unicellular or multicellular autotrophic, photosynthetic
protists. They are a food for fish and small aquatic animals
and, like all plants, put oxygen into the water.
I
Alqicide. Chemical agent added to water to destroy algae.
Copper sulfate is commonly used in large water systems.
Alkali. A water-soluble metallic hydroxide that ionizes
strongly.
Alkalinity. The presence of salts of alkali metals. The
hydroxides, carbonates, and bicarbonates of calcium, sodium and
magnesium are common impurities that cause alkalinity. A
quantitative measure of the capacity of liquids or suspensions to
neutralize strong acids or to resist the establishment of acidic
conditions. Alkalinity results from ; the presence of
bicarbonates, carbonates, hydroxides, 'alkaline salts and
occasionally borates and is usually expressed in terms of the
amount of calcium carbonate that would have an equivalent
capacity to neutralize strong acids.
! N
Alkaloids. Basic (alkaline) nitrogenous botanical products which
produce a marked physiological action when administered to ani-
mals or humans.
Alkvlation. The addition of a aliphatic group to another
molecule. The media in which this reaction is accomplished can
be vapor or liquid phase, as well as aqueous or non-aqueous.
Ammonia Nitrogen. A substance produced by the microbiological
decay of plant and animal protein. When ammonia nitrogen is
found in waters, it is indicative of incomplete treatment.
Ampules. A small glass container that can be seated and its con-
tents sterilized. Ampoules are used to hold hypodermic
solutions.
Anaerobic. Ability to live, grow, or take place where
no air or free oxygen present.
there is
A-2
-------
Anton. Ion with a negative charge.
Antagonistic Effect. The simultaneous action of separate agents
mutually opposing each other.
Antibiotic. A substance produced by a microorganism which has
the power, in dilute solution, to inhibit or destroy other
organisms, especially bacteria.
Aqueous Solution. One containing water or watery in nature.
Arithmetic Mean. The arithmetic mean of a number of items is
obtained by adding all the items together and dividing the total
by the number of items. It is frequently called the average. It
is greatly affected by extreme values.
Autoclave. A heavy vessel with thick walls for conducting
chemical reactions under high pressure. Also an apparatus using
steam under pressure for sterilization.
Azeotrope. A liquid mixture that is characterized by a constant
minimum or maximum boiling point which is lower or higher than
that of any of the components and that distills without change in
composition.
Bacteria. Unicellular protists having round, rodlike, spiral, or
filamentous bodies and often aggregated into colonies or mobile
by means of flagella. They exist in soil, water, organic matter,
and in the bodies of plants and animals. Nutritionally, they are
autotrophic, saprophytic, or parasitic. Temperature and pH play
an important role in the life cycle of bacteria. A few are
capable of performing photosynthesis. Any ^water supply
contaminated by sewage is certain to contain a bacterial group
called "coliform."
Bacteriophage. A submicroscopic, usually viral, organism that
destroys bacteria. Also called "phage."
BADCT Limitations for new sources which are based on the appli-
cation of the Best Available Demonstrated Control Technology.
Base. A substance that in aqueous solution turns red litmus
blue, furnishes hydroxyl ions and reacts with an acid to form a
salt and water only.
BAT Effluent Limitations. Limitations for point sources, other
tha"n publicly owned treatment works, which are based on the
application of the Best Available Technology Economically
Achievable. These limitations must be achieved by July 1, 1983.
-------
Batch Process. A process which has an intermittent flow of raw
materials into the the process and a resultant intermittent flow
of product from the process.
BCT. Best Conventional Pollutant Control Technology.
j •
Bioassay. An assessment which is made by using living organisms
as the sensors. :
i
Biochemical Oxygen Demand (BOD). A measure of .the oxygen
required to oxidize the organic material in a sample of
wastewater by natural biological process under standard
conditions. This test is presently universally accepted as the
yardstick of pollution and is utilized as a means to determine
the degree of treatment in a waste treatment process. Usually
given in mg/1(or ppm) units), meaning milligrams of oxygen
required per liter of wastewater, it can also be expressed in
pounds of total oxygen required per wastewater or sludge batch.
The standard BOD test is run for five days at 20 degrees C.
Biota. The flora and fauna (plant and animal life) of a stream
or other water body.
Biological Products. In the pharmaceutical industry, medicinal
products derived from animals or humans, such as vaccines,
toxoids, antisera and human blood fractions.
Biological Treatment System. A system that uses microoganisms to
remove organic pollutant material from a wastewater.
Fractionation. The separation of human blood into its
various protein fractions.
Slowdown. (1) Water intentionally discharged from a cooling or
heating system to maintain the dissolved solids concentration of
the circulating water below a specific critical level. The
removal of a portion of any process flow to maintain the
constituents of the flow within desired levels. Process may be
intermittent or continuous. (2) The water discharged from a
boiler or cooling tower to dispose of accumulated salts.
BODJ5. Biochemical oxygen demand (BOD) is the amount of oxygen
required by bacteria while stabilizing ! decomposable organic
matter under aerobic conditions. The BOD t|est has been developed
on the basis of a 5-day incubation period (i.e. BOD5_).
i. ..' ... ' ' . ...
Botanicals. Drugs made from a part of a plant, such as roots,
bark, or leaves. :
-------
BPT Effluent Limitations. Limitations for point sources, other
than publicly owned treatment works, which are based on the
application of the Best Practicable Control Technology Currently
Available. These Limitations must be achieved by July 1,1977.
Brine. Water saturated with a salt.
Buffer. A solution containing either a weak acid and its salt or
a weak base and its salt which thereby resists changes in acidity
or basicity (pH).
Capsules. A gelatinous shell used to contain medicinal chemicals
and as a dosage form for administering medicine.
Carbohydrate. A compound of carbon, hydrogen and oxygen, usually
having hydrogen and oxygen in the proportion of two to one.
Carbonaceous. Containing or composed of carbon.
Catalyst. A substance which changes the rate of a chemical reac-
tion but undergoes no permanent chemical change itself.
Cation. The ion in an electrolyte which carries the positive
charge and which migrates toward the cathode under the influence
of a potential difference.
Cellulose. The fibrous constituent of trees which is the
principal raw material of paper and paperboard. Commonly thought
of as a fibrous material of vegetable origin.
Chemical Oxygen Demand (COD). A measure of oxygen-consuming
capacity of organic and inorganic matter present in water or
wastewater. It is expressed as the amount of oxygen consumed
from a chemical oxidant in a specific test. It does ^not
differentiate between stable and unstable organic matter and thus
does not correlate with biochemical oxygen demand.
Chemical Synthesis. The processes of chemically combining two or
more constituent substances into a single substance.
Chlorination. The application of chlorine to water, sewage or
industrial wastes, generally for the purpose of disinfection but
frequently for accomplishing other biological or chemical
results.
Coagulation. The clumping together of solids to make them
settleout" of the sewage faster. Coagulation of solids is
brought about with the use of certain chemicals, such as lime,
alum or polyelectrolytes.
A-5
-------
Combined Sewer.
run-off.
One which carries both sewage and storm water
Composite Sample. A combination of individual samples of wastes
taken at selected intervals, generally hourly for 24 hours, to
minimize the effect of the variations in individual samples.
Individual samples making up the composite may be of equal volume
or be roughly apportioned to the volume of flow of liquid at the
time of sampling. '• '
Comprehensive Pharmaceutical Data Base. Combined data base
formed by the first 308 survey of PMA-member companies plus the
second, or Supplemental 308 survey.
Concentration. The total mass of the suspended or dissolved par-
ticles contained in a unit volume at a given temperature and
pressure.
i
Conductivity. A reliable measurement of electrolyte
concentration in a water sample. The conductivity measurement
can be related to the concentration of dissolved solids and is
almost directly proportional to the ionic concentration of the
total electrolytes.
Contact Process Wastewaters. These are process-generated waste-
waters which have come in direct or indirect contact with the
reactants used in the process. These include such streams as
contact cooling water, filtrates, centrates, wash waters, etc.
Continuous Process. A process which has a constant flow of raw
materials into the process and resultant constant flow of product
from the process. !
Contract Disposal. Disposal
outside party for a fee.
of waste products through an
Crustaceae. These' are small animals ranging in size form 0.2 to
0.3 millimeters long which move very rapidly through the water in
search of food. They have recognizable head and posterior sec-
tions. They form a principal source of food for small fish and
are found largely in relatively fresti natural water.
Crystallization. The formation of sol id particles within a
homogeneous phase. Formation of crystals separates a solute from
a solution and generally leaves impurities!behind in the mother
liquid.
Culture. A mass of microorganisms growing in a media.
A-6
-------
Cyanide, Total. Total cyanide as determined by the test
prodecure specified in 40 CFR Part 136 (Federal Register, Vol.
38, no. 199, October 16,1973).
Cyanide A_._ Cyanides amenable to chlorination as described in
"1972 Annual Book of ASTM Standards" 1972: Standard 2036-72,
Method B, p. 553.
Derivative.
substance.
substance extracted from another body or
Desorption. The opposite of adsorption. A phenomenon where an
adsorbed molecule leaves the surface of the adsorbent.
Diluent. A diluting agent.
Direct Discharge. The discharge of process wastewaters to navi-
gable waters such as rivers, streams and lakes.
Disinfectant. A chemical agent which kills bacteria.
Disinfection. The process of killing the larger portion (but
not necessarily all) of the harmful and objectionable
microorganisms in or on a medium.
Dissolved Oxygen (DO). The oxygen dissolved in sewage, water or
other liquids, usually expressed either in milligrams per liter
or percent of saturation. It is the test used in BOD
determination.
Distillation. The separation, by vaporization, of a liquid
miscible and volatile mixture into individual components, or, in
some cases, into groups of components. The process of raising
the temperature of a liquid to the boiling point and condensing
the resultant vapor to liquid form by cooling. It is used to
remove substances from a liquid or to obtain a pure liquid from
one which contains impurities or which is a mixture of several
liquids having different boiling temperatures. Used in the
treatment of fermentation products, yeast, etc., and other wastes
to remove recoverable products.
Effluent. A liquid which leaves a unit operation or process.
Sewage, water or other liquids, partially or completely treated
or in their natural states, flowing out of a reservoir basin,
treatment plant or any other unit operation. An influent is the
incoming stream.
Elution. (1) The process of washing out, or removing with the
use of a solvent. (2) In an ion exchange process it is defined
as the stripping of adsorbed ions from an ion exchange resin by
-7
-------
passing through the resin solutions
relatively high concentrations.
containing other ions in
Emulsion.
another.
A suspension of fine droplets of one liquid in
Equalization Basin. A holding basin in which variations in flow
and composition of a liquid are averaged* Such basins are used
to provide a flow of reasonably uniform volume and composition to
a treatment unit. j
Esterification. This generally involves the combination of an
alcohol and an organic acid to produce an ester and water. The
reaction is carried out in the liquid! phase, with aqueous
sulfuric acid as a catalyst. The use of sulfuric acid has, in
the past, caused this type ofonation.
Ethical Products. Pharmaceuticals promoted by advertising to the
medical/ dental and veterinary professions.
Fatty Acids. An organic acid obtained by the hydrolysis
(saponification) of natural fats and oils, e.g., stearic and
palmitic acids. These acids are monobasic and may or may not
contain some double bonds. They usually contain sixteen or more
carbon atoms.
i
i :
Fauna. The animal life adapted for living in a specified
environment.
Fermentation. Oxidative decomposition of organic substances
through the action of enzymes produced by microorganisms.
Fermentor Broth. A slurry of microorganisms in water containing
nutrientsTcarbohydrates, nitrogen) necessary for the
microorganisms' growth.
Filter Cakes. Wet solids generated by the filtration of solids
from a liquid. This filter cake may be a pure material (product)
or a waste material containing additional fine solids (i.e.,
diatomaceous earth) that have been added to aid in the
filtration.
Fines. Crushed solids sufficiently fine to pass through a
screen, etc. ,
Flocculants. Those water-soluble organic polyelectrolytes that
are used alone or in conjunction with inorganic coagulants such
as lime, alum or ferric chloride or coagulant aids to agglomerate
solids suspended in aqueous systems or both; the large dense
A-a
-------
floes resulting from this process
efficient solids-liquid separations.
permit more rapid and more
Flora. The plant life characteristic of a region.
Flotation. A method of raising suspended matter as scum to the
surface of the liquid in a tank by aeration, vacuum, evolution of
gas, chemicals, electrolysis, heat or bacterial decomposition and
the subsequent removel of the scum by skimming.
Fractionation (or Fractional Distillation). The separation of
constituents, or groups of constituents, of a liquid mixture of
miscible and volatile mixtures by vaporization and recondensation
over specific boiling point ranges.
Fungus. Any of a plant-like group of organisms that does not
produce chlorophyll; they derive their food either by decomposing
organic matter from dead plants and animals or by parasitic
attachment to living organisms, thus often causing infections and
disease. Examples of fungi are molds, mildews, mushrooms, and
the rusts and smuts that infect grain and other plants. They
grow best in a moist environment at temperatures of about 25°C,
little or no light being required. In sanitary engineering,
fungi are considered to be multicellular, nonphotosynthetic,
heterotrophic protists.
Gland. A device utilizing a soft wear-resistant material used to
minimize leakage between a rotating shaft and the stationary
portion of a vessel such as a pump.
Sometimes called
Gland Water. Water used to lubricate a gland.
"packing water."
Grab Sample. (1) Instantaneous sampling. (2) A sample taken at
a random place in space and time.
Grease. In sewage, grease includes fats, waxes, free fatty
acids, calcium and magnesium soaps, mineral oils and other non-
fatty materials. The type of solvent to be used for its
extraction should be stated.
Hardness. A measure of the capacity of water for precipitating
soap.ft is reported as the hardness that would be produced if a
certain amount of CaCoS were dissolved in water. More than one
ion contributes to water hardness. The "Glossary of Water and
Wastewater Control Engineering" defines hardness as: A
characteristic of water imparted by salts of calcium, magnesium
and iron, such as bicarbonates, carbonates, sulfates, chlorides
and nitrates, that causes curdling of soap, deposition of scale
in boilers, damage in some industrial processes, and sometimes
A-9
-------
objectionable taste. Calcium and magnesium are the most
significant constituents.
Hormone. Any of a number of substances formed in the body which
specifically receptive organs when transported to them
A material secreted by ductless glands
Most hormones as well as synthetic analogues
activate
by the body fluids.
(endocrine glands).
have in common the cyclopentanophenanthrene nucleus.
Indirect Discharge. The discharge of (process) wastewaters to
publicly owned treatment works (POTW).
Injectables. Medicinals prepared in a sterile
suitable for administration by injection.•'>
(buffered) form
Mycelia. The filamentous material which makes up the vegetative
body of a fungus.
i
New Source. Any facility from which there is or may be a
discharge of pollutants, the construction of which is commenced
after the publication of proposed regulations prescribing a
standard of performance under section 306 of the Act.
Non-contact Cooling Water. Water used for cooling that does not
come into direct contact with any raw material, intermediate pro-
duct, waste product or finished product.
Non-contact Process Wastewaters. Wastewaters generated by a
manufacturing process which have not come! in direct contact with
the reactants used in the process. These include such streams as
noncontact cooling water, cooling tower blowdown, boiler
blowdown, etc.
NSPS. New Source Performance Standards. '.
\ .' .
NPDES. National Pollution Discharge Elimination System. A
federal program requiring industry to obtain permits to discharge
plant effluents to the nation's water courses.
Nutrient. Any substance assimilated by an organism
promotes growth and replacement of cellular constituents.
which
Operation and Maintenance. Costs required to operate and
maintain pollution abatement equipment including labor, material,
insurance, taxes, solid waste disposal, etc.
Organic Loading. In the activated sludge1 process,the food to
microorganisms (F/M) ratio defined as the amount of biodegradable
material available to a given amount of microorganisms per unit
of time.
A-10
-------
Oxidation. A process in which an atom or group of atoms loses
electrons; the combination of a substance with oxygen,
accompanied with the release of energy. The oxidized atom
usually becomes less positive while the oxidizing agent becomes
more negative (in chlorination, for example).
Oxidation Reduction (OR). A class of chemical reactions in which
one of the reacting species gives up electrons (oxidation) while
another species in the reaction accepts electrons (reductions).
At one time, the term oxidation was restricted to reactions
involving hydrogen. Current chemical technology has broadened
the scope of these terms to include all reactions where electrons
are given up and taken on by reacting species; in fact, the
donating and accepting of electrons must take place
simultaneously.
Oxidation Reduction Potential (ORP). A measurement that
indicates the activity ratio of the oxidizing and reducing
species present.
Oxvaen. Available. The quantity of atmospheric oxygen dissolved
in the water of a stream; the quantity of dissolved oxygen
available for the oxidation of organic matter in sewage.
Oxygen, Dissolved. The oxygen (usually designated as DO)
dissolved in sewage, water or another liquid and usually
expressed in mg/1, parts per million, or percent of saturation.
Parts Per Million (ppm). Parts by weight in sewage analysis;ppm
by weight is equal to milligrams per liter divided by the
specific gravity. It should be noted that in water analysis, ppm
is always understood to imply a weight/weight ratio, even though
in practice volume may be measured instead of a weight.
Pathogenic. Disease producing.
pH. The negative logarithm of the hydrogen ion concentration or
activity in a solution. The number 7 indicates neutrality,
numbers less than 7 indicate increasing acidity and numbers
greater than 7 indicate increasing alkalinity.
Photosynthesis. The mechanism by which chlorophyll-bearing
plants utilize light energy to produce carbohydrate and oxygen
from carbon dioxide and water(ihe reverse of respiration.).
Physical/Chemical Treatment System. A system that utilizes
physical (i.e., sedimentation, filtration, centrifugation,
activated carbon, reverse osmosis, etc.) and/or chemical means
(i.e. coagulation, oxidation, precipitation, etc.) to treat
wastewaters.
A-11
-------
Plasma. The fluid part of blood, lymph, or intramuscular fluid
in which cells are suspended.
PMA. Pharmaceutical Manufacturers Association.
Point Source. Any discernible, confined and discrete conveyance,
including but not limited to any pipe, ditch, channel, tunnel,
conduit, well, discrete fissure, container, rolling stock,
concentrated animal feeding operation, or vessel or other
floating craft, from which pollutants are or may be discharged.
Potable Water. Drinking water sufficiently pure for human use.
Potash. Potassium compounds used in agriculture and industry.
Potassium carbonate can be obtained from wood ashes. The mineral
potash is usually a muriate (chloride). ^Caustic potash is its
hydrated form.
Preaeration.
A preparatory treatment of sewage, consisting of
remove gases and add oxygen or to promote the flo-
aeration to
tation of grease and aid coagulation.
Precipitation. The phenomenon which occurs when a substance held
in solution passes out of that solution into solid form. The
adjustment of pH can reduce solubility ancl cause precipitation.
Alum and lime are frequently used chemicals in such operations as
water softening or alkalinity reduction.
Pretreatment. Any wastewater treatment process used to partially
reduce the pollution load before the wastewater is introduced
into a main sewer system dr delivered to a treatment plant for
substantial reduction of the pollution load.
Process Waste Water. Any water which, during manufacturing or
processing, comes into direct contact with or results from the
production or use of any raw material, intermediate product,
finished product, by-product, or waste product.
! ' •' •
Process Water. Any water(solid, liquid or vapor) which, during
the manufacturing process, comes into direct contact with any raw
material, intermediate product, by-product, waste product, or
finished product.
Proprietary Products. Pharmaceuticals promoted by advertising
directly to the consumer.
PSES. Pretreatment Standards for Existing Sources.
PSNS. Pretreatment Standards for New Sources.
A-12
-------
Raw Waste Load (RWL). The quantity (kg) of pollutant being
discharged in a plant's wastewater measured in terms of some
common denominator (i.e., kkg of production or m2 of floor area).
Receiving Waters. Rivers, lakes, oceans or
receive treated or untreated wastewaters.
other courses that
Reduction.
electrons.
A process in which an atom (or group of atoms) gains
Such a process always requires the input of energy.
Refractory Orqanics. Organic materials that are only partially
biodegradable in biological waste treatment processes.
Refractory organics include detergents, pesticides, color- and
odor-causing agents, tannins, lignins, ethers, olefins, alcohols,
amines, aldehydes, ketones, etc.
Residual Chlorine. The amount of chlorine left in the treated
water that is available to oxidize contaminants if they enter the
stream. It is usually in the form of hypochlorous acid of
hypochlorite ion or of one of the chloramines. Hypochlorite
concentration alone is called "free chlorine residual" while
together with the chloramine concentration their sum is called
"combined chlorine residual."
Retort. A vessel, commonly a glass bulb with a long neck bent
downward,used for distilling or decomposing substances by heat.
Sanitary Sewers. In a separate system, pipes in a city that
carry only domestic wastewater. The storm water runoff is
handled by a separate system of pipes.
Saprophytic Organism.
matter.
One that lives on dead or decaying organic
Secondary Treatment. The second step in most waste treatment
systems in which bacteria consume the organic part of the wastes.
This is accomplished by bringing the sewage and bacteria together
either in trickling filters or in the activated sludge process.
Seed. To introduce microorganisms into a culture medium.
Serum. A fluid which is extracted from an animal rendered immune
against a pathogenic organism and injected into a patient with
the disease resulting from the same organism.
Settleable Solids. Suspended solids which will settle out of a
liquid waste in a given period of time.
Sewage, Storm. The liquid flowing in sewers during or following
a period of heavy rainfall.
A-13
-------
Sewerage. A comprehensive term which includes facilities for
collecting, pumping, treating and disposing of sewage; the
sewerage system and the sewage treatment works.
SIC Codes. Standard Industrial Classification. Numbers used by
the U.S. Department of Commerce to denote segments of industry.
Sludge, Activated. Sludge floe produced in raw or settled sewage
by the growth of zoogleal bacteria and other organisms in the
presence of dissolved oxygen and accumulated in sufficient con-
centration by returning the floe previously formed.
Sludge, Age. The ratio of the weight of volatile solids in the
digester to the weight of volatile solids added per day. There
is a maximum sludge age beyond which no significant reduction in
the concentration of volatile solids will occur.
Sludge, Digested. Sludge digested under anaerobic conditions
until the volatile content has been reduced, usually by
approximately 50 percent or more.
Solution. A homogeneous mixture of two or more substances of
dissimilar molecular structure. In a solution, there is a
dissolving medium, solvent, and a dissolved substance, solute.
Solvent Extraction. The treatment of a mixture of two or more
components by a solvent that preferentially; dissolves one or more
of the components in the mixture. The solvent in the extract
leaving the extractor is usually recovered jarid"reused.
Steam Distillation. Fractionation in whiph steam is introduced
as one of the vapors or in which steam is injected to provide the
heat of the system.
Sterilization. The complete destruction of all living organisms
in or on a medium; heat to 121 C at 5 psig for 15 minutes.
Steroid. Term applied to any one of a large group of substances
chemically related to various alcohols found in plants and
animals. !
Still Bottom. The residue remaining after distillation of a
material. Varies from a watery slurry to a thick tar which may
turn hard when cool.
Stillwell. A pipe, chamber, or compartment with comparatively
small inlet or inlets communicating with a main body of water.
Its purpose is to dampen waves or surges while permitting the
water level within the well to rise and fall with the major
A-14
-------
fluctuations of the main body of water. It is used with water-
measuring devices to improve accuracy of measurement.
Stoichiometric. Characterized by being a proportion of
substances exactly right for a specific chemical reaction with no
excess of any reactant or product.
Stripper. A device in which relatively volatile components are
removed from a mixture by distillation or by passage of steam
through the mixture.
Supernatant. Floating above or on the surface.
Surge Tank. A tank for absorbing and dampening the wavelike
motion of a volume of liquid; an in-process storage tank that
acts as a flow buffer between process tanks.
Suspended Solids. The wastes that will not sink or settle in
sewage. The quantity of material deposited on a filter when a
liquid is dreiwn through a Gooch crucible.
Svnerqistic. An effect produced by a group of contributors which
is greater than the sume of the individual contributors acting
individually.
Tablet. A small, disc-like mass of medicinal powder used as a
dosage form for administering medicine.
Tertiary Treatment. A process to remove practically all solids
and organic matter from wastewater. Granular activated carbon
filtration is a tertiary treatment process. Phosphate removal by
chemical coagulation is also regarded as a step in tertiary
treatment.
Thermal Oxidation. The combustion of organic materials through
the application of heat in the presence of oxygen.
Total Organic Carbon (TOO. A measure of the amount of carbon in
a sample originating from organic matter only. The test is run
by burning the sample and measuring the carbon dioxide produced.
Total Solids. The total amount of solids in a wastewater both in
solution and suspension.
Toxoid. Toxin treated so as to destroy its toxicity, but still
capable of inducing formation of antibodies.
Vaccine. A killed or modified live virus or bacteria prepared in
suspension for inoculation to prevent or treat certain infectious
diseases.
A-15
-------
Viruses. (1) An obligate intracellular parasitic microorganism
smaller than bacteria. Most can pass through filters that retain
bacteria. (2) The smallest (10-300 urn in diameter) form capable
of producing infection and diseases in man or other large
species. Occurring in a variety of shapes, viruses consist of a
nucleic acid core surrounded by an outer shell (capsid) which
consists of numerous protein subunits (capsomeres). Some of the
larger viruses contain additional chemical substances. The true
viruses are insensitive to antibiotics. They multiply only in
living cells where they are assembled as complex macromolecules
utilizing the cells' biochemical systems. They do not multiply
by division as do intracellular bacteria.
Volatile Suspended Solids (VSS). The quantity of suspended
solids lost after the ignition of total suspended solids.
Water Quality Criteria. Those specific values of water quality
associated with an identified beneficial use of the water under
consideration.
Zero Discharge. Plants that do not discharge wastewaters to
either publicly owned treatment works or to navigable waters.
Plants that use evaporation ponds or deep well sites, for
example, are considered zero dischargers.
A-16
-------
APPENDIX B
308 Portfolio for Pharmaceutical Manufacturing
-------
-------
Instructions
308 PORTFOLIO
FOR
PHARMACEUTICAL MANUFACTURING
INSTRUCTIONS AND DEFINITIONS
2.
3.
Please complete this portfolio for each pharmaceutical manufacturing site in your company which manufactures
Fermentation Products (Subcategory A), Biological and Natural Extraction Products (Subcategory B), Chemical
Synthesis Products (Subcategory C) and Formulation Products (Subcategory D). This.portfolio is also to be
completed for each pharmaceutical research facility (Sufacategory E) in your company. If this copy has been
received by or for a non-manufacturing site (i.e. main office, warehouse,-sales office, etc.) or by or for a
non-manufacturing site which also does not conduct pharmaceutical research, please follow the procedure below:
A. Please check the carbon copies list attached to Mr. Schaffer's letter to see if each of your company's
manufacturing locations has received a separate portfolio. If any of your manufacturing locations has not
received a portfolio, please request additional copies as Indicated in (C) below. Please ensure that the
requested information is provided for each site where your company manufactures pharmaceutical products or
conducts pharmaceutical research.
B. Please complete Part I, questions 1 through 5 of the portfolio only, write "not a manufacturing site" and
return the portfolio in the enclosed envelope. Portfolios have been sent to company headquarters as notifi-
cation that each manufacturing site will receive and should complete a separate portfolio. You may reproduce
this document and maintain a copy in your files for future reference.
C Extra copies of the portfolio may be obtained by contacting Mr. J. S. Vitalis at 202-426-2497. Since
each copy of this portfolio is coded, it is necessary to obtain additional copies from Mr. Vitalis.
Please read all definitions which follow these instructions carefully before completing this portfolio. It is
preferred that the individuals who respond to this portfolio be familiar with the manufacturing processes and
the wastewater treatment systems and operations at this site.
Please check the appropriate box or boxes in each question where they appear throughout this portfolio. (More
than one box may be checked for some questions, where appropriate.) Please complete all questions which
require written responses by printing or typing in the spaces provided. If separate sheets or attachments are
used to clarify or answer a question, please make certain that the code number for this portfolio, which
appears at the top right hand corner of each page, is also placed at the top right hand corner of each page of
the attachments.
Please indicate which information in your responses is confidential so that it may be treated properly.
Please answer all items. Also, please provide a separate set of responses for each plant. The purpose of
this request is to gather all available, pertinent information and is not designed to create an undue burden
of sampling requirements on your plant personnel. If a question is not applicable to a particular facility,
indicate by writing "N/A". If an item is not known, indicate unknown and explain why such information is not
available. If an item seems ambiguous, complete as best as possible and state your assumptions in clarifying
the apparent ambiguity.
The U.S. Environmental Protection Agency will review the information submitted and may, at a later date,
request your cooperation for site visits and additional sampling in order to complete the data base. Please
retain a copy of the completed portfolio in case future contact is necessary to verify your responses.
Use the Merck Index, Ninth Edition, 1976, to specify the Merck Index Identification Numbers (Merck Index
Number) in Part II of this questionnaire. Many of the Chemical Abstract Service Registry Numbers (CAS Numbers)
may be found in the Merck Index beginning on page REG-1 for use in completing Part II of this portfolio.
Pleas* use the enclosed, pre-addressed envelope to return the completed portfolio and appropriate attachments.
If you are sending supplemental information that will not fit into the return envelope provided, please send
it under separate cover to:
Mr. Robert B. Schaffer, Director
Effluent Guidelines Division
U.S. EPA (WH-552)
401 M. Street, S.W.
Washington, 0.C. 20460
9. If you have
Definitions
Subcategory
Subcategory
Subcategory
Subcategory
Attention: J.S. Vitalis
any questions, please telephone Mr. J.S. Vitalis at 202-426-2497
A - Fermentation Products-Pharmaceutical products derived from fermentation processes.
B - Biological and Natural Extraction Products-Pharmaceutical products which include blood
fractions; vaccines; serums; animal bile derivatives; endocrine products; and isolation of
medicinal products, such as alkaloids, from botanical drugs and herbs.
C - Chemical Synthesis Products-Pharmaceutical products which result from chemical synthesis.
D - Mixing/Compounding and Formulation Products- Pharmaceutical products from plants which
blend, mix, compound, and formulate pharmaceutical ingredients and includes pharmaceutical
preparations for human and veterinary use such as ampules, tablets, capsules, vials,
ointments, medicinal powders, and solutions.
Subcategory E - Research - Products or services which result from pharmaceutical research, which includes
micro-biological, biological and chemical operations.
POTW - Publicly Owned Treatment Works - Municipal sewage treatment plant
NPDES - National Pollutant Discharge Elimination System
BOD - Biochemical Oxygen Demand
COD - Chemical Oxygen Demand
TSS - Total Suspended Solids .
D-^i
TOC - Total Organic Carbon
-------
PART I
GENERAL INFORMATION
1. Name of Finn
308 PORTFOLIO FOR
Pharmaceutical Manufacturing
C0ttlp1ete one P°rtfoH° for *>ch manufacturing and research site, and return
2. Address of Firm Headquarters:
Robert 8. Schaffer, Director
Effluent Guidelines Division
U.S. EPA (WH-552)
401 M Street, S.W.
Washington, D.C. 20460
Attention: J. S. Vitalis
Street
3. Name of Plant
4. Address of Plant:
City
State
Street"~~~ City ' state 1
S. Hame(s) of firm personnel to be contacted for infonnation pertaining to tin Is data collection portfolio:
T.1t1e : (Area Code) Telephone
6. Number of Manufacturing Employees in 1976: Minimum
7. Year of operational startup
8. Type of production operation within this site for each subcategory:
Subcateqory
Maximum
Average
Bitch
Continuous
Semicontlnuous
9'*' e
Activities
n
n
n
8
n
n
a
C
a
D
a
D'
D
D
D
Total Laboratory
Square Footaqe
*"" devel°Pme"t activities conducted at this site and, for each activity
*' ** "" °f ^^ 1n C°lumn B and' ^f
Number of
Employees
C
Animal
Capacity
Hlcrobloloqical
Biological
CD
Chemical
Clinical
1— I
Development
D
Pilot Plant
b. If animals are used 1n the above research activities, list their type below:
1-1
B-2
-------
10. Does this plant have a National Pollutant Discharge Elimination System Permit (NPDES)? Yes
11. Has plant submitted NPDES permit application? YesQ N°D
12. Permit or application number ; ; ;
13. Date of permit expiration "
14. Does this plant have wastewater treatment facilities on site? Yes Q] NoQ
15. Name and address of publicly owned treatment works (POTVi) receiving plant wastewater, If any:
Name • '
16.
17.
18.
Type of wastewater discharge to POTW:
Level of treatment provided by POTW:
Is there a user charge for discharge to
Process Q
Primary Q
the POTW?
Sanitary Q
Secondary Q
YesQ NoQ
Cool ing [~1
Tertiary Q
If yes, provide the net annual charge below and indicate which parameters listed below serve as a basis for this
charge.
Net Annual Charge _ '
Basis for Charge
D COD
n TSS
n TOO
C] Other (Specify)
19. Is the plant under the requirements of a municipal sewer use ordinance or other ordinance regulating sewer use?
Yes Q No Q
20. Has an industrial wastewater survey report been submitted to the State and/or U.S. EPA Regional Office in
compliance with a municipal NPOES Permit compliance schedule for industrial discharge to POTW?
Yes Q No Q
If yes, attach copy of survey report. . ..
1-2
B-3
-------
PART II
3'
PRODUCTS AND PRODUCTION PROCESSES
1. A. ^r products which^re produced at this site, list the Fermentation Products (Subcategory A) in Table
Natural Extraction Products (Subcategory B) in Table II B, and the Chemical Synthesis
_, m Table II C. In each table, indicate for each product the number of production
a'nntlaj'n'.Si1::?! proce"?s and P^sical operations) which result in wastewater generation in column A and the
annual production as kilograms in column B. For the Chemical Synthesis Products (Subcategory C). list only
the products which are produced in quantities of 100 kilograms per year or greater? For each of the Feraen-
tation Products (in Subcategory A) that you list in Table II A provide a separate list of raw materials and
a rf"S; I!??? "«
_• Chemical wastes - organic and inorganic, process waste solvents, cleanup waste solvents
[21 Other (Specify) - - • „ ; ..
^.SrSdUCt1°n Er0"SS u?a?9us made '? date for the Primary -purpose of pollution control. Also
chnge accordilng^y? S" resulted in an increase or decrease of raw waste load indicating the
II-l
B-4
-------
TABLE II A
List below Fermentation Products (Subcategory A).
listed in Table IIA.
Abbreviations:
Merck Index Number - Merck Index Identification Number
CAS Number - Chemical Abstracts Service Registry Number
Photocopy this table before fining out
^^
Merck
Index
Number
Product
A
No. of '
Production
Steps
which result
in wastewater
Generation
Annual
Production
Kilograms
II-2
B-5
-------
TABLE II B
List below Biological and Natural Extraction Products (Subcategory B).
Abbreviations:
Herck Index Number - Merck Index Identification Number
CAS Nuaber - Chemical Abstracts Service Registry Number
Photocopy this table before filling out
CAS Nunber
Herck
Index
Number
Product
A
No. of
Production
; Steps
which result
in wastewater
Generation
Annual
Production
(Ki1oqrams)
TI-3
B-6
-------
TABLE II C
list below Chemical Synthesis Products (Subcategory C).
Abbreviations:
Merck Index Number - Merck Index Identification Number
CAS Number - Chemical Abstracts Service Registry Number
Photocopy this table before filling out.
CAS Number
Merck
Index
Number
Product
A
No. of
Production
Steps
which result
in wastewater
Generation
Annual
Production
(Kilograms)
11-4
B-7
-------
TABLE II 0
I
List below Chemical Synthesis Products not fn Table II C if they account for in unusually high pollution load either
In terms of pounds discharged per 1,000 pounds of production (Raw Waste Load) >or if they present difficult treatment
problems. ;
II-5
B-8
-------
PART III
USE. REUSE AND DISCHARGE
Total Plant Needs During the Period January 1. 1975 to'December 31. 1976
sr pe-rWiM ass
representative of that period. Check appropriate boxes
Average Flow
(Million gallons per
Time Period
of Calculation
A.
Water Source
O Municipal
Surface
Ground
Recycle Process
Other
Specify other.
Average Flow
(Million gallons per day)
Time Period
of Calculation
B.
Mater Uses
Q Non-contact cooling
£] Direct process contact (as diluent,
solvent carrier, reactant, by-product.
Q Indirect process contact
(pumps, seals, etc.)
n Non-contact ancillary uses
(boilers, utilities, etc.)
Q Maintenance, equipment cleaning and
work area washdown
n Air pollution control
[3 Sanitary and potable
C] Other
c.
Specify other_
Average Flow
(Million gallons per day)
Time Period
of Calculation
Sources of Wastewater Flows
Q Non-contact cooling
Direct process contact
Indirect process contact
Non-contact ancillary uses
Maintenance, equipment cleaning and
work area washdown
'Air pollution control
Sanitary/Potable water
Storm water (collected in treatment
system)
Other
Specify other_
III-l
B~9
-------
". Method of Disposal of Process Wastewater (exclude non-contact cooling water)
O Surface Water
£3 Subsurface
D deep Well
d Publicly Owned Treatment Works
D Land Application
D Recycle/Reuse
D Other
Treated
Average Flow
(Million gallons Time Period
per day) of Calculation
'
i
Untreated
Average Flow
(Hellion gallons Time Period
per day) of Calculation
Specify other
E.
2.
Method of disposal of non-contact coolinq water
O Surface Water
f") Subsurface
Q Deep Well
C] Publicly Owned Treatment Works
D Land Application
LJ Recycle/Reuse
D Other
Specify other
Quality of Water Discharged
Average Flow
(Million gallons per day)
i
;
Time Period
of Calculation
j..
31, 1976, summarize your influent, effluent and raw waste loads in
.. -, — ... „. . ,,r plants discharging directly to publicly owned waste treatment plants
«o««n«%"h»"n^t«»all raw WJSieJ°ad' Jnf?rroation for combined waste streams should be furnished which
represents the greatest degree of detail available. The tables are located at the end of this section.
Instructions for Completing Tables III A. Ill B. Ill C and III 0
shoruldbcorrespond with^hat^eTfo"^ II? "" f°110Win9 d-"»lt1«"s and ^ "»'<"*« "vered
Sfpercln^f^S^fKlchT^rlSu^ II Sff^fii''^^^^*1^ Si"?**"' ^^
lo n? ?I Quantity - The value for the highest 30 consecutive day average over the period January 1 ,
1975 to December 31, 1976 or over the actual period of analysis if less than this two year period. The 30
consecutive day period may be a calendar month or any other 30 consecutive day period for values which are
computed on a monthly basis.
A.
8.
°f a"y day'S "mples 1f' samples are taken av <"• ""
i« « nh •» « "mples are taken less frequently than daily, over the period January 1,
1975 to December 31, 1976 or over the actual period of analysis if less than this two year period.
D. Annual Average Quantity - The highest twelve consecutive month average over the period January 1, 1975 to
December 31, 1976 or over the actual period of analysis If less than this two year period. If the period of
analysis is less than one year, provide the average for the entire period of analysis.
E. Type of Sample - Insert a number from the following list in Tables III A, III B, III C, and III D to indicate
we type of samples collected.
Type of Sample
Flow cosiposlte
Tine composite
Grab
Continuous
Other
Number
1
2
3
4
5
III-Z
B-10
-------
F. Frequency of Sample - Insert a number from the following list in Tables III A, III B, III C and III.0.to
indicate the frequncy of samples collected.
G.
H.
I
J.
Frequency
Continuously
Hourly
Daily
Weekly
Monthly
Less than once
per month
One time sample
Other
Number
1
2
3
4
5
6
7
8
Use the blank lines at the end of each table to list additional pollutants not specifically listed, which are
inlroduced into the wastewater as the result of materials used or products produced, for which you have test
data. (Exclude the chemicals listed in Table V A of Part V of this portfolio.)
identify all data which results from abnormal operating or other conditions.
If use of a different time period (a 'portion of the time period January 1. 1975 to December -31 , {"6) results
IS? WMSrlS ttmeWrexSlaln wKy ^per^if ^^^^^ SScSl"
ment to this portfolio.
Tables
Table III A - Complete a separate Table III A for each plant intake water source at this site.
Table III B - Complete a separate Table III B for each untreated waste discharge point from this site (to
publicly owned treatment works, surface waters, deep Wells, land application, etc.).
Table III C - Complete a separate Table III C for the combined influent to ea ch treatment facility on this
site? Not applicable to plants that have not yet installed waste treatment facilities. This section is not
restricted by type or level of treatment.
Table III D - Complete a separate Table III 0 for the treated effluent ^om each treatMnt/acilltt on this
site Not applicable to plants that have not yet installed waste treatment facilities. This section is not
restricted by type or level of treatment.
So that you may have sufficient tables to report the requested inf onrat ion, please £hptocw ea|h of. TjbJss.
Ill A III B III C and III 0 before filling in. A separate table is required for each plant intake water
siuHe.eachuHtreTted wastewater discharge^ this site, and the influent to and the effluent from each
wastewater treatment facility on this site. , , .
•irt-3 B-H
-------
TABLE III A
INTAKE HATER
fnforaat1on- complete, to the best of your ability, a separate Table III A for each plant intake
Abbreviations:
ragd - Billion gallons per day
ng/1 - milligrams per liter
Ib/day - pounds per day
Photocopy this table before filling In the requested information
Parameter
Flow (inqd)
BOO 5 (nw/1)
BOO 5 Mb/day)
COO (mo/1)
COO ( Ib/davl
TSS fmo/1)
TSS (Ib/day)
TOC (BO/1)
TOC Ob/
-------
TABLE III B
UNTREATED WASTE DISCHARGE
""
""
With the
site (to
Abbreviations:
mgd - million gallons per day
mg/1 - milligrams per liter
.Ib/day - pounds per day
Photocopy this table before filling in the requested information
Percent Storm Water_
Frequency
of
Sample
Parameter
Flow (mgd)
BOO 5 (mg/1)
BOD 5 (Ib/da;
COD (mq/1) .
COD (Ib/day)
TSS (mg/1)
Maximum
Monthly
Average
uanti tv
III-5
B-13
-------
TABLE III C
COMBINED INFLUENT i
fnf°'7ia"on' complete a separate Table III C for the combined Influent to each treatment
' "
norestrced t
Abbreviations:
Bgd - nil lion gallons per day
eg/1 - Milligrams per liter
Ib/day - pounds per day
Photocopy this table before filling 1n the requested Information.
Percent Storm Water
Parameter
Flow (mad)
800 5 (mo/1)
800 5 (Ib/day)
COO (»q/l)
COO (Ib/day)
TSS (M/l)
TSS (Ib/day)
TOC r«o/l)
IOC (Ib/day)
NltjN (mo/1)
NH,H (Ib/dav)
PH
Sul fides (mq/1)
Oil and Grease (mq/1)
Chromium (isg/1)
Maximum
Monthly
Average
Quantity
Maximum
Daily
Average
Quantity
Annual
Average
Quantity
. ,
TJme
Period
of
Analysis
f: SJ ^
Type
of
Sample
Frequency
of
B-14
ni-6
-------
TABLE III 0
TREATED EFFLUENT
With the available information, complete a separate Table III D for the treated effluent from each treatment facility
on this site. Not applicable to plants that have not yet installed waste treatment facilities. This section is
not restricted by type or level of treatment-,
Abbreviations:
mgd - million gallons per day
mg/1 - milligrams per liter v
Ib/day -pounds per-day
Photocopy this table before filling in the requested information.
Percent Storm Water '
Parameter
Flow (mqd)
BOD 5 (mg/1)
BOD 5 (Ib/day)
COD (mg/1)
COD (Ib/day)
TSS jmg/1)
TSS (Ib/day)
TOC (mg/1)
TOC (Ib/day)
NH,-N (mg/1)
— 3 ' *' i
NH,-N (Ib/day)
— 3 1 — ' '
PH
Sulfides (mg/1)
Oil and Grease (mg/1)
Chromium (mq/1)
Maximum
Monthly
Average
Quanti ty
Maximum
Daily
Average
Quanti ty
Annual
Average
Quanti ty
Time
Period
of
Analysis
Type
of
Sample
Freguency
of
Sample
i
i
!
i
B-15
-------
3. Indicate all parameters listed In Part III. Tables III A through III D,: which were not measured by EPA approved
nethods.
Has the seed used 1n the BOO 5 test been acclimated to the waste waters that have been treated?
Yes O Nod
If yes. what Is the source of the seed?
Q Sewage treatment plant
C] Plant treatment facility
C] Laboratory acclimation ;
D Other
Explain
B-16
-------
PART IV
A. Do you have a treatment system(s) at this plant? Yes Q
No
^
For each treatment facility complete the following:
Name of Facility_
Source(s) of Waste Water_
1. Check which of the treatment processes listed below are employed at this plant:
Q Equalization
Q Neutralization
Q Coarse Settleable Solids Removal
Primary Separation
n Primary Sedimentation
Q Primary Chemical Flocculation/Clarification
Q Other
Specify Other —
Biological Treatment
Q Activated Sludge
n Trickling Filter
Qj Aerated Lagoon
Q Waste Stabilization Ponds
Q Bio-Discs
n Intermittent Sand Filtration
__ Other
Specify Other
Physical/Chemical Treatment
Polishing
Q Pond
rj Multi-media Filtration
Q Activated Carbon
Q Other
Specify Other
Sludge Handling
Thickening
Q Mechanical
n Flotation
Q Centrifugatioh
Stabilization
Q Anaerobic Digestion
n Chemical
Q Heat
I I Composting
Other
Specify Other
B-17
-------
Co nd ifion Ing
D "eat
Q Chemical
D Elutriation
Dewatering
O Vacuum Filtration
Q Centrifugation
D Drying Beds
D Other
Specify Other_
Reduction
f~| Incineration
n Wet Air Oxidation
D Pyrolysis
Final Disposal
D Landfill
O Cropland Use
D Ocean
D Other
Specify Other
Design Conditions for overall treatment facility
Flow (million gallons per day)
BOD (milligrams per liter)
300 (pounds per day)
TSS (milligrams per liter)
TSS (pounds per day)
2. a. Original installation (treatment only)
b. Other costs (include collection system, piping, pumping, etc.)
3. Estimated replacement cost
4. Estimated total capital expenditure for this facility to date
Year
Cost (1976 dollars)
5.
Annual cost of operation and maintenance
(exclude depreciation and debt service cost).
6.
SlnCe °rl91'nal 1"»"l«ion and state the purpose of the
Modification-Addition
Treatment
Facility
Year
Cost !
(1976 Dollhrs)
Purpose of
Modification
iv-a
B-18
-------
7. list future scheduled modifications or additions and estimated date of completion and state the purpose of
the modification or addition.
Modification-Addition
Treatment
Facility
Year
Cost
(1976 Dollars)
Purpose of
Modification
8. Is nutrient addition practiced? Yes Q No Q
9. How many employees (equivalent man-years/year) are primarily engaged as operators of the waste water
treatment facility? (exclude maintenance)
How many employees (equivalent man-years/year) are engaged as support personnel for the waste water
treatment facility?
10.
11.
12.
Is an operator always present? Yes Q No Q
Quantity of wastewater treatment facility solid wastes disposed of at present (dry basis).
_ _ pounds per day
Moisture content of waste solids disposed of at present.
percent moisture.
13. Present disposition of solids
14. Estimated annual cost of solids handling and disposal (1976 dollars).
... - .. L__iJ dollars per ton dry basis
15. Planned future disposition of solids:
16. What are the total annual energy requirements for the treatment facility?
Electrical _ kilowatt-hours
Other (e.g.. Heat) ' " '. British thermal .units
IV-3
B-19
-------
S. Carbon Adsorption Technology
Hive you determined carbon adsorption Isotherms on your waste waters?
Have carbon adsorption isotherms been determined for waste waters from
your plant(s) by a person(s) other than company personnel? i
Have you or anyone else evaluated carbon columns on waste waters from this plant?
Do you have carbon adsorption data from your plant(s) on: i
raw wastes '
biologically treated wastes :
individual process lines
combined process lines |
pilot plant studies
contractor evaluations '
cost evaluations
plant scale evaluations
operational units
For each question above which was answered affirmatively, give a brief description of
TVH0C Ar UJte +mr nAw^MfJ **f *4__ .... j ^ ^ . . j - «•*••»*•! i p i. > VM w i
d, plant involved, extent of da1
Yes
D
a
a
a
a
a
a
a
a
a
a
a
a
No
a
a
.a
a
a
a
a
a
a
a
a
a
a
, j
and
C. Filtration
NO
°" y°"r wastewate"
-------
£ Have other treatability studies, beyond what was described in Section A, Part IV, employing treatment
processes such as sedimentation, neutralization, hydrolysis, precipitation, oxidation/reduction, ion
exchange, phenol recovery, etc., been run on any of the process wastewater streams from the plant?
Yes n No Q
If yes, list below those product/process streams on which such treatability studies were conducted.
Note:
Use the Engineering News-Record (ENR) Index to project costs to December 1976 Dollars where requested
in this portfolio. ENR Indices for January 1964 through December 1976 are shown on page IV-6 of this
portfolio.- ,
IV-5
B-21
-------
PART V
PRIORITY POLLUTANTS
A. Please provide the information requested in Table V A, concerning the chemicals which are considered as priority
pollutants and which are listed in Table V A, in conformance with the folowing instructions: Priority
'° 1nd1cate a11 of the 11sted
B.
C.
1.
3'
0.
MteHaT A'
g instructions:
ijhich are used as raw or intermediate
2. In column B, place a check mark to indicate all of the listed chemicals which are manufactured at this plant
as a final or.intermediate material.
3. In column C, place a check mark to indicate all of the listed chemicals for which you have analyzed in your
wastewater. , J
4. In column 0, insert a number from the following list.to indicate the frequency that the influent (I) and
effluent (E) In your wastewater is analyzed for the presence of the listed chemicals.
Frequency
Continuously
Hourly
Dally
Weekly
Monthly
Less than once per
One time sample
Other
Number :
1 • •• !
2 j
3 ;
4 :
5 !
month 6
)•:. • .,.,•,.
.7 '
8
5" m°!?l7!!Ji ln?tr* ».number fr8fll th* following list to indicate the typelof sample used to analyze the influent
(I) and effluent (E) In your wastewater for the presence of the listed chemicals.
Type of Sample
Flow Composite
Time Composite
Grab
Continuous
Other
Number
1 :
2
3 ' i
4 :
5 ' - ' i
6. In columns F, G, and H, insert a value to indicate the average loading per day as pounds per day (Ib/day)
~™9S< ?** aJ m
-------
TABLE V A
PROCESSING OF CHEMICALS CONSIDERED AS PRIORITY POLLUTANTS
Merck
CAS Index
Number Number Chemical
1. 83-32-9 19 acenaphthene
2. 107-02-8 123 acrolein
3. 107-13-1 127 acrylonitrile
4. 71-43-2 1069 benzene
5. 92-87-5 1083 benzidine
6. 56-23-5 1821 carbon tetrachloride (tetr&chloromethane)
7. 108-90-7 2095 chlorobenzene
8. 120-82-1 9310 1,2,4-trichlorobenzene
9. 118-74-1 4544 hexachlorobenzene
10. 107-06-2 3733 1,2-dichloroethane
11. 71-55-6 9316 1,1,1-trichloroethane
12. 67-72-1 4545 hexachloroethane
13. 75-34-3 3750 1,1-dichloroethane
14. 79-00-5 9317 1,1,2,-trichloroethane
15. 79-34-5 8906 1, 1 ,2, 2- tetrachloroe thane
16. 75-00-3 3713 chloroethane
17. 542-88-1 3046 bis(chloromethyl) ether
18. 111-44-4 3040 bis (2-chloroethyl) ether
19. 110-75-8 2119 2-chloroethyl vinyl ether (nixed)
20. 91-58-7 2127 2-chloronaphthalene
21. 88-06-2 9323 2,4,6-trichlorophenol
22. 59-50-7 2108 parachlorometa cresol
23. 67-66-3 21.20 chloroform (trichloromethnne)
24. 95-57-8 2134 2-chlorophenol
25. 95-50-1 3029 1,2-dichlorobenzene
26. 541-73-1 3028 1,3-dichlorobenzene
27. 106-46-7 3030 1 , 4-dichlorobenzene
28. 91-94-1 3032 3,3'-dichlorobenzidine
29. 75-35-4 9647 1,1-dichloroethylene
30. 540-59-0 85 1,2- trans-dichloroethylene
A B C D E F C PI
Raw or
Inter-
mediate
1 "V
Final or
Inter-
mediate
Analyzed
in
Frequency
Analyzed
Type
Sample
'
Loading
(Ib/day)
I •
E""
Flow
•lillion Gallons
I *
E"
Ooncun-
tral ion
(|H/1 )
I *
fr
DO
u>
• I • Influent
" E - Effluent
-------
TABLE V A
FMXZ33IH5 or WDUCAIS CONSIDERED AS rmoun rouurwrs
Korek
CAS Index
Hu»toer murtxir Chwdcal
31. 2,4-diehlorophenol
32. 78-87-5 7643 1,2-dichloropropana
33. 542-75-6 3051 1,3-dichloropropylena (1,3-dlchloropropeno)
34. 1300-71-6 9744 2,4-dinethylphonol
35. 2,4-dinitrotoluene
36. 2f6-dinitrotoluene
37. 1,2-dlphenylhydrazine
38. 100-41-4 369S ethylbenzene
39. fluoranthene
40. 4-chlorophenyl phenyl ether
41. 4-bromophenyl phenyl ether
42. bls(2-chloroiuopropyl) ether
43. bis(2-chloroethyoxy) methane
44. 75-09-2 5932 methylene chloride (dlchloronethane)
45. 74-87-3 5916 nethyl chloride (chloromethane)
46. 74-83-9 5904 methyl bromide (bronomethane)
47. 75-25-2 1418 bronoform (tribromoraethonu)
48. dichlorobromomethane
49. 75-69-4 9320 trichlorofluoromethane
50. 75-71-8 3038 dichlorodifluoromethane
51. chlorodibroraome thane
52. hexachlorobutadiene
53. hexachlorocyclopentadiene
54. ioophorone
55. 91-20-3 6194 naphthalene
56. 98-95-3 6409 nitrobenzene
57. 88-75-5 6442 2-nitrophenol
58. 100-02-7 6443 4-nitrophenol
59. 51-28-5 3277 2,4-dinitrophenol
60. 534-52-1 3275 4 ,6-dinitro-o-cresol
Raw or
Intur-
Mdiate
Material
Final or
Intar-
Mdl«t«
Material
Analyzed
In
Wa»ceuat«r
rrcq
Ana!
!•
u>»ncy
E~"
*
T>
Sat
I •
P«
•Ei«_
E"
•
U»dln9
(Ib/dw)
I •
c •
riou
HI 11 Ion ttallon*
/Day
I •
E "
Concen-
tration
il>g/D
I •
E"
oo
• I - Influent
** E = Effluent
-------
TABUS V A
PROCESSING OF CHEMICALS CONSIDERED AS PRIORITY POLLUTANTS
A 8
Merck
CAS Index
Htmber Number Chemical
61. 62-75-9 6458 H-nitrosodimethylamine
62. N-nitrpsodiphenylamine
63. N-nitro30di-n-propylami.ne
64. 87-86-5 6901 pentachlorophenol
65. 108-95-2 7038 phenol
66. 117-81-7 1270 bto(2-ethyl!iexyl) phthalate
67. butyl benzyl phthalate
68. 84-74-2 1575 dl-n-butyl phthalate
69. dl-n-octyl phthalate
70. 84-66-2 3783 diethyl phthalate
71 131 -11-3 3244 dimethyl phthalate
72. 56-55-3 1063 1,2-benzanthracene
•f 73. 50-32-8 1113 benzo (a)pyrene (3,4-benzopyrene)
74. 3,4-benzofluoranthene
CO — ' ' •
I 75. 11, 12-benzof luoranthene
01 76. 218-01-9 2252 chrysene
77. acenaphthylene .
78. 120-12-7 718 anthracene
79 1,12-benzoperylene
80. 86-73-7 4037 fluorene
81. 85-01-8 6996 phenanthrene
82. 53-70-3 2971 l,2:5,6-dibenzanthracene
83. indeno(l,2,3-C,D) pyrene
84. 129-00-0 7746 pyrene
85. 127-18-4 8907 tetrachloroethylene
86. 108-88-3 9225 toluene
87. .79-01-6 9319 trichloroethylene
88. 75-01-4 9645 vinyl chloride (chloroethylene)
89. 309-00-2 220 aldrin
90. 60-57-1 3075 dieldrin
Raw or
Inter-
mediate
Material
' ,. ...
Final or
Inter-
Riediate
Material
'
>.
Analyzed
in
Hastewater
Frequency
Anal zed
I *
E*«
*
Ty
_Sam|
I*
36
pie
E**
Loading
(Ib day)
I*
E**
Flow
Million Gallons
/Day
I *
E"
Concen-
tration
-------
TAKLE V A
I'M* tSSJMC OF OltmCALS UJtBIW.RiO AS PRIORITY POtUTfAJfTS
CAS Index
Nimbftr Huttb*r Chenicdl
91. 57-74-9 20S1 chlordano (technical Mixture aitd mttabolltea)
92. 50-29-3 2822 4,4'-DDT
93. 4,4'-DBE (p,p'-DOX)
94. 6088-51-3 2821 4,4'-DDB (p.p'-TDK)
95. 115-29-7 3519 alpha-endosulfan
96. 115-29-7 3519 beta-endooulfan
97. endosulfan sulfate
98. 72-20-8 3522 endrin
99. endrin aldehyde
100. 76-44-8 4514 heptachlor
101. . heptachlor cpoxide
102. 58-89-9 5341 alpha-BIIC
< 103. 58-89-9 5341 beta-BIIC
104. 58-89-9 5341 gamma-BHC (lindane)
105. 58-89-9 5341 delta-BHC
J — — — —
n 106. PCB-1242 (Arochlor 1242) :
107. PCB-1254 (Arochlor 1254)
108. PCB-1221 (Arochlor 1221)
109. PCB-1232 (Arochlor 1232)
110. PCB-1248 (Arochlor 1248)
111. PCB-1260 (Arochlor 1260)
112. TCB-1016 (Arochlor 1016)
113. 8001-35-2 9252 Toxaphene
114., 7440-36-0 729 Antimony (Total)
115.;- 7440-38-2 820 Arsenic (Total)
116. 850 Asbestos (Fibrous) :
117. 7440-41-7 1184 Beryllium (Total)
118. 7440-43-9 1600 Cadmium (Total) 1 I
119. 7440-47-3 2229 iChromium (Total) . ,:
120. 7440-50-8 2436 . Copper (Total) =
A
flaw or
Intur-
•ocllat*
HjtorUl
B
final or
Inter-
Mxllata
Halerlal
C
Analyzed
in
Wascwater
— o e r r.
Pre<
Ana
uemcy
vied
£••
Tl
^2!
!
fpc'
TJB
E*
Ixwi ding
I * ('~— i*.... ^^
f
Hill ir
'lev
Uf
_ Jill.
Conccn-
t r.il Ion
(|M/I )
6"
* I •= Influent ,
*• E = Effluent
-------
TABLE V A
PROCESSING OP CHEMICALS CONSIDERED AS PRIORITY POLLUTANTS
Merck
CAS Index
Number Number Chemical
121. 420-05-3 2694 Cyanide (Total)
122. 7439-92-1 5242 Lead (Total)
123. 7439-97-6 5742 Mercury (Total)
124. 6312 Nickel (Total)
125. 7782-49-2 8179 SeleniuH (Total)
126. 7440-22-4 8244 Silver (Total
127. 7440-28-0 B970 Thallium (Total)
128. 7440-66-6 9782 Zinc (Total)
129. 2,3,7,8 - tetr»chlorodibenzo-p-dioxin (TCDD)
A B C D E
Raw or
Inter-
mediate
Final or
Inter-
mediate
Analyzed
in
Freq
Anal
jency
zed
Type
Sample
-
t C
Loading
(Ib/day)
Fli
Million
/D
I*
JW
Gallons
V
E**
H ,. _
Com
tra
T— S
:en-
tion
jq/i) —
E*
• I - Influent
• • E • Effluent
00
I
ro
-------
ro
cx>
YEAR
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
Jan.
917.94
947.56
987.94
1039.05
1107.37
1216.13
1308.61
1465.07
1685.72
1837.87
1939.47
2103.00
2300.42
Feb.
920.40
957.43
997.43
1040.67
1113.63
1229.56
1310.90
1466.85
1690J6
1849.70
1939.74
2127.72
23.09.97
Mar.
922.41
957.70
998.32
1043.31
1117.15
1238.14
1314.45
1494.06
_JL696.68
1858.96
1940.19
2127.65
2317.14
EN
Apr.
926.27
957.43
1006.06
1043.54
1123.73
1248.85
1329.21
1511.49
1706. 89
1873.62
1961.25
2135.03
2327.33
G INHERING
May
929.74
957.92
1014.03
1059.20
1140.31
1258.33
1345.36
1542.95
_JL735.15_
1880.26
1960.88
2163.72
2356.76
NEWS - REC
June
935.42
969.34
1028.65
1067.88
1152.78
1284.96
1368.66
1575.05
__1760,75j
1896.21
1993.47
2205.00
2409.51
!ORD (ENR)
July
944.97
977.08
1030.56
1078.45
1159.04
1282.77
1413.91
1597.80
_177L.56_
1901.24
2041.36
2247.65
2413.60
INDICES *
Aug.
947.92
984.16
1033.37
1089.14
1169.68
1292.20
1418.44
1614.78
-J1776.-80-
1920.79
2075.49
2274.30
2444.94
Sept.
947.36
986.29
1033.72
1092.22
1184.20
1285.29
1422.54
1639.64
0785,29
1929.03
2088.82
2275.34
2468.38 '-.
Oct.
947.74
986.18
1032.40
1096.22
1189.08
1299.31
1433.64
1642.59
-17-93,75-
1933.19
2094.74
2293.03
2478.22
1 Nov.
948.25
985.83
1032.71
1096.74
1190.73
1305.23
1445.13
1644.06
-1-807 ,-60
1934.85
2094.06
2291.65
2486.32
Dec.
948.12
987.74
1033.71
1098.39
1200.82
1304.76
1445.08
1654.75
1815-.86--
1938.84
2098.26
2297.15
2489.66
ANNUAL
( INDEX
936.38
971.22
1019.08
1070.40
1154.04
1270.46
1379.66
1570.57
—175-2^23
1896.74
2019.31
2211.77
2399.94
* CONSTRUCTION COST INDEX - BASE YEAR 1913=100
-------
APPENDIX C
Pharmaceutical Manufacturing Plants in the
Original 308 Data Base
-------
-------
APPENDIX C
PHARMACEUTICAL MANUFACTURING PLANTS
IN THE
ORIGINAL 308 DATA BASE
NAME
A. H. ROBINS COMPANY
A. H. ROBINS MANUFACTURING COMPANY
ABBOTT LABORATORIES
ABBOTT LABORATORIES
ABBOTT LABORATORIES - N. CHICAGO
ABBOTT: HOSPITAL PRODUCTS DIVISION
ABBOTT: MURINE COMPANY
ABBOTT: SCIENTIFIC PRODUCTS DIVISION
AHSC: DADE DIVISION
AHSC: HARLECO DIVISION
ALCON LABORATORIES (P.R.). INC.
ALCON LABORATORIES - OPHTHALMIC
ALCON: CENTER LABORATORIES, INC.
ALCON: OWEN LABORATORIES, INC.
ALZA CORPORATION
ALZA CORPORATION - BUILDING A
ALZA CORPORATION - BUILDING J
AMERICAN CYANAMID COMPANY
AMES COMPANY
AMES IMMUNOLOGY MANUFACTURING DIV.
ARBROOK INC
ARMOUR PHARMACEUTICAL COMPANY
ARNAR-STONE LABORATORIES, INC.
ARNAR-STONE, INC.
ASTRA PHARMACEUTICAL PRODUCTS, INC.
AYERST LABORATORIES, INC.
BARNES-HIND DIAGNOSTICS, INC.
BARNES-HIND PHARMACEUTICALS, INC.
BARRY LABORATORIES, INC.
BEECHAM LABORATORIES
BEECHAM PHARMACEUTICALS
BIO-REAGENTS AND DIAGNOSTICS, INC.
BLOCK DRUG COMPANY, INC.
BLOCK DRUG COMPANY, INC.
BOWMAN PHARMACEUTICALS, INC.
BRISTOL ALPHA AND BRISCHEM
BRISTOL LABORATORIES CORP.
BRISTOL-MYERS PRODUCTS
BRISTOL-MYERS PRODUCTS
BRISTOL-MYERS: IND. & BRISTOL LABS.
LOCATION
RICHMOND
BARCELONETA
BARCELONETA
NORTH CHICAGO
NORTH CHICAGO
ROCKY MOUNT
CHICAGO
LOS ANGELES
MIAMI
GIBBSTOWN
HUMACAO
FORT WORTH
PORT WASHINGTON
ADDISON
PALO ALTO
PALO ALTO
PALO ALTO
HANNIBAL
SOUTH BEND
ELKHART
ARLINGTON
KANKAKEE
MT. PROSPECT
AGUADILLA
WORCESTER
ROUSES POINT
CANOVANAS
SUNNYVALE
POMPANO BEACH
BRISTOL
PISCATAWAY
IRVINE
JERSEY CITY
MEMPHIS
CANTON
BARCELONETA
MAYAGUEZ
HILLSIDE
ST. LOUIS
EAST SYRACUSE
VA
PR
PR
IL
IL
NC
IL
CA
FL
NJ
PR
TX
NY
TX
CA
CA
CA
MO
IN
IN
TX
IL
IL
PR
MA
NY
PR
CA
FL
TN
NJ
CA
NJ
TN
OH
PR
PR
NJ
MO
NY
C-l
-------
BURDICK & JACKSON LABORATORIES, INC.
BURROUGHS WELLCOME COMPANY
BURROUGHS WELLCOME: VACCINE DIVISION
BYK-GULDEN, INC.
BYK-GULDEN: DAY-BALDWIN DIVISION
CARTER-WALLACE, INC.
CARTER-WALLACE: DENV. CHEM. (P.R.)
CENTRAL PHARMACAL COMPANY
CERTIFIED LABORATORIES, INC.
CIBA-GEIGY CORPORATION
CIBA-GEIGY CORPORATION
CIBA-GEIGY CORPORATION
CONNAUGHT LABORATORIES, INC.
COOPER LABORATORIES (P.R.), INC.
COOPER LABORATORIES (P.R.): SMP DIV.
COOPER LABORATORIES: WAYNE OLD DIV.
CUTTER LABORATORIES, INC.
CUTTER LABORATORIES, INC.
CUTTER LABORATORIES, INC.
CUTTER LABORATORIES, INC.
CUTTER LABORATORIES: BAYVET DIVISION
DADE DIAGNOSTICS, INC.
DAVIS AND GECK, INC.
DENTCO, INC.
DOME LABORATORIES DIVISION
DORSEY LABORATORIES DIVISION
DOW PHARMACEUTICALS
E. R. SQUIBB AND SONS, INC.
E. R. SQUIBB MANUFACTURING, INC.
EATON LABORATORIES, INC.
ELI LILLY - CLINTON LABS.
ELI LILLY - INDUSTRIAL CIR. 1200
ELI LILLY - OMAHA LABS
ELI LILLY - PARK FLETCHER
ELI LILLY - TIPPECANOE LABS.
ELI LILLY AND COMPANY
ELI LILLY AND COMPANY
ELI LILLY AND COMPANY
ELI LILLY AND COMPANY
ELI LILLY INDUSTRIES
ENDO LABORATORIES, INC.
ENDO, INC.
FERNDALE LABORATORIES, INC.
FIRST TEXAS PHARMACEUTICALS, INC.
HILTON DAVIS CHEMICAL COMPANY
HOECHST-ROUSSEL PHARMACEUTICALS, INC.
HOFFMANN-LA ROCHE - AG. DIVISION
HOFFMANN-LA ROCHE, INC.
HOFFMANN-LA ROCHE, INC.
HOFFMANN-LA ROCHE, INC.
MUSKEGON
GREENVILLE
DENVER
HICKSVILLE
HILLSIDE
CRANBURY
HUMACAO
SEYMOUR
WARRINGTON
CRANSTON
SU^FERN
SUMMIT
SWIFTWATER
SAN GERMAN
PALO ALTO
WAYNE
BERKELEY
CHATTANOOGA
CLAYTON
OGDEN
SHAWNEE
AGUADA
MANATI
HUMACAO
WEST HAVEN
LINCOLN
INDIANAPOLIS
NEW BRUNSWICK
HUMACAO
MANATI
CLINTON
INDIANAPOLIS
OMAHA
INDIANAPOLIS
LAFAYETTE
CAROLINA
GREENFIELD
INDIANAPOLIS
MAYAGUEZ
CAROLINA
GARDEN CITY
MANATI
FERNDALE
DALLAS
CINCINNATI
SOMERVILLE
FORT WORTH
AMES
BELVIDERE
FRESNO
MI
NC
CO
NY
NJ
NJ
PR
IN
PA
RI
NY
NJ
PA
PR
CA
NJ
CA
TN
NC
UT
KS
PR
PR
PR
CT
NE
IN
NJ
IN
IN
NE
IN
IN
PR
IN
IN
PR
PR
NY
PR
MI
TX
OH
NJ
TX
IA
NJ
CA
C-2
-------
HOFFMANN-LA ROCHE, INC.
HOFFMANN-LA ROCHE, INC.
HOFFMANN-LA ROCHE, INC.
HOLLISTER-STIER LABORATORIES
HYNSON, WESTCOTT, & DUNNING DIVISION
ICI AMERICAS, INC.
IMC, INC.
INOLEX CORPORATION: PHARM. DIVISION
IVERS-LEE DIVISION
IVERS-LEE DIVISION
IVERS-LEE .DIVISION
J. T. BAKER CHEMICAL COMPANY
J. T. CLARK COMPANY
JELCO LABORATORIES, INC.
JELCO LABORATORIES, INC.
JENSEN-SALSBERY LABORATORIES
JENSEN-SALSBERY LABORATORIES
JOHNSON AND JOHNSON
JOHNSON AND JOHNSON
JOHNSON AND JOHNSON
JOHNSON AND JOHNSON
JOHNSON AND JOHNSON D.O.C., INC.
KNOLL PHARMACEUTICAL COMPANY
KREMERS-URBAN COMPANY
LEDERLE LABORATORIES DIVISION
LEHN AND FINK PRODUCTS COMPANY
INC.
INC.
INC. - BULK LYSATE
INC. - NUCLEAR
- RALEIGH CHEMICAL
- RALEIGH PARENT.
INC. - RALEIGH PLASTICS
INC.
EAST. SURG. DR.
MIDWEST SUR. DR.
SW. SURG. DRESS.
MALLINCKRODT,
MALLINCKRODT,
MALLINCKRODT,
MALLINCKRODT,
MALLINCKRODT, INC.
MALLINCKRODT, INC.
MALLINCKRODT,
MARION HEALTH AND SAFETY,
MARION LABORATORIES, INC.
MCGRAW LABORATORIES
MCGRAW LABORATORIES
MCGRAW LABORATORIES
MCGRAW LABORATORIES
MCNEIL LABORATORIES, INC.
MCNEIL LABORATORIES, INC.
MEAD JOHNSON AND COMPANY
MEDIPHYSICS, INC.
MEDIPHYSICS, INC.
MEDIPHYSICS, INC.
MEDIPHYSICS, INC.
MEDIPHYSICS, INC.
MERCK AND CO., INC.
MERCK AND CO., INC. - CHEROKEE
MERCK AND CO., INC. - FLINT RIVER
NUTLEY
SALISBURY
TOTOWA
SPOKANE
BALTIMORE
DIGHTON
TERRE HAUTE
PARK FOREST SOUTH
NEWARK
SHIPSHEWANA
WEST CALDWELL
PHILLIPSBURG
GENEVA
RARITAN
RIVIERA BEACH
KANSAS CITY
KANSAS CITY
NORTH BRUNSWICK
NORTH BRUNSWICK
CHICAGO
SHERMAN
GURABO
WHIPPANY
MEQUON
PEARL RIVER
LINCOLN
DECATUR
ST. LOUIS
BEAUFORT
MARYLAND HEIGHTS
RALEIGH
RALEIGH
RALEIGH
ROCKFORD
KANSAS CITY
IRVINE
IRVINE
MILLEDGEVILLE
SABANA GRANDE
DORADO
FORT WASHINGTON
EVANSVILLE
EMERYVILLE
GLENDALE
MIAMI LAKES
ROSEMONT
SOUTH PLAINFIELD
RAHWAY
DANVILLE
ALBANY
NJ
MD
NJ
WA
MD
MA
IN
IL
NJ
IN
NJ
NJ
IL
NJ
FL
KS
MO
NJ
NJ
IL
TX
PR
NJ
WI
NY
IL
IL
MO
NC
MO
NC
NC
NC
IL
MO
CA
CA
GA
PR
PR
PA
IN
CA
CA
FL
IL
NJ
NJ
PA
GA
C-3
-------
DIV. - NORWICH
DIV. - W'DS CORNER
DIVISION
MERCK AND CO., INC. - STONEWALL
MERCK SHARP AND DOHME, INC.
MERCK SHARP AND DOHME (P.R.), INC.
MERRELL-NATIONAL LABORATORIES, INC.
MERRELL-NATIONAL LABORATORIES, INC.
MILES LABORATORIES, INC.
NORWICH-EATON PHARM
NORWICH-EATON PHARM
NORWICH-EATON PHARM
ORGANON, INC.
ORTHO DIAGNOSTICS, INC.
ORTHO DIAGNOSTICS, INC.
ORTHO PHARMACEUTICALS, INC.
PARKE-DAVIS AND COMPANY
PARKE-DAVIS AND COMPANY
PARKE-DAVIS AND COMPANY
PARKE-DAVIS AND COMPANY
PARKE-DAVIS LABORATORIES
PENNWALT CORPORATION
PFIZER PHARMACEUTICALS, INC.
PFIZER, INC.
PFIZER, INC.
PFIZER, INC. - MAYW'D CANCER RES'RCH
PFIZER, INC. - VIGO
PHARMASEAL LABORATORIES
PHILIPS ROXANE LABORATORIES, INC.
PLOUGH, INC.
PURDUE FREDERICK LABORATORIES, INC.
R. P. SCHERER (MIDWEST) CORP.
R. P. SCHERER (SOUTHEAST) CORP.
REEDCO, INC.
REHEIS CHEMICAL COMPANY
RIKER LABORATORIES, INC.
ROSS LABORATORIES
ROSS LABORATORIES
S. B. PENICK AND COMPANY
S. B. PENICK AND COMPANY
S. B. PENICK AND COMPANY
S. B. PENICK AND COMPANY
S. B. PENICK AND COMPANY
SANDOZ, INC.
SCHERING (P.R.) CORPORATION
SCHERING CORPORATION
SCHERING-PLOUGH CORPORATION
SCHERING: AMERICAN SCIENTIFIC LABS.
SEARLE AND COMPANY
SEARLE LABORATORIES
SMITHKLINE AND FRENCH COMPANY
SMITHKLINE AND FRENCH LABORATORIES
SMITHKLINE AND FRENCH LABORATORIES
ELKTON
WEST POINT
BARCELONETA
CAYEY
CINCINNATI
ELKHART
NORWICH
NORWICH
GREENVILLE
WEST ORANGE
ARLINGTON
RARITAN
DORADO
DETROIT
GREENWOOD
HOLLAND
ROCHESTER
FAJARDO
ROCHESTER
BARCELONETA
BROOKLYN
GROTON
MAYWOOD
TERRE HAUTE
IRWINDALE
COLUMBUS
MEMPHIS
TOTOWA
DETROIT
MONROE
HUMACAO
BERKELEY HEIGHTS
NORTHRIDGE
ALTAVISTA
COLUMBUS
LYNDHURST
MONTVILLE
NEWARK
VANCOUVER
WALLINGFORD
EAST HANOVER
MANATI
UNION
KENILWORTH
MADISON
CAGUAS
SKOKIE
CAROLINA
PHILADELPHIA
SWEPELAND
VA
PA
PR
PR
OH
IN
NY
NY
SC
NJ
TX
NJ
PR
MI
SC
MI
MI
PR
NY
PR
NY
CT
NJ
IN
CA
OH
TN
NJ
MI
NC
PR
NJ
CA
VA
OH
NJ
NJ
NJ
WA
CT
NJ
PR
NJ
NJ
WI
PR
IL
PR
PA
PA
C-4
-------
SMITHKLINE CORPORATION
SMITHKLINE: NORDEN LABORATORIES
SMITHKLINE: SEA AND SKI CORP.
STERLING DRUG, INC.
INC.
INC.
INC.
INC.
INC.
INC. - EAST GREENBUSH
INC.
STERLING DRUG,
STERLING DRUG,
STERLING DRUG,
STERLING DRUG,
STERLING DRUG,
STERLING DRUG,
STERLING DRUG,
STERWIN LABORATORIES, INC.
STERWIN LABORATORIES, INC.
STUART PHARMACEUTICALS DIVISION
STUART PHARMACEUTICALS DIVISION
SYNTEX (P.P.), INC.
SYNTEX AGRIBUSINESS, INC.
SYNTEX LABORATORIES, INC.
TENNECO CHEMICALS, INC.
TRAVENOL LABORATORIES, INC.
TRAVENOL LABORATORIES, INC.
TRAVENOL LABORATORIES, INC.
TRAVENOL LABORATORIES, INC.
TRAVENOL LABORATORIES, INC.
TRAVENOL LABORATORIES, INC.
TRAVENOL LABORATORIES, INC.
TRAVENOL LABORATORIES, INC.
TRAVENOL: CLINICAL ASSAYS
DAYTON FLEXIBLE PROD.
HYLAND DIVISION
HYLAND DIVISION
HYLAND DIVISION
DIV.
TRAVENOL
TRAVENOL
TRAVENOL
TRAVENOL
UPJOHN COMPANY
UPJOHN COMPANY
UPJOHN COMPANY
USV LABORATORIES
USV PHARMACEUTICAL CORP.
VICKS HEALTH CARE DIVISION
VICKS HEALTH CARE DIVISION
VICKS RESEARCH AND DEVELOPMENT DIV.
WARNER-CHILCOTT DIVISION
WARNER-CHILCOTT LABORATORIES
WARNER-CHILCOTT PHARMACEUTICAL CO.
WARREN-TEED LABORATORIES, INC.
WARREN-TEED, INC.
WESTWOOD PHARMACEUTICALS, INC.
WILLIAM H. RORER, INC.
WILLIAM H. RORER, INC.
WILLIAM P. POYTHRESS AND CO., INC.
WINTHROP LABORATORIES, INC.
LOWELL
LINCOLN
RENO
GULFPORT
MONTICELLO
MYERSTOWN
MYERSTOWN
RENSSELAER
TRENTON
RENSSELAER
MCPHERSON
MILLSBORO
OPELIKA
NEWARK
PASADENA
HUMACAO
DES MOINES
PALO ALTO
GARFIELD
CAROLINA
CLEVELAND
COSTA MESA
JAYUYA
MARICAO
MARION
MORTON GROVE
MOUNTAIN HOME
CAMBRIDGE
KINGSTREE
GLENDALE
LOS ANGELES
ROUND LAKE
ARECIBO
KALAMAZOO
KALAMAZOO
MANATI
TUCKAHOE
GREENSBORO
HATBORO
MT. VERNON
MORRIS PLAINS
CAROLINA
VEGA BAJA
COLUMBUS
HUMACAO
BUFFALO
FORT WASHINGTON
SAN LEANDRO
RICHMOND
BARCELONETA
AR
NE
NV
MS
IL
PA
PA
NY
NJ
NY
KS
DE
AL
DE
CA
PR
IA
CA
NJ
PR
MS
CA
PR
PR
NC
IL
AR
MA
SC
CA
CA
IL
PR
MI
MI
PR
NY
NC
PA
NY
NJ
PR
PR
OH
PR
NY
PA
CA
VA
PR
C-5
-------
WYETH LABORATORIES, INC.
WYETH LABORATORIES, INC.
WYETH LABORATORIES, INC.
WYETH LABORATORIES, INC.
- GR. VALLEY
MARIETTA
SKOKIE
WEST CHESTER
MALVERN
PA
IL
PA
PA
TOTAL NUMBER OF MFG. PLANTS IN THE ORIGINAL 308 DATA BASE: 244
Cr-6
-------
r
APPENDIX D
Supplemental 308 Portfolio for the
Pharmaceutical Manufacturing Industry
-------
-------
SUPPLEMENTAL 308 PORTFOLIO
FOR THE
PHARMACEUTICAL MANUFACTURING INDUSTRY
Instructions
1, Please complete the following portfolio and return within 30 days
of receipt to:
Mr. Robert B. Schaffer, Director
Effluent Guidelines Division
U.S. EPA (WH-552)
401 M. Street, S.W. '
Washington, D.C. 20460
Attention: J. S. Vital is
2. Please read all instructions and questions carefully before completing
this portfolio. It is preferred that the individual(s) who responds
to this portfolio be familiar with manufacturing processes and
wastewater treatment operations at the plant.
3. Please check the appropriate box or boxes in each question where
they appear throughout this portfolio. (More than one box may be
checked for some questions, where appropriate.) Please complete
all questions which require written responses by printing or typing
in the spaces provided.
4. Please indicate which information in your responses is confidential
so that it may be treated properly.
5. The U.S. Environmental Protection Agency will review the information
submitted and may, at a later date, request your cooperation for
site visits and additional sampling in order to complete the data
base. Please retain a copy of the completed portfolio in case
future contact is necessary to verify your responses.
6. If you have any questions, please telephone Mr. J. S. Vitalis at
202-426-2497.
D-l
-------
PART I
GENERAL INFORMATION
1. Kame of Plant
2. Address of Plant:
FORM APPROVED
OMB No. 158-R0160
PLANT CODE NO.
(For EPA Use OnTyT
3. Hame of Parent Firm
City
State
4. Address of Parent Firm Headquarters:
Tip-
Street~ city~Stati~~ Hp
5. HaBHs(s) of plant personnel to be contacted for Information pertaining to this data collection portfolio:
T1t1e ! (Area Code) Telephone
PART II
PLAHT DATA
1.
a.
"'
Does this plant manufacture or formulate pharmaceutical active ingredients?
(Research and development activities should not be considered.) i
rLt?nde?5Srthis(piifoTTo.PleaSe
Yes Q No D
the operations at thisifacility, but do not complete the
2.
c. If the answer to (a) is yes, please complete the remainder of this portfolio.
Type of production operation(s) at this facility (check a_n_ items that are appropriate):
Batch
D
D
D
d. Mixing/Compounding and Formulation r~|
3. HuBber of manufacturing or formulating employees in 1978:
a.
b.
c.
Fermentation
Biological and Natural Extraction
Chemical Synthesis
Average
Continuous
D
D
D
i D
Minimum
Semi continuous
D
D
D
D
Maximum
-1-
D-2
-------
PLANT CODE NO.
4 Please list in Table 1 all products manufactured at this plant site by the following production subcategories
during 1978: (A) Fermentation, (B) Biological and Natural Extraction, and/or (C) Chemical Synthesis. Place
an A, B, or C in the appropriate column to indicate the type of production subcategory used. Use the Merck
Index, Ninth Edition, 1976, to specify the Merck Index Identification Numbers (Merck Index Number). Many of
the Chemical Abstract Service Registry Numbers (CAS Numbers) may be found in the Merck Index beginning on
page REG-1.
Mote: Make as many photocopies of this sheet as necessary before fining in the requested information.
TABLE 1
CAS NUMBER
ERCK INDEX NO.
PRODUCT NAME
RODUCTION
UBCATEGORY
ANNUAL
PRODUCTION (kg/yr)
Examples:
87081
6890
Penicillin V
10.000
Allergenic extracts
300
103902
36
Acetaminophen
S.OOO.
-2-
D-3
-------
PLANT CODE NO.
PART III
WASTEWATER DATA
1. a. Does this plant site generate process wastewaters?
Yes Q ' NoQ
COctitoruf h «l dun'"9 """"^""ring o- processing, comes into direct
contact with or results from the production or use of any raw material, intermediate product finished
""*** ""*""• Thl'S d°eS — 1'"Clude ""It^y wastewaters, no'n-contact cooltng
b. Average dally quantity of process, wastewaters generated during 1978,! in gallons per day
i ......... • •
E11l"inat1°n Sys"
*"
for the ""charge
b. Permit or application number _ ____
c. Average daily flow rate of permitted discharge during 1978, in gallons ........ "per ''day'
3. a. Does this plant discharge process wastewaters to a municipal sewage treatment plant? Yes Q NoQ
b. Average daily flow rate of discharge to municipal sewage treatment plant during 1978, in gallons per day
wastewater disposal (e.g., Incineration, evaporation, deep well disposal,
Method
Average daily flow rate during 1978, gallons per day
Note.: "ow rates presented in Questions 2.c., 3.b. and 4. should total the flow rate given in Question l.b.
5. Are there wastewater treatment facilities on site? Yes Q Complete Question III.6.
No n Go to Part IV.
6. Check which of the treatment processes listed below are employed at this plant:
a. In-plant
Q Cyanide Destruction
D Metal Precipitation
[3 Chromium Reduction i
i
[U Steam Stripping
l~] Solvent Recovery
l"1 Other, Specify i
b. End-of-P1pe :
O Equalization I
d Neutralization ;
D Coarse Settleable Solids Removal
Primary Separation ',
Lj Primary Sedimentation i
Q Primary Chemical Flocculatlon/Clarification !
D Other, Specify :
Biological Treatment
D Activated Sludge
D Trickling Filter
Aerated Lagoon
Waste Stabilization Ponds
Rotating Biological Contactor
a
a
a
-3- D-4
-------
PUNT CODE NO.
a
D
a
Powdered Activated Carbon
Other, Specify
Physical/Chemical Treatment
Polishing
O Pond
Q Multi-media Filtration
Q Activated Carbon
O Other, Specify
Sludge Disposal
Q Landfill
Q Cropland Use
["] Ocean
Other, Specify_
If this plant operates an end-of-pipe treatment system and one or more boxes'in Question 6.b were checked,
then please provide available data on the performance of that system by completing Table 2. Data used to
compute long term average flow rates and concentrations should be for the time period from July 1, 1977 to
December 31, 1978. If data is not available for the entire 1-1/2 year period, then please provide data that
is available and indicate the actual time period used to compute long term average values. Do not include
data obtained before July 1, 1977. In addition, please indicate the frequency of sampling that occurred for
the subject parameter dur\ng the indicated time period. In Table 2, please insert a number from the following
list that corresponds to that frequency.
Frequency
One time sample
Less than one sample per month
One sample per month to less than one
sample per week 3
One sample per week to one sample per day 4
More than one sample per day 5
Note:
gal/d = gallons per day
mg/1 » milligrams per liter
Long Term Average Value
TABLE 2
Parameter
Influent to
End-of-Pipe System
Effluent from
End-of-Pipe System
Time Period over
which average
cone, occurred
Frequency of
sampling during the
indicated time period
Flow (gal/d)
BODc (mq/1)
COD (mg/1)
TSS (mq/1)
Cyanide (mg/1)
Phenol (rog/1)
PART IV
PRIORITY POLLUTANTS
Please provide the information requested in Table 3 concerning the chemicals which are considered as priority
pollutants and which are listed in Table 3 in confonnance with the following Instructions.:
1. In column A, place a check mark to indicate all of the listed chemicals which were used as raw or intermediate
material during 1978.
2. In column B, place a check mark to indicate all of the listed chemicals which were manufactured at this plant
as a final or Intermediate material during 1978.
3. In column C, place a check mark to indicate all of the listed chemicals for which you have analyzed In your
raw (untreated) process wastewater (R) and/or treated effluent (E), and for which analytical data are available.
4. If one or!more check marks have been placed in column C, then please attach a copy of the analytical results.
However, 1f the results are voluminous, the data may be summarized on a separate sheet of paper by computing
an average concentration and flow rate and stating minimum and maximum concentrations and flow rates for each
pollutant. In addition, please indicate the time period over which this data was collected and the frequency
of sampling that occurred during that time period.
-4-
D-5
-------
TABLES
PRIORITY POLLUTANTS
PLANT CODE NO.
Herck
CAS Index :
jJusiiser Niraber Chemical
i. 83-32-9 19 acenaphthene !
2. 107-02-8 123 acrolein j
3. 107-13-1 127 acrylonitrile ;
4. 71-43-2 1069 benzene
5. 92-87-5 1083 benzidine
6. 56-23-5 1821 carbon tetrachloride (tetrachloromethane)
7. 108-90-7 2095 chlorobenzene
8. 120-82-1 9310 1,2,4-trichlorobenzene I
9. 118-74-1 4544 hexachlorobenzene
10. 107-06-2 3733 1,2-dichloroethane j
11. 71-55-6 9316 1,1,1-trichloroethane
12. 67-72-1 4545 hexachloroethane
13. 75-34-3 3750 1,1-dichloroethane ;
14. 79-00-5 9317 1,1,2,-trichloroethane
15. 79-34-5 8906 1,1,2,2-tetrachloroetnane
16. 75-00-3 3713 chloroethane
17. 542-88-1 3046 bis (chloromethyl) ether j
18. 111-44-4 3040 bis (2-chloroethyl) ether
19. 110-75-8 2119 2-chloroethyl vinyl ether (mixed) ;
20. 91-53-7 2127 2-chloronaphthalene !
21. 88-06-2 9323 2,4,6-trichlorophenol ;
22. 59-50-7 2108 parachlorometa cresol
23. 67-66-3 2120 chloroform (trichloromethane)
24. 95-57-8 2134 2-chlorophenol j
25. 95-50-1 3029 1,2-dichlorobenzene
26. 541-73-1 3028 1,3-dichlorobenzene
27. 106-46-7 3030 1,4-dichlorobenzene
28. 91-94-1 3032 3,3'-dichlorobenzidine
29. 75-35-4 9647 1,1-dichloroethylene
30. 540-59-p 85 1,2- trans-dichloroethylene
'!• — - 2,4-dichloreph<;nol
32. 78-87-5 7643 1,2-dichloropropane
33. 542-75-6 3051 1,3-dichloropropylene (1,3-dichloropropene) i
34. 1300-71-6 9744 2,4-dimethylphenol
35. ™- 2,4-dinitrotoluene
36. — - 2,6-dinitrotoluene
3'. — 1,2-diphenylhydrazine
38. 100-41-4 3695 ethylbenzene
39. -— fluoranthene ]
40. ____ 4-chlorophenyl phenyl ether
41. -- — 4-broraophenyl phenyl ether
42. — - bis(2-chloroisopropyH ether
43. — - bis (2-chloroethyoxy) methane
ABC
Raw or
Inter-
Material
Final or
Inter-
Analyzed
in
Material ! E E
\
~"
\
-5-
DJ6.
-------
TABIi 3
PRIORITY POLLUTANTS
PLANT CODE HO.
'ABC
Merck
Index
Raw or
Inter-
mediate
Material
Final or
Inter-
mediate
Material
Analyzed
in
75-09-2 5932
methylene chloride (dichloromethane)
74-87-3 5916
methyl chloride (chloromethane)
74-83-9 5904 methyl bromide (bromomethane)
47.
75-25-2 1418.
bromoform (tribromome thane)
. dichlorobromomethane
-69-4 9320
trichlorofluoromethane
75-71-8 3038
dichlorodifluoromethane
chlorodibromomethane
hexachlorobutadiene
hexachlorocyclopentadiene
—— isophorone
91-20-3 6194
naphthalene
9B-9S-3 6409
nitrobenzene
57. 88-75-5 6442
,2-nitrophenol
100-02-7 6443
4-nitrophenol
51-28-5 3277
2,4-dinitrophenol
534-52-1 3275
4f6-dinitro-o-cresol
61.
62-75-9 6458
N-nitrosodimethy lamine
62.
H-nitrosodiphenylamine
N-nitrosodi-n-propy lamine
64.
87-86-5 6901
pentachlorophenol
108-95-2 7038
phenol
117-81-7 1270 bis(2-ethylhexyl) phthalate
butyl benzyl phthalate
84-74-2 1575
di-n-butyl phthalate
di-n-octyl phthalate
84-66-2
3783
diethyl phthalate
71.
131 -11-3 3244
dimethyl phthalate
56-55-3 1063
1,2-benzanthracene
50-32-8 1113 benzo (a)pyrene (3,4-benzopyrene)
74.
3,4-benzofluoranthene
11,12-benzofluoranthene
76.
218-01-9 2252
chrysene
acenaphthylene
120-12-7 718
anthracene
1,12-benzoperylene
86-73-7 4037
31.
85-01-8 6996
phenanthrene
53-70-3 2971
1,2:5,6-dibenzanthracene
indeno(l,2,3-C,D) pyrene
129-00-O 7746
pyrene
127-18-4 8907
tetrachloroethylene
108-88-3 9225
toluene
-6- 0-7
-------
TABLE 3
PLANT CODE NO.
PRIORITY POLLUTANTS
Korck
CAS Index
- ttusb«r Nurfcer (Chemical
87. 79-01-6 9319 trichloroethylane ~~
98. 75-01-4 9645 vinyl chloride (chloroethylene)
89. 309-00-2 220 aldrin
90. 60-57-1 3075 dieldrin
91. 57-74-9 2051 chlordane (technical nixture and metabolites)
92. 50-29-3 2822 4,4'-DDT
93. 4,4'-DDE (p,p'-DDX)
94. 6088-51-3 2821 4,4'-DOD (p,p'-TDE)
95. 115-29-7 3519 alpha-endosulfan
96. 115-29-7 3519 beta-endosulfan
9'« -- —- endosulfan sulfate
98. 72-20-8 3522 endrin
(99. endrin aldehyde
100. 76-44-8 4514 heptachlor.
101. heptachlor epoxide
102. 58-89-9 5341 alpha-BHC
103. 58-89-9 5341 beta-BHC
104. 58-89-9 5341 ganma-BHC (lindane) , . . ,
105. 58-89-9 5341 delta-BHC
106. PCB-1242 (Arochlor 1242) • ' '.
107. PC3-12S4 (Arochlor 1254)
108. PCB-1221 (Arochlor 1221) j
109. PCB-1232 (Arochlor 1232) ;
110. PCB-1248 (Arochlor 1248) i
111- PCS-1260 (Arochlor 1260) I
112. — — PCB-1016 (Arochlor 1016)
113. 8001-35-2 9252 Toxaphene
114. 7440-36-0 729 Antimony (Total) ~
115. 7440-38-2 820 Arsenic (Total)
116. 350 Asbestos (Fibrous)
117. 7440-41-7 1184 Beryllium (Total)
118. 7440-43-9 16OO Cadmium (Total)
119. 7440-47-3 2229 chromium (Total)
120. 7440-50-8 2496 Copper (Total)
121. 420-05-3 2694 Cyanide (Total)
122. 7439-92-1 5242 Lead (Total)
1 123. 7439-97-6 5742 Mercury (Total)
124. 6312 Nicxel (Total) |[
125. 7782-49-2 8179 Selenium (Total)
126. 7440-22-4 8244 Silver (Total I
127. 7440-28-0 8970 Thallium (Total)
1S8. 7440-66-6 9782 Zinc (Total)
129. 2,3,7,8 - tetrad' j« --henzo-p-dioxin (TCDD)
A
Raw or
Inter-
mediate
Material
B c
Final 01
Inter-
mediate
Analyzed
in
Wastewater
R E
-?- D-8
-------
APPENDIX E
Pharmaceutical Manufacturing Plants in the
Supplemental 308 Data Base
-------
-------
APPENDIX E
PHARMACEUTICAL MANUFACTURING PLANTS
IN THE
SUPPLEMENTAL 308 DATA BASE
NAME
A. E. STALEY MANUFACTURING COMPANY
AJAY CHEMICALS, INC.
ALLIED CHEMICAL COMPANY
AMERCHOL, INC.
AMERICAN AGAR AND CHEMICAL COMPANY
AMERICAN APOTHECARIES COMPANY
AMERICAN CYANAMID CO. - FINE CHEM.
AMERICAN CYANAMID CO. - FINE CHEM.
AMERICAN LABORATORIES, INC.
ANABOLIC, INC.
ANDERSON DEVELOPMENT COMPANY
ARAPAHOE CHEMICALS, INC.
ARAPAHOE CHEMICALS, INC.
ARENOL CHEMICAL CORPORATION
ASH STEVENS, INC. (PILOT PLT.)
ATLAS POWDER COMPANY
BANNER GELATIN PRODUCTS CORPORATION
BARR LABORATORIES
BAYLOR LABORATORIES, INC.
BEIERSDORF, INC.
BELPORT COMPANY, INC.
BEN VENUE LABORATORIES, INC.
BIOCRAFT LABORATORIES, INC.
BIOCRAFT LABORATORIES, INC.
BIOCRAFT LABORATORIES, INC.
BLISTEX, INC.
BOLAR PHARMACEUTICAL COMPANY, INC.
BOOTS PHARMACEUTICALS, INC.
BRIOSCHI, INC.
C AND M PHARMACAL, INC.
C. M. BUNDY COMPANY
CAMPANA CORPORATION
CARSON CHEMCIALS, INC.
CARTER-GLOGAU LABORATORIES
CARTER-GLOGAU LABORATORIES
CENTURY PHARMACEUTICALS, INC.
CHAP STICK COMPANY
CHASE CHEMICAL COMPANY
CHATTEM CHEMICALS DIVISION
CHATTEM LABORATORIES DIVISION
LOCATION
DECATUR
POWDER SPRINGS
CHICAGO
EDISON
SAN DIEGO
LONG ISLAND CITY
BOUND BROOK
WILLOW ISLAND
OMAHA
IRVINE
ARDIAN
BOULDER
NEWPORT
LONG ISLAND CITY
DETROIT
TAMAQUA
CHATSWORTH
NORTHVALE
HURST
SOUTH NORWALK
CAMARILLO
BEDFORD
ELMWOOD PARK
ELMWOOD PARK
WALDWICK
OAK BROOK
COPTAGUE
SHREVEPORT
FAIR LAWN
HAZEL PARK
ERLANGER
BATAVIA
NEW CASTLE
GLENDALE
MELROSE PARK
INDIANAPOLIS
LYNCHBURG
NEWARK
CHATTANOOGA
CHATTANOOGA
IL
GA
IL
NJ
CA
NY
NJ
WV
NE
CA
MI
CO
TN
NY
MI
PA
CA
NJ
TX
CT
CA
OH
NJ
NJ
NJ
IL
NY
LA
NJ
MI
KY
IL
IN
AZ
IL
IN
VA
NJ
TN
TN
E-i
-------
CHROMALLOY LABORATORIES
COHELFRED LABORATORIES, INC.
CORD LABORATORIES, INC.
CORWOOD LABORATORIES, INC.
CREOMULSTON COMPANY
CUMBERLAND MANUFACTURING COMPANY
D. M. GRAHAM LABORATORIES, INC.
DANBURY PHARMACAL, INC.
DEL LABORATORIES, INC.
DEL-RAY LABORATORY, INC.
DELL LABORATORIES, INC.
DEPREE COMPANY
DEVLIN PHARMACEUTICALS, INC.
DEWEY PRODUCTS COMPANY
DIAMOND SHAMROCK CORPORATION
DON HALL LABORATORIES
DORASOL LABORATORIES
DR. G. H. TICHENOR ANTISEPTIC CO.
DR. MADIS LABORATORIES, INC.
DR. ROSE, INC.
DRUGS, INC.
E. E. DICKINSON COMPANY, INC.
E-Z-EM COMPANY
EASTMAN KODAK CO. - KODAK PARK
ELKINS-SINN, INC.
EMERSON LABORATORIES
ENZYME PROCESS COMPANY, INC.
EX-LAX, INC.
FERMCO BIOCHEMICS, INC.
FLEMING AND COMPANY
FOREST/INWOOD LABORATORIES, INC.
FORT DODGE LABORATORIES
FRANKLIN LABORATORIES, INC.
FRESH LABORATORIES, INC.
FROMM LABORATORIES, INC.
G AND W LABORATORIES, INC.
G. E. LABORATORIES, INC.
GANES CHEMICALS, INC.
GANES CHEMICALS, INC.
GEBAUER CHEMICAL COMPANY
GENERIC PHARMACEUTICAL CORPORATION
GIBO/INVENEX DIVISION
GOODY'S MANUFACTURING COMPANY
GORDON LABORATORIES
GRANDPA BRANDS COMPANY
GUARDIAN CHEMICAL CORPORATION
H. CLAY GLOVER COMPANY, INC.
HALSEY DRUG COMPANY, INC.
HEATHER DRUG COMPANY, INC.
HENKEL CORPORATION
LOS ANGELES CA
CHICAGO IL
BROOMFIELD CO
HAUPPAUGE NY
ATLANTA GA
NASHVILLE TN
HOBART NY
DANBURY CT
FARMINGDALE NY
BIRMINGHAM AL
TEANECK NJ
HOLLAND MI
EL SEGUNDO CA
GRAND RAPIDS MI
LOUISVILLE KY
PORTLAND OR
HATQ REY PR
NEW ORLEANS LA
SOUTH HACKENSACK NJ
MADISON CT
ELIZABETH NJ
ESSEX CT
WESTBURY NY
ROCHESTER NY
CHERRY HILL NJ
DALLAS TX
NORTHRIDGE CA
HUMACAO PR
ELK GROVE VILLAGE IL
FENTON MO
INWOOD, L.I. NY
FORT DODGE IA
AMARILLO TX
WARREN MI
GRAFTON WI
SOUTH PLAINFIELD NJ
SHAMOKIN PA
CARLSTADT NE
PENNSVILLE NJ
CLEVELAND OH
PALISADES PARK NJ
GRAND ISLAND NY
WINSTON-SALEM NC
UPPER DARBY PA
CINCINNATI OH
HAUPPAUGE NY
TOMS RIVER NJ
BROOKLYN NY
CHERRY HILL NJ
KANKAKEE IL
E-2
-------
INC.
HEUN/NORWOOD LABORATORIES
HEXAGON LABORATORIES, INC.
HEXCEL SPECIALTY CHEMICALS
HIGH CHEMICAL COMPANY
HOBART LABORATORIES, INC.
HOLLAND-RANTOS COMPANY, INC.
HOPPE PHARMACAL CORPORTION
HUMPHREYS PHARMACAL, INC.
ICN PHARMACEUTICALS: COVINA DIVISION
INFRACORP, LTD.
INTERNATIONAL HORMONES, INC.
J. H. GUILD COMPANY, INC.
JOHN D. COPANOS COMPANY, INC.
KALLESTAD LABORATORIES, INC.
KENDALL COMPANY
KENDALL COMPANY
KEY PHARMACEUTICALS,
KOPPERS COMPANY, INC.
L. T. YORK COMPANY
LANNETT COMPANY, INC.
LARSON LABORATORIES, INC.
LEE PHARMACEUTICALS
LEWIS/HOWE COMPANY
LIBBY LABORATORIES, INC.
LILY WHITE SALES COMPANY, INC.
LORVIC CORPORATION
LYNE LABORATORIES, INC.
LYPHO-MED, INC.
M. K. LABORATORIES, INC.
MANHATTAN DRUG COMPANY
MANN CHEMICAL CORPORATION
MARSHALL PHARMACAL CORPORATION
MAURRY BIOLOGICAL COMPANY, INC.
MBH CHEMICAL CORPORATION
McCONNON AND COMPANY
MENTHOLAIUM COMPANY
MERICON INDUSTRIES, ING.
MERRICK MEDICINE COMPANY
MERRILL-NATIONAL LABORATORIES
MICROBIOLOGICAL ASSOCIATES
MILEX PRODUCTS, INC.
MILLER-MORTON COMPANY
MILROY LABORATORIES
MONSANTO CO. - JOHN F.
MORTON PHARMACEUTICALS,
MOYCO INDUSTRIES, INC.
MYLAN PHARMACEUTICALS, INC.
N.E.N. - MEDICAL DIAGNOSTIC DIVISION
NAPP CHEMICALS, INC.
NATCON CHEMICAL COMPANY, INC.
QUEENY PLT.
, INC.
ST. LOUIS
BRONX
LODI
PHILADELPHIA
CHICAGO
TRENTON
GRAND HAVEN
RUTHERFORD
COVINA
PETERSBURG
FORT MITCHELL
RUPERT
BALTIMORE
CHASKA
AUGUSTA
FRANKLIN
MIAMI
PETROLIA
BROOKFIELD
PHILADELPHIA
ERIE
SOUTH EL MONTE
ST. LOUIS
BERKELEY
ORISKANY FALLS
ST. LOUIS
NEEDHAM HEIGHTS
CHICAGO
FAIRFIELD
HILLSIDE
LOUISVILLE
SOUTH HACKENSACK
LOS ANGELES
ORANGE
WINONA
BUFFALO
PEORIA
WACO
MILWAUKEE
WALKERSVILLE
CHICAGO
RICHMOND
SARASOTA
ST. LOUIS
MEMPHIS
PHILADELPHIA
MORGANTOWN
NORTH BILLERICA
LODI
PLAINVIEW
MO
NY
NJ
PA
IL
NJ
MI
NJ
CA
VA
KY
VT
MD
MN
GA
KY
FL
PA
MD
PA
PA
CA
MO
CA
NY
MO
MA
IL
CT
NJ
KY
NJ
CA
NJ
MN
NY
IL
TX
WI
MD
IL
VA
FL
MO
TN
PA
WV
MA
NJ
NY
-------
NATIONAL PHARMACEUTICAL MFG. COMPANY
NELCO LABORATORIES, INC.
NEPERA CHEMICAL COMPANY, INC.
NORTH AMERICAN BIOLOGICALS, INC.
NUTRILITE PRODUCTS, INC.
O'NEAL, JONES, AND FELDMAN, INC.
O'NEAL, JONES-, AND FELDMAN, INC.
ORGANICS, INC.
ORMONT DRUG AND CHEMICAL CO., INC.
OTIS CLAPP AND SONS
OTTAWA CHEMICAL DIVISION
PASCAL COMPANY, INC.
PAUL B. ELDER COMPANY
PETERSON OINTMENT COMPANY
PFANSTIEHL LABORATORIES, INC.
PHARMACARE, INC.
PHARMACIA, INC.
PHILIPS ROXANNE, INC.
PIERCE CHEMICAL COMPANY
PITMAN-MOORE, INC.
PRALEX CORPORATION
PREMO PHARMACEUTICAL LABS., INC.
PRIVATE FORMULATIONS, INC.
RACHELLE LABORATORIES, INC.
RECSEI LABORATORIES
REED AND CARNRICK, INC.
REID-PROVIDENT LABORATORIES, INC.
REXALL DRUG COMPANY
REXAR PHARMACAL CORPORATION
RHONE-POULENC, INC.
RHONE-POULENC: HESS AND CLARK DIV.
RIKER LABORATORIES, INC.
ROEHR CHEMICALS COMPANY
RUETGERS-NEASE CHEMICAL COMPANY
RYSTAN COMPANY, INC.
SCHOLL, INC.
SCHUYLKILL CHEMICAL COMPANY
SEIN/MENDEZ LABORATORIES
SHELL CHEMICAL COMPANY
SHERWOOD LABORATORIES, INC.
SINCLAIR PHARMACAL COMPANY, INC.
SOUTHLAND CORPORATION
STANBACK COMPANY, LTD.
STANLABS PHARMACEUTICAL COMPANY
STIEFEL LABORATORIES, INC.
SUPPOSITORIA LABORATORIES, INC.
SYNTEX AGRI-BUSINESS, INC.
SYNTEX AGRI-BUSINESS, INC.
SYNTEX (F.P.), INC.
TABLICAPS, INC.
BALTIMORE MD
DEER PARK NY
HARRIMAN NY
MIAMI FL
BUENA PARK CA
STJ LOUIS MO
CINCINNATI OH
CHICAGO IL
ENGLEWOOD NJ
CAMBRIDGE MA
TOLEDO OH
BELLEVUE WA
BRYAN OH
BUFFALO NY
WApKEGAN IL
LARGO FL
PISCATAWAY NJ
ST. JOSEPH MO
ROCKFORD IL
WASHINGTON CROSSING NJ
ST. CROIX VI
SOUTH HACKENSACK NJ
EDISON NJ
LONG BEACH CA
GOLETA CA
KENILWORTH NJ
ATLANTA GA
ST. LOUIS MO
VALLEY STREAM NY
NEW BRUNSWICK NJ
ASHLAND OH
NORTHRIDGE CA
LONG ISLAND CITY NY
STAJ-E COLLEGE PA
LITTLE FALLS NJ
CHICAGO IL
PHILADELPHIA PA
RIO PIEDRAS PR
DENVER CO
EASTLAKE OH
FISHERS ISLAND NY
GREAT MEADOWS NJ
SALISBURY NC
PORTLAND OR
OAK HILL NY
FARMINGDALE NY
SPRINGFIELD MO
VERONA MO
HUMACAO PR
FRANKLINVILLE NJ
'E-4
-------
TAYLOR PHARMACAL COMPANY
TENNESSEE EASTMAN COMPANY
THOMPSON-HAYWARD CHEMICALS
TRUETT LABORATORIES
UPSHER SMITH LABORATORIES
V. K. BHAT
VALE CHEMICAL COMPANY, INC.
VINELAND LABORATORIES, INC.
VINELAND/EVSCO, INC.
VIOBIN CORPORATION
VISTA LABORATORIES, INC.
VITA-FORE PRODUCTS COMPANY
VITAMINS, INC.
VITARINE COMPANY, INC.
W. F. YOUNG, INC.
WALGREEN LABORATORIES, INC.
WATKINS,INC
WEST ARGO-CHEMICALS, INC.
WEST ARGO-CHEMICALS, INC.
WEST-WARD, INC.
WESTERN RESEARCH LABORATORIES
WESTWOOD PHARMACEUTICALS, INC.
WHITEHALL LABORATORIES
WHITEWORTH, INC.
WHORTON PHARMACEUTICALS, INC.
WILLIAM T. THOMPSON COMPANY
WORTHINGTON DIAGNOSTICS
XTTRIUM LABORATORIES, INC.
YAGER DRUG COMPANY
ZENITH LABORATORIES, INC.
DECATUR IL
KINGSPORT TN
KANSAS CITY KS
DALLAS TX
MINNEAPOLIS MN
EVERETT WA
ALLENTOWN PA
VINELAND NJ
BUENA NJ
MONTICELLO IL
ST. CROIX VI
OZONE PARK NY
CHICAGO IL
SPRINGFIELD GARDENS NY
SPRINGFIELD MA
CHICAGO IL
WINONA MN
EIGHTY FOUR PA
KANSAS CITY MO
EATONTOWN NJ
DENVER CO
BUFFALO NY
ELKHART IN
GARDENA CA
FAIRFIELD AL
CARSON . CA
FREEHOLD NJ
CHICAGO IL
BALTIMORE MD
NORTHVALE NJ
TOTAL NUMBER OF MFG. PLANTS IN THE SUPPLEMENTAL 308 DATA BASE: 220
E-5
-------
-------
APPENDIX F
Pharmaceutical Industry General Plant Information
(308 Data/
-------
-------
APPENDIX F
GENERAL PLANT INFORMATION
Plant
Code No.
12000
12001
12003
12004
12005
12006
12007
12011
12012
12014
12015
12016
12018
12019
12021
12022
12023
12024
12026
12030
12031
12035
12036
12037
12038
12040
12042
12043
12044
12048
12051
12052
12053
12054
12055
12056
12057
12058
12060
12061
12062
12063
12065
Subcateqories
D
D
A CD
C D
B
D
D
A B D
B D
B
D
D
A CD
D
D
A C
D
D
C
D
D
D
A
C D
A B C D
B D
A B D
C
A D
C D
.D
C D
D
D
D
D
C D
D
D
B
C D
N/A
D
Average
Employment(1)
2200
380
5930
72
10
54
1710
224
3540
N/A
365
132
210
850
39
176
442
1240
30
200
60
208
184
1118
1053
433
183
14
873
425
19
503
250
350
100
200
750
100
546
152
300
313
980
Start-Up
Year(2)
1965
1959
1931
1972
1971 ,
1963
1933
1968
1947
1977
1960
1968
1916
1960
1973
1951
1967
1920
1950
1966
1897
1972
1948
1937
1954
1967
1974
1973
1938
1951
1963
1971
1963
1958
1956
1971
1934
1955
1962
1967
1950
1974
1960
-------
12066
12068
12069
12073
12074
12076
12077
12078
12080
12083
12084
12085
12087
12088
12089
12093
12094
12095
12097
12098
12099
12100
12102
12104
12107
12108
12110
12111
12112
12113
12115
12117
12118
12119
12120
12122
12123
12125
12128
12129
12131
12132
12133
12135
12141
12143
12144
12145
12147
12155
A
A
A
A
BCD
D
D
C
D
D
C D
D
D
D
BCD
D
C
D
B D
C D
D
C D
C D
D
D
C D
C D
D
B D
C D
D
B D
C
D
B D
B I)
D
D
D
D
C D
D
D
D
D
C
D
BCD
D
D
D
D
D
C D
666
17
176
6
220
50
493
N/A
;1640
, 190
275
74
90
250
32
560
135
102
: 160
54
75
i 17
I 265
[1415
'•• 105
372
10
t 444
12
922
: 271
455
280
N/A
22
6
277
32
24
615
32
383
10
875
,112
1175
; 20
18
231
1668
1953
1934
1964
1961
1897
1972
1970
1977
1948
1972
1958
N/A
1957
1950
1914
1948
1967
1947
1951
1975
1970
N/A
N/A
1951
1923
1974
1974
1949
1959
1962
1963
1882
1972
1977
1974
1937
1937
1974
N/A
1975
1970
1941
1969
1896
1971
1924
1972
1972
1965
1849
F-2
-------
12157
12159
12160
12161
12166
12168
12171
12172
12173
12174
12175
12177
12178
12183
12185
12186
12187
12191
12194
12195
12198
12199
12201
12204
12205
12206
12207
12210
1221 1
12212
12217
12219
12224
12225
12226
12227
12230
12231
12233
12235
12236
12238
12239
12240
12243
12244
12245
12246
12247
12248
A B
B
B
B
B
B
A B
B
A
A B
B
D
C D
D
C D
D
C D
C D
D
D
D
D
D
C
C D
C
C
D
C
D
C D
D
C D
D
D
D
C
C
D
D
D
D
D
B
B
A
A B
D
D
C
C
D
D
C D
D
C
C
C D
C
D
8
356
215
905
90
250
70
34
3
75
66
70
40
270
26
051
0632
450
20
N/A
70
2061
N/A
2000
300
220
55
190
22
212
140
544
1333
22
124
25
20
685
341
84
250
42
46
53
70
224
230
716
6
810
1973
1942
1974
1969
1974
1938
1970
1974
1940
1939
1975
1960
1962
1903
1941
1976
1949
N/A
1973
1975
1949
1946
N/A
1907
1968
1971
1962
1973
1976
1976
1975
1964
1915
1972
1973
1963
1969
1968
1895
1971
1952
1976
1973
1972
1973
1947
1951
1948
1969
1961
F-3
-------
12249
12250
12251
12252
12254
12256
12257
12260
12261
12263
12264
12265
12267
12268
12269
12273
12275
12277
12281
12282
12283
12287
12289
12290
12294
12295
12296
12297
12298
12300
12302
12305
12306
12307
12308
12309
12310
12311
12312
12317
12318
12322
12326
12330
12331
12332
12333
12338
12339
12340
A
A
A B
A B
A B
B
B
B
B
D
D
D
C D
D
C D
C D
D
C
D
D
D
D
D
D
D
C
D
D
C D
D
D
D
D
C D
D
D
D
D
B
B
B
B
ABC
C
C
D
D
D
D
D
D
D
D
D
D
D
D
D
D
D
C D
D
115
259
53
1400
444
1239
4600
176
128
28
4450
; 65
122
112
135
14
1297
15
!303
85
37
31! 1 2
: 31
1 59
332
8
685
70
, 88
410
144
174
; 4
151
1052
30
170
1008
693
2387
210
98
60
2438
374
N/A
198
150
555
1595
1968
1940
1968
1939
1971
1948
1922
1943
1966
1973
1910
1965
1969
1974
1957
1975
1925
1965
1957
1900
1972
1964
N/A
1975
1969
1925
N/A
1972
1962
1953
1901
1971
1976
1975
N/A
1967
1970
1953
1873
1972
1960
1969
1975
1906
1967
N/A
1970
1974
1970
1957
F-4
-------
12342
12343
12345
12375
12384
12385
12392
12401
12405
12406
12407
12409
12411
12414
12415
12417
12419
12420
12427
12429
12433
12438
12439
12440
12441
12444
12447
12454
12458
12459
12460
12462
12463
12464
12465
12466
12467
12468
12470
12471
12472
12473
12474
12475
12476
12477
12479
12481
12482
12495
A
A
C D
C D
D
B
B
B
B
B
A B
B
B
B
B
B
B
B
B
B
B
D
D
D
C D
C
C
D
C D
D
D
D
D
D
D
D
D
D
C D
D
C
D
C D
D
C D
D
D
D
D
D
C
C
D
N/A
D
377
166
389
91
35
60
110
1324
85
163
67
18
750
627
450
10
123
160
579
51
180
560
1 15
235
1108
78
4095
710
120
4
70
25
224
4
315
18
67
628
14
328
44
242
64
153
55
298
5
N/A
N/A
130
1944
1967
1963
1953
1970
1966
1959
1968
1964
1948
1904
1920
1970
1951
1968
1950
1969
1973
1958
1886
1953
1964
1974
1965
1923
1977
1948
1947
1968
1977
1975
1972
1926
N/A
1967
1958
1959
1947
1967
1972
1971
1947
1969
1966
1967
1867
1977
1918
N/A
1959
F-!5
-------
12499
20006
20008
20012
20014
20015
20016
20017
20020
20026
20030
20032
20033
20034
20035
20037
20038
20040
20041
20045
20048
20049
20050
20051
20052
20054
20055
20057
20058
20062
20064
20070
20073
20075
20078
20080
20081
20082
20084
20087
20089
20090
20093
20094
20099
20100
20103
20106
20108
20115
B
D
D
D
C
D
D
D
D
D
D
C D
B D
C D
D
C
D
D
B
D
D
D
D
A B
D
D
D
D
D
D
D
D
D
D
D
D
D
D
C D
D
D
D
D
D
D
D
D
D
D
D
D
1150
2
20
4
1210
45
68
3
1
79
38
.14
25
1
81
12
20
12
10
31
31
6
30
21
15
, 35
16
150
; 2
! 4
1
35
I 14
! 6
; 75
10
55
40
; 3
2
5
34
3
3
62
7
1961
F-6
-------
20117
20120
20125
20126
20134
20139
20141
20142
20147
20148
20151
20153
20155
20159
20165
20169
20173
20174
20176
20177
20178
20187
20188
20195
20197
20201
20203
20204
20205
20206
20208
20209
20210
20215
20216
20218
20220
20224
20225
20226
20228
20229
20231
20234
20235
20236
20237
20240
20241
20242
B
B
B
B
D
D
D
D
C D
C D
D
D
D
D
C D
D
D
C
C
D
C
D
D
C
D
D
D
D
D
D
C
C D
C
C
D
D
D
D
D
C
D
D
D
D
D
D
D
C
D
D
C
D
C D
127
14
50
12
6
40
6
70
15
15
6
10
20
22
10
30
3
6
2
5
12
10
200
100
3
8
93
84
37
49
2
12
3
13
6
15
20
6
65
22
2
86
20
N/A
7
120
28
20
31
10
F-7
-------
20244
20245
20246
20247
20249
20254
20256
20257
20258
20261
20263
20264
20266
20267
20269
20270
20271
20273
20282
20288
20294
20295
20297
20298
20300
20303
20305
20307
20308
20310
20311
20312
20316
20319
20321
20325
20328
20331
20332
20333
20338
20339
20340
20342
20346
20347
20349
20350
20353
20355
B
B
B
B
B
B
C
C
C
C
C
C
C
C
C
C
C
C
C
C
C
D
D
D
D
D
D
D
D
D
D
D
D
C
C
D
D
D
D
D
D
D
D
D
D
C
C D
B C
C
1
59
171
25
3
3
90
60
20
15
2
1 1
13
1 16
10
6
6
70
2
38
9
53
10
N/A
40
1
19
29
3
15
15
44
60
272
100
5
10
60
24
3
130
4
4
35
60
1
50
20
35
25
F-8
-------
20356
20359
20361
20362
20363
20364
20366
20370
20371
20373
20376
20377
20385
20387
20389
20390
20394
20396
20397
20400
20402
20405
20413
20416
20421
20423
20424
20425
20435
20436
20439
20440
20441
20443
20444
20446
20448
20450
20452
20453
20456
20460
20462
20464
20465
20466
20467
20470
20473
20476
B
C D
D
C D
C D
B D
BCD
B C
D
C
D
C D
D
C
C
D
B D
D
D
D
D
D
D
D
D
D
C D
D
C D
D
D
D
D
C
C
B
B
B
D
D
D
D
D
D
D
D
D
D
D
D
D
D
D
2
16
N/A
4
N/A
9
315
45
3
N/A
15
3
240
7
40
40
4
4
18
N/A
65
21
3
25
2
85
60
2
2
80
200
11
25
3
5
3
6
15
7
20
6
4
2
4
240
110
3
1
150
50
F-9
-------
20483
20485
20486
20490
20492
20494
20496
20498
20500
20502
20503
20504
20507
20509
20511
20518
20519
20522
20526
20527
20529
D
D
D
D
C D
D
D
D
D
D
D
D
D
D
D
D
D
D
C D
D
D
2
,30
5
250
, 3
65
12
2
31
3
; i
2
i 3
33
i 8
!5
13
,6
18
24
2
(1) Average employment for orignal 308 (12000 series) plants is for
1976; for Supplemental 308, (20000 series) plants it is 1978.
f
(2) Data on year of operational start-up was not requested of the
Supplemental 308 (20000 series) plants. 1
F-10
-------
r
APPENDIX G
Screening/Verification Plant Data
-------
-------
APPENDIX G
SCREENING/VERIFICATION
PLANT DATA
Abbreviations; GT-greater than
j-approximate value
LT-less than
LTDL-less than detection limit
NAI-not able to analyze due to interference
ND-not detected
NQ-not quantifiable due to instrument
saturation
Notes: (1) numbers in parenthesis indicate number of data points.
(2) when more than one data point was available a range
(min-max.) is given.
(3) pollutants not listed were not detected, below
detection limit, or not analyzed for.
G-l
-------
SCREENING PROGRAM SWMARV OF PLANT 12015
SIWMARY OF SCREENING DATA
CONCENTRATION (ug/1]
Priority Pollutants Tnfi.,ant Effluent
Acid Extractables
Pentaehlorophenol 62
Phenol 8
Phenols (4AAP) 249
Base/Neutral Extractahl«
Bis (2-8thylhexyl) phthalate 170
Di-n-butyl phthalate 20
Volatile Oraanics
Benzene 79
1.2 Dtchloraethane 19
Chloroform 100GT
Ethylbcnzene 11
Hethylene chloride 100ST
Tctrachloroethylene 36
Toluene IOOGT
Trlchloroethylene 6
Ketals
Beryllitw ILT
Cattaiua 6
ChrOBlw 30
Copper 50 j
Lead 20LT ]
Mercury n 7
HJ«*«1 5LT ]
Zinc inn It
All other metals „ l
Cyanide 25LT (1
1 ND f
1 NO I
1 26 {
1) 30
1) 3
1 ND
1 ND
1 14
1 ND
1 12
1 ND
1 3
1 ND
I ILT (]
I 7 ]
1 10 ]
L 30 (]
1 20LT (]
0.1 (I
J 5LT (J
) 200 (1
) 25LT (1
1)
1)
1)
1
1
1)
I
!)
;
)
WASTEKATER TREATMENT PLANT UNIT OPERATIONS
Equalization
Primary Sedimentation
Activated Sludge with Powdered Activated Carbon
Secondary Chemical Flocculation/Clarification
Gravity Dewatering
Aerobic Digestion
Landfill
PLANT CHARACTERISTICS
Subcategory Wastewater Quantity (HGD) Employment
D .07 300-400
PERFORMANCE OF TREATMENT SYSTEM
?SP..te?X.U COD to/D TSS (mg/1)
I-lf.1.^!?^ ."fluent Influent Effluent Influent Effluent
* Data supplied by plant ° ^*
WASTEIVATER TREATMENT PLANT FLOW DIAGRAM
*
CUXClFlLd.
rl I
i. i
_ i
i
i
*
^>
LUt>6c. 70
&OU.M.IZATIOO
s^icv*^;ti. —~J
f.eaa era /
\tr.of9 tfo '
UCCTU-'M «.LI^«V
— -5^ -" — -^.-—r;
IC?0 Lt/CKf Tli
1
L_) m.r*mc*n
j U1. MC/L TM
,J
— .
r-
--_^ .
^3...6oe'6^i>_t_^
TV:"i.c,viy~t«s..
_SAMPLING PROGRAM
Saoplc Location
1. Influent to primary clarifier
2. XAD-2 resin
2. Tcnax column
J. Return sludge
4. clarifiot cffluont
6-2
No. of Samples
4
4
4 '
J
-------
r
SCREENING PROGRAM—SIMIARY OF PLANT 12022
SlfttlAKY OF SCREENING DATA
CONCEtn
Priority Pollutants Influen
Acid Extractables '••'••-
2,4,6-Trlchlorophenoi 20 (1
2-Chorophenol 50 I
Phenol 1400 1
Phenols (4AAP) 1367 (1
Base/Neutral Extractables
1,2-Dichlorobenzene M U
1,4-Dichlorobenzene 90 (l
Volatile Organlcs
Benzene •- • • ' i ,
Chlorobenzene 6400
1,2-Dichloroethane 11000
Chloroform 80
Ethyl benzene 19
Methylene chloride 170 (
Toluene HOOO (
Metals (Data supplied by plant)
Antimony jjOLT
Arsenic . 50LT
Beryllium 10LT
Cadmium 2-°
Chromium 125
Copper '0
Lead , , 20LT
Mercury 1;* J
Nickel _ 510 (
Selenium 50LT
Silver ' ' ' 3
Thallium 50LT
Zinc 480
Cyanide 168
[RATION (ug/1}
t Effluent
LTDL 11)
ND (1)
) ND (1)
) 867 (1)
) ND (1)
) ND (1)
) ' nu il)
) ND (1
) 500 (1
I LTDL (1
L ND (1
L ' LTDL (1
I) ND (1
1 BOLT (1
1 BOLT (1
1 10LT 1
1 1.2 (1
1 75 (1
1 20 (1
1). 20LT (1
1) 1.0 (1
1) 310 (1
(1) BOLT (1
(1) 1.6 (1
(1) BOLT (1
(1) 100 (1
(1) 400GT (1
•
-
[
)
WASTEWATER TREATMENT PLANT UNIT OPERATIONS
Equalization
Neutralization
. Coarse Setteable Solids Removal
Activated Sludge
TMrH-inn Fllfpr
Mechanical Thickening
Chemical Conditioning
Vacuum Dewaterlng
Incineration
Landfill
- ' 'fUS - ' ' -t ' • '
PLANT aiARACTERISTICS .
Subcategory Wastewater Quantity (MSD)' SlCjJJJ?.6.?.*..
A,C 1-30 100-200
PERFORMANCE OF TREATMENT SYSTEM
BOD (mg/1) COD (mg/1) .TSSjjmg/1).
Inf1!*# .!SG.'JS!.t. LlfAKSSiS. JitltJ.'iS!.*. iP.tJ.HS??. .E.tf.lH?P.?. '
2630 680 4619 1701
WASTEWATER TREATMENT PLANT FLOW DIAGRAM .
PIAHT
CgHTAMiaOTtO1'
UffilE
Average Flw
1.5 - ?.0 H50
35,0011 WHM.
tve. B.0.0 loail
Plant
Viet
Uell
PllTlIp
Station
3
equal-
ization
Tank
—5
neutral-
ization
Tank
Cooling Hater
20.0 I1GO Flow
Disc
Rive
/
large to
r
2 Secondary
Clarlflers
' Soli
Reno
T~
2 Primary
Clarifiers
ds
val
!
— ?
2 Trickling
Uio-Filters
\/
3 Parallel
Acntion
BaS'ns
* •
1
Solids
Sludge
Removal
Sludge'
Thickener
• - 5
Vacuum
Filtration
-•^ Incinerator
\/
Residue to
Landfill
SAMPLING PROGRAM
Sample Location
1. Influent to biological treatment
2. Final effluent before dilution
Potable water
G-3
Ho. of Samples
2
2
1
-------
SCREENING PROGRAM SUMMARY OF PLANT 12026
SIMURY OF SCREENING DATA
CONCENTRATION (ug/1)
Priority Pollutants Influent Effluent
Acid Extractables
I'hfiftOl 64 (1) 5.8 (1)
Base/Neutral Extractables
Acenapnthene 1.9 (1
Fluoranthenc 0.2 (1
Naphthalene 9.8 1
B1s(2-ethylhcxyl) phthalate 10.7 1
Anthracene 0.4 i
Volatile Organlcs
Benzene' 7 (1
Carbon Tetraehlorlde HOOD (1
1,2-Diohloroethane 17 (1
Chloroethane 1.6 (1
Chloroform 3170 (1
Ethylbenzene 130 (1
Toluene 470 (1
Acroleln 100LT" (1
Acrylonltrlle 100LT (1
Hauls.
Alimony 3 (
Arsenic 20LT (
Beryl Hum 30 (
Cadalum 1LT (
Chwwlua 11
Copper 410
Lead 10LT
Kereury 0.79
Nickel 4LT
SelcniuR 20LT
Silver 3LT
Thai 1 tun 8LT
Zinc 120
Cyanide . 1980
0.10LT 1)
0.10LT 1
0.10LT 1
14.6 1
0.10LT (1
0.01LT (1
0.01LT (1
0.01LT (1
0.01LT (1
8.1 (1
0.01LT (1
0.01LT (1
100LT (1
100LT (1
1 " 5LT (1
L 20LT (1
I 0.80 (1
L 1LT (1
1 40 1
I 80 1
1 ' 10LT 1
L 0.20 1
I 4LT 1
1 - 20LT (1
L 3LT (1
L 8LT (1
I 71 (1
63
WASTEWATER TREATMENT PLANT UNIT OPERATIONS
Equalization
Neutralization
Activated Sludge
Aerated lagoon
Polishing Pond
Anaerobic Digestion
i
PLANT CHARACTERISTICS
Subcategory Wastewater Quantity (H6D) Employment
C .101 0-100
PERFORMANCE OF TREATMENT SYSTEM
?.0.P..{mg/l) COD (mg/1) TSS (mg/1)
J"f.!".(:.n* £f.fl!i.e.nt influent Effluent Influent Effluent
1418 348.4 , 2375 159.7 621 117.6
WASTEKATER TREATMENT PLANT FLOW DIAGRAM
WMATCr
\OOOO
1O
.
R.&TE>-JTIOkJ J. r7ETE*JTlO|4 "2 H(Z
4C» ftPM iJOM* „. ^-^ f^ - £ W^& RWE .^fiPM/FT^
• — x 0 0 P ^_ . »)s
\ AERATIOO POM KJOMIUM. ?oO*?f ~/~ -| elLUDSt £ ReTUaM |
\ \c'^rt£"}.e'>iro'S2r' r"" */*«$5* I ,'°° &"M
•\ | — " * : ' z
iA r^ 3
ff\ '' 1^ If
\J. • \
I 1 f
, «?o fi.PM , ; , .,.,... ' \S
*ic &PM JOH. MA.»<. « 1
-x g u g — i- si -a
X ' ' ' ' ' ' / ^ ; 1
N^ 3eT|oHP°Ale^ATeS«^ FeCt? ! / CONTROL
1
t
f J
/ 7 1 Ot7O(2. CC^TROL.
rn -x r r . . r . /^- -i^-
\x. V I • r ; : : / /
\ t « » : ? J /'/•• - • .
sample Location No. of Sa
P£>UI^HI*J
-------
Appendix F
Verification Program
Analytical Results
Plant 12026
Day 3
Priority Pollutants (uq/1)
Volatile Organics
Carbon Tetrachloride
1,2 Dichlorethane
Chloroform
Ethyl benzene
Toluene
Bromod i chl oromethane
Acid Extractables
2,4,6-Trichlorophenol
Pentachlorophenol
Phenol
*Base/Neutra1 Extnactables
*Metal s
*Pesticides
Cyanides (mg/1)
Influent
15
1.1
1620
61
122
1
ND
ND
515-750
0.45
Effluent
1LT
1LT
1LT
1LT
1LT
1LT
ND
ND
ND-3
0.35
Influent
12
1
554
25
78
1
ND
ND
99
.06
Effluent
1LT
1LT
1LT
1LT
1LT
1LT
ND
ND
3
.53
Influent
59
1LT
1100
22
193
1LT
ND
ND
450
2.0
Effluen"
1LT
1LT
1LT
1LT
1LT
1LT
ND
ND
ND
0.49
Asbestos (verification program did not analyze for this compound)
Conventionals (mg/1)
BOD,-
TSS5
Non-Conventi onals (mg/1)
COD
*NOTE:
328
110
7310
216.7
98
970
3479
55
6650
98
110
900
4537
1600
7700
135
104
903
All analytical fractions were not analyzed for samples taken for this
plant.
G-5
-------
SCREENING PROGRAM StMUARY OF PLANT 1?n3fi
St*HARY OF SCREENING DATA
Priority Pollutants Influx Ffflupnt
Phenol 56-80 (2) ND (3)
Base/Neutral Extractables
Aeenaphthene ND-35 (3) ND (3)
Bis (2-ethylhexyl) phthalate ND-180 (2) 38-68 (3)
Di-n-butyl phthalate ND (2) NO-15 (3)
Oiethyl phthalate ND (2) ND-20 (3)
Volatile Organlcs
fcenzenc 260 (1
Carbon Tetrachloride 18 (1
1,1,1-Trichlorocthane 22 (1
Chlorofona 180 (1
1,1-Dlchlorocthylene 230 (1
Ethyl benzene 18 (i
Bsthylene chloride 6200 (1
Triehlorofluorowethane 970 (1
Tctraehloroethylene 14 (i
Toluene 310 (i
Hetals
Antimony 20LT (2
Arsenic 10-50LT (2
Chromium 16 (i
Beryllium ILT (2
Cadalu* ILT (2
Copper 50-73 (2
Lead 5LT (2
Karcury 0.5-1.2 (2
Nickel 10LT (2
Selenium 20-200LT (2
Thallium 8_18 (
Zinc 149-251 (
Cyanide 100-280 (
120 (1
16 (1
11 (1
110 (1
180 (1
22 (1
2600 (1
420 1
18 h
180 (1
10-20LT (3
10-11 (3
20LT (3
ILT (3
ILT (3
5LT-9 (3
5LT (3
0.2-0.7 (3
10LT (3
20LT (31
2) 10-11 (3
2) 60-100 (3
2) 28-30 (3
'
)
WASTEWATER TREATMENT PLANT UNIT OPERATIONS
Activated Sludge !
Trickling Filter ;
Aerated Lagoon :
Waste Stabilization Pond
Polishing Pond
Aerobic Digestion j
Cropland Use
i
PLANT CHARACTERISTICS
Subcategory Hastewater Quantity (MGD) Employment
A 1-13 100-200
PERFORMANCE OF TREATMENT SYSTEM
BOD (mg/1) COD (mg/1) TSS (mg/1)
J"f.li!SES Effluent Influent Effluent Influent Effluent
1326-1900 (2) 24-35 (3) 2800-4210 (2) 227-262 (3) 700-840 (2) 44-49 (3)s
WASTEKATER TREATMENT PLANT FLOW DIAGRAM
SAMPLING PROGRAM
Sample Location
Ho. of Samples
1 - Influent to Wastewater Treatment System at
Manhole M-5
2 - Agricultural Research Farm Discharge to the WTP
3 - Pond 4 Effluent Before Chlorination
4 - 001 Discharge
Raw Water Supply
Process Waste Discharge from Penicillin
Packaging Operation-Manhole 12A
Combined Process Wastestream at Manhole M-7
6-6
-------
SCREENING PROGRAM Sl»MARY OF PLANT
SUMJARY OF
Priority Pollutants
Acid Extractables
Phenols (Tot.)
Volatile Organics
Benzene
1 , 2-D i chl oroethane
Chloroform
1,1-Dichloroethylene
Ethyl benzene
Trichlorofluoromethane
Toluene
Methyl ene chloride
Metals
Antimony
Arsenic
Beryllium
Cadmium
Chromium
Copper
Lead
Mercury
Nickel
Selenium
Silver
Thallium
Zinc
Cyanide
SCREENING DATA
CONCENTRATION (ug/1)
Influent* Effluent
16-17 (2)
10LT-44 2)
15-65 2)
32-56 (2)
62-90 (2
57-160 (2
180-280 (2
120-NQ 2
NQ 2
20LT 2)
14.5-50LT 2)
l.OLT 2)
l.OLT 2)
20LT-26 2)
— 44-63 2)
5LT 2)
0.2-0.4 (2)
10LT (2)
20LT (2)
l.OLT (2)
— 10LT (2
55-63 (2
300 (2)
WASTEWATER TREATMENT PLANT UNIT OPERATIONS
Fermentation Waste Treatment System Chem. Waste Treatment System
Equalization Equalization
Neutralization Neutralization
Primary Sedimentation Primary Sedimentation
Activated Sludge Primary Chemical Flocculation/
Centrifugal Dewatering Clarification
Anaerobic Digestion Aerated Lagoon
Landfill Centrifugal Dewatering
Anaerobic Digestion
Thermal Oxidation System Landfill
Equalisation Pretreatment System
Neutralization In-Plant Treatment
Thermal Oxidation Heat Conditioning
PLANT CHARACTERISTICS
Subcategory Uastewater Quantity (MGD) Employment
A.B.C.D 2.60 1000-1100
PERFORMANCE OF TREATMENT SYSTEM
BOD (mg/1) COD (mg/1) TSS (mg/1)
Influent Effluent Influent,, Effluent Influent Effluent^
26-30(2) , 192-219(2) 20-24(2)
* Complex arrangement of multiple raw waste streams prevents simple
H0fVn
-------
SCREENING PROGRAM
SUMMARY OF PLANT
12038 (continued)
FERMENTATION WASTE TREATMENT SYSTKM
1. 001 tiischuge
J. Ceebiiwd effluent froa liaestone bed and
hlllaiJe stora sewer
3. gliding T-17 process yaste discharge
4. Q»olc*l synthesis influent, T302 to T303
S. tt«««n influent to T307B (clarifier)
*2 I"°Ce" V"tc linc feedlna lagoon
froa Building 1-66
7. CUeifier T-312 effluent
«. COiK««Mt«d antibiotic waste - influent to
t»iolQ9ic*l treataent ,
9. Bllut* antibiotic waste influent to T201 3
W.CUrifier T-212 effluent
Stora sewer
raw water supply
SECONDARY THERMAL OXIDATION SYSTEM
CHtMICAI. HASTE TREATMENT SYSTEM
-------
VERIFICATION PROGRAM
ANALYTICAL RESULTS
PLANT 12038
EFFLUENT
n mil umai wp
Apparent
Concentration
Pol lutant
Loading
/l/fl/Haul
Priority Pollutants
O
1
to
Volatile Organlcs
Benzene
1 , 2-0 1 ch 1 oroethane
Ch 1 orof orm
1, I -D Ichl oroethy 1 ene
1 , 2-Trans-O Ichl oroethy 1 ene
Ethyl benzene
Methyl ene Chloride
Monoch 1 orobenzene
Acid Extractables
Phenol
2-Chlorophenol
Pentachlorophenol
Phenol (4 AAP)
Base/Neutral Extractables
Pesticides
• Product X
D 1 propy 1 n I trosoam 1 ne
"Chrom 1 urn
Copper
Zinc
Cyanide
Asbestos
10
10-30
10
10
10-105
10
10-560
10
10
10-50
10-50
10
81-279
13,000-17,000
170-5,500
49-180
40-115
1
50-202
104,00-135,000
(Verification
.001- .0027
.001- .0079
.001- .0027
.001- .0027
.001- .011
.001- .0027
.001- .148
.001- .0027
.001- .0027
• .'
.0023-. 0068
.0023-. 0056
.0027
.009-. 075
3.03-4.49
.04-1.5 '
.0067-.019
.004-. 018
.0001-.0002
.006-. 055
11.1-15
program did not
Conventional
BODc (Concentration In Mb/L)
TSS (Concentration In MG/L)
Non-Convent 1 ona 1 s
COO (Concentration In Mb/L)
4,390-7,130
i
696-1,640
From Chemical
Apparent
Concentration
(ug/Llter)
100-10,300
3,500-14,000
160-690
10-20
10
5,600-42,000
6,400-16,000
26,000-227,000
100-123,000
3 500-6 400
' 10-25*
21,500-48,500
I
5
37-126
5,170-6,670
1-15
313-2,690
analyze for this
3,790-9,300
892-2,140
9,800-21,000
Operations
Pollutant
Load 1 ng
(kg/Day)
.09-9.74
3.31-13.2
.15I-.653
.009
.009
5.30-39.7
6.05-15.1
24.6-215
.09-116
3.31-6.05
.009-. 024
20.3-45.9
.0009
.0047
.035-. 1 19
4.89-6.65
.0009-.0142
.296-2.54
compound )
3,590-8,800
844-2,020
9,440-19,800
INI-LUENI _ —
*n«n+ fionr 0 1 1 ute Wastes
•3V™ " ' "qCT — _. — _ j •£ — D i 4 .^.-..j. Annarnnt
Apparent Pollutant Apparent ronutanT Apparent
Concentration Loading Concentration Loading Concentration
,"g/"It«rl (ko/Dav) (uq/Llter) (kq/Day) (uq/Llter)
!
10
22-44
10 '
10
10 :
10 ;
16-26
10
10
i
20-23
1-1.9
1- 2
60-81
57-61
1
68-82
32-136 .036-. 159 10-32 .01 1-.031 56-85 .
9,900-10,500 11,600-11,900 674-1,210 I^f*S,n ?»dfi
1,210-1,430 1,410-1.730 548-1,100 524-1,070 28-46
17 100-20.300 20,700-22,900 1,520-2,200 1,450-1,840 216-274
'78-128 ' 91.3-145 2.3-21.8 2.24-24.1 23.7-25
Pollutant
Loading
(ka/Day)
.275
.605-1.21
.275
.275
.275
.275
. .44-,715
.275
.275
.55-. 63
.028-.05
.02S-.05
1.65-2.23
1.65-1.68
.0275
1.87-2.26
1.54-2.34
578-1 ,270
770-1,270
5,940-7,540
652-688
NHj-N (Concentration In MG/L)
-------
SCREENING PROGRAM SUMMARY OF PUNT 12066
SU*tARY OF SCREENING DATA
CONCENTRATION (ug/l|
Priority Pollutants Influent Effluent
Acid Extractables
4.6-Dlnltro-b-cresol ND (1) 15 (i
Phenol 45 d) ND |:
Base/HBUtral Extractables
liZ-Olchlorobcnzene 12 (i) ND (1
H-nltrosodiphenylaraine 12 (1) ND (1
Bis (2-ethylhexyl) phthalate 130 (1) 44 (i
Volatile Organlcs
Cnlorofora 51 m un /i
Kcthylene chloride 35 (i) 31 {{
HaUls
SnTliohy 28 (1 9 (i
tos*"te ZOLT 1 30 1
Castelua 7 i g );
ChrcrafuB 136 i 165 fj
Copper 22 i 41 J
"«;:cujy 0.9 i o.s a
Selenium 16 (i 30 (1
Zinc 191 i oca n
•HXi"« ILT 1 ?LT !
H^C'(C1 SLT 1 5LT fl
Th»lH« BOLT 1 50LT(1
Pyanff FLOiV DIAGRAM
Location
1. Influent to Pretreataont Facility
S. Effluent froa Prctroatacnt Facility
Mo. of samples
G-10
-------
SCREENING PROGRAM SUMMARY OF PLANT _12Q2Z_
SUNWABY OF SCREENING DATA
Priority Pollutants
Acid Extractables
Phenol
Base/Neutral Extractables
Acenaphthene
Benzidine
2,4-Dinitrotoluene
• 2,6-Dinitrotoluene
Bis (2-chloroisopropyl) ether
Volatile Organics
Benzene
Chi oro benzene
1,1,1-Trichloroethane
Chloroform
Ethyl benzene
Methyl ene chloride
Bromoform
Toluene
Metals
Antimony
Aisenic
Beryllium
Cadmium
Chromium
Copper
Lead
Mercury
Nickel
Selenium
Silver
Thallium
Zinc
Influent Effluent
19
135
27
32
19
38
92
139
LTDL
LTDL
445
87
ND ,
617
2000LT
2000LT
ILT
6
55
154
119
1.8
31
2000LT
ILT
2000LT
458
ND
ND
ND
14
ND
48
80
LTDL
20
13
LTDL
397
44
LTDL
2LT
2LT
ILT
2LT
8
13
20LT
O.ILT
5LT
2LT
ILT
2LT
60LT
WASTEWATER TREATMENT PLANT UNIT OPERATIONS
rhemical Waste Treatment System Floor H^sl^jre^e"t1^^t^nlovj1
Neutralization ^vi^cSon^ ^^
Chemical°Stab11izition Secondary Chemical Flocculatlon/
Chemical Conditioning Uc1?rit 1" t^?4 ,+,„„
Vacuum Dewatering Chemical Stabilization
Lantm ' ' Vacuum Dewatering
Landfill
PLANT CHARACTERISTICS
Subcategory Hastewater Quantity (MGD) l?.?.1.?^.6."?..
CjD 0.035 If"-200
PERFORMANCE OF TREATMENT SYSTEM
BOD (mg/1) COD (mg/1) TSSjmg/l^
Influent Effluent . Jnf.li1.^ .!f^3"^.t. {.if.VJ?.?.*. .E.t.f.l.u.!.n.t.
"'_" "." """ — 262 5LT
Note: Weak chemical waste reported only. Strong chemical waste 1s
deep well injected.
25
48
WASTEWATER TREATMENT PLANT FLOW DIAGRAM
Sample Location
Raw Waste for Deep Well
Treated Waste for Deep Well
Raw Waste from Floor Drains
Treated Waste from Floor Drains
River Intake
Cooling Water Discharge
Well Water
No. of Samples
G-ll
-------
VERIFICATION PROGRAM
ANALYTICAL RESULTS
• PLANT 12097
Priority Pollutants
Volatile Organ Ics
Benzene
To Iuene
Acid Extractables
Phenol
TAP WATER
Concentration (tig/I)
12
WEAK CHEMICAL WASTE
CONCENTRATION (ug/I) POLLUTANT LOADIN6 (kg/day)
influent EffluSnfInfluentEffluent
STRONG CHEMICAL WASTE (Deep
(Ugyi) POLLUTMT
influent Effluent
15-180
90-6600
24-58
3-6
7-49
3-5
Base/Neutral Extractables
15000-87000 1100-10000
1400-130000 720-75000
44-5700
140-4600
Pesticides
Metals
Antimony
Arsenic
Bery 1 1 1 urn
Cadi mum
Chromium
Copper
Lead
Mercury
"4
J
6-11
1-13
244-336
91-206
1
15-36
1-2
1
i
j
134-397
31-154
program did not
1000-3973
85-109
7.1-7.3
39-43
798-1234
350-750
689-1148
309-710
.25-7.5
1762-4685
51 1-665
1.18-4.31
1-2
2
2
3-22
40-44
1
1
6
1-2
1
1
4
1-154
analyze for this compound)
186-240
3.5-16
7.1-7.6
2-5
1380-1662
176-392
1377-1646
174-387
304-508
80-150
.8-1.1
1-2
1-10
1
7-23
2-222
431-922
93-409
1-30
91-447
3-12
1
1
254-540
1-2
- 1-3
1
6-19
2-155
562-665
67-291
1-22
94-378
1-11
1
1
308-687
220-1090
16427-72320
118-354
5.0-6.7
79-216
19742-31148
1596-3736
19624-30794
1517-3520"
.3-130
40000-92928
13000-18000
252-455
69-5900
37760-54400
9-22
4.6-6.6
6-20
20652-30364
2068-3616
20634-30355
2582-3610
.1-.4
20200-78731
14500-20200
297-435
Influent Effluent
-------
SCREENING PROGRAM SUMMARY OF PT.ANT 12108
SUMMARY OF
Priority Pollutants
Acid Extractables
Phenols ( 4AAP)
Volatile Organics
Benzene
Carbon tetrachloride
1,1,1-Trichl oroethane
1,1-Dichloroethane
Chloroform
Methyl ene chloride
To! uene
Metals
Antimony
Arsenic
Beryllium
Cadmium
Chromium
Copper
Lead
Mercury
Nickel
Silver
Zinc
Selenium
Thallium
Cyanide
SCREENING DATA
CONCENTRATION (ug/1)
Influent* Effluent
925 (1)
390 (1)
300 (1)
1300 (1)
0.1 (1)
1350 (1)
200000 (1)
53 (1)
NAI
NAI
10LT (1)
32 (1)
107 (1)
116 (1)
286 (1) —
50 (1)
137 (1)
24 (1)
522 (1)
NAI
NAI
2LT
WASTEWATER TREATMENT PLANT UNIT OPERATIONS
Neutralization
* Plant 12108 is a zero discharger. Influent sample was taken
from a tank truck holding waste to be trucked off site.
PLANT CHARACTERISTICS
Subcategory Wastewater Quantity (HGD) Employment
A.C.D — . 30°-400
t
PERFORMANCE OF TREATMENT SYSTEM
BOD (mg/1) COD (mg/1) TSS (mg/D
Influent Effluent Influent Effluent Influent Effluent
11300 25900 — 2640
WASTEWATER TREATMENT PLANT FLOW DIAGRAM
NOT APPLICABLE
SAMPLING PROGRAM
Sample Location No. of Samples
Raw Process Wastewater 1
G-13
-------
SCREENING PROGRAM StMttRY OF PLANT 12119
SU.WARY OF SCREENING DATA
Priority Pollutants Influent Effluent
Acid Extractables
'l-Hitrophcnol ND
PenUchlorophenol 42
Phenols (4AAP) 190
Base/Neutral Extractables
bis (2-chloroisopropyl) ether 448 (
Isophorone 11 (
Butyl benzyl phthalate 18 (
Volatile Ornanlcs
1,1,1-trlchloroethane 10LT (
Kethylenc chloride 23 (
Hfltals
Antlsony 40
Arsenic 10LT
Beryllium 10LT
Chromium 57
Copper 93
Lead 75
Hercury 5.5
Nickel 112
SclcniuBi 28
Thallium NAI
Zinc 1395 (
Cyanide 2LT (
1) 15 (1)
1) 10LT (1)
2) 5LT (1)
1) ND (1)
1 ND 1
1} ND (1)
1) 10 (1)
1) 349 (1)
1 NAI
1 NAI
1 10LT 1)
1 19 1)
1 39 1)
1 89 (1)
1 0.5 1)
1 50 (1)
I) NAI
2LT (1)
I) 403 (1)
L) 2LT (1)
WASTEWATER TREATMENT PLANT UNIT OPERATIONS
Equalization
Neutralization '
Coarse Settleable Solids Removal
Primary Sedimentation:
Activated Sludge
Phys./Chem. Evaporation
Anaerobic Digestion
Drying Beds
Sludge to POTW
PLANT CHARACTERISTICS
Subcategory Wastewater Quantity (HGD) Employment
A,D ' .032 N/A
PERFORMANCE OF TREATMENT SYSTEM
KP.11!?/..1.) : co° ("19/1 ) TSS (mg/1)
Influent Effluent Influent Effluent Influent Effluent
833 10 1410 232 475 10
WASTEWATER TREATMENT PLANT FLOW DIAGRAM
Not available.
Sample Location
Raw process water
Process Wastewater
Stripped Wastewater
Influent to treatment
Effluent from treatment
SAMPLING PROGRAM
ijo. of Samples
6-14
-------
SCREENING PROGRAM SUMMARY OF PT ANT 12132
SIM1ARY OF SCREENING DATA
CONCENTRATION
Priority Pollutants
Add Extractables
2-Nitrophenol
4-Nitrophenol
Phenols (Tot.)
Base/Neutral Extractables
Bis (2-ethy1hexy1) phthalate
Di-n-butyl phthalate
Volatile Organics
Benzene
1,1,1-Trichloroethane
l,l-D1chloroethane
Chloroform
• Ethyl benzene
Heth'ylene chloride
Toluene
Metals
Beryllium
Cadmium
Chromium
Copper
Lead
Mercury
Nickel
Silver
Zinc
Cyanide
Influent
119 (1)
181 (1)
188 (1)
ND (1)
ND (1)
100GT (1)
19 (1)
5 (1)
100GT (1)
100GT (1)
100GT (1)
50 (1)
10LT (1)
20GT (1)
200 (1)
200 (1)
200LT (1)
0.7 (1)
50LT (1)
10LT (1)
600LT (1)
1485 (1)
J.??/.1.!
Effluent
ND (1)
ND (1)
126 (1)
liil
ND (1)
ND 1)
ND 1)
ND 1)
ND 1)
100GT (1)
ND (1)
400 GT (1)
WASTEWATER TREATMENT PLANT UNIT OPERATIONS
Equalization
Neutralization
Coarse Settleable Solids Removal
Primary Sedimentation
Primary Chemical Flocculation/Clarification
Activated Sludge
Trickling Filter
Waste Stablization Ponds
Flotation Thickening
Centrifugal Thickening
Centrifugal Dewatering
Incineration
Landfill
PLANT CHARACTERISTICS
Subcategory Wastewater Quantity (HGD)
A,C 1.02
PERFORMANCE OF TREATMENT SYSTEM
BOD (mg/1) COD (mg/1) TSS
Influent Effluent Influent Effluent Influent
Employment
300-400
(mg/1)
Effluent
420 246 5512 1803
WASTEWATER TREATMENT PLAMT FLOW DIAGRAM
a'
*!7I
&i_._"7,;
C-T '!••
AVa.'
os.y-i
TSS,
Sedimentation Basin Effluent
Final Clarifier Sludge
Final Clarifier Effluents
DAF Skimmings
6-15
-------
SCREENING PROGRAM SUf.MARY OF PLANT I?1fi1
SU.MARY OF SCREENING DATA
PrtoHty Pollutants
Acid Extractables
Phenol ics
Base/Heutral Extractables
&\s (Z-ethylhexyl) phthalate
Volatile Organics
benzene
1,1,2-Trichloroothane
Chloroethane
Chloroforn
Ethyl benzene
Bethylene chloride
Toluene
totals
Ant1«ony
Arsenic
Beryl Hun
Cficfwf UBI
Chromtun
Copper
Lead
Nickel
Silver
Zinc
Cyanide
CONCENTRATION (ug/1)
Influent
Effluent
57-204 (2) 8-16 (2)
39 (1) 0.10LT (1)
48
0.9
6.1
1050
7.5
2.2
10400
24 (
20LT (
1.6 (
32
14
27
46
89 (
4 (
250 {]
40LT (2
1) 0.01LT (1)
1) 0.01LT (1)
1) 0.01LT (1)
I) 2.8 (1)
1) 0.01LT (1)
U 1.7 (1)
I) 0.01LT (1)
I 0.17 (1)
L 20LT (1)
I 0.20LT (1)
1 l.OLT (1)
L 2.0LT (1)
L 0.2LT (1)
L 10LT (1)
I 56 (1)
L 3LT 1)
I) 14 (1)
!) 40LT (2)
WASTEWATER TREATMEOT PLANT UNIT OPERATIONS
Equalization
Neutralization
Coarse Settleable Solids Removal
Primary Sedimentation
Primary Chemical Flocculation/Clarification
Activated Sludge
Polishing Ponds :
Gravity Thickening
Aerobic Digestion
Compositing
Landfill
Cropland Use
PLANT CHARACTERISTICS
Subcategory Wastewater Quantity (MGD) Employment
""*""""*""
. A,C,D 1.33 900-1000
PERFORMANCE OF TREATMENT SYSTEM
?.°.P.lm?/.].! co° ("19/1 ) TSS (mg/1)
Influent Effluent Influent Effluent Influent Effluent
748-1043(2) 34-61(2) 1800-3000(3)600-780(3) 150-398(3) 60-88(3)
WASTEWATER TREATMENT PLANT FLOW DIAGRAM
CHLoraie poo-Men AMMOWU
j I PHOSPKSfilC AC10
©i .~i., i — !
pt—
— 2 «— |
CL, TANK
* POLISHING POflDS
'«'***-£ cxeSu *E™!LCB «_„.
X^^/ TANKS If G 1^ il
usafi • y
- »H-UfJC raw SUPENHATAHT "
--eHfii;e*tj 1 i'l
X
M
PRS-CUn«EJ! stUOOE ' ^
^ U
uJ
" 1
fSECONO\ SECOND STAGED j
\FINAL J ' n
X___X AERATIOK
I TANK 4
*
RETURN ^LUOGE zcJ STAGE
< "CESS SLUOGE L .^^^
Kruiw suiDGf i:: OT.'.G-
t '.
FIRST STAGE ' /*~
\ . T.v.x 3 /FiRSl
>jj
t?
3 ^
'os
as
ti
O LJ
H
dr:
i
^
iltri"-'" VsSf J 1 J 2 L t.~*(cLAt>rer,;) iri - -1 -[STAGS j ; J
' ' * V nf J < AERATIOM VFIKAL /
u -1 V^L/ [.... TANS 2 V /
EQUALIZATION PONDS
LIME rOL^UQ
sut.runic ACID
SAMPL
Sample Location
T
AMVCXIA '
tt*>*"«X>X ™° lsaHM
ENG PROGRAM
1. Raw waste (combined) to wwrp 5
2. Discharge 001 - Treated from WWTP t 5
Raw waste - Plant A
Raw waste - Plant B ' ^
Raw waste - Plant C 4
6-16
-------
SCREENING PROGRAM—-SUMMARY OF PLANT 1??na
SUMJARY OF SCREENING DATA
CONCENTRATION (ug/1)
Priority Pollutants Influent Effluent
Acid Extractables
2,4 Dimethyl phenol 62 (1) 0.10LT (1)
Phenol 38 (1) 3.8 (1)
Phenolics 134 (1) 17 (1)
Base/Neutral Extractables
Bis (2-ethylhexyl) phthalate 0.10LT (1) , 25 (1)
Volatile Organics
Acrolein 100LT (1) 100LT (1)
Acrylonitrile 100LT (1) 100LT (1)
Benzene 6.5 1) 0.10LT (1)
Chlorobenzene 1.9 1 0.10LT (1)
1,2-Dichloroethane 28 1 0.10LT (1)
1,1,1-Trichloroethane 27 (.1) 33 (1)
Chloroform 150 (1) 90 (1)
1,1-01 chloroethylene 2.1 (1) 0.01LT (1)
Ethyl benzene 14 (1) 0.01LT (1)
Hethylene chloride 1400 (1) 0.01LT (1)
Trichlorofluoromethane 0.9 1) 0.01LT (1)
Tetrachloroethylene 1.91) 1.4(1)
Toluene 190 1 0.01LT (1)
Trichloroethylene 6.6 1 0.8 (1)
Metals
Antimony 20J (1) 8J (1)
Arsenic 20LT 1) 20LT (1)
Beryllium 0.2LT 1) 0.2LT (1)
Cadmium 4J 1) 1LT (1)
Chromium 23 1) 19 (1)
Copper 88 J (1) 16 (1)
"Lead 63J (1 20 (1)
Mercury 1.3 (1 1.3 (1)
Nickel 28 1 37 1)
Silver 6J 1 31)
Thallium 7LT 1 7LT 1)
Zinc 500J 1) 300J 1)
Cyanide 40LT (1) 40LT (1)
WASTEWATER TREATMENT PLANT UNIT OPERATIONS
Neutralization
Coarse Settleable Solids Removal •
Primary Chemical Flocculation/Clarification
Activated Sludge with Pure Oxygen
Mechanical Thickening
Chemical Conditioning
Vacuum Dewatering
Compositing
PLANT CHARACTERISTICS
Subcategory Wastewater Quantity (MGD) Employment
A.B.C.D 0.85 2000-2100
PERFORMANCE OF TREATMENT SYSTEM
BOD (mg/1) COD (mg/1) TSS (mg/1)
Influent Effluent Influent Effluent Influent Effluent
690-1090 (3) 15-75 (3) 1215-1815 (3) 243-303 (3) 900-1200 (3) 90-120 (3)
Traditional data supplied by plant.
WASTEWATER TREATMENT PLANT FLOW DIAGRAM
Not available.
SAMPLING PROGRAM
Sample Location
Municipal water
Well water
Combined influent
Final effluent
Building "A" process wastewaters
No. of Samples
4
4
5
5
5
G-17
-------
SCREENING PROGRAM SUM.IARY OF PLANT 12210
SWtlAW OP SCREENING DATA
CONCENTRATION (ug/1)
Priority Pollutants Influent Effluent
Acid Extractables
4-Nhrophenol IOLT
Pentachlorophenol IQLT
Phenol IOLT
Phenols (4MP) 420
Basa/Meutral Extractables
Bis iz-ethyinexyi) phthalate 2700
Ofethyl phthalate IOLT
Fluorene IOLT
It-nUrosodiphenylamlne 10LT
Volatile Orqanlcs
Benzene 7 7
Chloroform 5^7
Ethyl benzene 5Q
Hethylene chloride 150
Tetrachloroethylene 5LT
Toluene 5LT
1,1,1-Trichloroethane SLT
Kotals
JuHony 10UT
Arsenic 10LT
Beryl Hum IOLT
Cstalius 10LT
Chroiaiwi 56
Copper 147
|;e*d NAI
Mercury 0.48
Klcfccl 96
felenlw 10LT
Silver IOLT
ThalHua 10LT
Zinc 503
.CyMJdc 4 (
{,
(]
a
8
!!
j!
1
!
i
i]
1
i
i)
i)
i)
L)
Li :::
>
i
—
WASTEWATER TREATMENT PLANT UNIT OPERATIONS
Aerated Lagoon (Receives only sanitary waste)
of ^ff 'site 1S a 2er° diischar9er- A11 P^cess wastewater is disposed
i
PLANT CHARACTERISTICS
Subcategory Wastewater Quantity (HGD) Employment
B>C -002 100-200
PERFORMANCE OF TREATMENT SYSTEM
BOD {rag/1 ) : COD (ng/1) TSS (mg/1)
Influent Effluent Influent Effluent Influent Effluent
480
WASTHYATER IREABENr
Not available
FIXHV DIAGRAM
SAMPLING PROGRAM
Location
process wastowater at waste storage tanks
Influent to pretreatment system for sanitary
wastewater
Effluent from pretreatment system for sanitary
wastewater
of Samples
6-18
-------
SCREENING PROGRAM SUMARY OF Pt.ANT 12231
SWtlARY
Priority Pollutants
Acid Extractables
. Phenols (4AAP)
Volatile Organics
Hethylene chloride
Metals
1 Antimony
1 Arsenic
Beryl 1 ium
1 Cadmium
1 Chromium
1 Copper
1 Lead
1 Mercury
Nickel
1 Selenium
Thallium
Zinc
1 Cyanide
OF SCREENING DATA
CONCENTRATION (ug/lj
Influent Effluent
180 (1
20LT (1
10LT (1
10LT (1
10LT (1
57 (1
150 (1
18 (1
0.72 J
10LT 1
10LT 1
NAI
208 (]
2LT (]
) 20 (1)
72 (1)
) 20LT (1)
) 10LT (1)
) 10LT (1)
10LT 1)
51 1)
59 1)
89 1)
) 0.5 1)
) 22 1)
) 10LT 1)
5 1)
) 48 (1)
) 2LT (1)
WASTEWATER TREATMENT PLANT UNIT OPERATIONS
Equalization
Neutralization
Coarse Settleable Solids Removal
Primary Sedimentation
Aerated Lagoon
Waste Stabilization Ponds
Anaerobic Digestion
Landfill
PLANT CHARACTERISTICS
Subcategory Wastewater Quantity (HGD) Employment
A,D 0.50 600-700
PERFORMANCE OF TREATMENT SYSTEM
BOD (mg/1) COD (rag/1) TSS (mg/1)
Influent Effluent Influent Effluent Influent Effluent
3200 147 2160 436 113 12
WASTSVATER TREATMENT PLANT FLOW DIAGRAM
To
SAMPLING PROGRAM
Sample Location
1. Influent - raw waste to treatment
2. Intermediate WW'P point
3. Final effluent
Raw process water
No. of Samples
2
2
2
1
G-19
-------
SCREENING PROGRAM SWMARY OF PLANT 12236
SU.MARY OF SCREENING QVTA
CONCENTRATION (ug/lj
Priority Pollutants Influent Effluent
Acid Extractables
Phenols (4AAP) 780
Bise/Heutral Extractables
Bis (2-chloroethyl) ether 10
l,Z-Dtph«nyl hydrazine 20 i
Volatile Organlcs
oenzcne 40
Chloroform 30
Methyl ene chloride 40000
Ethyl benzene 12
Toluene 33000
1,1-Dlchloroethylene 190
Kethyl chloride 1300
Brcnmethane 30
Hauls
fintTiony NAI
Arsenic NAI
Beryllium 10LT /
Ca*ti(iw 10LT (
Chromium 34 |
Copper 16
tead NAI
Kfcury 0.2LT
Hickel 63
Selenium HAI
Silver 10LT (
Thallium 30
Zinc 191 I
Cyanide 560 (
1) 580 (1)
1) 20 (1)
1) ND (1)
1
1
1 200 (1)
1 1350 (1)
1 "I
1)
NAI
NAI
1 10LT (1)
1 10LT (1)
1 10LT (1)
1 10LT (1)
1 96 1)
1 0.80 (1)
I) 63 (1)
NAI
1) 10LT (1)
1 NAI
1) 34 (1)
1) ' 220 (1)
WASTEWATER TREATMENT PLANT UNIT OPERATIONS
Equal Ization
Neutral Ization
Primary Sedimentation
Activated Sludge
Flotation Thickening
Chemical Conditioning
Vacuum Dewatering '
Landfill :
PLANT CHARACTERISTICS
Subcategory Uastewater Quantity (MGD) Employment
C ! -810 200-300
PERR3K.IANCE OF TREATMENT SYSTEM
BOD (rag/1) COD (mg/1) TSS (mg/1)
Influent Effluent . Influent Effluent; Influent Effluent
1200ST 300 3500 1370 188 94
WASTEWATER TREATf-IBrT PLAfH1 FLOllT DIAGRAM
faar>lc location
SflHPLMO PBOCRAM
EFFLUTIJT
FLOW METER
I. Influent to wastewater treatraant system
-------
r
VERIFICATION PROGRAM
ANALYTICAL RESULTS
PLANT 12236
Adjusted Concentration Pollutant Loading
Influent Effluent
(ug/Liter) (ug/Liter)
Priority Pollutants
Volatile Organics
Toluene
Methylene Chloride
Chloroform
1 , 1-Dichloroethylene
1 , 2-Dichloroethane
Benzene
Ethylbenzene
Ch lorome thane
Acid Extractables
56,000-71,000
14,000-80,000 1
10
10-16
68-560
10-27
10-12
8,000-13,000
10
500-8100
10
10
62-300
10
10
100-410
Influent
(kg/day)
170-210
42-2403
.030
.030-. 048
.2-1.7
.030-. 081
.030-. 036
24-39
Effluent
(kg/day)
.032
4.8-26
.032
.032
.2-. 96
.032
.032
.32-1.3
Base/Neutral Extractables
Pesticides
Metals
Beryl ium
Cadmium
Chromium
Copper
Lead
Mercury
Nickel
Selenium
Silver
Zinc
Cyanides
Phenol (4AAP)
Asbestos
Conventional
BOD
Non-Conventional
10
10
42-152
14-16
40
0.62-0.69
26-39
40
10
69-159
20-270
940-1900
(Verification
compound )
1023-1266
10
10
10-16
10
25
0.2-0.56
21-30
40
10
13-173
9-228
55-455
program
130-140
.030
.030 .
.126-. 456
.042-. 048
.12
.002
.078-. 117
.12
.030
.2-. 477
.06-. 81
2.82-5.7
.030
.030
.03-. 048
.030
.075
.0006-. 0017
.063-. 09
.12
.030
.039-. 52
.027-. 684
.16-1.4
did not analyze for this
3070-3800
390-420
COD
1904-2641
633-640
5712-7923 1900-1920
G-21
-------
SCREENING PROGRAM SUMMARY OF PLANT
SU-tlARY OF SCREENING DATA
CONCENTRATION (ug/1
Priority Pollutants Influent Efflue
Acid Extractables
Phenols (Tot.) 694 (1) NO
Base/Heutral Extractables
&ls (2-ethylhexyl) phthalate 50 1) 10
EH-n-butyl phthalate 20 1) 4
Volatile Orqanics
1,2-Dlchloroethane 15 1 ND
1,1,1-Trlchloroethane 17 1 ND
Chloroform 100GT 1 ND
Bethylene chloride 100GT 1 100GT
Toluene 2 (1 ND
totals
BeryTTiuw 1LT (i) ILT
Cadwiu* 2LT (1) 4
Chromium 30 (1 10
Copper 80 (1 20
lead 20LT (1) 20LT
Hlckel 5LT (1 5LT
Silver ILT (1) ILT
Zinc 60LT (l) 100
Cyanide 25LT (1) 25LT (
1
nt
(1)
(1)
(1)
1
1
1
1)
1)
1)
I
I
l\
1)
1)
WASTEWATER TREATMENT PLANT UNIT OPERATIONS
Equalization
Coarse Settleable Solids Removal
Activated Sludge
Mechanical Thickening
Aerobic Digestion
Gravity Dewatering ',
Landfill
PLANT CHARACTERISTICS
Subcategory Wastewater Quantity (HGD) Employment
D .035 800-900
PERFORMANCE OF TREATMENT SYSTEM
BOD (mg/1) COD (mg/1) TSS (mg/1)
Influent Effluent Influent Effluent Influent Effluent
. —
WASTEWATER TREATMENT PLANT FLOW DIAGRAM
1. Influ'-.'lt To KWTP
2. Efflil'tit from wvn-p
G-22
-------
SCREENING PROGRAM SUM-tARY OF PLANT 12256
SUMMARY OF SCREENING DATA
CONCENTRATION (up/1)
Priority Pollutants
Add Ex trac tables
Phenol
Volatile Organics
Chloroform
Methylene chloride
Toulene
Hetals
Antimony
Arsenic
Beryllium
Cadmium
Chromium
Copper
Lead
1 Mercury
1 Nickel
Selenium
Silver
Thallium
1 Zinc
Influent Effluent
10 (1)* 33 (1)<
40 (
300LT (
0 40 (1)
I) 300LT (1)
100J (1) 100J (1)
400LT-1000LT (2) 400LT-1000LT
Cl T 1 O /O\ CI X 1 A
Dl_ I - 1 3 V
10LT (,
10LT-40 (
50LT ('
100LT (I
100LT-500 (.
0.2-10 (,
100LT-300
5LT-21 .
5LT-40 /
100LT !
-i yi.i~i*?
I 10LT
2 10LT-40
I BOLT
2 . 100LT
2) 100LT-400
2)
9^
<•)
2)
2)
2)
2)
2)
2) 0.2-0.7J (2)
2) 100LT-300 (2)
2) 5LT-12
2) 5LT-40
2) 100LT
2
2
2
50LT-310 (2) 50LT-230 (2
1 * Influent and effluent samples believed to be
| Interchanged when labeled.
WASTEWATER TREATMENT PLANT UNIT OPERATIONS
Equalization
Neutralization
Coarse Settleable Solids Removal
Primary Sedimentation w/Skimming
PLANT CHARACTERISTICS
Subcategory Wastewater Quantity (MGD)
A.B.C.D 30.0
PERFORt.lANCE OF TREATMENT SYSTEM
BOD (mg/1) COD (mg/1) TSS
Influent Effluent Influent Effluent Influent
— .177-242(3) — 300-420(3)
Traditional data supplied by plant.
i
Employment
1200-1300
(mg/1)
Effluent
29-42 (3)
WASTEWATER TREATMENT PLANT FLOW DIAGRAM
NOT AVAILABLE
SAMPLIHG PROGRAM
Sample Location
Well Area before Discharge Through Outfall #001
Split Manhole Discharging To Outfall #002
Manhole Prior to Discharge To Outfall #003
Skimming Basin Which Discharges To Outfall #008
Collection Basin Discharge to the Skimming Basin
Municipal Sewers Pumping station
Raw Freshwater Supply '
Saltwater Supply At Intake structures
NOTE: ALL REPORTED CONCENTRATION VALUES HAVE NOT BEEN CLEARLY ASSOCIATED
WITH PROCESS FLOW STREAMS. THEREFORE DATA FROM THIS SAMPLING EFFORT
WILL NOT BE USED IN S/V DATA ANALYSIS.
G-23
-------
SCREENING PROGRAM SUMMARY OF PLANT 12257
StJMIARY OF SCREENING DATA
CONCENTRATION (ug/1)
Priority Pollutants Influent
Acid Extraetables
Fncnol (Tot.) 320LT-4700 (
Volatile Organics
l,Z-Dichlorocthane
Hethylcne chloride
totals
Antimony 12-100LT (
Arsenic 10LT-43 (
Beryl H wa l
Cadmium l.OLT
Chrosilum 630-650
Copper 97-110 I
Lead 5LT-14 !
Mercury 0.20LT <
Nickel 56-630 <
Selenium IOL.T ;
Silver 2LT-4LT :
Thallium 40-43 2
Zinc 289-319 (2
Cyanide 440-580 (2
Effluent
2} 50LT-540LT(3
13-290(3
30-67(3
2 10LT(3
2 10LT-20(3
2 1LT(3
3 1.0LT(3)
2 160-190 3
> 21-31 3
'. 20-24 3
> .20LT(3
'. 160-190(3
! 10LT(3)
1 2LT(3)
10LT-29(3
) 113-163(3
) 70-7700(3)
WASTEWATER TREATMENT PLANT UNIT OPERATIONS
Equalization
Neutralization ;
Activated Sludge '
Centrifugel Dewaterring
Cropland Use
. PLANT CHARACTERISTICS
Subcategory Wastewater Quantity (H6D) Employment
i
A.B.C.D r .600 2100-2200
PERFORMANCE OF TREATMENT SYSTEM
?.°.P.lm9/1) C00 (mg/1) TSS (mg/1)
Influent Effluent Influent Effluent Influent Effluent
3100-4500 (2) 36-56 (3); 4610-6430 (2) 482-626 (3) 876-968 (2) 94-144 (3)
WASTEWATER TREATMENT PLANT FLOW DIAGRAM
Sample Location
No. o£'...SampI gs
1. Raw fermentation process wastes
2. Raw chemical synthesis process wastes
3. Combined plant process wastes after
neutralization
4. Treated effluent to WWTP
Cooling water discharge at bypass line
"nricipal water supply
G-24
-------
r
SCREENING PROGRAM Slf*IARY OF PT.ANT 12342
SIM1ARY OF SCREENING DATA
CONCENTRATION (ug/1)
Priority Pollutants
Acid Extractables
Phenol
Base/Neutral Extractables
Bis (2-ethylhexyl) phthalate
Volatile Organics
Chloroform
Toluene
1,1-Dichloroethane
Ethyl benzene
Acrolein
Metal s
Antimony
Arsenic
Cadmium
Chromium
Copper
Lead
Nickel
Selenium
Silver
Thallium
Cyanide
* Plant 12342 is an indirect
influent is an influent to
Influent * Effluent
14000 (1)
760 (1)
2 (1)
2 1)
2 1)
1 (1)
100LT (1)
27 1)
20LT 1)
1LT 1
20 1
130 1)
10LT 1
22 1
20LT 1
3LT (1)
8LT (1)
40LT (1)
discharger and the
a POTW.
WASTEWATER TREATMENT PLANT UNIT OPERATIONS
NO TREATMENT PROVIDED
PLANT CHARACTERISTICS
Subcategory Wastewater Quantity (HGD) Employment
A,C,0 .701 300-400
PERFORMANCE OF TREATMENT SYSTEM
BOD (mg/1) COD (mg/1) TSS (mg/1)
Influent Effluent Influent Effluent Influent Effluent
5810 — 12840 — 3480
WASTEWATER TREATMENT PLANT FLOW DIAGRAM
NOT APPLICABLE
SAMPLING PROGPAM
Sample Location
Discharge from Manhole No. 1
Discharge from Manhole No. 5
Discharge from Manhole No. 6
Discharge from Manhole No. 7
Potable Water - Building 28
Potable Water - Building 1
Potable Water - Building 5
Potable Water - Building 20R
No. of Samples
3
3
3
3
1
1
1
1
G-25
-------
SCREENING PROGRAM SUMMARY OF PLANT 12411
SUMMARY OF SCREENING DATA
CONCENTRATION (ug/1)
Priority Pollutants Influent Effluent
Acid Ex trac tables
Phenol 34 (1) 10LT (1)
Phenols (4AAP) NAI 70 (1)
Base/Neutral Extractables
Bis (2-ethylhexyl) ph thai ate 38 (1) 28 (1)
Volatile Qrganics
Benzene 6.7
Chloroform 860
ft ht/l hiftn9Ann Rl T
ciny lucfizcnQ OLI
Tetraehloroethylene 5LT
1
1
i
NO
5LT
wn
nu
ND
Toluene 290 (1) 5LT
Kethylene chloride 11000 (1) 32
totals
Antimony 68 (1
Arsenic 32 1
Beryl Hun 10LT
Cadiaiw) 10LT
Chroaiua 16
Copper 35
Lead 80
Kercury NAI
Nickel 20
Selenium 30
Silver 10LT
Thai Hun 5
i
I
i
i
i
i
!
Zinc 146 (1
Cyanide 590 (1)
NAI
NAI
1)
}
l)
1)
1)
1)
10LT (1)
i nt T M \
1UU 1
16
tl
26 (1)
NAI
1.58
40
NAI
10LT (
7
99
52
1)
1)
1)
i)
1!
i)
WASTEWATER TREATMENT PLANT UNIT OPERATIONS
Equalization
Neutralization
Aerated Lagoon
Incineration
PLANT CHARACTERISTICS
Subcategory Uastewater Quantity .(MGD) Employment
B.C.D 0.35 700-800
PERFORI.IANCE OF TREATI.IENT SYSTEM
BOO (mg/1) COD (mg/1) TSS (mg/1)
Influent Effluent Influent Effluent Influent Effluent
167GT 167GT — — 316 585
WASTEWATER TREATMENT PLANT FLOW DIAGRAM
.
ni
.
n
j ro,t>oa
itccso
1 JURU
c . comiottu
r noi
1 IKDICilOR
11 LIOUIB UY£l
i BECOME*
1C 13UI C1RI!K
TflC IQIU CIC1SIC C1M3H
Location
SAMPLING PROGRAM
1. Influent to pretreatment system
2. Effluent from pretreatment system
Combined sanitary cooling water and pretreated '•
process wastewater at access pit 13
No. Of Samples
;3
6-26
-------
VERIFICATION PROGRAM
ANALYTICAL RESULTS
PLANT 12411
Concentration
Pollutant Loading
Priority Pollutants
Volatile Organics ,
Toluene
Methylene Chloride
Chloroform
Acid Extractables
Influent
(ug/Liter)
Effluent
(ug/Liter)
Influent
(kg/day)
Effluent
(kg/day)
10
110-380
11000-280,000
2-Chlorophenol 10
2-Nitrophenol 14
Phenol 10
2,4-Dimethylphenol 10
2,4-Di chlorophenol 10
2,4,6-Trichloro Phenol 10
4-Chloro-3-Methylphenol 10
2,4-Dinitro-2-Methylphenol 10
Pentachlorophenol 10
4-Nitrophenol 10
Base/Neutral Extractables
Pesticides
10
10
10-170
10
10
10
10
10
10
10
48
114
10
Metals
Berylium
Cadmium
Chromium
Copper
Nickel
Lead
Selenium
Zinc
Mercury
Cyanides
Asbestos
Convent ional
BOD
Non-Conventional
COD
10
10
35-89
20-30
126-130
25
40
111-388
1-310
96-268
10
10
27-40
19-21
51-85
25
40
110-2009
.74-.96
144-254
,0086-.011
.095-.33
9.5-310
.01
.015
.011
.011
.011
.011
.011
.011
.011
.011
,0086-.011
,0086-.011
,0086^.19
.011
.011
.011
.011
.011
.011
.011
.053
.13
.011
.009
.009
.03-.095
,018-.03
,113-.136
.027
.04
.12-.39
0-.0045
106-260
.009
.009
.036
.02
.055-.07
.27
.04
.12-1.7
0
160-246
(Verification program did not analyze for this
compound)
1470
294
1270
254
4400-5750 2900-3300 4830-5600 2770-3610
6-27
-------
SCREENING PROGRAM—SUMMARY OF PI.ANT 12420
SU-MARY
Priority Pollutants
Acid Extraetables
i-Mltrophenol
Phenol
Volatile Organics
Benzene
Toluene
fatal s
beryllium
Cadmium
Chromium
Copper
Lead
Hereury
Nickel
Zinc
Cyanide
OF SCREENING DATA
CONCENTRATION (ug/1)
Influent
23 (1
240-51000 (2
580 (1
1050 (1
ILT (1
2LT h
212 (1
106 (1
27 (1
0.4 (1
5LT 1
151 (1
5LT (1)
Effluent
) ND (1)
I ND-120 (2)
NO (1)
LTDL (1)
ILT (1)
2LT 1
304 1
14 1)
42 1
0.1 (1
5LT (1
83 (1
5LT (1)
WASTEWATER TREATMENT PLANT UNIT OPERATIONS
Activated Sludge
Chemical Conditioning
Centrifugal Dewatering
Landfill
PLANT CHARACTERISTICS
Subcategory Wastewater Quantity (MGD) Employment
B,D — 100-200
PERFORMANCE OF TREATMENT SYSTEM
BOD (mg/1) , COD (mg/1) TSS (mg/1)
Influent Effluent Influent Effluent Influent Effluent
3250 195 355 638 490
WASTEKATER TREATMENT PLANT FLOW DIAGRAM
t*. .1.1.1
<»»;.* •
ii
|i-u
> r
111
I*AI
'MM.*- f
®
>T
V_J
IF
V*
ill
i i
— i
i
.-.*
s?£ -
i»
H —
-«-
ji.u. O 1 s*
n'S' ' '' \
* I CM 1*1 11 \
4J \ k
Sample Location
1. Influent to pr
2. Effluent from
Rescreening: 1
2
,v
^^^^ 20,000 Cal/H^y
,6t< rr?j nc^
,000 Pl-D EC1[!5
,Kt TKS TSS
,1 .SJl rw rr.s txn
Ri.-,,! >A:A ;5 Ji; p.i;.
3r..l:..ir.c V. J U(>
(l=.,li ricx) >^ S7
B.U v.,.t. r,« ru.vt jj£
SAMPLING PROGRAM
No. of
H't . I/-,.
4 i
20.000 Callon ' " -^jii^l
Clarltlcr ' j "•• | ' ^O1 ,„,„„,.
! "' , 190,000 aro
' >!„.•., m,..!, ttfc FfM SOff
flu«,.B|Troi.rh l.COOWJ BOD
* Tot,-.l 52.3M CPO i,
-------
SCREENING PROGRAM SUMMARY OF PLANT 12439
SIS-MARY OF SCREENING DATA
CONCENTRATION (ug/lj
.•••••••••••••••••••*••••••••"•'
Priority Pollutants Influent Effluent
Add Extractables
2,4-Dimethyl phenol 10LT (1 15
Phenols (4AAP) 42 (1 36
Base/Neutral Extractables
Acenaphthene 9Z (1) NO
2,4-D1n1trotoluene 65 (1) 10LT
B1s (2-Chlorosopropyl) ether 300 1) 181
Isophrone 1014 (1) 10LT
Butyl benzyl phthalate 719 (l) ND
01-n-butyl phthalate 19 (1) 10LT
Dlethyl phthalate 61 (1) ND
Anthracene 14 (1) 10LT
Fluorene 27 (1) 10LT
Phenanthrene 14 (1) 10LT
Volatile Organics
Benzene 73 (1) 10LT
Chlorobenzene 12 (1) ND
1,1,1-Trlchloroethane 261 (1) 10LT
1,1,2-Trlchloroethane 19 (1 ND
Chloroform 26 (1 16
Ethyl benzene 82 (1 10LT
Methyl ene chloride 640 (1 108
Tetrachloroethylene 26 (1 ND
Toluene 342 (1) 270
Trlchloroethylene 124 (1) 11
Metals
Antimony 20LT (1 20L
Arsenic 10LT (1 10L
Beryllium 10LT (1 10L
Cadmium 10LT (1 10L
Chromium 9 (1) 1
Copper . 32 (1) 3
Lead ' 10LT (0) 1
It
.!
!
1)
18
(l)
i)
l
i
1 .
:i
i)
i)
1}
T (1)
T 1)
T 1)
T 1
5 1
2 (1
4 (1
WASTEWATER TREATMENT PLANT UNIT OPERATIONS
Equalization
Neutralization
Primary Sedimentation
Activated Sludge
Aerated Lagoon
Landfill
PLANT CHARACTERISTICS
Subcategory Wastewater Quantity (MGD) Employment
C,D 0.01 100-200
PERFORMANCE OF TREATt.a-OT SYSTEM
BOD (mg/1) COO (mg/1) TSS (mg/1)
Influent Effluent Influent ' Effluent Influent Effluent
6841 2297 10 125
CONCENTRATION (ug/1)
Metals (Continued) Influent Effluent
Mercury 0.67 (1) 0.76 (1)
Nickel 10LT (1) 10LT (1)
Silver 10LT (1) 10LT (1)
Thallium 5 (1) 8 (1)
Z1nc 29 (1) 153 (1)
Cyanide 2LT (1) 2LT (1)
WASTEWATER TREATMENT PLANT FLOW DIAGRAM
Raw Waste ^Neutralization ^-Primary Sedimentation-
(activated sludge) >-Lagooning.
—^-Aeration Units
Design Considerations
Detention time of Aerators—2 hrs
Detention time of lagoons 60 days
Treatment Plant Capacity——30,000 gpd
Solvent Wastes >-recovery
SAMPLING PROGRAM
Sample Location
Industrial Stream Influent
Secondary Clarifier Effluent
Mo. of Samples
G-29
-------
SCREENING PROGRAM SIM4ARY OF PLANT 12(144
StMlARY OF SCREENING DATA
CONCENTRATION (ug/1)
Priority Pollutants Influent Effluent
Acid Extractables
Phenols (4AAP) 5
Base/lleutral Extractables
STsTZ-ethylhexyl) phthalate 10
Volatile Organlcs
Ehloro benzene ' 11
1,1,1-Trlchloroethane 22
Ethyl benzene 21
Hathylene chloride 16
Bromfom 12
HeUTs
Antiiohy 210
Beryl HIM 2
ChroaliM 102
Copper 148
Lead 30
Kereury 0.1
Hlckel 23
Silver 4
Zinc 254
Arsenic 20LT
Cadalun 2LT
Selenium 2LT
Thallium 100LT
Cyanide 7
[1
[1
!
[i
>
i
!
[i
—
—
...
WASTEWATER; TREATMENT PLANT UNIT OPERATIONS
Neutralization
Note: The arrangement of the wastewater streams was such that a
representative sample of untreated influent could not be
obtained. The influent samples analyzed were taken at
MH-81 through with 90 percent of the process wastewater flows.
PLANT CHARACTERISTICS
Subcategory Wastewater Quantity (MGD) Employment
A,D 2.97 MGD 000-900
PERFORMANCE OF TREATMENT SYSTEM
BOD (mg/1) COD (mg/1) TSS (mg/1)
Influent Effluent Influent Effluent Influent Effluent
1425 — , 3390
* Influent Is Influent to POTW.
WASTEWATER TREATMENT PLANT FLOW DIAGRAM
NOT APPLICABLE
SAMPLING PROGRAM
Sample Location
Citric Acid Effluent After Lime
Neutralization-881 Manhole
Effluent At #83 Manhole
Effluent At «7A Manhole
Effluent At #6 Manhole
Effluent At 874 Manhole
No. of Samples
G-30
-------
SCREENING PROGRAM SUMMARY OF PLANT
SUMMARY OF SCREENING DATA
CONCENTRATION (ug/1)
Priority Pollutants * Influent ** Influent
Acid Extractables
Phenol 280 (
Phenols (Tot.) 129 (
Volatile Organlcs
Benzene 100 (
1,1,1-Trichloroethane 12 (
1,1-Dichloroethane ND
Chloroform 460
l,l-D1chloroethylene NO (
l,2-Trans-d1chloroethylene ND (]
Hethylene chloride 1700000 (]
Toluene 700 (1
Metals
Antimony 57 (
Arsenic 20LT (]
Beryllium 1LT (I
Cadmium 2LT-(]
Chromium 91 :
Copper 86
Lead 21 (1
Hercyr 0.7 (1
Nickel 50 1
Selenium ' • 48 ]
Silver 41
Thallium 100LT 1
Zinc 311 ]
Cyanide 19 0
L) ND 1
I) 54 1
I) 500 1
I) 720000 1
I) 54 1
L 900 1
I 20 1
1100 1)
t 80000 1}
) 40 (1)
I) 10 1)
) 91)
) 1LT (1)
) • ' 2LT (1)
) 20 (1
181 (1
96 (1
) 0.1 (1
5LT (1
2LT (1)
4 (1)
2.9 (1)
154 (1)
) 38 (1)
WASTEWATER TREATMENT PLANT UNIT OPERATIONS
Plant 12447 is an indirect/zero discharger. Strong chemical wastes
are 'deep well injected. With no pretreatment, these two streams
are discharged to a POTW.
* Fermentation. and fine chemicals process wastewaters.
** Formulation process wastewaters.
PLANT CHARACTERISTICS
Subcategory Uastewater Quantity (MGD) Employment
A.B.C.D *1.0 **1.0 4000-4100
PERFORMANCE OP TREATMENT SYSTEM
BOD (mg/1) COD (mg/1) TSS (mg/1)
Influent **Influent *Influent **Influent *Influent **Inf1uent
2600 ,45 7400 139
WASTEWATER TREATMENT PLANT FLOW DIAGRAM
NOT AVAILABLE
SAMPLING PROGRAM
Sample Location
No, of Samples
Process Wastes From Building 197 5
Process Wastes From Building 42 5
Process Wastes To Injection Wells 4
Non-Contact Cooling Water to Outfall 001 5
Non-Contact Cooling Water to 85 Acre Pond 5"
G-31
-------
SCREENING PROGRAM Stff.WARY OF PI.ANT 12462
SUMMARY OF SCREENING DATA
CONCENTRATION (ug/lj
Priority Pollutants Influent Effluent
Acid Extrac tables
4-MHrophenol 1600
Phenol 70
PbinoU (Tot.) 1200
Volatile Organics
Ho thy 1 one cnl orlde —
(totals
Antimony 10LT
Arsenic 10LT
Beryl HM 1LT
Cactalwi 1LT
Chrcniiw 10LT
Copper 48
Lead 31
Kercury 0.60
Hickel 50LT
Selenium 22
Silver 1LT
Thill 1us 100LT
Zinc 76
1) 400LT
1) 20LT
1) 70LT-540LT
70
1 21-51
1 IOLT-20LT
1 1LT-2.4
1 1LT
1 10LT-17
1 36-48
1 5LT-6
1 0.4-1.3
1 60LT
1 43-56
1 1LT
1 100LT
1 57-122
jl)
|3)
(1)
3)
1}
3)
3
3
3
3)
3)
3
3
3
WASTEWATER TREATMENT PLANT UNIT OPERATIONS
Activated Sludge
Aerated Lagoon
Sludge Hauling
PLANT CHARACTERISTICS
Subcategory Uastewater Quantity (MGD) Employment
A .170 0-100
PERFORMANCE OF TREATKBTT SYSTEM
BOD (mg/1) ; COD (mg/1) TSS (mg/1)
Influent Effluent Influent Effluent Influent Effluent
2090 84-156 (3) 2690 548-1300 (3) 150 372-1000 (3)
I!!!1:"" •! • • f.'." . ' , .! , "i1' ,• • • • .• •:• ,. i -
V/ASTBVATER TREATMENT PLANT FLOW DIAGRAM
Not available.
SAMPLING PROGKflM
Sample Location
Raw water supply
Existing backwash lagoon effluent
Biological waste treatment system effluent
Process wastes influent line to the biological
treatment system
Combined influent to the biological wastewater
treatment system
Effluent from final clarifier
No. of Samples
1
1
6
G-32
-------
SIMIARY OF SCREENING DATA
CONCENTRATION (ug/1)
Priority Pollutants
Acid Extractables
2-Nitrophenol
4-Nitrophenol
Phenol
Base/Neutral Extractables
Nitrobenzene
Volatile Orgam'cs
1,1-Dichloroethylene
1,2-Dichloroethane
1,1,2-Trichloroethane
Metal s
Antimony
Arsenic
Cadmium
Chromium
Copper
Lead
Nickel
Selenium
Silver
Thallium
Zinc
Influent Effluent
4100 (1)
1100 (1)
16500 (1)
30 (1)
370 (1)
20 (1)
6650 (1)
35-90 3
5700-7200 3
ILT 3
5LT-9 (3)
19-35 (3)
5LT (3)
50LT (3)
210-310 (3)
2LT (3)
5LT-10LT (3)
49-70 (3)
WASTEWATER TREATMENT PLANT UNIT OPERATIONS
Equalization
Neutralization
Primary Chemical Flocculation/Clarification
Detention Pond
PLANT CHARACTERISTICS
C,D 0.45 Unknown
PERFORMANCE OF TREATt.STr SYSTEM
BOD (mg/1) COO (mg/1) TSS (mg/1)
Influent Effluent Influent Effluent i."!1."?.".1; F.f.f.l.u.!.1*.
310-675 (3) — 680-1380 (3) . — 3-31 (3)
WASTEWATER TREABEMT PLANT FLOW DIAGRAM
NOT AVAILABLE
SAMPLING PROGRAM
Sample Location
Detention Pond Effluent
Raw Waste Feed for Bench Scale Treatment 2
Units
activated Sludge Effluent 1
Powdered Activated Carbon Treatment (PACT)
Effluent 1
Mo. of Samples
3
G-33
-------
-------
APPENDIX H
Priority Pollutant Occurrence as Reported in
Original 308 Portfolio Data
-------
-------
APPENDIX H
PRIORITY POLLUTANT OCURRENCE
AS REPORTED IN ORIGINAL 308 PORTFOLIO DATA
Priority Pollutants by Plant
Plant 12003:
A CD
N*
Copper
Nickel
Zinc
Plant 12018:
A CD N*
Zinc
Plant 12037:
Concentrations (ug/1)
Influent Effluent
100
10
80
5
CD
N*
Methylene Chloride
Chromium
Copper
Lead
Mercury
Nickel
Zinc
Cyanide
Plant 12038:
ABCD
Phenol
Chromium
Lead
Mercury
Cyanide
AS, AL, PC*
Plant 12052:
CD
AS*
Phenol
Chromium
Copper
Lead
Mercury
Nickel
Zinc
Cyanide
Plant 12056:
AC*
Chromium
Zinc
12
930
190
50
0.
100
40
89
102
20
100
0,
30
1100
21
45
100
10
100
92
100
5
17900
H-l
-------
Plant 12057:
Toluene
CD
N*
780
Plant 12062:
CD
N*
Zinc
Plant 12065:
Cyanide
Plant 12089:
Mercury
Plant 12102:
Phenol
Chromium
Copper
Lead
Mercury
Nickel
Zinc
Cyanide
Plant 12107:
Phenol
Chromium
Lead
Plant 12123:
200
N*
1000
B D
TF, AS, PP*
CD
N*
B D
N*
CD
N*
Benzene
Carbon Tetrachloride
Chloroform
Methylene Chloride
Toluene
Chromium
Copper
Lead
Mercury
Nickel
Zinc
Cyanide
Phenol
Chromium
Zinc
0.3
8000
100
500
100
1 .
500
1000
1000
290
290
90
6
50
50
15
67
108
73
13
35.
50
368
110
30
50
370
Plant 12161
A CD
As, PP*
Phenol
Benzene
800
14
250
H-2
-------
Chloroform
Toluene
Chromium
Copper
Lead
Mercury
Nickel
Zinc
Plant 12186:
11000
9100
CD
Phenol
Chromium
Copper
Lead
Mercury
AS, AL*
Copper
Plant 12195: C
Chromium
Copper
Lead
Mercury
Nickel
Zinc
Cyanide
Plant 12204: ABCD
Chromium
Plant 12224: D
Copper
Zinc
Plant 12235: C
Cyanide
Plant 12236: C
Cyanide
Plant 12244: C
Chromium
Mercury
Plant 12245: ABC
Toluene
Plant 12252: A CD
Chromium
Plant 12257: ABCD
N*
AS*
N*
N*
AS*
N*
N*
p*
AS*
34
120
290000
6
17
10
80
70
2,
2100
137
240
200
200
200
0.1
300
400
10
15
97
177
14
290
500
0.5
14000
70
30
100
50
50
0.1
H-3
-------
Nickel
Zinc
Cyanide
Plant 12282: BCD
Mercury
Plant 12287: D
Phenol
Chromium
Zinc
Cyanide
Plant 12289: D
Chromium
Copper
Lead
Mercury
Nickel
Zinc
Cyanide
Plant 12302: C
SF*
AL*
N*
N*
Toluene
Plant 12339;
A CD
Phenol
Chloroform
Methylene Chloride
Chromium
Copper
Lead
Mercury
Zinc
Cyanide
Plant 12342:
A CD
Phenol
Methylene Chloride
Plant 12407:
-31
100
80
AS, PC*
22000000
117
120000
N*
AS, PC, PP*
Chromium
Copper
Lead
Mercury
Zinc
Cyanide
Plant 12411 ;
Phenol
BCD
AL*
1300
250
10
80.0
10
100
80
20
300
540
680
7.0
200
2050
15
79
9
742
85
541
117
4,
983
2100
210
9300
70
23
90
10.0
21
2300
106
H-4
-------
Chloroform
Methylene Chloride
Plant 12414;
D
N*
Chromium
Copper
Lead
Nickel
Zinc
Plant 12420;
B D
AS*
Phenol
Toluene
Copper
Lead
Nickel
Zinc
Cyanide
Plant 12440;
168
174
N*
Phenol
Chloroform
Methylene Chloride
Chromium
Copper
Lead
Mercury
Nickel
Zinc
Cyanide
Plant 12458:
CD
N*
Phenol
Plant 12468;
3990
1650
4
49
4
7
130
160
174
300
170
260
600
3
750
300
1000
11
70
70
0,
26
80
200
192
N*
Copper
Lead
Mercury
Nickel
Zinc
Plant 12475;
140
24
0.
100
180
AS*
Phenol
Plant 12477:
10
10
BC
N*
Phenol
Chromium
Copper
Lead
Mercury
50
20QO
300
50
5.0
H-5
-------
Nickel
Zinc
Cyanide
Plant 20033;
Phenol
Chromium
Copper
Mercury
Nickel
Zinc
CD
P*
Plant 20037:
Phenol
D
AS, AL. PP*
Plant 20245:
Phenol
A C
AS*
Benzene
Chloroform
Methylene Chloride
Toluene
Chromium
Copper
Lead
Mercury
Nickel
Zinc
Cyanide
200
130
130
72
4
40000
1700
37
8400
0.
490
37000
1500
Plant 20246
Phenol
AS, MF*
Benzene
Chloroform
Methylene Chloride
Toluene
Chromium
Copper
Lead
Mercury
Nickel
Zinc
Cyanide
Plant 20254;
Phenol~~
AL, PP*
Cyanide
Plant 20297:
Phenol
Cyanide
TF, AS. PC*
1800
200
500
5600
760
200
250
110
0.2
200
250
34
2
42
2
1
86
23
41
0.
6
3500
40
172
3
8
6
1
19
55
2
0.
2
88
36
65
70
60
110
H-6
-------
Plant 20321;
N*
Copper
Zinc
Plant 20342:
P*
Phenol
Chloroform
Toluene
Chromium
Copper
Mercury
Nickel
*End-of-Pipe Treatment Abbreviations:
N = No Treatment
P = Primary
TF = Trickling Filter
AS = Activated Sludge
AL = Aerated Lagoon
PP = Polishing Pond
PC = Physical/Chemical
AC = Activated Carbon
MF = Multimedia Filter
SF = Sand Filtration
21
300
2000
12
20
8
50
50
0,
50
H-7
-------
-------
APPENDIX I
308 Portfolio
(Traditional Pollutant Data)
-------
-------
APPENDIX I
308 PORTFOLIO TRADITIONAL POLLUTANT DATA
12000
12001
12012
12015
12016
12018
12022
12023
12026
12031
12036
12037
12038
Sub-
Category
B D
D
D
A CD
A C
D
C
D
A
CD
ABCD
12040
12053
12062
12066
12069
12084
12087
12089
12095
12097
12098
12102
12104
12119
12125
12132
12135
12141
12143
12159
12160
B D
D
CD
BCD
D
BCD
C
B D
CD
CD
D
CD
D
A D
D
A C
BCD
D
D
CD
D
Major End-of-Pipe
Treatment*
N
AL
P
AS, AC, OP
N
TF, AS
N
AS, AL, PP
N
TF, AS, AL, PP
N
Fermentation Wastes
AS, PC
Chemical Wastes
AL, PC
N
TF, AS, SF
N
AS, AL
N
N
P
TF, AS, PP
PC, OP
ASw/PAC, OP
AS
N
SP
AS, PC
PC
TF, AS, SP
P
AS
N
N
AS, PC, MF
BOD(mg/l)
Inf.
80
611
259
1210
33
1551
4597
1865
344
1340
1811
6210
5717
210
2 9
2600
1195
320
5772
27416
465
2705
85
2330
200
93
79
530
Eff.
21
19
105
93
13
244
1140
8
331
13
28
693
12
7
218
29
4
5
COD(mg/l)
Inf. Eff.
TSS(mg/l)
Inf. Eff.
80
916
489
76
4240
2521
6893
12023
1741
800
1205
2924
450
10450
56902
2556
5124
157
256
4800
400
358
54
946
197
273
146
135
11
512
84
222
705
775
15
326
44
1453
67
289
2886
40
40
456
203
2264
4483
280
383
49
116
30
1465
2501
193
354
143
19
53
200
143
4128
306
457
2
251
13
6
29
336
22
70
88
29
12
43
-------
APPENDIX I (coat.)
308 PORTFOLIO TRADITIONAL POLLUTANT DATA
Plant
Code
12161
12168
12183
12185
12186
12187
12191
12195
12199
12204
12205
12231
12235
12236
12239
12240
12248
12257
12261
12275
12283
12287,
12294!
12298'
12307*
12308
12317
12338
12339^
12343 ••
12406
12407
12411
12420
12454 i
12462 I
12463 '
r
Sub-
Category
A CD
ABCD
B
BC
CD
C
BCD
C
A CD
ABCD
D
D
C
C
D
CD
D
ABCD
C
BC
D
D
CD
D
D
D
D
D
A CD
A CD
C
C
BCD
B D
B D
A
B D
Major Knd-of-Pipe
Treatment*
AS, PP
N
N
N
AS, AL
TF
P
N
N
AS
AS, SP
AL, SP
N
AS
AS
PC
AS
AS
AL, PC
P
AS
AL
AS, MF
AS
AS, AL
AS
AS, PC, MF
AS, SF
AS, PC
P
PC, PP, OP
AS, PC, PP
AL
AS
TF
AS, AL
AS, SP, PC, OP
BODjng/1)
Inf.
•^^•M
987
1300
4
47
653
215
2180
1220
2500
12374
1117
1573
244
3000
366
- -
30
1404
732
130
760
200
636
54
7100
7520
102
Eff.
IBMBMIT*
72
129
146
60
200
149
284
3636
10
120
35
56
208
15
18
32
30
45
869
4636
288
143
6
COD (nag/1)
TS8(ag/l)
Inf.
2978
3300
10
154
1950
1352
584
2628
22250
2674
1608
486
15574
— ... _
50
3288
2390
372
1064
430
Bgf.
944
683
407
81
600
553
290
8481
63
9880
..
51
658
83
107
2370
Ing.
398
500
3
7
124
92
650
2000
100
950
3089
—
12
A9-7
67
3*
200
EM.
196
328
320
40
50
90
174
286
35
500
567
50
13
28
26
90
50
30
15700
12032
7418
297
29
420
30
369
4923
10
17
1793
4048
97
9
-------
APPENDIX I (cont.)
308 PORTFOLIO TRADITIONAL POLLUTANT DATA
12471
12475
12476
12477
20037
20165
20201
20204
20206
20245
20246
20257
20297
20312
20319
20342
20363
Sub-
Category.
B
C
D
BC
D
BC
D
CD
C
A C
C
C
C
BCD
D
C
A CD
Major Bnd-of-Pipe
Treatment* f
AL, PP, OP
AS
AS
N
AS, &L, B2
AL
AS
AL
AL
AS
ASf MFf
AS
TF, AS, PC
AL
TF, SP
P
P
BOD(«q/l)
Inf. Bff.
C00(»g/l)
Inf. Bff.
T8S(ag/l)
Inf. Bff.
50
10670
10670
327
200
1600
1600
497
484
380
1500
609
846G
14
1960
1960
20
32
6
370
5
56
13
143
20
150
15
169
16140
16140
725
541
1370
12000
1350
1358
870
16748
6440
6440
113
50
340
74
128
329
93
47
147
500
32
1535
59
2340
2340
47
24
14
10
32
33
36
150
9
* ABBREVIATIONS:
N - No Treatment
P - Primary
TF - Trickling Filter
.AS - Activated Sludge (w/PAC
AL • Aerated Lagoon
SP - Stabilization Pond
pp « Polishing Pond
OP » Other Polishing
PC » Physical/Chemical
AC - Activated Carbon
MF - Multimedia Filter
SF - Sand Filtration
with Powdered Activated Carbon)
-------
-------
APPENDIX J
308 Portfolio
(Wastewater Flow Data)
-------
-------
APPENDIX J
308 PORTFOLIO
WASTEWATER FLOW DATA
DIRECT DISCHARGERS
Plant No. Subcategor
12001
12006
12014
12015**
12022
12026
12030
12036
12038**
12053
12057*
12073
12085
12089
12095
12097*
12098
12104*
12117
12119
12132*
12160
12161
12175
12187*
12194
12205
12236
12239
12248
12256*/**
D
D
B
D
A C
C
D
A
A B C D
D
C D
C
D
B D
C D
C D
D
D
B D
A D
A C
D
A CD
D
C
D
D
C
D
D
A B C D
Discharge
Flow. MGD
0.155
0.125
***
0.074
1.300
0.101
0.030
1.128
2.607
0.004
0.005
0.015
0.001
0.155
0.071
0.035
0.002
0.367
0.121
0.032
0.460
.0.006
1.332
0.004
0.913
0.002
0.030
0.810
0.002
0.035
30.000
Plant No.
12261
12264*
12267
12281*
12283
12287*
12294**
12298
12307
12308**
12317
12338
12339**
12406
12407
12459
12462
12463**
12471.
20037
20165
20201
20245
20246
20257**
20297
20298
20319
20370
20402
Subcategory
A
A
A
A
C
B D
D
D
D
D
C D
D
D
D
D
D
C
C
C
D
B D
B
D
B C
D
C
C
C
C
C
D
B C
D
Discharge
Flow, _MGD
0.051
0.044
0.005
***
0.013
0.131
0.089
0.003
0.001
0.059
0.390
0.001
1.600
0.370
0.731
0.073
0.170
0.003
0.043
0.037
0.004
0.002
0.500
1.250
0.015
***
***
0.003
0.014
0.024
J-l
-------
APPENDIX J
308 PORTFOLIO
WASTEWATER FLOW DATA
INDIRECT DISCHARGERS:
Plant No.
12000
12003
12004
12005
12007
12011
12012
12016
12018**
12019
12023
12024**
12031
12035
12037
12040
12042
12043**
12044**
12048
12051
12054
12055
12056
12057*
12058
12060
12061
12062
12065**
12066
12068
12069
12074
12076
12077
12078
12080
12083
12084
12087
Subcategory
D
A CD
C D
B
D
A B D
B D
D
A CD
D
D
D
D
D
C D
B D
A B D
C
A D
C D
D
D
D
D
C D
D
D
B
C D
D
BCD
D
D
D
D
C D
D
D
D
BCD
C
Discharge
Flow, HGD
0.140
0.980
0.003
0.001
0.527
0.031
0.340
0.009
0.020
****
0.020
0.033
0.001
0.003
0.125
0.063
****
0.001
• 2.973
0.089
0.009
0.008
0.002
0.110
0.080
0.005
0.104
0.042
0.075
0.005
0.259
***
0.017
0.037
0.001
0.022
***
0.090
0.217
0.008
0.232
Plant No.
120881
12093
12094'
121001
12104!*
12107
12108**
12110
12112
12113
12115
12118*
12120
12122:
12123
12125;
12128;
12129'
12131'
12135:
12141
12143 :
12144
12145
12147
12155,
12157:
12166
12168
12171
12172
12177
12178
12183
12186
12191
12195
12198
12199
Subcategory
D
C D
D
C D
D
B D
A CD
D
B D
C
D
A B D
D
D
D
C D
D
D
D
D
BCD
D
D
D
D
D
C D
D
D
A B C D
BCD
D
D
B
B
C D
C
A B C D
C
B D
A CD
Discharge
Flow, MGD
0.002
0.004
****
0.062
0.190
0.009
****
****
****
0.005
0.380
0.010
0.009
0.001
****
0.404
****
****
****
" "67604
1.650
0.001
0.037
****
0.001
****
1.170
****
O.OQ4
0,159
0.001
****
****
0.005
0.090
0.052
0.078
****
0.080
0.012
0.500
J-2
-------
APPENDIX J
308 PORTFOLIO
WASTEWATER FLOW DATA
NDIRECT DISCHARGERS (CONT'D.)
'lant No.
2204
2206
2207
L2210
2211
2212
12217**
L2219
L2224
2226
L2230
L2233
L2235**
L2238
[2240**
L2243
.2244
L2245**
.2246**
.2247
L2249
.2250
.2251
,2252
.2254**
L2256*
L2257**
L2260
L2264*
L2265
L2268
L2273
L2275
12277
L2281
L2282
L2287*
L2289
L2290
L2295
L2296
L2300
L2302
Subcategory
A B C D
D
D
B C
D
D
D
D
D
B
B
D
C
D
C D
C
C
ABC
C D
C
D
D
D
A
A
A B
B
C D
D
A B C D
A B C D
D
D
D
D
D
B C
D
D
BCD
D
D
D
B
D
D
Discharge
Flow, MGD
0.850
0.130
****
0.002
****
0.040
****
0.053
****
0.040
0.001
****
0.295
0.010
0.013
****
0.042
0.085
0.362
0.029
0.002
0.047
0.001
0.865
0.213
0.410
0.600
0.125
0.127
0.003
****
****
0.426
****
0.034
0.004
0.070
0.003
****
****
0.016
0.160
1.028
Plant No.
12305
12309
12310
12311
12312
12318
12322
12330
12331
12332
12333
12340
12342
12343
12345
12375
12384
12385
12392
12401
12405
12409
12411
12414
12415
12417
12419
12420**
12427
12429
12433
12438
12440
12441
12444
12454
12458
12460
12464
12465
12467
12468
12470
Subcategory
D
B C
C D
A B C D
B D
D
D
A B C D
D
C
C D
D
A CD
A CD
D
B
B
D
D
A D
C D
D
BCD
D
D
D
B' D
B D
D
D
D
D
D
C
D
B D
C D
B
D
D
D
A
Discharge
Flow. MGD
0.034
0.007
0.018
0.240
****
0.100
0.010
1.606
0.380
0,045
0.017
0.034
0.701
0.088
0.020
****
0.002
****
****
0.223
****
****
0.300
0.464
0.080
****
****
****
0.011
0.005
****
0.004
****
1.300
0.076
0.100
0.778
****
****
0.018
0.002
0.038
0.001
J-3
-------
APPENDIX J
308 PORTFOLIO
WASTEWATER FLOW DATA
DIRECT DISCHARGERS (CONT'D.)
Plant No.
12472
12473
12474
12477
12479
12481
12482
12495
12499
20012
20017
20026
20032
20033
20034
20050
20052
20057
20058
20062
20064
20081
20089
20117
20120
20126
20139
20142
20147
20153
20155
20169
20174
20177
20187
20188
20203**
20205
20216
20220
20224
20231
20234
Subcategory
B C
B C
D
B C
B
****
A B
D
D
C
D
D
D
C D
D
D
D
D
D
D
D
D
D
D
D
C D
D
D
D
D
D
D
C
D
D
C
C
D
D
D
D
C
Discharge
Flow, MGD
0.001
0.023
0.003
2.400
****
****
****
****
****
****
****
****
****
0.200
0.001
****
****
****
****
****
0.001
****
****
****
****
****
0.060
0.001
****
****
****
0.026
****
0.001
0.002
0.008
0.034
****
0.001
****
****
****
****
Plant No.
20237
20240
20244
20247
20254
20258
20261
20263
20264
20267
20269
20270
20273
20282
20288
20303
20307
20310
20311
20312
20321
20328
20331
20333
20339
20342
20346
20349
20350
20353
20355
20356
20359
20361
20362
20363
20364
20366
20371
20377
20385
20389
20400
Subcategory
B
C
C
B
C
C D
D
D
D
D
D
D
D
D
D
B
B
C
C
BCD
D
D
C
D
D
C
B C
C
C D
B C
C
C D
B D
A
A
C D
C D
B D
BCD
D
C D
D
Discharge
Flow, MGD
0.040
0.002
0.001
0.059
0.020
0.002
****
****
****
****
****
0.002
****
****
0.037
****
****
0.190
0.034
0.900
0.008
0.001
0.107
***
0.500
0.039
****
0.018
0.003
0.006
0.033
****
****
****
****
0.125
0.006
0.010
****
****
****
****
****
J-4
-------
APPENDIX J
308 PORTFOLIO
WASTEWATER FLOW DATA
INDIRECT DISCHARGERS (CONT'D.)
Plant No.
20405
20423
20439
20441
20443
20446
20450
20453
20456
20460
20465
20466
20473**
20476
20490
20492
20494
20503
20519
20527
Subcategory
D
D
D
D
B D
D
D
D
D
D
D
D
B
D
D
D
D
C D
D
D
Discharge
Flow. MGD
****
****
****
****
0.023
***
****
0.010
****
****
****
0.001
0.001
****
****
****
0.001 '
****
0.010
0.001
J-5
-------
APPENDIX J
308 PORTFOLIO
WASTEWATER FLOW DATA
ZERO DISCHARGERS (ONLY)
Plant No.
12021
12052
12063
12099
12102
12133
12159
12173
12174
12175
12185
12225
12231
12263
12269
12297
12306
12326
12439
12447
12466
12475
Plant No.
12476
20006
20014
20015
20016
20030
20035
20038
20040
20041
20045
20048
20049
20051
20054
20055
20070
20073
20075
20078
20080
20082
Plant No.
20084
20087
20090
20093
20094
20099
20100
20103
20106
20108
20115
20125
20134
20141
20148
20151
20159
20173
20176
20178
20195
20197
Plant No.
20204
20206
20208
20209
20210
20215
20218
20225
20226
20228
20235
20236
20241
20242
20249
20256
20266
20271
20294
20295
20300
20305
Plant No.
20308
20316
20325
20332
20338
20340
20347
20373
20376
20387
20390
•20394
20396
20397
20413
20416
2'0421
20424
20425 " -
20435
20440
Plant No.
20440
20444
20448
20452
20462
20464
20467
20470
20483
20485
20486
20496
20498
20500
20502
20504
20507
20509
20511
20518
20522
20526
20529
J-6
-------
APPENDIX J
308 PORTFOLIO
WASTEWATER FLOW DATA
* These plants are combined direct/indirect dischargers.
is for the appropriate portion of the total discharge.
** These plants also have some zero discharge operations.
is not .included.
*** Flow is negligibly small (less than 500 MGD).
**** Data unavailable.
The value reported
Zero discharge flow
Notes:
The above plants were the only ones to report flow data in the 308
Portfolio. For all others the discharge flows were unknown or
negligible.
The discharge flows consist of wastewater from the following sources.
- Direct process contact
- Indirect process contact
- Non-contact
- Maintenance and equipment cleaning
- Air pollution control
The discharge flows do not contain:
- Non-contact cooling water
- Sanitary/potable water
- Storm water
J-7
-------
-------
APPENDIX K
RSKERL Data
-------
-------
ANALYTICAL DATA (PLANT 4)
Influent Return Sludge Effluent
Priority Pollutant Gig/1)
CLASSICAL
TOTAL CYANIDES (mg/1)* <.05 *
TOTAL PHENOL 35°
TOTAL METALS
Arsenic *1
Selenium - *!"
o
Cadmium *
Beryllium *
Copper 120
Antimony <^
Chromium 12
Nickel <10
Zinc 620
Silver <10
Thallium <10
Lead 12
Mercury ^.B
ORGANICS (GAS CHROMATOGRAPHY)
PURGEABLES
1 , 2-Dichloroethane
Toluene <1^
Chloroform • <1^
Methylene chloride <10
Benzene <40
Ethylbenzene • ^0
Tetrachloroethylene 10
Trichloroethylene <10
PHENOLICS
Phenol 17
Pentachlorophenol 18
PHALLATES
Bis(2-ethylhexyl) phthallate
Di-n-butyl phthallate
*Note: Total Cyanides expressed in mg/1.
**Key: N.D. - Not Detectable, or less than detectable
N.A. - Not Applicable
N.S. - No Standard Available
N.P. - No Procedure "
(ug/D
<.05*
74
-------
ANALYTICAL DATA (PLANT 5)
Priority Pollutant
CLASSICAL
TOTAL CYANIDES (mg/1)*
TOTAL PHENOL
TOTAL METALS
Arsenic
Selenium
Cadmium
Beryllium
Copper
Antimony
Chromium
Nickel
Zinc
Silver
Thallium
Lead
Mercury
ORGANICS (GAS CHROMATOGRAPHY)
PURGEABLES
•Benzene
Chloroform
Methylene( chloride
Toluene
Ethylbenzene
1,1, 1-trichloroethane
1, 2-dichloroethane
PHENOLICS
4-Nitrophenol
2-Nitrophenol
PHTHALLATE ^ ESTERS
Bis (2-ethylhexyl) phthallate
Influent
(PR/1)
.25*
945
<10
3
120.
10.
12
39
41
<10
<10
22
<2.0
127
47
150
<10
<10
N.D.
123'
« DAF
Skimmings
(PR/1)
.22*
107
16
<10
: 11
<3
1,900
<10
1,500
42
5,600
17
12
N.A.
; ii
ii
ii
it
1 it
1 it
381
387
Clarifier
Effluent
(PR/1)
.17*
39
<10
<10
<1
<3
34
<10
34
38
9
<10
<10
<2.0
<40
<10
<3.0
<10
-------
4-
(Continued)
Priority Pollutant
Sparged Air, XAD-2 . Sparged Air, Tenax3
U grams per 1,755 ft ugrams per ft
POLYNUCLEAR AROMATICS
Naphthalene
2-Chloronaphthane
Acenaphthalene
Acenaphthene
Fluorene
Phenanthrene/Anthracene
Fluoranthene
Pyrene
1,2-Benzanthracene
Chrysene
3,4-Benzopyrene
1-, 2:5,6-Dibenzanthracene
PHENOLICS
2-Chlorophenol
2-Nitrophenol
Phenol
2,4-Dimethylphenol
2,4-Dichlorophenol
2,4,6-Trichlorophenol
4-Chloro-m-cresol
2,4-Dinitrpphenol
4,6-Dinitro-o-cresol
Pentachlorophenol
4—Nitrophenol
PURGEABLES
Methylene chloride
1,1-Dichloroethane
1,2-Trans-dichloroethylene
Chloroform
1,2-Dichloroethane
1,1,1-Trichloroethane
Carbon tetrachloride
Dichlorobromomethane
1,2-Dichloropropane
Benzene
Trichloroethylene
Chlorodibromomethane
1,1,2-Trichloroethane
Methyl bromide
Bromoform
1,1,2,2-Tetrachloroethane
Tetrachloroethylene
Toluene
Chlorobenzene
Ethylbenzene
90
<35
N.D.
<25
<25
<25
80
110
100
<25
<25
<25
No results - sample
lost. Analytical
equipment malfunction.
K-3
-------
(Continued)
Priority Pollutant
Sparged Air, XAD-2
Sparged Air, Tenax
(ug)
POLYNUCLEAR AROMATICS
Naphthalene
2-Chloronaphthane
Acenaphtbalene
Acenaphthene
Fluorene
Phenanthrene/Anthracene
Fluoranthene
Pyrene
1,2-Benzanthracene
Chrysene
3,4-Benzopyrene
1,2:5,6-Dibenzanthracene
PHENOLICS
2-Chlorophenol
2-Nitrophenol
Phenol
2,4-Diroethylphenol
2,4-Dichlorophenol
2,4,6-Trichlorophenol
4-Chloro-m-cresol
2,4-Dinitrophenol
4,6-Dinitro-o-cresol
Pentachlorophenol
4-Nitrophenol
PURGEABLES ; '
Methylene chloride
1,1-Dichloroethane
1,2-Trans-dichloroethylene
Chloroform
1,2-Dichloroethane
1,1,1-Trichloroethane
Carbon tetrachloride
Dichlorobromomethane
1,2-Dichloropropane
Benzene
Trichloroethylene
Chlorodibromometharie
1,1,2-Trichloroethane
Methyl bromide
Bromoform
1,1,2,2-Tetrachloroethane
Tetrachloroethylene
Toluene
Chlorobenzene
Ethylbenzone
940
5,000
<60
60
<78
150
<6U
<60
<60
<60
<210
N.D.
<150
<150
<60
<150
1,500
1,800
<600
600
<150
<150
Sample lost -
Analytical apparatus
malfunction.
K-4
-------
APPENDIX L
Current In-Place Treatment Technologies
-------
I I
..I i*
-------
APPENDIX L
CURRENT IN-PLACE TREATMENT TECHNOLOGIES
Plant
Code No.
12001
12022
Subcateqories
D
12003
12007
12011
12012
12014
12015
A C D
D
A B D
B D
B
D
A C
Treatment
System
Industrial Wastes
Equalization
Primary Chemical Flocculation/
Clarification
Aerated Lagoon
Drying Beds
Landfill
Sanitary Wastes
Activated Sludge
Sand Filtration.
Mechanical Thickening
Sludge to POTW
Neutralization
Neutralization
Sludge to Sewer System
Neutralization
Equalization
Biological Treatment
Equalization
Primary Sedimentation
Activated Sludge with Powdered
Activated Carbon
Secondary Chemical Flocculation/
Clarification
Gravity Dewatering
Aerobic Digestion
Landfill
Cyanide Destruction
Equalization
Neutralization
Coarse Settleable Solids Removal
Primary Sedimentation
Activated Sludge
BPT
Treatment
X
X
X
L-l
-------
12026
12030
12036
D
A
12038
A B C D
Trickling Filter
Mechanical Thickening
Chemical Conditioning
Vacuum Dewatering
Incineration ;
Landfill ;
Equalization '
Neutralization \
Activated Sludge
Aerated Lagoon \
Polishing Pond •
Anaerobic Digestion'
Retention for Radioactive Decay
Activated Sludge
Trickling Filter
Aerated Lagoon
Waste Stabilization Pond
Polishing Pond :
Aerobic Digestion
Cropland Use |
Fermentation Wastes
Equalization
Neutralization
Coarse Setteable Solids Removal
Primary Sedimentation
Activated Sludge
Tertiary Plant
Centrifugal Dewatering
Anaerobic Digestion
Landfill
Chemical Wastes ;
Solvent Recovery
Equalization
Neutralization
Coarse Settleable Solids Removal
Primary Sedimentation
Primary Chemical Flocculation/
Clarification
Aerated Lagoon ;
Tertiary Plant .
Centrifugal Dewatering
Anaerobic Digestion
Landfill
Pretreatment
X
X
1-2
-------
12042
12043
12044
12052
12053
12056
12066
A B D
C
A D
C D
BCD
12077
C D
Solvent Recovery
In-Plant Evaporation
Steam Stripping
Tertiary Plant
Heat Conditioning
Thermal Oxidation
Equalization
Neutralization
P/C: Thermal Oxidation
Tertiary Plant
Equalization
Neutralization
Solvent Recovery
Neutralization
Coarse Settleable Solids Removal
Neutralization
Primary Sedimentation
Activated Sludge
Equalization
Coarse Settleable Solids Removal
Activated Sludge
Trickling Filter
Sand Filtration
- Jfteclianical Thickening
Drying Beds
Cropland, Use
De-Gas if ier
De-Mineral izer
Neutralization
Activated Carbon Filtration
Neutralization
Activated Sludge
Aerated Lagoon
^Mechanical Thickening
Sludge to POTW
Equalization
Neutralization
Coarse Settleable Solids Removal
Primary Sedimentation
Dissolved Air Flotation
Sludge to POTW
X
X
L-3
-------
12085
12087
D
C
12089
B D
12093
2
12095
C D
C D
12097
C D
Activated Sludge
Landfill
Solvent Recovery
Neutralization '
Coarse Settleable Solids Removal
Dissolved Air Flotation
Sludge Hauling
Equalization
Neutralization ,
Coarse Settleable Solids Removal
Primary Sedimentation
Activated Sludge
Trickling Filter
Polishing Pond
Mechanical Thickening
Anaerobic Digestion
Drying Beds
Cropland Use
Equalization
Aerated Equalization Tanks
i , '
Equalization
Neutralization, !
Coarse Settleable'Solids Removal
Primary Chemical Flocculation/
Clarification
Physical/Chemical Treatment
Secondary Neutralization
Flotation Thickening
Sludge Hauling
i
Chemical Wastes
Equalization
Neutralization
Physical/Chemical Treatment
Filtration/Presses
Chemical Stabilization
Chemical Conditioning
Vacuum Dewatering
Landfill
Floor Washes ; ' "
Coarse Settleable Solids Removal
Activated Sludge with Powdered
Activated Carboy
Physical/Chemical Treatment
L-4
-------
12098
12102
12104
12108
12113
12117
12119
12123
12125
12132
D
C D
D
A C D
D
B D
A D
C D
D
A C
Secondary Chemical Flocculation/
Clarification
Chemical Stabilization
Chemical Conditioning
Vacuum Dewatering
Landfill
Activated
Landfill
Sludge
Equalization
Neutralization
Equalization
Neutralization
Waste Stabilization Ponds
Chemical Conditioning
Mechanical Dewatering
Landfill
Neutralization
Equalization
Neutralization
Activated Sludge
Chlorination
Gravity
Aerobic Digestion
Dewatering
x
Equalization
Neutralization
Coarse Settleable Solids Removal
Primary Sedimentation
Activated Sludge
P/C: Evaporation
Anaerobic Digestion
Drying Beds
Sludge to POTW
Equalization
Neutralization
Neutralization
Physical/Chemical Treatment
Secondary Neutralization
Solvent Recovery
Equalization
L-5
-------
12132 (cont'd) A C
12135
12141
12159
12160
BCD
C D
D
12161
A C D
Neutralization
Coarse Settleabje Solids Removal
Primary Sedimentation
Primary Chemical Flocculation/
Clarification
Activated Sludge
Trickling Filter
Waste Stablization Ponds
Flotation Thickening
Centrifugal Thiqkening
Centrifugal Dewatering
Incineration
Landfill |
Cyanide Destruction
Equalization ;
Neutralization
Neutralization
Primary Sedimentation
Activated Sludge!
Sludge Hauling \
Solvent Recovery
Steam Stripping
Equalization
Neutralization
Coarse Settleable Solids Removal
Primary Sedimentation
Activated Sludge
P/C: Evaporation
Multi-Media Filtration
Flotation Thickening
Anaerobic Digestion
Sludge Hauling
Solvent Recovery
Equalization
Neutralization '
Coarse Settleable Solids Removal
Primary Sedimentation
Primary Chemical Flocculation/
Clarification :
Activated Sludge
Polishing Pond ;
Gravity Thickening
Aerobic Digestion
Composting
X
L-6
-------
12175
12186
12187
D
C D
12191
12199
12204
ABC
A C D
A B C D
12205
12210
12231
B C
A D
Landfill
Cropland Use
Equalization
Neutralization
Activated Sludge
Aerated Lagoon
Ozone Polishing
Solvent Recovery
Zinc Isolation
Equalization
Neutralization
Coarse Settleable Solids Removal
Dissolved Air Flotation
Trickling Filter
Gravity Thickening
Sludge to POTW
Vacuum Dewatering
Landfill
Neutralization
Solvent Recovery
Solvent Recovery
Mercury Collection
Neutralization
Coarse Settleable Solids Removal
Primary Chemical Flocculation/
Clarification
Activated Sludge with Pure Oxygen
Mechanical Thickening
Chemical Conditioning
Vacuum Dewatering
Composting
Equalization
Activated Sludge
Sand Filtration
Mechanical Thickening
Aerobic Digestion
Sludge to POTW
Aerated Lagoon
Equalization
Neutralization
Coarse Settleable Solids Removal
X
X
L-7
-------
12236
12239
12240
12246
12248
D
C D
C D
D
12252
12254
A C D
A D
Primary Sedimentation
Aerated Lagoon
Waste Stabilization Ponds
Anaerobic Digestion
Landfill
Weak Wastes :
Cyanide Destruction
Solvent Recovery ;
Equalization :
Neutralization •
Primary Oil/Solvent Skimming
1
Strong Wastes
Cyanide Destruction
Solvent Recovery
Equalization ;
Neutralization
Primary Sedimentation
Activated Sludge ;
Flotation Thickening
Chemical Conditioning
Vacuum Filtration
Landfill '
Activated Sludge
Landfill
i
Equalization ;
Neutralization '•.
Physical/Chemical Treatment
Chlorination
I
Solvent Recovery
In-Plant Evaporation
Equalization
Coarse Settleable Solids Removal
Activated Sludge
Mechanical Thickening
Gravity Dewatering
Aerobic Digestion
Dewatering
Landfill |
Equalization
Neutralization
Coarse Settleable (Sol ids Removal
I
Equalization
X
X
X
L-8
-------
Neutralization
12256
A B C D
12257
A B C D
12261
12275
12282
B C
BCD
12283
12287
12294
C D
Solvent Recovery
In-Plant Evaporation
Equalization
Neutralization
Coarse Settleable Solids Removal
Primary Sedimentation w/Skimming
Equalization
Neutralization
Activated Sludge
Centrifugal Dewatering
Cropland Use
Equalization
Neutralization
Coarse Settleable Solids Removal
Primary Sedimentation
Aerated Lagoon
P/C: Thermal Oxidation
Secondary Neutralization
Ch1orination
Vacuum Dewatering
Landfill
Equalization
Neutralization
Neutralization
Coarse Settleable Solids Removal
Primary Sedimentation
Primary Chemical Flocculation/
Clarification
Sand Filtration
Gravity Dewatering
Sludge Storage
Activated Sludge
Landfill
Coarse Settleable Solids Removal
Primary Sedimentation
Aerated Lagoon
Solvent Recovery
Equalization
Neutralization
Activated Sludge
Multi-Media Filtration
X
X
L-9
-------
12298
12305
12307
12308
12311
12317
12330
12332
12333
D
D
A B C D
A B C D
C
C D
12338
Centrifugal Thickening
Centrifugal Dewatering
Incineration
Landfill
i
Activated Sludge
Landfill
Equalization
Neutralization
Primary Sedimentation
Activated Sludge
Aerated Lagoon
Chlorination
Mechanical Thickening
Flotation Thickening
i
Activated Sludge
Chlorination
Landfill
Activated Sludge
Mechanical Thickening
Centrifugal Thickening
Landfill
Equalization
Neutralization
Coarse Settleable Solids Removal
Activated Sludge
Physical/Chemical Treatment
Multi-Media Filtration
Mechanical Thickening
Aerobic Digestion
Cropland Use
Neutralization
Equalization
Neutralization
Waste Stabilization Pond
Solvent Recovery
Coarse Settleable Solids Removal
Primary Sedimentation
Multi-Media Filtration
Landfill
Coarse Settleable Solids Removal
L-10
-------
12339
A C D
12343
12392
12406
A C D
D
C
12407
Primary Sedimentation
Activated Sludge
Sand Filtration
Mechanical Thickening
Anaerobic Digestion
Sludge Hauling
Thermal Oxidation (3 Units)
Neutralization
Coarse Settleable Solids Removal
P/C: Thermal Oxidation
Tertiary Plant
Oil Dehydration
Neutralization
P/C: Evaporation
Tertiary Plant
Centrifugal Dewatering
Pyrolysis
Landf ill
Sanitary Wastes
Primary Separation
Activated Sludge
Tertiary Plant
Mechanical Thickening
Evaporation
Aerobic Digestion
Dewatering
Pyrolysis
.Landfill >;
Solvents
Solvent Recovery
Steam Stripping
Tertiary Plant
Neutralization , vj
Neutralization
Neutralization
Physical/Chemical Treatment
Secondary Chemical Flocculation/
Clarification
Polishing Pond-,
Sludge Dewatering
Landfill
Equalization
X
L-ll
-------
12411
BCD
Neutralization
Coarse Settleabl^ Solids Removal
Primary Sedimentation
Primary Chemical Flocculation/
Clarification
Activated Sludge
Physical/Chemical Treatment
Polishing Pond ;
Flotation Thickening
Landfill
i
Solvent Recovery
Equalization
Neutralization
Aerated Lagoon
Incineration
12420
12438
12439
B D
D
'C D
12441
12447
A B C D
12454
B D
Activated Sludge j
Chemical Conditioning
Centrifugal Dewat'ering
Landfill !
Aerated Equalization Tanks
Equalization'
Neutralization
Primary Sedimentation
Activated Sludge
Aerated Lagoon
Landfill
i
Equalization I
Neutralization
Coarse Settleable Solids Removal
Primary Sedimentation
Deep Well Injection
Equalization ;
Neutralization ;
Coarse Settleable 5!plids Removal
Primary Sedimentation
Physical/Chemical Treatment
Diatomaceous-Eartl? Filtration
Primary Sedimentation
Trickling Filter
Anaerobic Digestion
Landfill
L-12
-------
12458
12459
12462
12463
12471
12475
12476
12477
20014
20017
20030
C D
D
B D
B
B C
D
D
C D
Equalization
Neutralization
Equalization
Aerated Lagoon
Polishing Pond
Ch1orination
Activated Sludge
Aerated Lagoon
Sludge Hauling
Coarse Settleable Solids Removal
Activated Sludge
Waste Stabilization Pond
Physical/Chemical Treatment
Secondary Chemical Flocculation/
Clarification
Flotation Thickening
Sludge Hauling
Coarse Settleable Solids Removal
Aerated Lagoon
Secondary Chemical Flocculation/
Clarification
Polishing Pond
Secondary Neutralization
Chlorination
Drying Beds
Landfill
Equalization
Neutralization
Activated Sludge
Forest Land Use
Equalization
Neutralization
Activated Sludge
Forest Land Use
Equalization
Neutralization
In-Plant Evaporation
Activated Carbon Filtration
Landfill
In-Plant Evaporation
L-13
-------
20033
20037
20057
20139
20153
20165
20177
20195
20201
20203
20204
20205
C D
D
D
C D
D
B C
C
D
D
C D
20206
Primary Sedimentation
Activated Sludge
Aerated Lagoon
Polishing Pond
Landfill
j
Primary Sedimentation
Landfill ,
Cyanide Destruction
Solvent Recovery!
In-Plant Neutralization
Multi-Media Filtration
Aerated Lagoon
Neutralization
P/C: Evaporation
Solvent Recovery
Activated Sludge
Cyanide Destruction
Chromium Reduction
Metals Precipitation
Solvent Recovery
Equalization
Neutralization
Coarse Settleable Solids Removal
Primary Chemical Flocculation/
Clarification
Landfill '• ' \
i
Solvent Recovery
In-Plant Neutralization
Neutralization ;
Aerated Lagoon
Sludge Lagoon
Solvent Recovery
Neutralization •
Coarse Settleable Solids Removal
Aerated Lagoon
Landfill j
|
Solvent Recovery
X
X
X
X
L-14
-------
20234
20236
20237
20244
B
20245
A C
20246
20254
20257
Equalization
Aerated Lagoon
Landfill
Solvent Recovery
Neutralization
Primary Sedimentation
Activated Sludge
Solvent Recovery
Steam Stripping
Equalization
Solvent Recovery
Equalization
Neutralization
Primary Chemical Flocculation/
Clarification
Landfill
Solvent Recovery
Steam Stripping
In-Plant Neutralization
Equalization
Neutralization
Coarse Settleable Solids Removal
Primary Chemical Flocculation/
Clarification
Activated Sludge
Landfill
Equalization
Neutralization
Primary Sedimentation
Activated Sludge
Multi-Media Filtration
Chi or inaction
Vacuum Filtration
Incineration
Solvent Recovery
Neutralization
Primary Sedimentation
Aerated Lagoon
Polishing Pond
Equalization
Neutralization
Coarse Settleable Solids Removal
L-15
-------
20258
20263
20273
20297
20298
20310
20339
20342
20349
C D
D
D
20312
20319
BCD
D
Primary Sedimentation
Activated Sludge
Sludge Lagoon i
Equalization
Neutralization ;
Activated Sludge ;
Coarse Settleable; Solids Removal
Coarse Settleable Solids Removal
Sludge Hauling
Neutralization ;
Coarse Settleable; Solids Removal
Primary Sedimentation
Activated Sludge
.Trickling Filter
P/C: Evaporation
Metals Precipitation
Xn-Plant Evaporation
Neutralization >
Primary Sedimentation
Activated Sludge
incineration
Cropland Use
I
Cyanide Destruction
Solvent Recovery
Steam Stripping
Neutralization
Coarse SEttleable Solids Removal
i
Aerated Lagoon
Landfill
Coarse Settleable Solids Removal
P/C: Oxidation
Trickling Filter
Waste Stabilization'Pond
Sludge Hauling
Waste Stabilization Pond
In-Plant Neutralization
Coarse Settleable Solids Removal
Sludge Hauling ;
Neutralization
X
X
X
L-16
-------
20355
20356
20363
20370
20373
20376
20389
20402
C
C D
C D
B C
20423
20456
20476
D
D
D
Neutralization
In-Plant Neutralization
Equalization
Neutralization
Primary Sedimentation
Rotating Biological Contractor
Chlorination
Sludge Hauling
Steam Stripping
In-Plant Evaporation
Neutralization
Primary Sedimentation w/Skimming
In-Plant Evaporation
Aerated Lagoon
Primary Sedimentation
Waste Stabilization Pond
Multi-Media Filtration
In-Plant Evaporation
Primary Sedimentation
Metals Precipitation
Ultraviolet Sterilization
Chlorination
L-17
-------
-------
APPENDIX M
Pharmaceutical Industry Wastewater
Discharge Methods
-------
-------
APPENDIX M
PHARMACEUTICAL INDUSTRY
WASTEWATER DISCHARGE METHODS
Plant
Code No.
12000
12001
12003
12004
12005
12006
12007
12011
12012
12014
12015
12016
12018
12019
12021
12022
12023
12024
12026
12030
12031
12035
12036
12037
12038
12040
12042
12043
12044
12048
12051
12052
12053
12054
12055
12056
12057
12058
12060
Indirect
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
Direct
Zero
Comment
X
X
Recycle/Reuse
Land Application
No Process Wastewater
POTW1
Treatment
Level
P
S
S
S
S
T
S
S
X
X
X
X
Recycle/Reuse
Private Treatment System
Evaporation
Subsurface Discharge
Subsurface Discharge
Subsurface Discharge
T
T
S
S
S
S
S
S
S
P
S
S
M-r
-------
12061
12062
12063
12065
12066
12068
12069
12073
12074
12076
12077
12078
12080
12083
12084
12085
12087
12088
12089
12093
12094
12095
12097
12098
12099
12100
12102
12104
12107
12108
12110
12111
12112
12113
12115
12117
12118
12119
12120
12122
12123
12125
12128
12129
12131
12132
12133
12135
12141
12143
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
Subsurface Discharge
Septic System
Private Treatment System
Contract Disposal
X
X
X
X
X
Deep Well Injection
i
Contract Disposal
Ocean Discharge
!
Ocean Discharge
X
X
Private Treatment System
Subsurface Discharge
Land Application
No Process Wastewater
S
S
S
T
T
P
P
P
S
P
T
S
P
S
T
P
P
T
S
S
S
S
S
T
S
s
s
M-2
-------
12144
12145
12147
12155
12157
12159
12160
12161
12166
12168
12171
12172
12173
12174
12175
12177
12178
12183
12185
12186
12187
12191
12194
12195
12198
12199
12201
12204
12205
12206
12207
12210
1221 1
12212
12217
12219
12224
12225
12226
12227
12230
12231
12233
1 2235
12236
12238
12239
12240
12243
12244
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
T
s
s
X
X
X
X
X
X
Recyc1e/Reuse
Private Treatment System
Evaporation
No Process Wastewater
Evaporation
Private Treatment System
Ocean Discharge
(Also Contract Disposal)
Private Treatment System
X
X
X
Land Application
Contract Disposal
No Process Wastewater
Subsurface Discharge
Ocean Discharge
Contract Disposal
S
S
S
S
S
S
S
S
S
S
S
s
s
p
s
p
s
p
s
s
p
T
M-3
-------
12245
12246
12247
12248
12249
12250
12251
12252
12254
12256
12257
12260
12261
12263
12264
12265
12267
12268
12269
12273
12275
12277
12281
12282
12283
12287
12289
12290
12294
12295
12296
12297
12298
12300
12302
12305
12306
12307
12308
12309
12310
12311
12312
12317
12318
12322
12326
12330
12331
12332
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
Evaporation
Contract Disposal
Private Treatment System
X
X
X
X
(Also Land Application)
LanJ3 Application
I
Septic System
Septic System
X
X
X
X
X
Contract Disposal
Septic System
S
P
S
S
S
S
S
S
S
T
T
S
S
Septic System
P
T
S
S
P
S
T
S
S
P
,,g
S
S
P
P
S
S
M-4
-------
12333
12338
12339
12340
12342
12343
12345
12375
12384
12385
12392
12401
12405
12406
12407
12409
12411
12414
12415
12417
12419
12420
12427
12429
12433
12438
12439
12440
12441
12444
12447
12454
12458
12459
12460
12462
12463
12464
12465
12466
12467
12468
12470
12471
12472
12473
12474
12475
12476
12477
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
Land Application
Land Application
X
X
Contract Disposal
Land Application
Deep Well Injection
X
X
Land Application
Septic System
P
S
P.
S
S
S
T
S
S
T
T
T
S
S
S
S
S
S
S
S
S
S
P.
P
S
X
X
Land Application
Land Application
M-5
-------
12479
12481
12482
12495
12499
20006
20008
20012
20014
20015
20016
20017
20020
20026
20030
20032
20033
20034
20035
20037
20038
20040
20041
20045
20048
20049
20050
20051
20052
20054
20055
20057
20058
20062
20064
20070
20073
20075
20078
20080
20081
20082
20084
20087
20089
20090
20093
20094
20099
20100
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
Ocean Discharge
No Process Wastewater
Evaporation
No Process Wastewater
No Process Wastewater
Evaporation
No Process Wastewater
S
P
No Process
No Process
No JProcess
No {Process
No Process
No Process
Wastewater
Wastewater
Wastewater
Wastewater
Wastewater
Wastewater
No Process Wastewater
Septic System
Contract Disposal
No Process Wastewater
No JProcess
No process
No Process
No Process
No process
Wastewater
Wastewater
Wastewater
Wastewater
Wastewater
No Process Wastewater
No Process Wastewater
No Process Wastewater
No
No
No
No
Process
Process
process
Process
No Process
Wastewater
Wastewater
Wastewater
Wastewater
Wastewater
M-6
-------
20103
20106
20108
20115
20117
20120
20125
20126
20134
20139
20141
20142
20147
20148
20151
20153
20155
20159
20165
20169
20173
20174
20176
20177
20178
20187
20188
20195
20197
20201
20203
20204
20205
20206
20208
20209
20210
20215
20216
20218
20220
20224
20225
20226
20228
20229
20231
20234
20235
20236
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X No Process Wastewater
X No Process Wastewater
X Evaporation
X Septic System
X No Process Wastewater
X No Process Wastewater
X No Process Wastewater
Contract Disposal
X No Process Wastewater
X No Process Wastewater
X No Process Wastewater
Contract Disposal
X No Process Wastewater
X No Process Wastewater
X No Process Wastewater
X Evaporation
X No Process Wastewater
Land Application
X Land Application
X Land Application
X No Process Wastewater
X No Process Wastewater
X No Process Wastewater
X No Process Wastewater
X No Process Wastewater
X No Process Wastewater
X No Process Wastewater
X No Process Wastewater
X No Process Wastewater
X Contract Disposal
M-7
-------
20237
20240
20241
20242
20244
20245
20246
20247
20249
20254
20256
20257
20258
20261
20263
20264
20266
20267
20269
20270
20271
20273
20282
20288
20294
20295
20297
20298
20300
20303
20305
20307
20308
20310
20311
20312
20316
20319
20321
20325
20328
20331
20332
20333
20338
20339
20340
20342
20346
20347
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
No Process Wastewater
No Process Wastewater
No Process Wastewater
No Process Wastewater
Contract Disposal
No Process Wastewater
No Process Wastewater
No Process Wastewater
No Process Wastewater
No Process Wastewater
l^o Process Wastewater
ita Process Wastewater
Contract Disposal
|
No Process Wastewater
No Process Wastewater
Kfo Process Wastewater
No Process Wastewater
Evaporation
No Process Wastewater
M-8
-------
20349
20350
20353
20355
20356
20359
20361
20362
20363
20364
20366
20370
20371
20373
20376
20377
20385
20387
20389
20390
20394
20396
20397
20400
20402
20405
20413
20416
20421
20423
20424
20425
20435
20436
20439
20440
20441
20443
20444
20446
20448
20450
20452
20453
20456
20460
20462
20464
20465
20466
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
Contract Disposal
Land Application
Evaporation
Contract Disposal
No Process Wastewater
No Process Wastewater
No Process Wastewater
No Process Wastewater
Contract Disposal
No Process Wastewater
No Process Wastewater
Evaporation
No Process Wastewater
No Process Wastewater
No Process Wastewater
No Process Wastewater
No Process Wastewater
No Process Wastewater
No Process Wastewater
No Process Wastewater
No Process Wastewater
No Process Wastewater
M-9
-------
20467
20470
20473
20476
20483
20485
20486
20490
20492
20494
20496
20498
20500
20502
20503
20504
20507
20509
20511
20518
20519
20522
20526
20527
20529
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
Subsurface Discharge
No Process Wastewater
Deep Well Injection
No Process Wastewater
No Process Wastewater
No Process Wastewater
No Process Wastewater
No Process Wastewater
No Process Wastewater
No Process Wastewater
No Process
No Process
No Process
No Process
No Process
Wastewater
Wastewater
Wastewater
Wastewater
Wastewater
No Process Wastewater
Contract Disposal
No Process Wastewater
1POTW Treatment Level Symbols;
P - Primary
S - Secondary
T - Tertiary
2Data on POTW treatment level was not requested from the
Supplemental 308 (20000 series) plants
M-10
-------
APPENDIX N
Cost of Treatment and Control Systems
-------
-------
.APPENDIX N
COSTS OF TREATMENT AND CONTROL SYSTEMS
N-l APPROACH (Also see Section VIII):
1. Define industry as represented by cost data.
2. Define subcategories.
3 Determine representative flow for each subcategory based
on single subcategory plants from 308 data base.
4. Determine representative raw waste loads for each sub-
category from screening/verification data base.
5 Estimate the respective treatment system investment costs
(catalytic treatment cost model) and adjust to 1978 dollar
basis which is the baseline year for all costs.
6. Estimate annual treatment costs for the various systems
including operating, maintenance and annual ized investment
costs (catalytic treatment cost model).
7. Estimate costs for contract hauling and other low volume
wastewater treatment systems .
8 Using costs estimated above for base case "model conditions
develop variations of cost with flow, RWL and effluent target
as parameters for the various wastewater systems.
9. Plot these variations in the form of cost sensitivity curves.
N-2
2.
RECORD (ENR) CONSTRUCTION COST INDICES
CHEMICAL ENGINEERING (CE) PLANT INDICES
N-l
-------
APPENDIX "N
ENGINEERING NEWS - RECORD (BNR) CXtHgTRPCTION COST INDICES *
1964
1965 '
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
...1976— -
1977
1978
1979
1580
Jan.
918
948 '
988
1039
1107
1216
1309
1465
1686
1838
1940
2103
2305
2494
2672
2872
3237
Feb.
920
957
997
1041
1114
1229
13-11
1467
1691
1850
1940
2128
2314
2505
2681
2877
Mar.
922
958
998
1043
1117
1238
1314
1496
1697
1859
1940
2128
2322
2513
2693
2886
Apr.
926
957
1006
1044
1124
1249
1329
1513
1707
1874
1961
2135
2327
2514
2698
2886
May
930
958
1014
1059
1142
1258
1351
1551
1735
1880
1961
2164
2357
2515
2733
2889
June
935
969
1029
1068
1154
1270
1375
1589
1761
1896
1993
2205
2410
2541
2753
2984
July
945
S77
1031
1078
1158
1283
1414
1618
1772
1901
2040
2248
2414
2579
2821
3052
Aug.
948
984
1033
1089
1171
1292
1418
1629
1777
1902
2076
2274
2445
2611
2829
3071
Sept.
947
986
1034
1092
1186
1285
1421
1654
1786
1929
2089
2275
2465
2644
2851
3120
Oct.
948
986
1032
1096
1190
1299
1434
1657
1794
1933
2100
2293
2478
2675
2851
3122
Nov.
948
986
1033
1097
1191
1305
1445
1665
1808
1935
2094
2292
2486
2659
2861
3131
Dec.
948
988
1034
1098
1201
1305
1445
1672
1816
1939
2101
2297
2490
2660
2869
3140
Annual
Index
936
971
1019
1070
1155
1269
1385
1581
1753
. . .1895
2020
2212
2401
2557
2776
3003
* Construction Cost Index - Base Year 1913 - 100
-------
APPENDIX N
CHEMICAL ENGINEERING (CB) PLANT COST INDICES*
Year
1972
1973
1974
1975
1976
1977
1978
1979
1980
Jan*
136.5
140.8
150.0
179.6
187.1
198.7
210.6
225.9
249.9
Feb.
136.0
140.4
150.7
179.5
187.5
198.5
213.1
231.0
255.1
Mar.
137.0
141.5
153.8
180.7
188.4
199.3
214.1
232.5
Apr.
137.1
141.8
156.7
180.7
188.9
200.3
215.7
234.0
May
137.1
142.4
161.4
161.0
190.2
201.4
216.9
236.6
June
136.5
144.5
164.7
181.8
191.1
202.3
217.7
237.2
July
136.5
144.6
168.8
181.8
192.0
204.7
219.2
239.3
Aug.
137.0
145.0
172.2
181.9
193.9
206.4
221.6
240.7
Sept.
137.8
146.4
174.8
183.7
195.6
208.8
221.6
243.4
Oct.
138.2
146.7
176.0
185.4
196.3
209.0
223.5
245.8
Nov.
138.4
147.5
177.4
185.7
196.4
209.4
224.7
246.8
Dec.
139.1
148.2
177.8
186.6
197.4
210.3
225.9
247.6
Annual
Index
137.2
144.1
165.4
182.4
192.1
204.1
218.8
238.7
I
CO •
* CB Plant Cost Index - Base Year 1957-59 » 100
-------
-------
r
APPENDIX 0
Screening/Verification
Plant Descriptions and
Sample Points
-------
-------
Screening Samples
Location
Lab No.
Sample Type
Discharge from Treatment Plant
Sta 12
Extractable (NVQA)
Composite Sampler Blank Flush
Metals Scan*, Phenols, Cyanides,
purgeables (VGA)
TSS, COD, BOD5.
Influent to Neutralization Bldg.
Sta ft!
Extractables (NVOA)
Composite Sampler Blank Flush
Metals Scan*, Phenols, Cyanides,
purgeables (VOA)
TSS, COD, BOD5
Lab and Sanitary Waste Manhole
Building *46. Sta'tS
Extractables (NVOA)
Composite Sampler Blank Flush
Metals Scan*, Phenols, Cyanides,
purgeables (NOA)
TSS, BODJ5, COD
Concentrated Waste Bldg.
Sta. #4
Extractables (NVOA)
Metals Scan, Phenols, Cyanides,
Purgeables (VOA)
TSS, COD, BOD5
Animal and Sanitary Waste near
Bldq ft74, Standoipe Sta »3
Extractables (NVOA)
Composite Sampler Blank Flush
Metals Scan*, Phenols, Cyanides
purgeables (VOA)
TSS, COD, BOD5
Super "0" Blank
1935
1925
1935,
1935B
1935
1934
1924
1934,
1934B
1934
1933
1922
1933,
1933B
1933
1932
1932B
1932
1931
1926
1931,
1931B
1931
1935A,
1934A
1933A
1931A
Composite
Grab
3 Grabs
Composite
Composite
3 Grabs
Composite
Compos i te
Grab
3 Grabs
Grab**
Grab**
Grab**
Composite
Grab
3 Grabs
Composite
0-1
-------
Extractables (NVOA)
Purgeables (VOA)
Well $1 - Bldq 44
Extractables
Purgeables
Well »2 - Bldq 34
Extractables
Purgeables
Well. »3 - Bldq 49
Extractables
Purgeables
1930
1930
1927
1927
1928
1928
1929!
1929
Grab
Grab
Grab***
Grab
Grab***
Grab
Grab***
Grab
* Composited in Edison Lab |
** Two Grab Samples Composited - All Samples Taken from Composite
*** Flow from three wells totals about 0.8'MGD
0-2
-------
Plant 12026
Verification Samples
Sample
Location
Sample
Type
Pollutants
Analyzed
Intake Water (Well #34)
Intake Water (Well #44)
Intake Water (Well #49)
Return Slud,ge
(Secondary Clarifier)
Treated Effluent (Day 1 )
Treated Effluent (Day 2)
Treated Effluent (Day 3)
Grab
Blank
Grab
Blank
Grab
Blank
Grab
Grab
Grab
Blank
Blank
Composite
Grab
Composite
Grab
Blank
Composite
Grab
Blank
Extractables, VOA
Cyanides
Extractables, VOA
Extractables, VOA,
Cyanides
Extractables, VOA
Extractables, VOA
Cyanides
Extractables, VOA
Extractables, VOA
Cyanides
Extractables, VOA
Cyanides
Extractables, VOA
Cyanides
Extractables
VOA, Extractables
COD, BOD
TSS
VOA, Cyanides
BOD, TSS
VOA, Cyanides
VOA
BOD, TSS
VOA, Cyanides
VOA
0-3
-------
4. Plant 12036
Plant 12036 is a Subcategory A plant which discharges 1.13 MGD of
wastewater from pesticide manufacturing processes. This plant
also manufactures synthetic organic chemicals.
The treatment system for this plant consists of activated sludge,
trickling filters, secondary clarification, aerated lagoons
(other than activated sludge), a stabilization lagoon, and
chlorination. The sampling points and parameters sampled for
follow;
001 Discharge
Date
8/31/77
8/31 -
9/1/77
9/1/77
Time
0905
0910
to 1010
1010
Temp
25
Pond 4 Effluent Prior to Chlorination
Temp ~C
Date
8/31/77
8/31 -
9/1/77
Time
0930
0930
to 0955
9/1/77
9/1 -
2/77
9/2/77
9/1/77
0955
0955
to 0855
0855
1120
24
Parameters
i
i
Organics (sampler blank)
Priority pollutants,
pH, BOD5_, COD, NFS,
nutrients
Volatile organics,
phenolics, cyanide
Parameters
!
Organics (sampler blank)
Priority pollutants,
BQD5_, pH, COD, nutrients,
NFS
Volatile organics,
phenolic, cyanide
Priority pollutants,
BOD5_, pH, COD, NFS,
nutrients
Volatile orgcmics,
phenolics, cyanide
Priority pollutants,
BQD5_, pH, COD, NFS,
nutrients
0-4
-------
Agricultural Research Farm Discharge to the Waste Treatment Plant
Date Time Parameters
1140
9/1/77
9/1 -
2/77
9/2/77
1140
to 0955
0955
Organics (sampler blank)
Priority Pollutants
Volatile organics, phenolics,
cyanide
Process Waste Discharge from Packaging Operations
Date Time • Parameters"
9/1/77
9/1 -
2/77
0910
0915
to 0930
Organics (sampler blank)
Priority Pollutants
9/2/77 0930
Combined Wastestreams from Organic Chemical Synthesis, Most of
Volatile organics, phenolics,
cyanide
the Fermentation, the Offices and
Date
8/31/77
8/31 -
9/1/77
Time Temp °C
. 1000 —
1015
to 0830
the Laboratories
Parameters
Organics (sampler blank)
Priority pollutants
9/1/77
0830
44
Volatile organics, phenolics,
cyanide
5. Plant 12038
Plant 12038 is a multiple-subcategory plant (A, B, C> D) with an
annual average flow of 2.61 MGD. A brief description of the
wastewater sampling points is as follows:
Screening Samples
Point 1 - Wastewater treatment plant effluent (001 Discharge).
Four manual composite samples were taken here and analyzed for
priority pollutants, BOD5, COD, pH, nutrients, non-fillerable
solids (NFS), and Al.
0-5
-------
Point 2 - Combined effluent from limestone bed and hillside storm
sewer. Three samples (one blank) were taken here and were
analyzed for priority pollutants.
i
Point 3 - Building T-17 process waste discharge (pesticide).
Three samples (one blank) were taken here and analyzed for
priority pollutants.
Point 4 - Chemical synthesis influent T302 to T303. Three
samples (1 blank) were taken here and analyzed for priority
pollutants.
Point 5 - Influent to T307B clarifier.
and analyzed for priority pollutants.
One sample was taken here
Point 6 - Effluent line from carbon column train. One sample was
taken here and analyzed for metals, BOD£, COD, pH, nutrients, and
phenols '
Points 7 and 10 - Adjacent points near T312 and T212 clarifier.
Point 8 - Concentrated antibiotic waste-influent to biological
treatment. One sample was taken here and analyzed for priority
pollutants.
i
Point 9 - Dilute antibiotic waste influent to T201. Three
samples (one blank) were taken here and analyzed for priority
pollutants.
Plant 12038 uses a number of wastewater treatment technologies
which include equalization, neutralization, activated sludge,
aerated lagoon, and in-plant treatments.
0-6
-------
Plant 12038
Verification Samples
Sample
Location
T66 Influent
(Pesticides)
T57 Effluent
(Pesticides)
T66 Effluent
(Pesticides)
307B Influent
(Pesticides)
307B Effluent
(Pesticides)
Tertiary Plant
Effluent (All)
312 Effluent
Type
Grab
Grab
Grab
Grab
Grab
Grab
Grab
Sample Pollutants
Analyzed
Priority Pollutants,
COD
Priority Pollutants,
Priority Pollutants,
COD
Priority Pollutants,
BOD, COD, TSS
Priority Pollutants,
Priority Pollutants
BOD, COD, TSS, NH3-N
Priority Pollutants
(Synthesis &
Pesticides)
300 Effluent
(Synthesis)
(302/306 Influent)
212 Effluent
(Fermentation)
Beer Storage
Tank (Fermentat ion)
100 & 200 Influent
(Fermentation)
Thermal Oxidizer
Waste (Pesticides)
Tertiary Plant
Influent (All)
Grab
Grab
Grab
Grab
Grab
BOD, COD, TSS
Priority Pollutants
BOD, COD, TSS
Cyanide, BOD, COD,
TSS, NH3-N
Cyanide, BOD, COD,
TSS, NH3-N
Cyanide, BOD, COD
TSS, NH3-N
Cyanide
Priority Pollutants
BOD, COD, TSS, NH3-N
0-7
-------
6.
Plant 12044
Plant 12044 is a multiple subcategory (A, D) pla'ht with an annual
average flow of 2.97 MGD. I
,,,!!„,' ;,i,|i ;„ , .if;,,;
Seven sample points were identified;
actually sampled.
Screening Samples
however, only five were
Citric acid production effluent after neutralization with lime -
Location 1, #81 manhole:
CDO Sample
Number
23-05-CM13R03
23-05-CM13S05
Date
8/1/78
8/2/78
Time
(Hours)
1500
0822 8/2
to 0822 8/3
23-05-CM13SO6
23-05-CM13S07
23-05-CM1 3SO8
8/2/78
8/2/78
8/2/78
Effluent at Location 2, #83
CDO Sample
Number
23-05-CM13S11
23-05-CM13S12
23-05-CM13S13
23-05-CM13S14
Date
8/2/78
8/2/78
8/2/78
8/2/78
0749
0735
0735
manhole:
Time
(Hours)
0850 to
1445
1003
1000
1000
Parameters
___^^_^___
Quality control (QC) blank
for extractable organics,
metals and COD
24-jiour composite for
extractable organics, metals,
COD and BOD
Grab for VOA
i
Grab for phenol
Grab for cyanide
Parameters
I
Composite Comprising three
3-liter grabs for extractable
organics, metals, BOD and COD
Grab for VOA
Grab for phenol
"f
Grab for cyanide
0-8
-------
Effluent at Location 4, #37A manhole:
CDO Sample
Number
23-05-CM13S21
23-05-CM13S22
23-05-CM13S23
23-05-CM13S24
Effluent at Location
CDO Sample
Number
23-05-CM13S31
23-05-CM13S32
23-05-CM13S33
23-05-CM13S34
Effluent at Location
CDO Sample
Number
23-05-CM13S36
23-05-CM13S37
23-05-CM13S38
23-05-CM13S39
Date
8/2/78
8/2/78
8/2/78
8/2/78
6, *6
Date
8/2/78
8/2/78
8/2/78
8/2/78
7, #74
Date
8/2/78
8/2/78
8/2/78
8/2/79
Time
(Hours)
0905 to
1455
1035
1033
1033
manhole:
Time
(Hours)
0926 to
1510
1115
1115
1115
manhole:
Time
(Hours)
0920 to
1415
1 125
1125
1125
Parameter
Composite comprising three
3-liter grabs for extractable
organics, metals, BOD and COD
Grab for VOA
Grab for phenol
Grab for cyanide
Parameter
Composite comprising three
3-liter grabs for extractable
organics, metals, BOD and COD
Grab for VOA
Grab for phenol
Grab for cyanide
Parameter
Composite comprising three
3-liter grabs for extractable
organ ics, metals, BOD and COD
Grab for VOA
Grab for phenol
Grab for cyanide
The only method of wastewater treatment
is neutralization.
employed by plant 12044
0-9
-------
7. Plant 12066
Plant 12066 is predominately a Subcategory B manufacturer with a
small percentage of activities under Subcategories C and D. The
annual average flow is 0.26 MGD. Wastewater treatment
technologies employed are neutralization, activated sludge, and
aerated lagoon.
Screening Samples
Influent to Pretreatment Facility
An ISCO Model 1680 automatic sampler #104 was installed to pump
equal volume aliquots from the wet well of the raw sample house.
Grab samples were also obtained. The following samples were
collected:
SAD
Sample No.
23-05-CMIIS02
(Blank)
23-05-CMIIS02
23-05-CMIISO3
23-05-CMIIS04
23-05-CMIISO
6/28/78
6/29/78
6/29/78
6/28/78
6/28/78
0825
0830
1015
1515
1515
Parameters
Quality Control (QC)
Blank for extractable
organics, metals and
COD
24 hr. composite for
extractable organics,
metals, COD, and BOD
Grab for VOA
Grab for phenols
Grab for cyanide
Effluent from Pretreatment Facility
An ISCO Model 1680 automatic sampler #108 was installed to pump
equal volume aliquots from the discharge flume of the final
clarifier. Grab samples were also obtained. The following
samples were collected:
0-10
-------
SAD
Sample No.
23-05-CMIISOI
(Blank)
23-05-CMIISOI
23-05-CMIISO6
23-05-CMIIS07
23-05-CMIISO8
8. PLant 12097
Date
6/27/78
Time
1315
6/28/78
6/29/78
6/29/78
6/28/78
6/28/78
0825
0835
0930
1430
1435
Parameters
Quality Control (QC)
Blank for organics,
metals and COD
24 hr. composite
for organics, metals,
COD and BOD
Grab for VOA
Grab for phenols
Grab for cyanide
Plant 12097 is a multiple-subcategory plant (C, D) with an annual
average flow of 0.10 MGD. The wastewater treatment technologies
employed include equalization, neutralization, and activated
sludge with powdered activated carbon.
Screening Samples
Well Water - Sample #2305EG16S13
A single grab sample was obtained directly from a tap in building
141 .
River Intake - Sample #2305EG16S09-10
Composite samples were obtained by ISCO sampler through a grating
covering the intake structure. Grab samples were obtained from
the surface water below the grating..The intake was located in a
small creek estuary of the Black River.
Cooling Water Discharge - Sample I2305EG16S11-12
Composite samples were obtained by ISCO sampler below the weir at
the discharge point to Black River. Grab samples were obtained
from the surface water of the cooling water discharge.
Treated Floor Drain - Sample I2305EG16SO7-78
Composite samples were obtained by ISCO sampler from a small sump
receiving water from 90° V-notch weir. Grab samples were
collected from the flow over the V-notch weir.
0-11
-------
Raw Waste Floor Drain - Sample #2305EG16S05-06
Composite samples were obtained by ISCO sampler from a small
equilization tank prior to activated sludge aeration. Grab
samples were obtained from the surface water of the equilization
tank.
Treated Deep Well - Sample #2305EG16S03-04
Composite samples were obtained by ISCO sampler from a metal
bucket receiving water from a pipe inside the pump house,
building #31. Grab samples were collected Directly from the pipe
flow.
Raw Waste Deep Well - Sample #2305EG16S01-02
obtained by ISCO sampler from c
jar which receives water from a small pipe.
Composite samples were
2 1/2-gallon glass
Grab samples were obtained directly from the pipe.
Sample Types and Frequency
All sample sites, except the well-water sites, included a 24-hour
composite sample and one grab sample. All composite samples were
obtained by ISCO samplers programmed to collect aliquots every 30
minutes. Two samplers were used at each site to obtain
sufficient sample volume to provide a split with the company.
Composite sample types included general Chemistry, nutrients,
metals, and liquid extraction organics.! One additional grab
sample was collected at each composite site!for phenols, cyanide,
and volatile organic analyses. The sample ;types obtained from
the well-water site were all grab samples for the same analyses
as those collected at the composite sites. .
Field parameters, pH and temperature, were determined for each
grab sample, while pH was determined on each composite sample at
the end of the survey. Flow data was obtained for the two
treated waste streams and the cooling water discharge.
0-12
-------
Plant 12097
Verification Samples
Sample
Location
Tap Water SP6
Tap Water SP6
Tap Water SP6
Tap Water SP6
River Water SP7
River Water SP7
River Water SP7
River Water SP7
Infl Floor SP1
Infl Floor SP1
Infl Floor SP1
Infl Floor SP1
Infl Floor SP1
Infl Floor SP1
Effl Floor SP2
Effl Floor SP2
Effl Floor SP2
Effl Floor SP2
Effl Floor SP2
Effl Floor SP2
Infl DP Well SP3
Infl Dp Well SP3
Infl Dp Well SP3
Infl Dp Well SP3
Effl Dp Well SP4
Effl Dp Well SP4
Effl Dp Well SP4
Effl Dp Well SP4
Effl Dp Well SP4
Effl Dp Well SP4
Tap Water SP6
Tap Water SP6
Tap Water SP6
Tap Water SP6
Tap Water SP6
River Water SP7
River Water SP7
River Water SP7
Sample
Type
Grab
Grab
Grab
Grab
Grab
Grab
Grab
Grab
Grab
Grab
Grab
Grab
Comp
Comp
Grab
Grab
Grab
Grab
Comp
Comp
Grab
Grab
Grab
Grab
Grab
Grab
Grab
Grab
Comp
Comp
Grab
Grab
Grab
Grab
Grab
Grab
Grab
Grab
Pollutants
Analyzed
Phenol
Cyanide
BOD5 - TSS
COD - TOC
Phenol
Cyanide
BOD5. - TSS
COD - TOC
Phenol
Cyanide
Phenol
Cyanide
BOD5. - TSS
COD - TOC
Phenol
Cyanide
Phenol
Cyanide
BOD5. - TSS
COD - TOC
Phenol
Cyanide
BOD5 - TSS
COD - TOC
Phenol
Cyanide
Phenol
Cyanide
BOD5. - TSS
COD - TOC
VGA
VOA (Dup)
VGA (Sup 2)
Extractable
Extrac (Dup)
VOA
VOA (Dup)
VOA (Dup2)
0-13
-------
Plant 12097
Verification Samples (Cont'd.)
Sample
Location
River Water SP7
River Water SP7
Infl Floor SP1
Infl Floor SP1
Infl Floor SP1
Infl Floor SP1
Infl Floor SP1
Infl Floor SP1
InflFloor SP1
Infl Floor SP1
Infl Floor SP1
Infl Floor SP1
Infl Floor SP1
Effl Floor SP2
Effl Floor SP2
Effl Floor SP2
EFfl floor SP2
Effl Floor SP2
Effl Floor SP2
Effl Floor SP2
Effl Floor SP2
Effl Floor SP2
Infl DP Well SP3
Infl Dp Well SP3
Infl DP Well SP3
Infl Dp Well SP3
Infl Dp Well SP3
Effl Dp Well SP4
Effl Dp Well SP4
Effl Dp Well SP4
Effl Dp Well SP4
Effl Dp Well SP4
Effl Dp Well SP4
Effl Dp Well SP4
Effl Dp Well SP4
Effl Dp Well SP4
Tap Water SP6
River Water SP7
Infl Floor SP1
Effl Floor SP2
Infl Dp Well SP3
Effl Dp Well SP4
Sample
Type
Grab
Grab
Grab
Grab
Grab
Grab
Grab
Grab
SB
Comp
Comp
TB
TB
Grab
Grab
Grab
Grab
Grab
Grab
SB
Comp
Comp
Grab
Grab
Grab
Grab
Grab
Grab
Grab
Grab
Grab
Grab
Grab
SB
Comp
Comp
Grab
Grab
Comp
Comp
Grab
Comp
0-14
SB
TB
Pollutants
Analyzed
Extractable
Extrac (Dup)
VOA
VGA (Dup)
VOA (Dup2)
VOA
VOA (Dup)
VOA (Dup2)
Sampler Blnk
Extractable
Extrac (Dup)
VOA
VOA (Dup)
VOA (Pres)
VOA-DUP-PRES
VOA-DP2-PRES
VOA (Pres)
VOA-DUP-PRES
VOA-DP2-PRES
Sampler Blnk
Extractable
Extrac (Dup)
VOA
VOA (Dup)
VOA (Dup2)
Extractable
Extrac (Dup)
VOA
VOA (Dup)
VOA (Dup2)
VOA
VOA (Dup)
VOA (Dup2)
Sampler Blnk
Extractable
Extrac (Dup)
Metals
Metals
Metals
Metals
Metals
Metals
Sampler Blank
Trip Blank
-------
9. Plant 12108
Plant 12108 is a multiple-subcategory (A7 C, D) plant with an
annual average flow of 0.14 MGD. The facility utilizes ocean
disposal of their wastewater; they provide no treatment.
Screening Samples
Point 1 - sample set taken from tank truck loading from holding
tanks.
Samples:
(1) One gallon for extractable organics
(2) Four 1/2-gallon samples for BOD's, metals, cyanides, COD,
and TOC
(3) Two 1-pint samples for phenol and mercury
(4) Two 4-ounce vials for volatile organics
10. Plant 12119
Plant 12119 has fermentation (A) and formulation (B) subcategory
operations. Wastewaters are collected in an equalization tank
and then treated in an activated sludge system.
Screening Samples
Intake Water (EL-OOR) - A grab sample was collected from a tap on
the city water distribution line.
SAD Sample No.
23-04-78C-1783
Date Time Parameter
7/27/78 0940 BOD, COD, TOC, TKN,
NH3-N, N0?-N03, Total P,
solid series, chlorides,
pH, temperature, non-
volatile organics, Hg,
metals, CN, phenol,
volatile organics
Fermentation Wastewater (EL-OOF)—A grab sample was collected at
a tap on the waste broth tanks (C-135). ~
0-15
-------
SAD Sample No.
23-04-78C-1784
Date
7/27/78
Time
0925
Parameter
BOlL COD. TOG. TKN,NH,-N,
Total P, solids series, pH,
Hg, temperature, metals,
non-volatile orqanics, phenol,
CN. volatile orpanics
Ammonia Stripped Wastewater |EL-OON)—A grab sample vtes collected
at a tap on the Ammonia Stripping line.
SAD Sample No.
23-04-78C-1785
Date Time Parameter
7/27/78 0910 BOD, COD, TOC, TKN, NH3-N,
N03-N02, Total P, solids
series, metals, pH, Hg, CN,
temperature, non-volatile
orqanics, VOA, phenol
Influent to Treatment (EL-OOI)—A composite sample was collected
atthe flow eauilization box upstream of any treatment, using an
ISCO 1680
collected.
"automatic sampler. The following samples were
SAD Sample No.
23-04-78C-1565
23-04-78C-1786
23-04-78C-1786
Date
7/6/78
7/26/78
7/27/78
7/27/78
Time Parameter
1505 QC Blank precollected at
the SAD Lab, Athens, GA
noiji-volatile organics,
metals, mercury
!
1000/ BOD, COD, TOC, Total P,
0830 solids series, TKN, NH3-N,
N03-N02, nonvolatile organics,
mercury, metals
0835 cyanide, phenol, pH, tem-
perature, volatile organics
0-16
-------
1]• Plant 12132
Plant 12132 is a combination A and C plant with an annual average
flow of 1.0 MGD. The wastewater treatment consists of
equalization, neutralization, activated sludge and trickling
filter.
Samples Collected
(1) Sedimentation Basin Effluent (Influent to Biotreatment) -
Grab and composite samples taken and analyzed for priority
pollutants.
(2) Final Clarifier Effluents - Grab and composite samples taken
and analyzed for priority pollutants.
No analyses were run for traditional pollutants; however, the
plant did supply these data. Two additional sample points were
identified (final clarifier sludge and DAF skimmings), but were
not sampled in the screening program.
12. Plant 12161 ;
Plant 12161 is a multiple-subcategory (A, C, D) plant with an
annual average flow of 1.0 MGD. The wastewater treatment
employed includes equalization, neutralization, activated sludge
and polishing ponds.
0-17
-------
Screening Samples
Lab No.
Raw Waste-Vitamin C Plant
Nonvolatile Organics, Metals 50689
Phenols, Cyanides, Purgeables 50677
Phenols, Cyanides, Purgeables 50682
Composite Sampler Blank Rinse 50671
Raw Waste-Sulfa Plant
Nonvolatile Organics, Metals 50690
Phenols, Cyanides, Purgeables 50678
Phenols, Cyanides, Purgeables 50683
Composite Sampler Blank Rinse 50672
Raw Waste-Fermentation Plant
Nonvolatile Organics, Metals 50691
Phenols, Cyanides, Purgeables 50679
Phenols, Cyanides, Purgeables 50684
Composite Sampler Blank Rinse 50673
Raw Waste (Combined) to WWTP
Nonvolatile Organics, Metals 50688
Phenols, Cyanides, Purgeables .50676
Phenols, Cyanides, Purgeables 50681
BOD5., TSS, COD 50687
Composite Sampler Blank Rinse 50670
Discharge 001 - Treated from WWTP
Nonvolatile Organics, Metals 50692
Phenols, Cyanides, Purgeables 50680
Phenols, Cyanides, Purgeables 543685
BOD5_, TSS, COD 50693
composite Sampler Blank Rinse 50674
Sample
Type
Compos i te
Grab
Grab
Grab
Compos i te
Grab
'Grab
Grab
Composite
Grab
Grab
Grab
Composite
Grab
Grab
Composite
Grab
Composite
Grab
Grab
Grab
Grab
Flow
(MGD)
1 .45*
0.726*
0.726*
Blank
0.018*
0.009*
0.009*
Blank
0.062
0.028
0.035
Blank
3.74
1 .73
2.01
1 .73
Blank
3.54
1 .78
1 .76
1 .76
Blank
* Estimates
0-18
-------
13. Plant 12204
Plant 12204 is a multiple-subcategory (A, B, C, D) plant with an
annual average flow of 0.20 MGD. This plant employs primary
treatment and pure-oxygen activated sludge for wastewater
treatment.
Sample
Location
Municipal Water
Well WAter
Combined Treated
Process Wastewaters
Combined Raw
Process Wastewaters
Fermentation Processing
Area Discharge
Screening Samples
Sample
Type
Grab
Grab
Grab
Grab
Grab
Grab
Grab
Grab
Composite
Grab
Grab
Grab
Grab
Composite
Grab
Grab
Grab
Grab
Composite
Grab
Grab
Grab
Grab
Pollutants
Analyzed
Non-volatile Organics, Metals
Cyanides/ Phenols
Purgeable Organics
Purgeable Blank
Non-Volatile Organics, Metals
Cyanides/ Phenols
Purgeable Organics
Purgeable Blank
Non-Volatile Organics/ Metals
Composite Sampler Blank Rinse
Cyanides, Phenols
Purgeable Organics
Purgeable Blank
Non-volatile Organics, Metals
Composite Sampler Blank Rinse
Cyanides, Phenols
Purgeable Organics
Purgeable Blank
Non-volatile Organics/ Metals
Composite Sampler Blank Rinse
Cyanides, Phenols
Purgeable Organics
Purgeable Blank
No analyses were made for traditional pollutants; however, the
plant provided data for these pollutants.
14. Plant 12210
Plant 12210 is a multiple-subcategory (B, C) plant with an annual
average flow of 0.01 MGD. The only method of wastewater
treatment utilized by Plant 12210 is an aerated lagoon.
0-19
-------
Screening Samples
Volatile Organics Blank (CL-OOB) — Samples of MJ116Q water from
the Region IV laboratory were returned for analyses.
Sample Number*
23-04-78C-1022
Date
4/25/78
Time
1015
Parameter
Volatile Organics
Process Wastewater at Waste Storage Tanks (CL-OOP) —An ISCO
Model 1580 automatic sampler was used to pump wastewater from
each of the three wastewater storage tanks into a single
composite jug. The following samples were collected.
Date Time Parameter
4/25/78 1025 Quality control blanks
for non-volatile organics,
metals, mercury
4/25/78 1030 Non-volatile organics,
metals, mercury,
TSS, volatile organics,
cyanide, phenols
Influent to Pretreatment System for Sanitary Wastewater (CL-OOI)
—- A single grab sample was collected at ;the influent to the
aeration system. :
Sample Number
23-04-78C-1020
23-04-78C-1021
Sample Number
23-04-78C1024
I •
Date Time Parameter
4/25/78 1055 Nori-volatile organics,
metjals, mercury, volatile
organics, cyanides, phenols,
Bod5_, TSS
Effluent from Pretreatment System for Sanitary Wastewater (CL-
OOE) — A single grab sample was collected at the effluent from
the aeration system. ;
Sample Number
23-04-78C-1023
15. Plant 12231
Date
4/25/78
Time
1100
Parameter
i
Non-volatile organics,
metals, mercury, volatile
organics, cyanide, phenols,
BOD5_, TSS
0-20
-------
a^-- -v- QV'-0o
„ ** W*^ ~
,rt °^ ^*^0^
a^-AtapO ^v a^
-------
-------
Effluent from Wastewater Treatment System (MA-OOE)—An ISCO Model
1680 automatic sampler was installed at the effluent from the
final clarifiers. The intake line was placed in the wastewater
stream. The following samples were collected.
SAD Sample No.
23-04-78C-1142
23-04-78C-1143
23-04-78C-1144
Date Time Parameter
5/9/78 0945 Quality control blank for
non-volatile organics, metals,
mercury
5/9/78 1000 pH
5/9/78 1000 Non-volatile organics, metals,
5/10/78 0930 mercury, BOD5, TSS, TKN, COD
5/10/78 0930 Cyanide, phenols, volatile
organic, pH
Non-contact Cooling Water Discharge (MA-OOC)—An ISCO Model 1580
automatic sampler was installed adjacent to the non-contact
cooling water discharge ditch. The intake line was placed in the
cooling water stream. The following samples were collected.
SAD Sample No.
23-04-78C-1148
23-04-78C-1 149
23-04-78C-1150
Date
5/9/78
5/9/78
5/10/78
Time
1030
1045/
1030
5/10/78 1015
Parameter
Quality control blank for
non-volatile organics, metals,
mercury
non-volatile organics, metals,
mercury
Volatile organics, phenols,
cyanide
Verification Samples
Volatile Organics Trip Blank - Preserved and unpreserved volatile
organic trip blanks (one each) were prepared in Athens EPA Region
IV laboratory prior to the sampling trip. The blanks were left
exposed to ambient conditions and shipped with the organic
samples to the contract laboratory.
SAD Sample No.
Samples shipped
to contract lab
Date
Time
6/21/79 1435
Parameter
Volatile Organics
0-23
-------
Raw Water Supply (MH-OOR) - Raw water was collected from the
facility's well No. 6 at"the discharge side of the well pump.
SAD Sample No. Date Time
Samples shipped 6/26/79 1100
to contract lab
Parameter
volatile organics
Influent to the Waste Treatment System (MH-OOI) - An ISCO Model
1680 automatic sampler was installed at the equalization basin
discharge. The intake line was placed in the wastewater stream
at the overflow ditch. The following samples were collected.
SAD Sample No.
23-04-79C-1571
23-04-79C-1572
Samples shipped to
contract lab
Samples shipped to
contract lab
23-04-79C-1573
23-04-79C-1574
Samples shipped to
contract lab
23-04-79C-1575
23-04-79C-1625
Samples shipped to
contract lab
23-04-79C-1626
Date
6/25/79
6/26/79
6/27/79
6/26/79
6/27/79
6/27/79
6/28/79
6/27/79
6/28/79
6/28/79
6/29/79
Time
1540
0830/
0830
6/26/79 0930
1330
0825
0845/
0830
1345
0830
0840/
0815
6/28/79 1330
6/29/79 0815
Parameter
Quality control blank
for metals sample
mercury
Metals, mercury
pH, temp, volatile
organics
pH, temp, volatile
organics
pH, temp, phenols,
cyanide, volatile organics
BOD, COD, Metals, TKN,
TSS, mercury
Volatile organics
pH, temp, cyanide,
phenols, volatile organics
BOD\COD, Metals, TKN,
TSSf Mercury
Volatile organics
pH, temp, cyanide, phenols,
volatile organics
0-24
-------
Effluent from the Waste Treatment System (MH-OOE)—An ISCO Model
1680 automatic smapler was installed at the final effluent after
secondary clarification. The intake line was placed in the waste
stream at the facility's rectangular weir. The following samples
were collected:
SAD Sample No.
23-04-79C-1576
23-04-79C-1577
Samples shipped to
contract lab
Samples shipped to
contract lab
23-04-79C-1578
23-04-79C-1579
Samples shipped to
contract lab
23-04-79C-1580
23-04-79C-1627
Samples shipped
to contract lab
23-04-79C-1628
Date Time Parameters
6/25/79 1600 Quality control blanks
for metals, mercury
6/26/79 0840- Metals, mercury
6/27/79 0845
6/26/79 0950 pH, temp, volatile
organics
6/26/79 1400 pH, temp, volatile
organics
6/27/79 0900 pH, temp, cyanide,
phenols, volatile organics
6/27/79 0900- BOD, COD, Metals, TKN,
6/28/79 0855 TSS, mercury
6/27/79 1415 Volatile organics
6/28/79 0900 pH, temp, cyanide, phenols
volatile organics
6/28/79 0900 BOD, COD, metals, TKN,
6/29/79 0900 TSS, mercury
6/28/79 1400 Volatile organics
6/29/79 0900 Cyanide, phenols, volatile
organics
0-25
-------
Effluent from Sludge Thickener (MH-OOS) six grab samples were
collected from the sludge thickener (before addition of polymers)
at a discharge line leading from the bottom of the mix tank. The
following samples were collected:
SAD Sample No. Date Time
Samples shipped 6/26/79 1030
Samples shipped 6/26/79 1445
to contract lab
23-04-79C-1569 6/27/79 1000
Samples shipped 6/27/79 1515
23-04-79C-1570 6/28/79 1000
Samples shipped 6/28/79 1430
contract lab
23-04-79C-1629 6/29/79 0945
Parameters
Volatile organics
i
Volatile organics
i
i
Cyahide, metals, volatile
organics, mercury
Voljatile organics
!"•• - • •• ••
Volatile organics, mercury,
metals, cyanide
Voljatile organics
Volatile organics,
metals, mercury
Effluent from the Cyanide Destruct Unit (MH-CN) - Grab samples
were colelcted by facility personnel from a bleedoff value
leading from the cyanide destruct unit effluent. The following
samples were collected.
SAD Sample No.
23-04-79C-1566
23-04-79C-1567
23-04-79C-1568
Date Time Parameters
6/26/79 1600 Cyanide
6/27/79 1030 Cyanide
i
6/28/79 1030 Cyanide
In-line Process from Factory !_ (NH-IP) - In-line process samples
were collected from the production of acrylonitrile by facility
personnel. The following samples were collected.
SAD Sample No.
23-04-79C-1565
Date
6/27/79
Time
1500
Parameters
COD, cyanide, metals, TKN,
extractable organics,
phenols, TSS, volatile,
organics, mercury
0-26
-------
17. Plant 12248 ;
Plant 12248 is a single subcategory (D) plant with an annual
average flow of 0.04 MGD. Wastewater treatment employed includes
equalization and activated sludge.
Screening Samples
(1)
(2)
Equalization Basin (Influent to treatment) - All samples
taken were 24-hour composites and were analyzed for priority
pollutants.
Final Clarifier (Effluent from treatment) - All samples
taken were 24-hour composites and were analyzed for priority
pollutants.
No traditional pollutant data were available for this plant.
18. Plant 12256
Plant 12256 is a multiple-subcateogry (A, B, C, D) plant with an
annual average flow of 30 MGD. End-of-pipe treatment is limited
to equalization, neutralization and solids removal.
Screening Samples1
(1) Well area before discharge through outfall #001
(2) Split Manhole discharging to outfall t002
(3) Manhole prior to discharge to outfall #003
(4) Skimming basin discharging to outfall f008
(5) Collection basin discharge to skimming basin
(6) Municipal sewers pumping station
(7) Freshwater supply
(8) Saltwater supply
In general, composite samples (24 hour) were taken for priority
pollutants other than phenols, cyanides, and volatile organics,
for which grab samples were taken.
19. Plant 12257
Plant 12257 is an A, B, C, and D subcategories plant. A
treatment system composed of neutralization, equalization, and
0-27
-------
activated sludge is used to treat 0.5 MGD o£ wastewater prior to
discharge to a POTW.
A summary of sample points and parameters analyzed for are
presented below.
Screening Samples
Combined plant process wastes after neutralization and activated
sludge treatment. ,
Date
10/24/77
10/25/77
10/25/77
10/26/77
1 0/26/77
10/26/77
Combined
Date
1 0/24/77
1 0/25/77
Time
0940
0900
0900
0820
0820
0923
Plant
Time
0950
0925
Description
i
Tubing flush blank
Set of grab samples for phenol/
cyanide, volatile organics
24-hour automatic composite
i
i
Set of grab samples for phenol,
cyanide, and volatile organics
24-hour automatic composite
Set of grab samples for phenol,
cyanide, volatile organics, and
a 2 1/2-gallon grab sample
Process Wastes After Neutralization
Description
Tubing flush blank
Set of grab samples for !phenol,
10/26/77
10/26/77
0830
0830
cyanide, volatile organics, and
a 2 1/2-gallon grab sample
Set of grab samples for phenol,
cyanide, and volatile organics
24-hour automatic composite
0-28
-------
Raw Fermentation Process Wastes
Date
Time
10/24/77 1005
10/25/77 mo
10/25/77 .1110
10/26/77 0855
10/26/77 0855
10/26/77 0940
Description
Tubing flush blank
Set of grab samples for phenol,
cyanide, and volatile organics
24-hour automatic composite
Set of grab samples for phenol,
cyanide, and volatile organics
24-hour automatic composite
Set of grab samples for phenol,
cyanide, volatile organics, and
a 2 1/2-gallon grab sample
Raw Chemical Synthesis Process Wastes
Date
Time
10/24/77 1015
10/25/77 1130
10/26/77 0905
10/26/77 0905
10/26/77 0910
Description
Tubing flush blank
Set of grab samples for phenol,
cyanide, volatile organics, and
a 2 1/2-gallon grab sample
Set of grab samples for phenol,
cyanide, and volatile organics
24-hour automatic composite
Set of grab samples for phenol,
cyanide, volatile organics, and
a 2 1/2-gallon grab sample
Cooling Water Discharge at Bypass Line
Date Time Description
10/24/77 1040
Set of grab samples for phenol,
cyanide, volatile organies, and
a 2 1/2-gallon grab sample
0-29
-------
Municipal Water Supply
Date
10/25/77
10/25/77
Time
1500
1500
Description
Flow measurement
Set of grab samples for phenol,
cyanide, volatile organics, and
a 2 1/2-gallon grab sample
Volatile Organics Blank
Description
Volatile organics blank
Date Time
10/25/77 1510
Plant 12311
20. Plant 12342 l
i • . . .
Plant 12342 is an A, C, and D subcategories plant which
discharges 1.06 MGD of process wastewater without pretreatment to
a POTW. Below, is a table of sample points and sampled
parameters for this plant.
Discharge from Manhole No. 1*
Extractables (NVOA)
Sampler Blank (flush)
Metals**, Phenols, Cyanides,
purgeables (VOA)
BOD, TSS, COD
Discharge from Manhole No. 5*
Extractables (NVOA)
Sampler Blank (flush)
Metals**, Phenols,
cyanides, Purgeables (VOA)
BOD, TSS, COD
Discharge from Manhole No. 5*
Extractables (NVOA)
Sampler Blank (flush)
Metals**, Phenols,
cyanides, Purgeables (VOA)
BOD, TSS, COD
Super "Q" Blank
Sample Type
Composite
[ Grab
3 Grabs
"• Composite
l
Sample Type
| Composite
I Grab
j 3 Grabs
i
i Composite
i ., ,
Sample Type
Composite
Grab
3 Grabs
Composite
i
', Sample Type
0-30
-------
Extractables (NVOA)
Purgeables (VGA)
Potable Water - Building 28
Extractables {NVOA)
Purgeables (VOA)
Grab
Grab
Sample Type
Grab
Grab
Lab No
Sample Type
Potable Water - Building No. 1
Extractables (NVOA) 2082
Purgeables (VOA) 2082
Potable Water - Building No. 5
Extractables (NVOA) 2083
Purgeables (VOA) 2083
Potable Water - Building No. 20A
Extractables (NVOA) 2084
Purgeables (VOA) 2084
Grab
Grab
Grab
Grab
Grab
Grab
21. Plant 12411
Plant 12411 is a B, C, and D subcategories plant. Wastewater
from the process area is treated with neutralization,
equalization, and aeration, then combined with sanitary waste and
once-through cooling water, and then discharged to a sanitary
sewer. The flow of process wastewater is 0.35 MGD.
The sample points and pollutants sampled for are presented below.
Screening Samples
Influent to Pretreatment System ™ An ISCO Model 1680 automatic
sampler was installed at the pretreatment system influent. The
intake line was placed in the equalization basin, the following
samples were collected.
0-31
-------
Date
Time
Parameters
4/26/78 0945
4/26/78 1100
4/26/78
4/27/78
1045
0945
4/27/78 0945
Quality control blank
for non-volatile o|rganics,
metals, mercury ;
Temperature, pH ;
Non-volatile organics,
metals, mercury, TSS BOD5_,
total phosphorus
Volatile organics, cyanide,
phenols, temperature, pH
Effluent from Pretreatment System—An ISCO Model 1680 automatic
sampler was installed at the pretreatment system effluent. The
intake line was placed in the mid-channel upstream fron the
V-notch weir. The following samples were collected.
Date
Time
4/26/78 1000
4/26/78 1045
4/27/78 0930
4/26/78 1100
4/27/78 0930
Parameters
Quality control blank for
non-volatile organics, metals,
mercury
Non-volatile organics,
mercury, TSS, BOD5_
phosphorus
Temperature, pH
metals,
total
Volatile organics, cyanide,
phenols, temperature, pH
Combined Sanitary Cooling Water and Pretreated Process Wastewater
at Access Pit —An ISCO Model 1680 automatic sampler was
installed at the "access pit." The intake line was places in the
waste stream at
were collected.
the bottom of the pit. The following samples
4/26/78
4/27/78
1100
1015
Parameters
Quality control blank for
non-volatile organics, metals
mercury
Non-volatile organics, metals,
mercury, TSS, BOD5_> total
phosphorus
0-32
-------
4/26/78
4/27/78
1 100
1015
Temperature, pH
Volatile organics, cyanide,
phenols, temperature, pH
Plant 12411
Verification Samples
Volatile Organic Blanks (VOA) — A trip blank consisting of well
water was placed in a preserved and unpreserved VOA bottle and
carried into the field.
SAD Sample No
79C-1502
Date
6/7/79
Time
0900
Parameters
VOA
Effluent from Aeration Basins (BS-001E) — An ISCO Model 1680
automatic sampler was installed at the discharge weir box from
the aeration basins and collected the following samples:
SAD Sample No
79C-1578
79C-1519
79C-1520
79C-1521
Sample sent to
contract lab
79C-1522
79C-1523
Sample sent to
contract lab
79C-1524
Date
6/12/79
6/12/79
6/13/79
Time
1130
1200
1130
6/13/79 1130
6/13/79
6/14/79
1 130
1100
6/13/79 1325
6/14/79
6/14/79
6/15/79
1100
1100
1000
6/14/79 1130
6/15/79
1000
Parameters
Quality control blanks
for non-volatile organics,
metals, mercury
Non-volatile organics,
metals, mercury, COD, TSS
VOA, phenol, cyanide
Non-volatile organics,
metals, mercury, COD, TSS
VOA
VOA, phenol, cyanide
Non-volatile organics,
metals, mercury, COD,
BOD5_, TSS
VOA
VOA, phenol, cyanide
Influent to Aeration Basins Collected from Holding/Mix Basin
(BW-001I) —An ISCO Model 1680 automatic sampler was installed in
0-33
-------
•, .Jit: 'tifS!1: 1!;i|!-tt:;:":*J|!111!
the holding basin before aeration.
collected:
SAD Sample No
79C-1504
79C-1505
79C-1506
79C-1507
Sample sent to
contact lab
79C-1508
79C-1509
Sample sent to
contract lab
79C-1510
Date
6/12/79
6/12/79
6/13/79
6/13/79
6/13/79
6/14/79
6/14/79
6/15/79
Time
1115
1230
1015
1015
1100
1030
6/13/79 1335
6/14/79 1030
1030
0920
6/14/79 1145
6/15/79 0930
The following samples were
Parameters
Quality control blanks
for non-volatile organics,
metaljB, mercury
Non-volatile organics,
metals, mercury, COD, TSS
VOA, phenol, cyanide
Non-volatile organics, metals,
mercury, COD, TSS
VOA |
VOA, phenol, cyanide
Non-volatile organics,
metals, mercury, COD, BODS,
TSS
VOA
VOA, phenol, cyanide
Barometric Condenser Mix Basin (BW-002I) — Art ISCO Model 1680
automatec sampler was installed in the mix basin and collected
the following samples:
0-34
-------
SAD Sample No
79C-1511
79C-1512
79C-1513
79C-1514
Sample sent to
contract lab
79C-1515
79C-1517
Sample sent to
contract lab
79C-1517
Date
6/12/79
6/12/79
6/13/79
Time
1145
1215
1100
6/13/79 1100
6/13/79
6/14/79
1115
1000
6/13/79 1320
6/14/79
6/14/79
6/15/79
1000
1000
0900
6/14/79 1140
6/15/79
0900
Parameters
Quality control blanks
for non-volatile organics,
metals, mercury
Non-volatile organics,
metals, mercury, COD,TSS
VGA, phenols, cyanide
Non-volatile organics,
metals, mercury, COD, TSS
VGA
VOA, phenol, cyanide
Non-volatile organics,
metals, mercury, COD, BOD5_
TSS
VOA
VOA, phenol, cyanide
Raw Water Sample (BS-RW) — A grab sample was collected from the
City of Greenville water supply from a tap in the wastewater
treatment plant laboratory.
SAD Sample No
79C-1503
Date
6/12/79
Time
1430
Parameters
Non-volatile organics,*
metals, mercury, phenol,
VOA,* cyanide
*The VOA and non-volatile organics samples were shipped to the
contract lab; the metals, COD, BOD5_ and TSS samples were taken to
the Revion IV, US-EPA Laboratory, Athens, Georgia.
22. Plant 12420
Screening Samples
Plant 12420 is a subcategory B, D plant. The wastewater flow of
0.17 MGD from this plant is pretreated with an aeration pond
followed by a secondary clarifier, then discharged to a private
wastewater treatment facility.
0-35
-------
The sample points and pollutants analyzed for are tabulated
below. !
VOA Pest. Base Neut.
Acid
Effluent to pretreatment plant x x x x
Effluent from Sec. clarifier x x , x x
Effluent at manhole x x x x
Intake water x x x x
23. Plant 12439
Screening Samples
Plant 12439 is a C and D subcategories plant. A flow of 0.01 MGD
is reported for this plant/even though this plant is classified
as a zero discharger. This flow arises from wastewater which is
discharged to an irrigation system after neutralization,
settling, activated sludge, and lagooning.
\
Two sampling points were used during the screening visit: the
industrial stream influent and the secondary clarifier effluent.
The secondary clarifier effluent contains treated wastewater from
the industrial stream influent and sanitary wastewater. These
two streams were sampled for priority and traditional pollutants.
24. Plant 12447 ;
Screening Samples
Plant 12447 is an A, B, C, and D subcategories plant which
discharges 1.5 MGD of wastewater. ; This plant produces
non-pharmaceuticals. Wastewater is dischariged without treatment
to a POTW except for some very concentrated; wastes which are deep
welled.
i, , „, ,, , ,
The following table lists dates, times, and parameters sampled
for at the various sampling sites. I
0-36
-------
0-
-------
Co,
-------
8/9/78
8/9/78
8/9/78
8/9/78
1105
1450
1437
1437
1437
25. Plant 12462
A 3-grab composite for
extractable organics,
metals, BOD, and COD
Grab for VOA
Grab for phenol
Grab for cyanide
pH and temperature
measured 6.5 and 21°C
Organic free water used
in field to pump through
samplers for sampler blanks.
Also used direct for reagent
blanks for phenol and cyanide
and as VOA trip blanks
Plant 12462 is a Subcategory A plant which discharges to an
aerated lagoon 0.3 MGD from pharmaceutical manufacture.
Non-pharmaceutical products are also produced at this plant.
Six sample sites were selected during the screening visit. Grab
samples were taken from the intake water and backwash lagoon
discharge. Composite samples were obtained of the phamaceutical
manufacturing influent to the aerated lagoon the total influent
to the aerated lagoon, the effluent from the final clarifier, and
the final plant effluent. Pollutants analyzed for include the
traditional pollutants and priority pollutants.
The table shown below gives a breakdown of the samples taken and
pollutants sampled for:
Screening Samples
9/19/77
9/20/77
9/20/77
Time
1510
0850
1200
1240
Flow
(gallons)
29,400
Parameters
Organics (sampler blank)
Priority pollutants, BOD,
pH, COD, NFS, nutrients
Volatile organics,
phenolics, cyanide
0-39
-------
Combined influent to aerated lagoon
Date Time Temp °C
9/20/77
9/21/77
9/21/77
1230
1025
1025
30
Parameters
i
Priority pollutants/ pH,
BOD, COD, NFS, nutrients
Volatile organics,
phenolics, cyanide
Biological waste treatment system effluent
9/19/77 1540
9/19/77 1550
9/20/77 11 45
9/20/77 1230
9/20/77 1200
9/21/77 1020
9/21/77 1020
9/21/77 1200
Plant outfall
Date Time
9/1 9/77 1 545
9/19/77 1600
9/20/77 1150
9/20/77 1230
9/21/77 1015
26. Plant 12999
21
21
Temp
25
Organics (sample blank)
Priority pollutants, pH,
BOD5, COD, NFS, nutrients
volatile organics,
phenolics, cyanide
Priority pollutants, Ph,
BOD5_,; COD, NFS, nutrients
Volatile organics,
phenolics, cyanide
Priority pollutants, pH,
BOD5, COD, NFS, Nutrients,
phenolics, volatile organics,
cyanide
Parameters
I
Organics (sampler blank)
Priority pollutants, pH
BOD5_, COD, NFS, nutrients
i
Volatile organics,
phenolics, cyanide
Priority pollutants, pH,
BOD5_, COD, NFS, Nutrients
volatile organics,
phenolics, cyanide
0-40
-------
Screening Samples
Plant 12999 is a subcategories C and D plant which discharges
0.45 MGD of wastewater to a municipal treatment plant.
The Plant 12999 wastewater treatment facility currently consists
of a primary clarifier and an equalization pond. However, the
plant is performing bench scale treatability studies to determine
the effectiveness of activated sludge and powdered activated
carbon on its wastewater. The activated sludge unit effluents
and the powdered activated carbon unit effluents were two of the
sample points during the screening visit. The other two sample
points were the raw waste feed to the bench scale units and the
equalization pond effluent which is discharged to the POTW. The
parameters sampled for were the traditional pollutants and
priority pollutants.
0-41
-------
-------
APPENDIX P
English Units to Metric Units Conversion Table
-------
L ,,,
-------
APPENDIX P
ENGLISH UNITS TO METRIC UNITS CONVERSION TABLE
Multiply (English Units)
English Unit
acre
acre-feet
British Thermal
Unit
British Thermal
Unit/pound
cubic feet
per minute
cubic feet
per second
cubic feet
cubic feet
cubic inches
degree Farenheit
feet
gallon
gallon per
minute
pounds per
square inch
ac
ac ft
BTU
BTU/lb
cfm
cfs
cu ft
cu ft
cu in
°F
ft
gal
gpm
psi
By To Obtain (Metric Units)
Conversion Metric Unit
0.405
1233.5
0.252
0.555
0.028
1 .7
0.028
28.32
16.39
0.555(F-32)*
0.3048
3.785
0.0631
0.06803
ha
cu m
kg cal
kg cal/
kg
cu m/
min
cu m/
min
cu m
1
cu cm
°c
m
1
I/sec
atm
hectares
cubic meters
Kilogram-
calories
kilogram
calories per
kilogram
cubic meters
per minute
cubic meters
per minute
cubic meters
liters
cubic centi-
meters
degree Centi
grade
meters
liter
liters per
second
atmospheres
(absolute)
* Actual conversion, not a multiplier
P-l
*U.S. G07EHSMENT PRINTING OFFICE : 1982 0-381-085/4484-
-------
------- | |